data_6nhy_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6nhy _Structure_validation_residue.Date_analyzed 2019-02-22 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.521 3.085 0 N-CA-C 109.979 -0.378 . . . . 479.91 109.979 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.41 -50.64 9.53 Favored Glycine 0 N--CA 1.511 3.681 0 CA-C-N 115.78 -0.645 . . . . 221.67 113.236 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -66.48 -37.48 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.596 0.698 . . . . 706.9 111.002 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.89 -41.86 92.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 C-N-CA 122.59 0.356 . . . . 633.01 110.488 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.58 -45.02 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 O-C-N 121.665 -0.647 . . . . 298.69 109.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.17 -40.56 86.61 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 114.482 1.29 . . . . 999.99 114.482 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.7 -31.57 40.2 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.227 0 CA-C-N 119.076 0.853 . . . . 351.49 111.209 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.6 p -69.52 -48.63 59.85 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.419 0.688 . . . . 84.92 110.282 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.89 -34.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.192 0 CA-C-N 115.296 -0.865 . . . . 419.9 109.09 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.83 72.88 Favored 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 123.278 0.631 . . . . 172.75 111.039 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.68 68.88 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 115.801 -0.636 . . . . 133.81 111.121 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.62 -45.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 C-N-CA 123.422 0.689 . . . . 127.72 111.716 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.78 -32.83 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 CA-C-N 118.332 0.514 . . . . 521.39 110.432 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 49.6 tp -63.98 -36.16 83.06 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.482 0.713 . . . . 316.63 112.194 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.8 -52.64 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 122.838 0.455 . . . . 300.01 110.357 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.2 -37.5 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 O-C-N 121.807 -0.558 . . . . 384.53 112.162 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.23 85.35 Favored 'General case' 0 N--CA 1.536 3.836 0 N-CA-C 112.818 0.673 . . . . 153.06 112.818 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 -34.28 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.648 0 N-CA-C 109.838 -0.431 . . . . 357.19 109.838 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -69.76 -42.59 73.65 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 109.647 -0.501 . . . . 719.11 109.647 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.46 -31.96 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.3 0.64 . . . . 610.06 109.474 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.7 t -65.07 -39.37 93.13 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.188 0.595 . . . . 404.36 110.467 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.67 -33.02 53.52 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.645 0.778 . . . . 999.99 110.328 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 77.8 p -63.42 -24.1 67.69 Favored 'General case' 0 N--CA 1.533 3.698 0 CA-C-O 120.9 0.381 . . . . 406.88 110.409 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.93 -33.16 30.49 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 124.094 0.958 . . . . 836.08 109.577 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 47.0 tp . . . . . 1 N--CA 1.54 4.026 0 C-N-CA 124.619 1.167 . . . . 952.15 111.832 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.524 3.234 0 CA-C-O 120.843 0.354 . . . . 459.36 111.41 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.3 -35.82 56.22 Favored Glycine 1 N--CA 1.517 4.047 0 CA-C-N 115.444 -0.798 . . . . 156.55 111.417 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.6 mm -65.87 -36.92 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.747 0.819 . . . . 509.04 110.187 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -65.72 -40.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.59 0 C-N-CA 123.151 0.58 . . . . 522.79 109.834 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 83.4 mt -70.08 -38.33 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.421 0.688 . . . . 339.37 109.302 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -62.04 -47.44 84.72 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.504 0.927 . . . . 999.99 113.504 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 15.2 m -59.24 -27.86 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 O-C-N 122.28 -0.262 . . . . 439.1 111.223 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.0 p -66.23 -48.22 71.26 Favored 'General case' 0 N--CA 1.535 3.816 0 CA-C-O 121.39 0.614 . . . . 106.26 110.368 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.13 -51.61 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 CA-C-N 115.281 -0.872 . . . . 361.56 109.076 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.23 -34.69 61.27 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 122.889 0.476 . . . . 142.95 111.545 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.86 92.38 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 122.717 0.407 . . . . 115.72 111.166 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 80.5 t -69.75 -46.74 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 N-CA-C 109.471 -0.566 . . . . 251.43 109.471 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.5 -33.81 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.281 0.632 . . . . 426.62 110.192 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.27 -39.46 92.64 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.778 0.431 . . . . 324.0 110.632 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.01 -46.91 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 109.042 -0.725 . . . . 295.24 109.042 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.25 -36.73 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.199 1.0 . . . . 347.1 111.344 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.0 -31.59 67.08 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.72 0.637 . . . . 136.6 112.72 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.97 -44.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 CA-C-N 118.473 0.579 . . . . 338.63 109.661 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -66.06 -42.62 89.21 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 122.842 0.457 . . . . 652.28 110.202 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.08 -38.73 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 N-CA-C 109.509 -0.552 . . . . 530.36 109.509 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.13 -48.48 67.97 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.003 0.521 . . . . 422.11 111.418 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.73 -42.12 70.97 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.601 0.76 . . . . 999.99 111.112 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 98.4 p -63.8 -13.33 43.29 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 119.228 -0.415 . . . . 357.85 111.308 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -37.94 12.99 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.704 0.801 . . . . 999.99 109.214 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.531 3.623 0 C-N-CA 123.329 0.652 . . . . 784.75 110.728 -178.614 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 N--CA 1.525 3.306 0 CA-C-O 120.472 0.177 . . . . 803.81 110.887 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -70.2 -22.52 62.93 Favored 'General case' 0 N--CA 1.52 3.033 0 C-N-CA 122.889 0.476 . . . . 591.55 109.996 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.4 -50.73 9.39 Favored Glycine 0 N--CA 1.512 3.751 0 CA-C-N 115.926 -0.579 . . . . 143.79 113.157 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.0 tp -66.41 -37.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 117.481 0.641 . . . . 552.88 110.918 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.62 -41.08 88.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 C-N-CA 122.617 0.367 . . . . 670.5 110.189 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.42 -38.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 109.37 -0.604 . . . . 381.83 109.37 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.49 -46.38 83.25 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.995 1.109 . . . . 999.99 113.995 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.85 -27.89 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.966 0 CA-C-N 118.133 0.424 . . . . 410.68 111.424 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 23.9 p -69.79 -48.22 59.99 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-O 121.401 0.62 . . . . 97.17 110.227 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.96 -47.72 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 CA-C-N 115.321 -0.854 . . . . 375.31 108.967 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.62 56.12 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.246 0.618 . . . . 136.07 111.504 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.21 -44.01 85.08 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 122.969 0.508 . . . . 130.67 110.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.11 -41.55 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.323 0.649 . . . . 278.98 109.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.58 -35.28 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.396 0.678 . . . . 439.4 109.935 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.4 -42.41 96.12 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.989 0.516 . . . . 228.94 111.953 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.27 -51.3 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 C-N-CA 123.186 0.594 . . . . 310.41 111.196 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.31 -36.85 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 112.751 0.648 . . . . 362.96 112.751 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.11 -44.71 87.84 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.281 0.845 . . . . 164.95 113.281 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 30.0 m -59.45 -34.69 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 CA-C-N 118.69 0.677 . . . . 308.08 110.594 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -71.32 -42.26 68.82 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 109.615 -0.513 . . . . 644.67 109.615 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.82 -40.03 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 N-CA-C 109.153 -0.684 . . . . 411.19 109.153 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.4 m -67.09 -40.25 86.92 Favored 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 109.525 -0.546 . . . . 351.75 109.525 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.528 3.448 0 C-N-CA 123.71 0.804 . . . . 999.99 110.139 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.524 3.272 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.54 -50.07 70.3 Favored Glycine 0 N--CA 1.514 3.899 0 CA-C-N 114.808 -1.087 . . . . 0.0 114.477 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.7 tp -58.72 -35.91 57.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 CA-C-N 117.863 0.831 . . . . 0.0 110.61 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.64 -34.48 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.077 0.551 . . . . 0.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.69 -45.11 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -67.19 -46.36 74.15 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.71 -40.63 76.56 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 49.9 p -64.75 -49.22 71.64 Favored 'General case' 0 N--CA 1.528 3.43 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.24 -31.59 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.71 71.59 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.825 0.45 . . . . 0.0 111.928 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.88 70.87 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.48 0.312 . . . . 0.0 111.418 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -68.68 -50.93 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 123.514 0.726 . . . . 0.0 111.502 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.29 -31.89 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 122.064 -0.397 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -47.14 66.4 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 123.561 0.744 . . . . 0.0 110.889 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.5 mm -67.77 -42.95 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 C-N-CA 122.794 0.438 . . . . 0.0 110.437 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.4 -39.69 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.576 0.75 . . . . 0.0 111.756 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.27 85.86 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.71 0.404 . . . . 0.0 111.981 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.63 -33.58 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.76 -42.82 99.48 Favored 'General case' 0 N--CA 1.538 3.966 0 C-N-CA 123.245 0.618 . . . . 0.0 110.903 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.96 -32.63 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.955 0.502 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.23 -45.1 89.68 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 122.903 0.481 . . . . 0.0 111.401 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.67 -37.31 73.67 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.222 0.609 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.2 t -63.87 -28.77 70.07 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.414 0.686 . . . . 0.0 111.82 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 59.9 tp -73.74 -37.54 65.03 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 123.688 0.795 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.528 3.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.864 -178.289 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.518 2.934 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.44 -50.6 8.06 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.327 0.489 . . . . 0.0 113.912 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.87 -41.03 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.18 -34.04 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 118.874 0.761 . . . . 0.0 111.745 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.37 -44.83 99.63 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.085 0 CA-C-O 120.985 0.421 . . . . 0.0 110.174 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -61.22 -36.9 81.19 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.501 0.72 . . . . 0.0 111.983 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 -36.39 63.17 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.206 0 CA-C-N 118.343 0.52 . . . . 0.0 111.29 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' THR . . . . . 0.455 ' HG1' ' H ' ' B' ' 220' ' ' VAL . 10.2 p -66.67 -49.8 64.99 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . 0.455 ' H ' ' HG1' ' B' ' 219' ' ' THR . 8.3 p -71.34 -31.9 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.79 79.68 Favored 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 122.768 0.427 . . . . 0.0 111.217 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.36 69.31 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 122.936 0.494 . . . . 0.0 112.106 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.59 -43.07 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.493 0 C-N-CA 123.453 0.701 . . . . 0.0 111.973 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.88 -32.59 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 CA-C-N 118.7 0.682 . . . . 0.0 110.36 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.77 -38.7 75.91 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.172 0.589 . . . . 0.0 111.24 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.11 -52.09 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 CA-C-O 122.04 0.924 . . . . 0.0 109.621 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.59 -36.4 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 C-N-CA 126.02 1.728 . . . . 0.0 113.135 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.47 66.35 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.29 -38.1 76.98 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 118.971 0.805 . . . . 0.0 110.218 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.48 -41.98 75.41 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.112 0.565 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.46 -33.57 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 C-N-CA 122.914 0.486 . . . . 0.0 110.128 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.6 m -67.52 -44.38 78.53 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 121.576 0.703 . . . . 0.0 109.674 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.66 -27.07 65.66 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 124.59 1.156 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.5 t -67.51 -15.85 63.89 Favored 'General case' 0 N--CA 1.52 3.047 0 C-N-CA 123.138 0.575 . . . . 0.0 111.972 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.22 -37.31 13.4 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.57 0.748 . . . . 0.0 111.468 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.537 3.923 0 C-N-CA 123.025 0.53 . . . . 0.0 110.34 -177.664 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.528 3.43 0 CA-C-O 120.572 0.225 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 -20.56 62.82 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.275 0.63 . . . . 0.0 109.91 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.29 58.6 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 124.053 0.835 . . . . 0.0 114.109 -177.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.5 tt -61.07 -35.57 66.38 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 CA-C-N 117.844 0.822 . . . . 0.0 110.513 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.4 mm -54.71 -33.96 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 C-N-CA 123.401 0.68 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 34.8 mm -69.26 -41.9 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 CA-C-O 121.262 0.553 . . . . 0.0 109.573 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -66.03 -42.45 89.59 Favored 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -57.94 -32.94 44.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.341 0 CA-C-N 119.354 0.979 . . . . 0.0 111.329 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 -48.45 72.36 Favored 'General case' 0 N--CA 1.531 3.608 0 C-N-CA 123.586 0.754 . . . . 0.0 110.979 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.18 -36.92 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.39 0 C-N-CA 123.781 0.832 . . . . 0.0 109.434 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.61 77.27 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 123.442 0.697 . . . . 0.0 111.221 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.97 -38.27 79.27 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 123.131 0.573 . . . . 0.0 112.099 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.19 -46.24 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 C-N-CA 122.729 0.411 . . . . 0.0 111.479 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.16 -32.51 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.643 0 CA-C-N 118.331 0.514 . . . . 0.0 110.305 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 55.0 tp -59.21 -43.59 92.26 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 122.983 0.513 . . . . 0.0 110.78 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.36 -54.13 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.12 -37.19 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.621 1.168 . . . . 0.0 114.082 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.0 71.82 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 119.223 0.92 . . . . 0.0 110.925 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.28 -41.93 72.76 Favored 'General case' 0 N--CA 1.53 3.568 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.01 -35.57 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.55 -48.09 67.97 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.139 0.576 . . . . 0.0 111.748 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 28.7 pttt . . . . . 0 N--CA 1.537 3.88 0 C-N-CA 123.485 0.714 . . . . 0.0 111.643 -177.467 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.522 3.141 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.62 -37.4 77.3 Favored Glycine 1 N--CA 1.517 4.088 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.685 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.24 -38.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 C-N-CA 124.45 1.1 . . . . 0.0 110.593 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.08 -38.31 79.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.0 mt -70.11 -37.43 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.08 -47.92 83.47 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.46 -30.93 37.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.395 0 CA-C-N 118.41 0.55 . . . . 0.0 112.218 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -72.2 -48.11 45.62 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 123.47 0.708 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.45 -31.95 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.32 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.24 -34.96 64.45 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.96 -45.47 64.08 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-O 121.162 0.506 . . . . 0.0 111.887 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.15 -38.43 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.886 0.875 . . . . 0.0 112.693 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.44 -32.59 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 CA-C-N 119.334 0.97 . . . . 0.0 111.667 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.05 -47.83 75.97 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.92 -44.96 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.52 -41.08 85.52 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.25 0 CA-C-N 119.53 1.059 . . . . 0.0 112.986 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.34 -43.47 92.74 Favored 'General case' 0 N--CA 1.53 3.549 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.86 -34.54 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.16 -42.36 69.19 Favored 'General case' 1 N--CA 1.539 4.005 0 CA-C-N 118.831 0.741 . . . . 0.0 109.819 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.25 -34.96 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.572 0.749 . . . . 0.0 109.792 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.92 -43.13 84.07 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.282 0.633 . . . . 0.0 111.012 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 123.9 0.88 . . . . 0.0 111.273 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.76 -16.23 60.65 Favored 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 123.215 0.606 . . . . 0.0 111.814 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 mt -91.21 -37.59 13.23 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.854 0.861 . . . . 0.0 111.308 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 1 N--CA 1.541 4.086 0 C-N-CA 123.489 0.716 . . . . 0.0 110.589 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 N--CA 1.528 3.437 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -49.23 14.87 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 124.202 0.906 . . . . 0.0 113.17 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -36.64 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.347 0 C-N-CA 123.262 0.625 . . . . 0.0 110.163 -177.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.41 -34.09 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 21.1 mm -67.29 -40.62 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 CA-C-O 121.386 0.612 . . . . 0.0 109.958 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -64.63 -46.42 82.64 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 m -62.56 -34.13 63.33 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 CA-C-N 118.495 0.589 . . . . 0.0 112.334 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 66.8 p -66.36 -49.22 67.65 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.119 0.568 . . . . 0.0 112.192 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.76 -37.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.62 88.09 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 122.582 0.353 . . . . 0.0 110.713 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.73 95.68 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 122.962 0.505 . . . . 0.0 111.817 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.3 -45.34 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.5 -32.93 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 C-N-CA 123.689 0.795 . . . . 0.0 109.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.8 tp -60.51 -40.82 92.83 Favored 'General case' 0 N--CA 1.535 3.783 0 C-N-CA 122.739 0.415 . . . . 0.0 110.577 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.46 -53.83 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.494 0.664 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.52 -37.96 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 124.208 1.003 . . . . 0.0 113.054 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.64 90.61 Favored 'General case' 1 N--CA 1.54 4.038 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.25 -34.34 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 C-N-CA 122.942 0.497 . . . . 0.0 109.883 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -43.25 79.87 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 122.657 0.383 . . . . 0.0 111.582 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.09 -31.65 51.03 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.47 0.577 . . . . 0.0 110.31 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.68 -45.03 93.31 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.152 0.581 . . . . 0.0 111.982 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -70.35 -24.87 63.05 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.169 0.587 . . . . 0.0 111.592 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.532 3.671 0 CA-C-N 118.413 0.552 . . . . 0.0 110.503 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.3 -14.33 31.03 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.645 1.178 . . . . 0.0 110.406 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.6 tp . . . . . 0 N--CA 1.536 3.857 0 CA-C-N 118.405 0.548 . . . . 0.0 111.425 -176.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.523 3.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -68.81 -34.14 75.03 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.931 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.53 -31.14 65.76 Favored Glycine 0 N--CA 1.514 3.897 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.406 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.86 -36.69 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 123.856 0.862 . . . . 0.0 110.46 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.06 -36.32 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 123.197 0.599 . . . . 0.0 109.649 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.51 -39.09 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -64.04 -41.75 97.3 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.45 -27.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-N 118.842 0.746 . . . . 0.0 111.486 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -68.54 -49.42 59.69 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.89 -38.44 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.75 68.29 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 123.038 0.535 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.41 91.67 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.155 0.582 . . . . 0.0 111.395 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.03 -43.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.723 0.809 . . . . 0.0 109.166 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -32.91 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 C-N-CA 123.953 0.901 . . . . 0.0 109.785 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -47.43 79.53 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.3 -55.86 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 19.9 m -68.35 -38.38 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.83 Favored 'General case' 0 N--CA 1.534 3.732 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.32 -34.73 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.884 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.87 -42.63 69.81 Favored 'General case' 1 N--CA 1.539 4.006 0 CA-C-N 119.559 1.072 . . . . 0.0 111.419 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 32.3 m -68.63 -31.24 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 122.066 -0.396 . . . . 0.0 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.21 -48.19 81.11 Favored 'General case' 0 N--CA 1.523 3.208 0 C-N-CA 123.203 0.601 . . . . 0.0 111.615 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.527 3.396 0 C-N-CA 123.159 0.583 . . . . 0.0 110.709 -179.11 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.525 3.294 0 CA-C-O 121.375 0.607 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.49 -29.53 74.97 Favored Glycine 1 N--CA 1.517 4.092 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.903 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.06 -36.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 123.62 0.768 . . . . 0.0 110.504 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.26 -36.64 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 C-N-CA 122.879 0.472 . . . . 0.0 110.383 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.18 -42.89 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 CA-C-O 121.802 0.811 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.99 -44.48 92.56 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.31 -33.27 53.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 CA-C-N 118.898 0.772 . . . . 0.0 112.117 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -66.82 -49.67 65.04 Favored 'General case' 0 N--CA 1.529 3.501 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.09 -37.24 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.82 -34.85 70.11 Favored 'General case' 0 N--CA 1.526 3.346 0 C-N-CA 122.664 0.386 . . . . 0.0 111.281 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.94 97.74 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 122.966 0.506 . . . . 0.0 111.727 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.05 -41.4 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.466 0 C-N-CA 123.538 0.735 . . . . 0.0 109.828 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.0 t -67.33 -32.82 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.791 0.836 . . . . 0.0 110.132 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.81 -48.05 73.02 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 18.6 tt -71.24 -44.46 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.8 m -66.86 -37.37 79.3 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.537 0 CA-C-N 120.447 1.476 . . . . 0.0 112.364 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.11 -31.84 69.29 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.62 -35.08 73.76 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.083 0.856 . . . . 0.0 111.011 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.89 -37.27 81.53 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-O 120.893 0.378 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.05 -40.66 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 C-N-CA 123.748 0.819 . . . . 0.0 109.792 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.79 -42.18 86.43 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.348 0.659 . . . . 0.0 110.472 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.06 -29.39 60.44 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 124.46 1.104 . . . . 0.0 111.901 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.4 t -63.86 -22.79 67.08 Favored 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 122.914 0.485 . . . . 0.0 111.558 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -90.63 -18.18 25.59 Favored 'General case' 0 N--CA 1.534 3.733 0 C-N-CA 123.78 0.832 . . . . 0.0 109.956 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 1 N--CA 1.54 4.063 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.526 3.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.03 60.45 Favored Glycine 1 N--CA 1.519 4.194 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.367 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.63 -45.97 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.245 0 C-N-CA 124.056 0.942 . . . . 0.0 111.255 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.24 -36.8 77.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.078 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.15 -39.52 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 123.335 0.654 . . . . 0.0 109.32 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -67.01 -44.31 80.63 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 23.5 m -57.71 -27.94 31.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 CA-C-N 118.984 0.811 . . . . 0.0 111.756 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' THR . . . . . 0.463 ' HG1' ' H ' ' B' ' 220' ' ' VAL . 26.4 p -71.9 -48.58 44.56 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.329 0.651 . . . . 0.0 110.301 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . 0.463 ' H ' ' HG1' ' B' ' 219' ' ' THR . 48.1 t -69.07 -31.81 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.306 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.56 81.56 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.409 0.683 . . . . 0.0 111.384 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.94 98.77 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 121.153 0.501 . . . . 0.0 111.499 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.08 -38.5 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 123.766 0.826 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -33.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.446 0.698 . . . . 0.0 111.394 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.58 -39.01 92.33 Favored 'General case' 0 N--CA 1.533 3.676 0 C-N-CA 122.454 0.302 . . . . 0.0 111.561 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.16 -55.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.77 -36.5 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.01 0.924 . . . . 0.0 113.237 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.39 67.72 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.35 -40.35 85.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 119.072 0.851 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -63.07 -38.97 93.3 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 122.641 0.376 . . . . 0.0 110.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.36 -39.8 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 C-N-CA 123.632 0.773 . . . . 0.0 109.703 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.81 -45.69 77.52 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.77 0.828 . . . . 0.0 110.995 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -70.49 -41.88 72.1 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.864 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 94.2 p -63.15 -27.05 69.11 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 122.834 0.454 . . . . 0.0 110.624 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -79.19 -31.16 43.74 Favored 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 N--CA 1.528 3.454 0 C-N-CA 123.07 0.548 . . . . 0.0 110.165 -178.571 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.53 3.563 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -70.91 -20.87 62.44 Favored 'General case' 0 N--CA 1.523 3.211 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.773 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.59 -50.03 16.61 Favored Glycine 0 N--CA 1.512 3.749 0 C-N-CA 124.201 0.905 . . . . 0.0 113.711 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.39 -35.65 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 CA-C-N 117.924 0.862 . . . . 0.0 111.364 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.08 -34.81 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 122.626 0.37 . . . . 0.0 110.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.23 -42.25 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.11 -40.45 97.66 Favored 'General case' 0 N--CA 1.526 3.364 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.57 -27.81 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 119.131 0.878 . . . . 0.0 111.906 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 33.8 p -69.13 -49.61 55.45 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.98 -39.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.57 -34.73 69.51 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 122.906 0.482 . . . . 0.0 111.268 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.26 99.38 Favored 'General case' 0 N--CA 1.522 3.161 0 C-N-CA 123.127 0.571 . . . . 0.0 111.604 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.16 -43.21 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.261 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.94 -32.22 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 123.883 0.873 . . . . 0.0 109.367 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -47.18 74.67 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 122.969 0.508 . . . . 0.0 109.824 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.76 -51.41 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.44 0.696 . . . . 0.0 110.404 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.44 -37.9 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.803 0.841 . . . . 0.0 112.748 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.09 82.85 Favored 'General case' 0 N--CA 1.539 3.977 0 CA-C-N 118.542 0.61 . . . . 0.0 112.186 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.17 -33.68 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.349 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.21 -43.18 99.41 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 123.246 0.618 . . . . 0.0 110.517 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.69 -34.75 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 C-N-CA 123.103 0.561 . . . . 0.0 109.674 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.15 -27.68 69.25 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.259 0.624 . . . . 0.0 111.233 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm . . . . . 0 N--CA 1.531 3.605 0 C-N-CA 123.527 0.731 . . . . 0.0 110.922 -179.716 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.531 3.577 0 CA-C-O 121.254 0.549 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.04 97.73 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.729 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.78 -36.03 63.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.127 0 CA-C-N 117.885 0.843 . . . . 0.0 111.679 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.58 -37.58 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.21 0.604 . . . . 0.0 109.708 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.05 -41.06 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -59.61 -48.47 81.52 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 124.5 1.12 . . . . 0.0 114.015 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.8 m -59.7 -32.36 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.914 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -72.15 -48.99 39.49 Favored 'General case' 0 N--CA 1.533 3.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.859 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.62 -32.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.696 0.398 . . . . 0.0 110.044 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.97 74.01 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.235 0.614 . . . . 0.0 111.332 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.44 77.49 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.396 0.278 . . . . 0.0 111.571 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.06 -43.62 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.512 0.725 . . . . 0.0 112.084 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.09 -32.86 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 CA-C-N 118.919 0.781 . . . . 0.0 111.931 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.1 mt -60.65 -36.92 79.87 Favored 'General case' 0 N--CA 1.537 3.898 0 CA-C-N 117.97 0.35 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.08 -47.72 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-O 121.489 0.662 . . . . 0.0 109.332 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.3 t -67.0 -37.73 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.263 0 C-N-CA 124.202 1.001 . . . . 0.0 111.606 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.11 90.25 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.94 -34.5 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 122.777 0.431 . . . . 0.0 109.943 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.81 -42.45 73.67 Favored 'General case' 1 N--CA 1.544 4.273 0 CA-C-N 118.875 0.762 . . . . 0.0 109.564 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.1 -31.66 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.13 -46.26 84.92 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.299 0.64 . . . . 0.0 111.472 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -69.0 -38.11 79.1 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.408 0.683 . . . . 0.0 110.772 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.6 p -63.77 -34.92 78.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 123.206 0.602 . . . . 0.0 110.668 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.78 -37.21 70.48 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 124.091 0.956 . . . . 0.0 109.731 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 N--CA 1.528 3.426 0 C-N-CA 123.925 0.89 . . . . 0.0 110.397 -179.308 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' B' ' 213' ' ' GLY . 98.7 p . . . . . 0 N--CA 1.525 3.321 0 CA-C-O 121.286 0.565 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . 0.43 ' N ' ' HG ' ' B' ' 212' ' ' SER . . . -73.55 -30.27 62.42 Favored Glycine 0 N--CA 1.515 3.917 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.237 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.01 -36.83 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.662 0.785 . . . . 0.0 110.662 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.02 -37.82 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 C-N-CA 123.068 0.547 . . . . 0.0 109.605 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.9 -37.89 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -62.7 -46.41 88.26 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.95 -38.86 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 118.583 0.629 . . . . 0.0 112.074 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -64.46 -48.96 73.3 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.72 -37.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.32 80.54 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.57 0.348 . . . . 0.0 111.097 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.39 70.85 Favored 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.86 -38.61 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 O-C-N 122.121 -0.362 . . . . 0.0 110.416 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.2 t -64.83 -32.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 123.495 0.718 . . . . 0.0 110.016 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.44 -36.91 76.81 Favored 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 122.615 0.366 . . . . 0.0 110.28 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.4 -52.28 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 123.327 0.651 . . . . 0.0 109.435 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.28 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 C-N-CA 124.322 1.049 . . . . 0.0 112.85 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.77 83.42 Favored 'General case' 0 N--CA 1.537 3.916 0 CA-C-N 118.607 0.64 . . . . 0.0 112.338 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -69.33 -33.83 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 C-N-CA 123.497 0.719 . . . . 0.0 109.091 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.56 -42.67 99.18 Favored 'General case' 0 N--CA 1.537 3.892 0 C-N-CA 123.498 0.719 . . . . 0.0 111.33 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.09 -31.76 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.126 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.22 -46.51 80.37 Favored 'General case' 0 N--CA 1.529 3.503 0 CA-C-O 120.776 0.322 . . . . 0.0 111.005 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.66 -25.21 59.04 Favored 'General case' 0 N--CA 1.525 3.308 0 C-N-CA 123.547 0.739 . . . . 0.0 111.021 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 60.5 p -65.17 -33.57 76.33 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.654 0.382 . . . . 0.0 111.065 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 66.5 mt -90.78 -21.1 21.69 Favored 'General case' 0 N--CA 1.531 3.598 0 C-N-CA 124.122 0.969 . . . . 0.0 111.0 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 1 N--CA 1.543 4.213 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.53 3.549 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 88.2 p -66.63 -39.55 88.33 Favored 'General case' 0 N--CA 1.528 3.438 0 C-N-CA 123.289 0.636 . . . . 0.0 109.931 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.44 -32.79 82.33 Favored Glycine 1 N--CA 1.519 4.201 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.366 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.57 -36.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.73 -34.24 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 C-N-CA 123.713 0.805 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.48 -43.68 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 CA-C-O 121.774 0.797 . . . . 0.0 109.337 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -67.18 -43.51 82.03 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.62 -36.65 55.05 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.288 0 CA-C-N 118.934 0.788 . . . . 0.0 111.47 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -65.95 -48.46 71.26 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.435 0.694 . . . . 0.0 111.149 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.97 -34.76 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.524 0.73 . . . . 0.0 109.826 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.85 75.62 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.04 74.49 Favored 'General case' 0 N--CA 1.519 3.007 0 C-N-CA 122.511 0.324 . . . . 0.0 111.555 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.87 -44.89 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.164 0.586 . . . . 0.0 111.939 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -65.98 -32.85 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 CA-C-N 118.648 0.658 . . . . 0.0 110.834 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.88 -43.19 98.79 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.125 0.57 . . . . 0.0 111.181 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.33 -52.94 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.252 0.621 . . . . 0.0 110.156 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.48 -37.16 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 124.759 1.224 . . . . 0.0 113.726 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.12 -35.86 72.09 Favored 'General case' 0 N--CA 1.537 3.88 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.88 -34.88 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.972 0.806 . . . . 0.0 110.526 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -69.38 -42.3 75.35 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.22 -42.44 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 73.0 m -67.18 -48.07 69.05 Favored 'General case' 0 N--CA 1.528 3.453 0 CA-C-O 121.448 0.642 . . . . 0.0 110.542 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 N--CA 1.523 3.215 0 C-N-CA 124.256 1.022 . . . . 0.0 111.248 -178.884 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.524 3.24 0 CA-C-O 120.451 0.167 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.99 -50.29 8.79 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.491 0.567 . . . . 0.0 113.893 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.74 -36.92 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -59.24 -33.22 50.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 118.57 0.623 . . . . 0.0 111.022 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.65 -43.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.32 -34.73 77.96 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.48 -36.95 55.33 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.511 0 CA-C-N 119.906 1.23 . . . . 0.0 111.562 -175.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' THR . . . . . 0.468 ' HG1' ' H ' ' A' ' 220' ' ' VAL . 31.1 p -67.1 -48.58 67.74 Favored 'General case' 0 N--CA 1.525 3.312 0 C-N-CA 123.547 0.739 . . . . 0.0 110.358 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . 0.468 ' H ' ' HG1' ' A' ' 219' ' ' THR . 48.4 t -67.42 -31.87 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.92 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.94 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.115 0.566 . . . . 0.0 111.378 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.35 72.97 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 122.879 0.472 . . . . 0.0 111.689 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.95 -46.2 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.42 0 C-N-CA 123.377 0.671 . . . . 0.0 111.892 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.47 -32.42 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 CA-C-N 118.057 0.39 . . . . 0.0 111.074 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.02 -47.68 61.13 Favored 'General case' 0 N--CA 1.525 3.289 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.65 -41.53 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.7 -47.91 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.6 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.42 89.26 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.13 -37.61 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.612 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -34.09 65.56 Favored 'General case' 1 N--CA 1.549 4.512 0 CA-C-N 120.371 1.441 . . . . 0.0 109.991 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.78 -33.51 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.18 -33.15 74.87 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.77 27.66 Favored 'General case' 1 N--CA 1.541 4.105 0 CA-C-N 118.968 0.804 . . . . 0.0 110.443 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 33.7 t -63.03 -43.36 98.91 Favored 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -86.88 -14.67 41.3 Favored 'General case' 1 N--CA 1.549 4.515 0 CA-C-N 118.229 0.468 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.538 3.964 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.42 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.527 3.392 0 N-CA-C 111.241 0.089 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.57 -40.92 31.02 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.718 0.675 . . . . 0.0 111.432 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.51 -43.63 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 124.583 1.153 . . . . 0.0 112.311 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.25 -33.71 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 C-N-CA 122.753 0.421 . . . . 0.0 111.002 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.4 -41.01 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.93 -45.49 89.01 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.69 -30.88 38.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.943 0.792 . . . . 0.0 111.782 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 29.6 p -69.69 -48.64 58.97 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.377 0.671 . . . . 0.0 110.606 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.87 -32.26 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.595 0.758 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.52 78.83 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.323 0.649 . . . . 0.0 111.817 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.37 71.66 Favored 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 122.854 0.461 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.37 -44.0 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.377 0.671 . . . . 0.0 111.591 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.88 -32.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.529 -0.732 . . . . 0.0 110.427 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.23 -47.58 76.33 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.86 -43.18 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.93 -37.4 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.117 0.872 . . . . 0.0 112.738 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.66 68.38 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -66.38 -34.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.984 0.811 . . . . 0.0 110.864 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -66.6 -33.8 76.47 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 122.682 0.393 . . . . 0.0 110.513 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.37 -42.56 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 123.25 0.62 . . . . 0.0 109.717 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.8 t -65.46 -45.61 83.08 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.489 0.716 . . . . 0.0 111.085 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.05 -47.03 60.82 Favored 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.68 0.792 . . . . 0.0 110.896 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 97.9 p -63.67 -13.68 45.04 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.846 0.458 . . . . 0.0 111.879 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.34 -34.68 15.6 Favored 'General case' 0 N--CA 1.531 3.58 0 C-N-CA 123.928 0.891 . . . . 0.0 110.512 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 1 N--CA 1.539 4.019 0 C-N-CA 123.991 0.916 . . . . 0.0 112.296 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.53 3.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.7 p -61.5 -21.96 64.68 Favored 'General case' 0 N--CA 1.53 3.539 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.91 86.59 Favored Glycine 0 N--CA 1.509 3.528 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.782 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.58 71.46 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.082 0 CA-C-O 121.224 0.535 . . . . 0.0 109.651 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.55 -35.75 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 C-N-CA 123.07 0.548 . . . . 0.0 109.589 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 29.7 mm -69.99 -38.82 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -63.57 -45.55 89.94 Favored 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.94 -29.7 36.63 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.252 0 CA-C-N 118.929 0.786 . . . . 0.0 111.484 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 21.2 p -68.77 -48.71 63.01 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.2 0.6 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.41 -36.18 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.443 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.49 -37.56 74.22 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.762 0.425 . . . . 0.0 110.943 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.44 -45.52 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.366 0 C-N-CA 123.461 0.704 . . . . 0.0 111.5 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.29 -33.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 121.371 -0.831 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.83 -47.55 80.36 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 123.229 0.612 . . . . 0.0 112.402 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 7.9 tp -70.65 -38.86 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.78 -36.02 76.19 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 C-N-CA 124.022 0.929 . . . . 0.0 111.341 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.53 74.68 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 13.3 m -72.49 -35.8 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 CA-C-N 118.427 0.558 . . . . 0.0 111.761 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -70.98 -42.34 69.82 Favored 'General case' 0 N--CA 1.533 3.681 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.17 -35.93 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 CA-C-N 118.287 0.494 . . . . 0.0 110.985 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.6 m -66.6 -36.52 82.81 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-O 121.215 0.531 . . . . 0.0 109.929 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.523 3.202 0 C-N-CA 123.939 0.896 . . . . 0.0 109.908 179.657 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.524 3.258 0 CA-C-O 121.266 0.555 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.61 -36.49 48.55 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.24 -47.75 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.299 1.04 . . . . 0.0 110.997 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.47 -34.54 70.17 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.993 0.361 . . . . 0.0 110.792 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.5 -48.16 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.32 -38.57 85.12 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.79 -36.89 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.43 0 CA-C-N 119.645 1.111 . . . . 0.0 111.339 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.0 p -66.9 -48.41 68.81 Favored 'General case' 0 N--CA 1.524 3.235 0 C-N-CA 123.665 0.786 . . . . 0.0 110.714 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.68 -31.68 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 C-N-CA 123.918 0.887 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.42 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.034 0.533 . . . . 0.0 111.147 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.04 68.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 122.929 0.492 . . . . 0.0 111.947 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.84 -44.05 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.548 0.739 . . . . 0.0 111.981 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.57 -32.56 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 CA-C-N 118.323 0.511 . . . . 0.0 110.766 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.81 -34.93 76.8 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.22 0.608 . . . . 0.0 112.513 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -69.82 -54.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 118.075 0.398 . . . . 0.0 111.326 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.15 -36.59 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.84 66.91 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.1 -34.85 73.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.075 0 CA-C-N 119.306 0.957 . . . . 0.0 110.816 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.69 -36.64 76.14 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 122.958 0.503 . . . . 0.0 110.021 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 80.9 t -67.35 -44.54 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.516 0.727 . . . . 0.0 109.444 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 86.3 m -61.74 -41.95 98.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.327 0.651 . . . . 0.0 110.746 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -68.11 -39.93 82.68 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.933 0.893 . . . . 0.0 109.911 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -64.97 -40.11 94.5 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.444 0.697 . . . . 0.0 110.393 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -37.2 82.63 Favored 'General case' 0 N--CA 1.533 3.717 0 C-N-CA 124.309 1.044 . . . . 0.0 110.068 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.4 tp . . . . . 0 N--CA 1.53 3.56 0 C-N-CA 123.061 0.544 . . . . 0.0 110.248 -178.876 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.526 3.359 0 CA-C-O 121.326 0.584 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.97 -45.55 20.18 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.416 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -38.66 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.845 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -69.04 -34.78 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.709 -0.619 . . . . 0.0 110.975 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.25 -39.71 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -58.39 -49.08 78.52 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.8 -33.68 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -70.06 -49.17 53.78 Favored 'General case' 0 N--CA 1.529 3.502 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.18 -33.19 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 122.671 0.388 . . . . 0.0 110.372 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.32 78.08 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.09 0.556 . . . . 0.0 111.001 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.42 80.18 Favored 'General case' 0 N--CA 1.52 3.066 0 C-N-CA 122.777 0.431 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.22 -50.65 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 123.04 0.536 . . . . 0.0 111.09 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 m -62.88 -32.27 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 O-C-N 121.926 -0.484 . . . . 0.0 110.792 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.45 -43.02 88.67 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.334 0.654 . . . . 0.0 111.465 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -70.21 -48.01 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.24 -37.75 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 124.118 0.967 . . . . 0.0 112.584 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.539 3.994 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.86 -33.98 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.93 -43.34 93.07 Favored 'General case' 0 N--CA 1.535 3.789 0 C-N-CA 123.188 0.595 . . . . 0.0 112.532 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.9 -30.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 O-C-N 122.263 -0.273 . . . . 0.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 36.9 t -58.63 -46.0 88.04 Favored 'General case' 0 N--CA 1.526 3.337 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -74.09 -32.5 63.27 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 118.225 0.466 . . . . 0.0 111.187 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 83.4 p -63.22 -23.78 67.58 Favored 'General case' 0 N--CA 1.53 3.562 0 C-N-CA 122.717 0.407 . . . . 0.0 111.132 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.85 -23.13 22.87 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.886 0.874 . . . . 0.0 109.917 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.534 3.766 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.524 3.248 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 89.3 p -70.66 -30.9 67.63 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.203 0.601 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.01 9.86 Favored Glycine 1 N--CA 1.516 4.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.167 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -42.08 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 C-N-CA 123.345 0.658 . . . . 0.0 111.759 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.96 -34.88 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.874 -0.516 . . . . 0.0 111.746 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.34 -43.95 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.74 -43.55 83.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.5 -38.48 63.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.132 0 CA-C-N 118.886 0.766 . . . . 0.0 111.987 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 31.3 p -66.08 -48.05 72.25 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.406 0.682 . . . . 0.0 111.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.1 -33.36 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 C-N-CA 123.638 0.775 . . . . 0.0 109.683 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.72 -34.61 76.09 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.73 73.99 Favored 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 122.603 0.361 . . . . 0.0 111.537 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.47 -44.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.332 0.653 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.13 -32.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 CA-C-N 118.61 0.641 . . . . 0.0 110.857 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.87 -42.12 93.04 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.216 0.606 . . . . 0.0 111.511 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 63.0 mt -70.14 -48.79 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.35 -36.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 124.972 1.309 . . . . 0.0 113.091 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.73 67.03 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.83 -36.79 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.918 0.781 . . . . 0.0 110.24 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -70.61 -42.25 71.21 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.977 0.511 . . . . 0.0 109.887 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.07 -35.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.24 -38.83 85.83 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 123.362 0.665 . . . . 0.0 110.323 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.531 3.577 0 C-N-CA 124.954 1.301 . . . . 0.0 111.902 -179.097 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 96.8 p . . . . . 0 N--CA 1.526 3.354 0 CA-C-O 121.183 0.516 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.94 -29.86 62.26 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.437 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.03 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.702 0.801 . . . . 0.0 110.499 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.19 -38.39 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.288 0.635 . . . . 0.0 109.93 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.16 -39.1 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -67.02 -46.71 73.65 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.06 -35.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.947 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.1 p -66.5 -49.49 66.39 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.84 -32.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.35 78.28 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 122.531 0.333 . . . . 0.0 111.665 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.49 73.98 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 122.628 0.371 . . . . 0.0 111.818 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.9 t -69.96 -43.46 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.324 0.649 . . . . 0.0 111.722 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.27 -32.6 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.581 0.628 . . . . 0.0 110.547 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.18 -34.63 72.35 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.19 -55.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 CA-C-N 117.868 0.304 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.87 -37.14 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.45 81.47 Favored 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.19 -34.78 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.453 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.397 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -69.56 -42.5 74.49 Favored 'General case' 1 N--CA 1.539 4.021 0 CA-C-N 119.407 1.003 . . . . 0.0 111.345 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.7 -31.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 O-C-N 121.981 -0.449 . . . . 0.0 110.303 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.96 -37.27 81.84 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.523 0.729 . . . . 0.0 111.696 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -82.84 -25.19 32.85 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.428 0.691 . . . . 0.0 110.449 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 m -68.02 -43.41 78.87 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.058 0.543 . . . . 0.0 111.828 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.1 -24.5 47.53 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.791 0.437 . . . . 0.0 111.143 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.532 3.661 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.196 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.518 2.942 0 CA-C-O 120.727 0.299 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.84 -50.12 9.39 Favored Glycine 0 N--CA 1.516 3.971 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.271 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.87 -36.71 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 122.984 0.514 . . . . 0.0 112.112 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 36.6 pt -62.9 -33.75 62.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 CA-C-N 119.185 0.902 . . . . 0.0 110.852 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 84.3 mt -69.67 -39.25 77.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -66.14 -43.34 87.35 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.84 -28.18 32.4 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.37 0.986 . . . . 0.0 111.345 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' THR . . . . . 0.41 ' HG1' ' N ' ' B' ' 220' ' ' VAL . 19.4 p -66.3 -48.52 70.1 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 123.509 0.723 . . . . 0.0 111.063 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . 0.41 ' N ' ' HG1' ' B' ' 219' ' ' THR . 51.5 t -69.85 -39.47 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 C-N-CA 123.694 0.797 . . . . 0.0 109.186 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.49 71.6 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.664 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.9 -33.21 75.31 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 122.712 0.405 . . . . 0.0 111.373 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.02 -48.54 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.334 0 C-N-CA 123.139 0.576 . . . . 0.0 111.102 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.55 -32.38 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 O-C-N 121.577 -0.702 . . . . 0.0 110.377 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.65 -47.78 83.28 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 123.424 0.689 . . . . 0.0 112.471 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -70.75 -37.48 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.879 0 CA-C-N 118.302 0.501 . . . . 0.0 110.085 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.92 -37.57 79.67 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 C-N-CA 123.155 0.582 . . . . 0.0 111.084 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.93 68.19 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.39 -37.08 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-N 118.893 0.769 . . . . 0.0 110.405 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -70.28 -42.08 72.56 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 122.739 0.416 . . . . 0.0 109.934 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.7 -42.63 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.26 -28.65 68.22 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 123.025 0.53 . . . . 0.0 111.062 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -68.18 -35.72 78.48 Favored 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 123.584 0.754 . . . . 0.0 110.617 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.7 m -63.59 -23.29 67.32 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.166 0.587 . . . . 0.0 109.828 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.6 -33.32 68.91 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.549 1.139 . . . . 0.0 108.299 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.524 3.273 0 C-N-CA 123.613 0.765 . . . . 0.0 110.149 -179.291 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.518 2.973 0 CA-C-O 121.615 0.722 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 36.4 t -69.62 -24.93 63.72 Favored 'General case' 0 N--CA 1.524 3.251 0 O-C-N 121.532 -0.73 . . . . 0.0 110.007 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.32 -46.19 57.88 Favored Glycine 0 N--CA 1.511 3.669 0 C-N-CA 124.513 1.054 . . . . 0.0 114.242 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 13.6 tt -59.14 -36.36 62.37 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.303 0 CA-C-N 118.233 1.016 . . . . 0.0 111.03 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.83 -34.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.391 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.22 -41.8 78.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-N 119.175 0.898 . . . . 0.0 108.73 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.54 -45.27 94.49 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.6 -37.26 78.47 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.658 0.663 . . . . 0.0 112.025 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 73.0 p -65.41 -48.85 71.39 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 123.201 0.6 . . . . 0.0 112.512 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.45 -32.09 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.26 80.32 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 122.766 0.426 . . . . 0.0 111.792 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.43 55.17 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.66 -38.37 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.23 -32.29 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.994 -0.441 . . . . 0.0 110.536 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.1 -34.88 75.65 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 122.966 0.506 . . . . 0.0 111.557 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.49 -54.78 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 122.899 0.479 . . . . 0.0 111.475 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.04 -35.86 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.853 0 C-N-CA 124.236 1.015 . . . . 0.0 112.893 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.36 66.19 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.47 -34.51 66.0 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.502 1.047 . . . . 0.0 110.487 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.83 -26.22 66.81 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 122.836 0.454 . . . . 0.0 110.871 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -37.74 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.83 -40.44 88.0 Favored 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 123.487 0.715 . . . . 0.0 109.577 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 N--CA 1.525 3.285 0 C-N-CA 124.219 1.008 . . . . 0.0 109.782 179.244 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.534 3.734 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -42.11 40.79 Favored Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.097 0.873 . . . . 0.0 111.26 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.6 mm -57.96 -38.88 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 124.223 1.009 . . . . 0.0 110.861 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.86 -34.52 31.03 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 CA-C-O 119.458 -0.306 . . . . 0.0 111.029 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.57 -49.13 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 CA-C-N 119.279 0.945 . . . . 0.0 108.804 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -67.88 -27.55 66.76 Favored 'General case' 0 N--CA 1.53 3.564 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -56.46 -38.85 58.16 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.546 0 CA-C-N 120.109 1.322 . . . . 0.0 112.084 -174.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.3 p -64.05 -48.08 77.66 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 123.907 0.883 . . . . 0.0 110.769 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.87 -44.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.124 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.78 58.77 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.455 0.702 . . . . 0.0 111.812 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.64 95.89 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 122.998 0.519 . . . . 0.0 111.718 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -39.04 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.429 0.692 . . . . 0.0 109.719 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.82 -34.32 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.652 0.781 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -37.29 86.63 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.066 0.546 . . . . 0.0 111.881 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.13 -54.42 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 C-N-CA 122.911 0.484 . . . . 0.0 111.433 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.55 -36.3 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 C-N-CA 124.374 1.07 . . . . 0.0 113.747 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.68 -31.02 65.94 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.3 -38.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 119.036 0.834 . . . . 0.0 110.472 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.33 -32.76 73.11 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.899 0.48 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.61 -37.9 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.614 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.33 -46.67 72.78 Favored 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 123.397 0.679 . . . . 0.0 110.352 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.24 -26.64 65.8 Favored 'General case' 0 N--CA 1.524 3.265 0 C-N-CA 124.114 0.966 . . . . 0.0 110.915 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 68.9 m -63.33 -21.67 66.41 Favored 'General case' 0 N--CA 1.529 3.515 0 CA-C-N 118.133 0.424 . . . . 0.0 110.049 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 57.4 mt -91.44 -17.33 25.95 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 124.375 1.07 . . . . 0.0 110.592 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.537 3.904 0 CA-C-O 119.029 -0.51 . . . . 0.0 112.179 -176.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.531 3.602 0 CA-C-O 121.106 0.479 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -24.79 75.56 Favored Glycine 0 N--CA 1.505 3.279 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.55 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -59.77 -48.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.982 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.14 -33.75 65.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 O-C-N 122.154 -0.341 . . . . 0.0 110.221 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.62 -38.93 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -67.12 -43.78 81.59 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.75 -32.72 43.48 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.367 0 CA-C-N 119.136 0.88 . . . . 0.0 111.645 -176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -64.93 -48.22 74.88 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.51 0.724 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.03 -46.14 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.477 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -34.88 58.76 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 123.123 0.569 . . . . 0.0 111.903 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.13 91.93 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.825 0.45 . . . . 0.0 111.955 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.14 -40.12 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.273 0.629 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.36 -33.0 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 123.667 0.787 . . . . 0.0 110.151 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.31 -47.48 73.42 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.3 tt -70.69 -41.71 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.02 -37.29 79.07 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.079 0.854 . . . . 0.0 112.257 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.85 68.64 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 m -64.38 -34.87 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.027 0.831 . . . . 0.0 110.613 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -68.94 -40.35 79.02 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.828 0.451 . . . . 0.0 109.858 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.55 -38.4 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.95 -42.22 97.37 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.688 0.795 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.57 -44.21 91.43 Favored 'General case' 0 N--CA 1.527 3.381 0 C-N-CA 124.269 1.028 . . . . 0.0 109.784 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.2 t -64.55 -27.13 68.75 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.274 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 50.8 tp -91.56 -25.32 19.27 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.422 1.089 . . . . 0.0 111.315 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.5 tp . . . . . 0 N--CA 1.535 3.803 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.53 3.526 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 61.0 m -57.93 -35.01 70.48 Favored 'General case' 0 N--CA 1.523 3.205 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.07 -38.21 40.94 Favored Glycine 0 N--CA 1.513 3.793 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.162 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.78 -44.34 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.874 0.87 . . . . 0.0 111.976 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.71 -33.82 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 C-N-CA 122.583 0.353 . . . . 0.0 110.919 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 89.3 mt -68.43 -38.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 O-C-N 121.79 -0.569 . . . . 0.0 109.54 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -67.04 -47.0 72.7 Favored 'General case' 0 N--CA 1.529 3.487 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.17 -34.8 58.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.145 0 CA-C-N 118.786 0.721 . . . . 0.0 111.926 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' THR . . . . . 0.43 ' HG1' ' H ' ' C' ' 220' ' ' VAL . 82.7 p -66.62 -48.65 68.82 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.596 0.758 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . 0.43 ' H ' ' HG1' ' C' ' 219' ' ' THR . 89.1 t -68.11 -35.05 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.556 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.19 77.12 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.268 0.627 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.61 75.18 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 122.822 0.449 . . . . 0.0 111.632 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.93 -46.1 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.019 0.528 . . . . 0.0 111.64 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.83 -32.57 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 CA-C-N 118.697 0.68 . . . . 0.0 111.156 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.95 -41.5 99.52 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.21 0.604 . . . . 0.0 112.046 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 74.8 mt -70.56 -55.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 14.4 p -68.67 -41.73 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.36 82.14 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.15 -33.92 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 CA-C-N 118.101 0.41 . . . . 0.0 110.777 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -69.65 -27.11 64.77 Favored 'General case' 0 N--CA 1.536 3.864 0 CA-C-N 118.713 0.688 . . . . 0.0 110.539 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.26 -50.07 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 122.677 0.391 . . . . 0.0 110.508 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 31.3 p -63.81 -35.79 81.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 122.708 0.403 . . . . 0.0 111.2 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 tttm . . . . . 0 N--CA 1.525 3.307 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 179.431 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.518 2.941 0 CA-C-O 121.597 0.713 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.69 -49.63 68.89 Favored Glycine 0 N--CA 1.515 3.94 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.61 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.52 -35.97 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 CA-C-N 117.405 0.603 . . . . 0.0 110.753 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.4 mt -62.19 -36.66 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.975 0 C-N-CA 122.638 0.375 . . . . 0.0 110.44 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.91 -48.08 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 CA-C-O 121.584 0.707 . . . . 0.0 109.112 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -67.33 -41.2 85.63 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.42 -33.81 44.96 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.172 0.896 . . . . 0.0 112.082 -175.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 35.1 p -71.45 -48.56 48.64 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.338 0.655 . . . . 0.0 110.011 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.01 -31.71 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.288 0 C-N-CA 123.892 0.877 . . . . 0.0 109.621 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.66 Favored 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 123.455 0.702 . . . . 0.0 111.827 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.47 74.06 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 122.346 0.259 . . . . 0.0 111.174 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.97 -46.7 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 C-N-CA 123.411 0.684 . . . . 0.0 111.573 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.78 -32.11 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.411 0.55 . . . . 0.0 110.443 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -46.08 73.46 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.961 0.904 . . . . 0.0 111.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.13 -55.25 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.0 -36.41 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.19 66.4 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.65 -37.27 79.68 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.208 0.913 . . . . 0.0 110.59 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.79 -29.18 68.3 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 122.956 0.502 . . . . 0.0 110.732 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.52 -38.36 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.24 -47.23 71.39 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.349 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.44 -41.71 84.3 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.821 0.848 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -64.22 -31.45 72.66 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.022 0.529 . . . . 0.0 111.171 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.32 -37.65 74.78 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.461 0.704 . . . . 0.0 110.763 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.531 3.622 0 C-N-CA 123.316 0.647 . . . . 0.0 109.909 -179.638 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.521 3.1 0 CA-C-O 119.919 -0.086 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.93 -50.88 7.39 Favored Glycine 1 N--CA 1.519 4.203 0 C-N-CA 123.439 0.543 . . . . 0.0 113.923 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.19 -39.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.66 -33.85 28.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.337 0.517 . . . . 0.0 111.007 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 23.5 mm -62.84 -42.99 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-O 121.278 0.561 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -64.38 -35.4 80.78 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.022 0.929 . . . . 0.0 112.717 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.47 -41.5 78.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-O 121.03 0.443 . . . . 0.0 110.476 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -65.03 -48.23 74.63 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.607 0.763 . . . . 0.0 111.271 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.72 -33.88 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.673 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.0 -35.19 80.41 Favored 'General case' 0 N--CA 1.523 3.217 0 C-N-CA 122.989 0.516 . . . . 0.0 111.56 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.33 63.3 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 122.832 0.453 . . . . 0.0 112.192 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.15 -43.63 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 123.107 0.563 . . . . 0.0 111.826 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.35 -32.82 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 CA-C-N 118.311 0.505 . . . . 0.0 110.713 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.64 -41.12 85.29 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.899 0.48 . . . . 0.0 111.339 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.09 -54.08 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 CA-C-O 121.686 0.755 . . . . 0.0 109.631 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.52 -35.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 125.788 1.635 . . . . 0.0 113.26 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.62 70.79 Favored 'General case' 0 N--CA 1.529 3.513 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.35 -41.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 CA-C-N 118.942 0.792 . . . . 0.0 111.454 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -65.15 -42.52 93.71 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.28 -36.97 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 CA-C-N 118.314 0.506 . . . . 0.0 110.822 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 97.0 m -67.75 -48.19 67.13 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 122.818 0.447 . . . . 0.0 111.346 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.2 -28.37 70.0 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.511 0.724 . . . . 0.0 111.411 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.65 -21.41 66.36 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 122.733 0.413 . . . . 0.0 110.88 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.1 mt -91.3 -30.4 16.61 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 124.197 0.999 . . . . 0.0 110.969 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.534 3.75 0 C-N-CA 122.839 0.456 . . . . 0.0 112.13 -177.365 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.531 3.586 0 CA-C-O 120.8 0.333 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -67.08 -24.68 65.98 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.343 0.657 . . . . 0.0 111.174 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.41 -51.04 7.65 Favored Glycine 0 N--CA 1.516 3.997 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.58 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 tp -66.71 -37.02 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.082 0.553 . . . . 0.0 112.367 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -37.0 77.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.217 0 CA-C-N 118.256 0.48 . . . . 0.0 110.579 -177.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 87.4 mt -70.42 -48.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 CA-C-O 121.429 0.633 . . . . 0.0 109.595 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.36 -39.16 85.7 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.81 -39.04 68.98 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.251 0 CA-C-N 119.106 0.866 . . . . 0.0 111.914 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 20.1 p -63.75 -46.65 84.39 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.458 0.703 . . . . 0.0 110.756 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.65 -47.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.244 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.57 54.34 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.475 0.71 . . . . 0.0 111.902 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.61 95.9 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.95 0.5 . . . . 0.0 111.128 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.97 -40.43 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.5 -32.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 123.862 0.865 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -47.4 86.11 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-O 121.563 0.697 . . . . 0.0 110.797 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.11 -54.92 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.228 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.7 m -67.08 -37.03 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.73 68.04 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.1 m -65.06 -38.61 83.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 119.214 0.915 . . . . 0.0 110.558 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.53 -31.69 73.01 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 122.919 0.488 . . . . 0.0 110.878 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.89 -41.24 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 66.9 m -67.09 -39.91 86.87 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.627 0.771 . . . . 0.0 110.937 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.523 3.2 0 C-N-CA 123.626 0.771 . . . . 0.0 110.248 -179.278 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.523 3.182 0 CA-C-O 121.109 0.48 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.16 -34.22 55.56 Favored Glycine 1 N--CA 1.518 4.134 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.79 -49.64 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.904 0.882 . . . . 0.0 111.103 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -63.44 -33.68 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 122.172 -0.33 . . . . 0.0 110.789 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.1 mt -69.57 -41.6 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -66.14 -44.34 84.46 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.72 -37.6 60.33 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.226 0 CA-C-N 119.101 0.864 . . . . 0.0 111.723 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 p -63.99 -48.24 77.17 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 123.553 0.741 . . . . 0.0 111.158 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.97 -45.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.261 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.89 67.66 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.142 0.577 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.93 96.77 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 122.976 0.51 . . . . 0.0 111.401 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.05 -41.89 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 123.189 0.595 . . . . 0.0 109.723 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.04 -32.83 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.857 0.863 . . . . 0.0 110.235 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.41 -40.96 89.89 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.095 0.558 . . . . 0.0 111.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -70.04 -52.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 122.936 0.495 . . . . 0.0 111.614 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.2 m -66.28 -37.42 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.26 92.39 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.74 -33.87 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -63.17 -43.44 98.26 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.522 0.729 . . . . 0.0 112.446 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.05 -31.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 122.393 0.277 . . . . 0.0 110.488 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 44.7 t -62.44 -32.39 73.24 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 123.044 0.538 . . . . 0.0 111.037 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.32 -44.84 78.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.653 0.781 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.0 p -64.66 -41.31 96.19 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-O 121.465 0.65 . . . . 0.0 109.616 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.8 -34.44 78.17 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 124.538 1.135 . . . . 0.0 109.694 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 N--CA 1.531 3.603 0 C-N-CA 123.586 0.754 . . . . 0.0 110.041 -179.097 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.53 3.537 0 CA-C-O 120.706 0.288 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.99 -23.32 76.52 Favored Glycine 0 N--CA 1.511 3.683 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -51.27 74.0 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.72 -33.84 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 C-N-CA 122.778 0.431 . . . . 0.0 110.947 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.44 -38.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -66.78 -45.11 79.49 Favored 'General case' 0 N--CA 1.531 3.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.84 -34.06 47.27 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.992 0.815 . . . . 0.0 111.672 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.7 p -64.64 -48.43 74.86 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.233 0.613 . . . . 0.0 111.087 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.57 -41.01 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.33 -34.3 78.01 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.931 0.492 . . . . 0.0 111.576 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.03 67.55 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.26 -38.35 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.95 -32.64 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 CA-C-N 118.589 0.631 . . . . 0.0 110.55 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.7 tp -54.9 -34.7 63.34 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.145 0.578 . . . . 0.0 112.55 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.95 -55.74 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 CA-C-N 117.677 0.217 . . . . 0.0 111.382 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.5 -36.13 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 C-N-CA 124.33 1.052 . . . . 0.0 113.128 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.5 -31.02 65.61 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -58.32 -37.07 61.19 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.977 0.808 . . . . 0.0 110.641 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.21 -35.46 71.53 Favored 'General case' 0 N--CA 1.526 3.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.999 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.04 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.19 -41.87 85.12 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 123.481 0.712 . . . . 0.0 110.2 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -71.73 -37.01 70.66 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.851 0.86 . . . . 0.0 110.535 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 92.2 p -63.83 -17.68 63.36 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.027 0.531 . . . . 0.0 111.546 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.7 tp -83.57 -37.5 22.89 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.473 0.709 . . . . 0.0 110.338 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 1 N--CA 1.542 4.139 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.53 3.532 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 91.9 p -68.19 -25.78 65.41 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 122.699 0.4 . . . . 0.0 110.758 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.02 -51.48 6.91 Favored Glycine 1 N--CA 1.518 4.16 0 O-C-N 123.117 0.261 . . . . 0.0 113.726 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 17.7 tt -67.18 -40.79 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 tp -54.45 -33.35 26.22 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.86 -42.05 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-O 121.458 0.647 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -64.87 -44.69 88.89 Favored 'General case' 0 N--CA 1.525 3.315 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 32.7 m -57.82 -35.15 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 CA-C-N 119.117 0.872 . . . . 0.0 111.95 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 36.7 p -62.83 -48.21 80.07 Favored 'General case' 0 N--CA 1.53 3.545 0 C-N-CA 123.527 0.731 . . . . 0.0 110.674 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.72 -48.76 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.346 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.97 -36.84 60.62 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 122.98 0.512 . . . . 0.0 111.882 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.81 94.61 Favored 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.077 0.551 . . . . 0.0 111.741 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.09 -41.36 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 C-N-CA 123.372 0.669 . . . . 0.0 109.571 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.15 -32.91 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.432 0.693 . . . . 0.0 109.495 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -47.3 79.19 Favored 'General case' 0 N--CA 1.539 3.985 0 CA-C-O 121.68 0.752 . . . . 0.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.34 -52.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.413 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.1 -36.05 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 124.875 1.27 . . . . 0.0 113.321 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.17 75.18 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.5 -37.98 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.639 0 CA-C-N 118.543 0.61 . . . . 0.0 111.732 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -69.31 -42.66 75.13 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 122.205 -0.31 . . . . 0.0 111.656 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.54 -32.11 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.41 0.55 . . . . 0.0 110.136 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.32 -39.25 85.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 N--CA 1.523 3.182 0 C-N-CA 124.346 1.058 . . . . 0.0 111.557 -178.701 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.527 3.416 0 CA-C-O 120.796 0.332 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.2 -26.89 67.27 Favored Glycine 0 N--CA 1.51 3.601 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -49.33 84.9 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 C-N-CA 123.219 0.608 . . . . 0.0 111.744 -177.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -67.15 -33.99 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.973 -0.455 . . . . 0.0 110.616 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.41 -38.84 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.8 -48.45 76.82 Favored 'General case' 0 N--CA 1.525 3.311 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.18 -36.12 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.933 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.8 p -66.85 -49.46 65.64 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.03 -33.09 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.33 77.6 Favored 'General case' 0 N--CA 1.523 3.189 0 C-N-CA 122.882 0.473 . . . . 0.0 111.211 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.5 83.35 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 122.759 0.424 . . . . 0.0 111.997 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.95 -45.23 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.406 0 C-N-CA 123.201 0.6 . . . . 0.0 111.263 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -67.66 -32.67 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 O-C-N 121.755 -0.591 . . . . 0.0 110.63 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -47.86 83.05 Favored 'General case' 0 N--CA 1.523 3.216 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.95 -44.62 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.82 -36.58 77.55 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 119.301 0.955 . . . . 0.0 112.448 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.11 67.19 Favored 'General case' 0 N--CA 1.526 3.338 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 4.3 m -70.24 -38.46 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 118.737 0.699 . . . . 0.0 111.543 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.23 -43.09 92.54 Favored 'General case' 0 N--CA 1.532 3.671 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.28 -31.9 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 CA-C-N 117.999 0.363 . . . . 0.0 110.03 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.9 t -66.5 -46.17 77.14 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.304 0.642 . . . . 0.0 110.712 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.09 -35.1 76.12 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.985 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 88.3 p -64.22 -34.93 79.23 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 122.791 0.436 . . . . 0.0 111.693 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.59 -20.07 25.47 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 124.035 0.934 . . . . 0.0 111.376 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 N--CA 1.535 3.801 0 C-N-CA 122.713 0.405 . . . . 0.0 110.284 -178.788 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.528 3.458 0 CA-C-O 120.262 0.077 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.54 -40.85 31.37 Favored Glycine 1 N--CA 1.52 4.24 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.18 -45.65 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.2 0 C-N-CA 124.443 1.097 . . . . 0.0 112.054 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 5.9 tp -55.58 -33.21 32.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 CA-C-N 118.529 0.604 . . . . 0.0 110.052 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.28 -46.5 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-O 121.822 0.82 . . . . 0.0 109.021 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.2 -41.9 85.04 Favored 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.74 -38.26 64.16 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 119.042 0.837 . . . . 0.0 111.776 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.9 p -64.04 -48.01 77.95 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.678 0.791 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.82 -45.74 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.07 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.44 54.07 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 123.372 0.669 . . . . 0.0 111.729 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -41.3 98.7 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-O 120.932 0.396 . . . . 0.0 111.384 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.11 -38.97 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.325 0 C-N-CA 123.558 0.743 . . . . 0.0 109.657 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.37 -33.1 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 123.617 0.767 . . . . 0.0 111.03 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.49 -43.47 93.29 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-N 118.594 0.634 . . . . 0.0 110.161 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.4 -54.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.36 0.664 . . . . 0.0 110.102 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.03 -37.82 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.301 1.04 . . . . 0.0 113.314 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.94 92.52 Favored 'General case' 1 N--CA 1.541 4.091 0 CA-C-N 118.575 0.625 . . . . 0.0 112.515 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.86 -34.1 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.21 -43.77 93.99 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.176 0.59 . . . . 0.0 112.051 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.29 -36.07 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 CA-C-O 120.818 0.342 . . . . 0.0 110.438 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.24 -39.44 86.18 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.297 0.639 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.44 -29.99 64.2 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 99.1 p -75.37 -43.15 51.92 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 122.748 0.419 . . . . 0.0 110.745 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.3 mt -77.27 -31.66 55.05 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.892 0.877 . . . . 0.0 111.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.536 3.829 0 C-N-CA 123.069 0.547 . . . . 0.0 111.662 -176.977 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.532 3.642 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 24.4 t -62.27 -20.43 64.26 Favored 'General case' 0 N--CA 1.522 3.173 0 C-N-CA 123.829 0.851 . . . . 0.0 110.624 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.61 94.14 Favored Glycine 0 N--CA 1.508 3.488 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.184 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.3 pt -65.79 -35.39 75.05 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 CA-C-N 117.897 0.849 . . . . 0.0 111.265 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.14 -34.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 C-N-CA 123.203 0.601 . . . . 0.0 109.636 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.07 -44.31 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.421 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -67.02 -45.41 77.61 Favored 'General case' 0 N--CA 1.533 3.687 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.65 -35.85 52.15 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.3 p -66.06 -49.45 67.61 Favored 'General case' 0 N--CA 1.529 3.492 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.93 -37.82 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.14 72.76 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 122.64 0.376 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.23 94.87 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.938 0.495 . . . . 0.0 111.747 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.76 -42.12 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 123.322 0.649 . . . . 0.0 109.893 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.79 -32.97 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.547 0.739 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.87 -37.7 88.38 Favored 'General case' 0 N--CA 1.529 3.506 0 C-N-CA 122.89 0.476 . . . . 0.0 111.954 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.73 -54.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.707 0 C-N-CA 122.887 0.475 . . . . 0.0 111.624 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 22.7 m -66.86 -36.88 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.49 67.83 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.26 -36.55 77.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 119.393 0.997 . . . . 0.0 110.593 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.54 -30.27 71.0 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 122.784 0.434 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.16 -41.08 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.607 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.41 -48.31 67.7 Favored 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 123.465 0.706 . . . . 0.0 111.166 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.53 3.531 0 C-N-CA 124.068 0.947 . . . . 0.0 111.708 -178.933 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.517 2.912 0 CA-C-O 120.684 0.278 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.36 -50.57 8.16 Favored Glycine 0 N--CA 1.512 3.734 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.805 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.35 -36.89 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 8.5 tp -60.12 -33.58 53.82 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.64 0.655 . . . . 0.0 110.42 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.13 -42.22 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -64.34 -29.23 70.31 Favored 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.22 -44.8 84.28 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.455 0 CA-C-N 119.673 1.124 . . . . 0.0 113.455 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.5 p -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.88 -36.76 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.142 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.6 70.41 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 122.616 0.366 . . . . 0.0 111.358 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.94 -43.68 98.13 Favored 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 122.651 0.38 . . . . 0.0 111.482 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.3 -42.77 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 C-N-CA 123.508 0.723 . . . . 0.0 110.003 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.42 -33.29 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.347 0 C-N-CA 123.407 0.683 . . . . 0.0 110.193 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.94 -38.57 91.55 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 122.813 0.445 . . . . 0.0 111.96 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.0 mt -70.34 -55.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 122.416 0.286 . . . . 0.0 111.546 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.7 -37.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.25 82.89 Favored 'General case' 0 N--CA 1.533 3.683 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.11 -34.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.622 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.0 -42.3 66.61 Favored 'General case' 1 N--CA 1.54 4.056 0 CA-C-N 119.504 1.047 . . . . 0.0 111.547 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.36 -32.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.4 p -67.27 -37.64 83.79 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-N 118.282 0.492 . . . . 0.0 111.103 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.61 -27.72 67.92 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.463 0.705 . . . . 0.0 111.452 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.6 p -72.21 -16.74 61.95 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 122.645 0.378 . . . . 0.0 111.32 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.4 -37.7 13.05 Favored 'General case' 0 N--CA 1.535 3.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.268 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 1 N--CA 1.545 4.298 0 C-N-CA 122.916 0.487 . . . . 0.0 111.152 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.526 3.351 0 CA-C-O 121.122 0.487 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.99 81.19 Favored Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.271 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.05 -36.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 C-N-CA 124.026 0.93 . . . . 0.0 110.533 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.42 -35.93 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 C-N-CA 122.966 0.506 . . . . 0.0 110.151 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.98 -38.13 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.54 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -65.21 -47.01 78.41 Favored 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.82 -29.92 41.44 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 118.699 0.682 . . . . 0.0 112.335 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.5 p -69.57 -49.9 49.75 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.55 -31.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.098 0.559 . . . . 0.0 111.238 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.04 79.39 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 122.855 0.462 . . . . 0.0 111.626 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.4 t -70.05 -48.26 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 123.268 0.627 . . . . 0.0 111.212 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.0 -32.02 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 CA-C-N 118.251 0.478 . . . . 0.0 110.106 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -46.98 62.93 Favored 'General case' 0 N--CA 1.535 3.776 0 C-N-CA 123.667 0.787 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.33 -54.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.81 -37.03 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 124.768 1.227 . . . . 0.0 113.818 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.43 -31.92 68.2 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.7 m -69.45 -36.09 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 119.332 0.969 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.92 -42.44 66.7 Favored 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.22 -38.36 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.24 -38.93 86.0 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 124.004 0.921 . . . . 0.0 111.039 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 22.1 t -70.08 -32.47 70.55 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 122.947 0.499 . . . . 0.0 110.108 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.31 -32.21 62.76 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.939 0.896 . . . . 0.0 109.904 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.533 3.71 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.528 3.439 0 CA-C-O 121.054 0.454 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.0 m -70.65 -23.79 62.58 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.706 -0.621 . . . . 0.0 109.85 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.88 -50.09 55.04 Favored Glycine 0 N--CA 1.512 3.718 0 C-N-CA 124.264 0.935 . . . . 0.0 114.616 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.15 -36.03 60.69 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.094 0.947 . . . . 0.0 110.748 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.03 -34.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 122.871 0.468 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.4 -41.09 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.872 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -56.72 -41.8 78.09 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.512 0.725 . . . . 0.0 111.867 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 50.5 t -57.76 -45.88 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 19.3 p -62.87 -49.28 75.45 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.05 -38.45 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.133 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.8 78.79 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.46 64.39 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.99 -38.39 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.32 -32.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.551 0.614 . . . . 0.0 110.668 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.73 -36.02 71.48 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.149 0.58 . . . . 0.0 112.371 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -69.57 -54.85 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 122.763 0.425 . . . . 0.0 111.193 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.14 -35.99 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 C-N-CA 124.236 1.014 . . . . 0.0 113.227 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -31.11 65.9 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.27 -35.21 74.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.077 0 CA-C-N 119.401 1.001 . . . . 0.0 110.594 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.79 -33.79 75.51 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 122.887 0.475 . . . . 0.0 110.422 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.58 -43.0 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 C-N-CA 123.29 0.636 . . . . 0.0 109.8 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 61.7 m -65.47 -48.45 72.62 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.155 0.582 . . . . 0.0 110.891 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 N--CA 1.522 3.152 0 C-N-CA 124.06 0.944 . . . . 0.0 111.487 -179.285 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.525 3.301 0 CA-C-O 121.237 0.541 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.21 -41.38 31.59 Favored Glycine 1 N--CA 1.517 4.082 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.716 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -47.62 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.974 0.91 . . . . 0.0 110.886 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.2 -34.2 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 O-C-N 121.939 -0.475 . . . . 0.0 111.576 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.84 -43.13 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -67.05 -40.93 87.24 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.79 -33.28 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.151 0 CA-C-N 119.347 0.976 . . . . 0.0 112.791 -175.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -49.72 61.24 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.07 -31.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.435 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.24 -41.29 77.18 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.643 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.22 -43.66 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.505 0.722 . . . . 0.0 111.793 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.91 -32.26 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 CA-C-N 118.332 0.514 . . . . 0.0 110.791 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.11 -38.34 79.35 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.115 0.566 . . . . 0.0 112.317 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.23 -55.14 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.84 -37.41 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.09 89.19 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.8 -34.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.11 -43.82 97.99 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.413 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.59 -36.0 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 CA-C-O 120.987 0.422 . . . . 0.0 110.211 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.34 -48.33 67.83 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.375 0.67 . . . . 0.0 111.687 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -72.28 -45.16 61.26 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.871 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' SER . . . . . 0.411 ' HG ' ' N ' ' A' ' 235' ' ' LEU . 94.8 p -65.04 -39.42 93.29 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 234' ' ' SER . 53.5 tp -72.89 -37.69 67.2 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 122.682 0.393 . . . . 0.0 111.909 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 N--CA 1.539 3.987 0 C-N-CA 123.612 0.765 . . . . 0.0 111.247 -177.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.526 3.363 0 CA-C-O 120.324 0.106 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.71 -44.74 19.44 Favored Glycine 0 N--CA 1.515 3.954 0 O-C-N 123.849 0.718 . . . . 0.0 111.48 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.72 -46.24 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 C-N-CA 124.708 1.203 . . . . 0.0 111.585 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.9 -32.62 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 O-C-N 122.143 -0.348 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.72 -48.57 87.52 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.73 -0.606 . . . . 0.0 110.62 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -67.85 -40.04 83.74 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 20.1 m -57.52 -38.58 64.36 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 CA-C-N 119.929 1.24 . . . . 0.0 112.067 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -61.34 -48.1 82.85 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.694 0.798 . . . . 0.0 111.266 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.67 -44.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.479 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 -34.78 75.42 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 122.994 0.518 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.0 94.12 Favored 'General case' 0 N--CA 1.523 3.195 0 C-N-CA 123.017 0.527 . . . . 0.0 111.902 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.4 -44.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.49 -35.03 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.045 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.34 -38.06 79.39 Favored 'General case' 0 N--CA 1.532 3.629 0 C-N-CA 123.123 0.569 . . . . 0.0 111.327 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.98 -48.81 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.0 -35.53 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 C-N-CA 125.442 1.497 . . . . 0.0 112.158 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.85 68.57 Favored 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.01 -44.19 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.662 0.664 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -63.77 -42.11 97.84 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.93 -33.62 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.589 0.632 . . . . 0.0 110.798 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.9 m -67.22 -43.64 81.52 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.026 0.53 . . . . 0.0 110.611 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.49 -31.13 65.14 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.711 0.804 . . . . 0.0 110.249 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.92 -43.01 97.22 Favored 'General case' 0 N--CA 1.522 3.143 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.8 -14.76 41.28 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.683 0.793 . . . . 0.0 112.543 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 1 N--CA 1.542 4.133 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.534 3.748 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -55.75 -20.88 16.28 Favored 'General case' 0 N--CA 1.528 3.461 0 O-C-N 121.781 -0.574 . . . . 0.0 111.493 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.95 -39.79 93.34 Favored Glycine 0 N--CA 1.51 3.594 0 O-C-N 124.112 0.883 . . . . 0.0 113.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -38.05 80.25 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 CA-C-N 117.524 0.662 . . . . 0.0 109.866 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 50.7 mt -56.74 -34.36 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.389 0.675 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 25.8 mm -69.6 -44.26 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.614 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.44 -36.81 75.5 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.276 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 40.5 p -63.77 -49.26 73.68 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.9 -38.88 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.78 73.71 Favored 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 122.718 0.407 . . . . 0.0 110.972 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.52 85.42 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.087 0.555 . . . . 0.0 112.04 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.291 0.636 . . . . 0.0 109.839 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.95 -32.48 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 123.592 0.757 . . . . 0.0 110.291 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.6 tp -64.23 -48.53 75.46 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 tt -71.95 -52.08 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.06 -37.01 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -31.78 68.9 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.18 -34.9 66.09 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.251 0.932 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -68.86 -38.62 79.86 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.046 0.451 . . . . 0.0 109.807 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.1 -41.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 C-N-CA 123.91 0.884 . . . . 0.0 109.599 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.21 -38.79 92.31 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.526 0.73 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.6 tttm . . . . . 0 N--CA 1.524 3.245 0 C-N-CA 123.47 0.708 . . . . 0.0 109.481 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.521 3.098 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.24 -50.28 8.58 Favored Glycine 0 N--CA 1.513 3.8 0 C-N-CA 123.984 0.802 . . . . 0.0 113.78 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.84 -36.91 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 42.5 pt -57.96 -33.81 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 118.951 0.796 . . . . 0.0 110.667 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.65 -41.19 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.66 -34.48 77.17 Favored 'General case' 0 N--CA 1.529 3.493 0 C-N-CA 123.471 0.708 . . . . 0.0 111.687 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.89 -38.03 63.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 CA-C-O 120.921 0.391 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.5 p -66.02 -49.15 68.74 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.302 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.02 -44.93 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.022 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.061 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.75 -34.57 67.68 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.351 0.66 . . . . 0.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.24 98.57 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 122.904 0.482 . . . . 0.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.1 t -69.94 -39.06 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.397 0.679 . . . . 0.0 109.627 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.7 -32.87 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 123.755 0.822 . . . . 0.0 109.869 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -47.21 84.89 Favored 'General case' 0 N--CA 1.535 3.794 0 CA-C-O 121.58 0.705 . . . . 0.0 110.748 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.06 -54.11 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.926 0.89 . . . . 0.0 112.702 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.63 -36.79 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.57 -31.73 68.27 Favored 'General case' 0 N--CA 1.528 3.455 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.09 -34.93 73.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.104 0 CA-C-N 119.348 0.976 . . . . 0.0 110.581 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -65.12 -36.08 83.15 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 122.561 0.344 . . . . 0.0 110.297 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.03 -37.43 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.633 0.773 . . . . 0.0 109.764 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 66.6 m -67.11 -48.33 68.45 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.236 0.614 . . . . 0.0 111.002 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -70.38 -27.72 64.53 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 123.784 0.834 . . . . 0.0 110.351 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.9 t -63.92 -37.9 89.09 Favored 'General case' 0 N--CA 1.528 3.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.546 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.79 -37.23 76.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 123.971 0.908 . . . . 0.0 110.505 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.531 3.625 0 C-N-CA 123.586 0.754 . . . . 0.0 110.384 -179.022 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.519 2.979 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.46 93.28 Favored Glycine 1 N--CA 1.518 4.158 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.272 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.9 tp -57.6 -36.38 53.92 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 118.116 0.958 . . . . 0.0 110.785 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.98 -40.17 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.781 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.72 -41.3 87.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.144 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -59.25 -36.47 75.54 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.334 0.654 . . . . 0.0 112.042 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.21 -42.27 83.03 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.154 0 CA-C-O 121.023 0.439 . . . . 0.0 110.029 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 5.5 p -63.21 -48.39 78.5 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.602 0.761 . . . . 0.0 110.974 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.6 -42.94 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.441 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.87 75.86 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 122.885 0.474 . . . . 0.0 111.066 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.36 -48.99 68.42 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.05 0.54 . . . . 0.0 111.513 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -38.84 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 C-N-CA 123.248 0.619 . . . . 0.0 110.055 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.15 -32.91 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 C-N-CA 123.099 0.56 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.05 -34.89 79.51 Favored 'General case' 0 N--CA 1.534 3.76 0 C-N-CA 122.83 0.452 . . . . 0.0 111.83 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.66 -54.62 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 C-N-CA 122.804 0.442 . . . . 0.0 111.039 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -36.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.78 82.35 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.5 -34.78 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.215 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.86 -40.18 79.48 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 119.197 0.908 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.01 -31.62 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.808 0 CA-C-N 118.435 0.561 . . . . 0.0 110.964 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.25 -40.72 95.11 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 122.818 0.447 . . . . 0.0 111.345 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.27 -45.43 32.71 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.271 0.628 . . . . 0.0 109.973 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.8 t -63.16 -12.82 30.55 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 122.804 0.442 . . . . 0.0 111.68 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 64.3 tp -89.1 -35.92 16.02 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 124.308 1.043 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 1 N--CA 1.543 4.179 0 C-N-CA 123.979 0.912 . . . . 0.0 110.703 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.528 3.441 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -70.5 -21.03 62.8 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 122.968 0.507 . . . . 0.0 110.857 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.43 -50.14 22.36 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 123.614 0.626 . . . . 0.0 113.814 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.24 -36.65 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 CA-C-N 117.432 0.616 . . . . 0.0 111.149 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.74 -35.1 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 117.942 0.337 . . . . 0.0 110.832 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.37 -42.56 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.737 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -66.58 -42.75 86.52 Favored 'General case' 0 N--CA 1.527 3.414 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.41 -33.47 47.95 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.847 0.749 . . . . 0.0 112.287 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 25.3 p -66.97 -50.27 62.82 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.98 -39.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.74 68.89 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.967 0.507 . . . . 0.0 111.306 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.21 94.06 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 122.841 0.457 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 51.3 t -70.05 -41.17 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 123.622 0.769 . . . . 0.0 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.81 -34.14 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.876 0.871 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.44 -36.76 83.61 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.125 0.57 . . . . 0.0 111.588 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.83 -54.24 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 C-N-CA 123.109 0.564 . . . . 0.0 111.085 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 m -67.76 -42.02 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.34 92.35 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.07 -37.02 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 CA-C-O 118.047 -0.977 . . . . 0.0 112.218 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -73.32 -36.57 66.25 Favored 'General case' 1 N--CA 1.548 4.443 0 CA-C-N 120.631 1.559 . . . . 0.0 109.801 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.86 -32.03 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 C-N-CA 123.188 0.595 . . . . 0.0 109.713 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.56 -38.12 83.51 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 123.304 0.642 . . . . 0.0 111.192 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 N--CA 1.531 3.586 0 C-N-CA 124.362 1.065 . . . . 0.0 111.633 179.613 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.574 1.867 0 N-CA-C 108.561 -0.903 . . . . 999.99 108.561 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.7 -34.77 8.6 Favored 'Trans proline' 1 N--CA 1.538 4.124 0 C-N-CA 122.153 1.902 . . . . 999.99 110.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 64.58 145.88 0.03 OUTLIER Glycine 1 N--CA 1.519 4.22 0 CA-C-N 115.449 -0.796 . . . . 999.99 111.367 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.8 p -166.46 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.576 0.75 . . . . 999.99 109.114 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.2 mt -72.9 -24.79 60.88 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 115.099 -0.955 . . . . 999.99 110.203 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -70.24 -23.61 62.94 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.819 0.448 . . . . 479.91 109.979 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.41 -50.64 9.53 Favored Glycine 0 N--CA 1.511 3.681 0 CA-C-N 115.78 -0.645 . . . . 221.67 113.236 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -66.48 -37.48 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.596 0.698 . . . . 706.9 111.002 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.89 -41.86 92.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 C-N-CA 122.59 0.356 . . . . 633.01 110.488 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.58 -45.02 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 O-C-N 121.665 -0.647 . . . . 298.69 109.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.17 -40.56 86.61 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 114.482 1.29 . . . . 999.99 114.482 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.7 -31.57 40.2 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.227 0 CA-C-N 119.076 0.853 . . . . 351.49 111.209 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.6 p -69.52 -48.63 59.85 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.419 0.688 . . . . 84.92 110.282 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.89 -34.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.192 0 CA-C-N 115.296 -0.865 . . . . 419.9 109.09 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.83 72.88 Favored 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 123.278 0.631 . . . . 172.75 111.039 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.68 68.88 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 115.801 -0.636 . . . . 133.81 111.121 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.62 -45.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 C-N-CA 123.422 0.689 . . . . 127.72 111.716 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.78 -32.83 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 CA-C-N 118.332 0.514 . . . . 521.39 110.432 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 49.6 tp -63.98 -36.16 83.06 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.482 0.713 . . . . 316.63 112.194 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.8 -52.64 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 122.838 0.455 . . . . 300.01 110.357 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.2 -37.5 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 O-C-N 121.807 -0.558 . . . . 384.53 112.162 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.23 85.35 Favored 'General case' 0 N--CA 1.536 3.836 0 N-CA-C 112.818 0.673 . . . . 153.06 112.818 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 -34.28 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.648 0 N-CA-C 109.838 -0.431 . . . . 357.19 109.838 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -69.76 -42.59 73.65 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 109.647 -0.501 . . . . 719.11 109.647 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.46 -31.96 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.3 0.64 . . . . 610.06 109.474 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.7 t -65.07 -39.37 93.13 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.188 0.595 . . . . 404.36 110.467 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.67 -33.02 53.52 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.645 0.778 . . . . 999.99 110.328 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 77.8 p -63.42 -24.1 67.69 Favored 'General case' 0 N--CA 1.533 3.698 0 CA-C-O 120.9 0.381 . . . . 406.88 110.409 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.93 -33.16 30.49 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 124.094 0.958 . . . . 836.08 109.577 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 47.0 tp -93.71 -8.25 41.36 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 124.619 1.167 . . . . 952.15 111.832 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -115.24 13.3 16.68 Favored 'General case' 0 N--CA 1.536 3.85 0 N-CA-C 105.935 -1.876 . . . . 999.99 105.935 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -64.06 169.85 4.06 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.832 1.253 . . . . 999.99 108.075 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -53.17 -9.54 0.16 Allowed 'General case' 0 N--CA 1.537 3.889 0 CA-C-N 114.498 -1.228 . . . . 999.99 111.545 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 85.6 t -134.11 120.77 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 N-CA-C 104.399 -2.445 . . . . 999.99 104.399 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.05 142.21 44.27 Favored Pre-proline 0 N--CA 1.521 3.083 0 C-N-CA 125.731 1.612 . . . . 999.99 107.531 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 1 N--CA 1.54 4.239 0 CA-C-N 122.487 1.924 . . . . 999.99 110.588 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 CA--C 1.58 2.124 0 N-CA-C 108.579 -0.897 . . . . 999.99 108.579 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -59.74 -76.95 0.02 OUTLIER 'Trans proline' 1 N--CA 1.544 4.487 0 C-N-CA 121.823 1.682 . . . . 999.99 111.233 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 58.78 73.3 0.48 Allowed Glycine 1 N--CA 1.518 4.15 0 C-N-CA 123.602 0.62 . . . . 999.99 112.223 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 67.9 m -158.9 21.03 0.2 Allowed 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 123.611 0.764 . . . . 999.99 110.374 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.21 -38.87 50.52 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 124.827 1.251 . . . . 966.02 107.766 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 63.4 m -55.81 -29.29 59.52 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 114.978 -1.01 . . . . 459.36 111.41 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.3 -35.82 56.22 Favored Glycine 1 N--CA 1.517 4.047 0 CA-C-N 115.444 -0.798 . . . . 156.55 111.417 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.6 mm -65.87 -36.92 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.747 0.819 . . . . 509.04 110.187 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -65.72 -40.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.59 0 C-N-CA 123.151 0.58 . . . . 522.79 109.834 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 83.4 mt -70.08 -38.33 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.421 0.688 . . . . 339.37 109.302 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -62.04 -47.44 84.72 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.504 0.927 . . . . 999.99 113.504 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 15.2 m -59.24 -27.86 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 O-C-N 122.28 -0.262 . . . . 439.1 111.223 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.0 p -66.23 -48.22 71.26 Favored 'General case' 0 N--CA 1.535 3.816 0 CA-C-O 121.39 0.614 . . . . 106.26 110.368 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.13 -51.61 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 CA-C-N 115.281 -0.872 . . . . 361.56 109.076 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.23 -34.69 61.27 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 122.889 0.476 . . . . 142.95 111.545 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.86 92.38 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 122.717 0.407 . . . . 115.72 111.166 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 80.5 t -69.75 -46.74 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 N-CA-C 109.471 -0.566 . . . . 251.43 109.471 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.5 -33.81 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.281 0.632 . . . . 426.62 110.192 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.27 -39.46 92.64 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.778 0.431 . . . . 324.0 110.632 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.01 -46.91 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 109.042 -0.725 . . . . 295.24 109.042 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.25 -36.73 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.199 1.0 . . . . 347.1 111.344 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.0 -31.59 67.08 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.72 0.637 . . . . 136.6 112.72 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.97 -44.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 CA-C-N 118.473 0.579 . . . . 338.63 109.661 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -66.06 -42.62 89.21 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 122.842 0.457 . . . . 652.28 110.202 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.08 -38.73 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 N-CA-C 109.509 -0.552 . . . . 530.36 109.509 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.13 -48.48 67.97 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.003 0.521 . . . . 422.11 111.418 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.73 -42.12 70.97 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.601 0.76 . . . . 999.99 111.112 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 98.4 p -63.8 -13.33 43.29 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 119.228 -0.415 . . . . 357.85 111.308 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -37.94 12.99 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.704 0.801 . . . . 999.99 109.214 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.9 tp -80.88 -27.77 36.22 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.329 0.652 . . . . 784.75 110.728 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -90.27 -3.81 57.57 Favored 'General case' 0 N--CA 1.539 3.983 0 C-N-CA 123.738 0.815 . . . . 999.99 110.314 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.23 -6.42 28.96 Favored 'General case' 0 N--CA 1.535 3.795 0 C-N-CA 122.866 0.466 . . . . 999.99 109.82 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.0 6.1 5.74 Favored 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 124.721 1.208 . . . . 999.99 111.236 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.82 122.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 107.47 -1.307 . . . . 999.99 107.47 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.33 114.16 64.37 Favored Pre-proline 0 N--CA 1.527 3.402 0 CA-C-O 116.822 -1.561 . . . . 999.99 107.083 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 1 N--CA 1.547 4.644 0 C-N-CA 122.465 2.11 . . . . 999.99 114.26 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 2.001 0 N-CA-C 109.366 -0.605 . . . . 999.99 109.366 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.31 42.03 0.96 Allowed 'Trans proline' 1 N--CA 1.541 4.309 0 C-N-CA 122.416 2.077 . . . . 999.99 110.271 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.23 28.09 Favored Glycine 1 N--CA 1.519 4.208 0 N-CA-C 110.976 -0.849 . . . . 999.99 110.976 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.0 t -167.77 71.14 0.1 Allowed 'General case' 0 N--CA 1.517 2.924 0 C-N-CA 123.787 0.835 . . . . 999.99 108.999 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.92 -18.2 65.02 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 123.416 0.686 . . . . 803.81 110.887 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -70.2 -22.52 62.93 Favored 'General case' 0 N--CA 1.52 3.033 0 C-N-CA 122.889 0.476 . . . . 591.55 109.996 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.4 -50.73 9.39 Favored Glycine 0 N--CA 1.512 3.751 0 CA-C-N 115.926 -0.579 . . . . 143.79 113.157 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.0 tp -66.41 -37.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 117.481 0.641 . . . . 552.88 110.918 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.62 -41.08 88.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 C-N-CA 122.617 0.367 . . . . 670.5 110.189 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.42 -38.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 109.37 -0.604 . . . . 381.83 109.37 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.49 -46.38 83.25 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.995 1.109 . . . . 999.99 113.995 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.85 -27.89 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.966 0 CA-C-N 118.133 0.424 . . . . 410.68 111.424 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 23.9 p -69.79 -48.22 59.99 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-O 121.401 0.62 . . . . 97.17 110.227 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.96 -47.72 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 CA-C-N 115.321 -0.854 . . . . 375.31 108.967 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.62 56.12 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.246 0.618 . . . . 136.07 111.504 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.21 -44.01 85.08 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 122.969 0.508 . . . . 130.67 110.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.11 -41.55 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.323 0.649 . . . . 278.98 109.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.58 -35.28 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.396 0.678 . . . . 439.4 109.935 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.4 -42.41 96.12 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.989 0.516 . . . . 228.94 111.953 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.27 -51.3 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 C-N-CA 123.186 0.594 . . . . 310.41 111.196 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.31 -36.85 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 112.751 0.648 . . . . 362.96 112.751 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.11 -44.71 87.84 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.281 0.845 . . . . 164.95 113.281 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 30.0 m -59.45 -34.69 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 CA-C-N 118.69 0.677 . . . . 308.08 110.594 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -71.32 -42.26 68.82 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 109.615 -0.513 . . . . 644.67 109.615 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.82 -40.03 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 N-CA-C 109.153 -0.684 . . . . 411.19 109.153 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.4 m -67.09 -40.25 86.92 Favored 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 109.525 -0.546 . . . . 351.75 109.525 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.16 -28.89 62.48 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.71 0.804 . . . . 999.99 110.139 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.6 t -69.16 -37.91 78.46 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 122.788 0.435 . . . . 491.67 110.233 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.03 -37.56 83.02 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.103 0.961 . . . . 842.81 112.156 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.52 -27.5 37.62 Favored 'General case' 0 N--CA 1.538 3.954 0 N-CA-C 108.831 -0.803 . . . . 904.38 108.831 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -89.26 -4.2 58.25 Favored 'General case' 0 N--CA 1.537 3.92 0 C-N-CA 123.375 0.67 . . . . 999.99 110.002 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -86.09 -25.88 25.59 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.582 0.753 . . . . 999.99 109.09 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -66.02 -33.23 75.34 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 124.217 1.007 . . . . 999.99 110.088 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.2 122.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 N-CA-C 107.418 -1.327 . . . . 999.99 107.418 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.04 141.92 23.91 Favored Pre-proline 0 N--CA 1.527 3.398 0 N-CA-C 107.408 -1.33 . . . . 999.99 107.408 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 1 N--CA 1.539 4.199 0 C-N-CA 122.006 1.804 . . . . 999.99 110.688 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.572 1.804 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.96 -167.55 0.36 Allowed 'Trans proline' 1 N--CA 1.54 4.222 0 C-N-CA 122.223 1.949 . . . . 0.0 110.257 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -165.08 33.91 0.25 Allowed Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.9 p -167.47 179.69 4.82 Favored 'General case' 0 N--CA 1.52 3.058 0 C-N-CA 124.34 1.056 . . . . 0.0 108.735 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt -159.98 -37.71 0.05 Allowed 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.6 m -70.74 -30.43 66.94 Favored 'General case' 0 N--CA 1.524 3.272 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.54 -50.07 70.3 Favored Glycine 0 N--CA 1.514 3.899 0 CA-C-N 114.808 -1.087 . . . . 0.0 114.477 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.7 tp -58.72 -35.91 57.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 CA-C-N 117.863 0.831 . . . . 0.0 110.61 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.64 -34.48 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.077 0.551 . . . . 0.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.69 -45.11 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -67.19 -46.36 74.15 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.71 -40.63 76.56 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 49.9 p -64.75 -49.22 71.64 Favored 'General case' 0 N--CA 1.528 3.43 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.24 -31.59 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.71 71.59 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.825 0.45 . . . . 0.0 111.928 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.88 70.87 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.48 0.312 . . . . 0.0 111.418 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -68.68 -50.93 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 123.514 0.726 . . . . 0.0 111.502 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.29 -31.89 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 122.064 -0.397 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -47.14 66.4 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 123.561 0.744 . . . . 0.0 110.889 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.5 mm -67.77 -42.95 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 C-N-CA 122.794 0.438 . . . . 0.0 110.437 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.4 -39.69 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.576 0.75 . . . . 0.0 111.756 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.27 85.86 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.71 0.404 . . . . 0.0 111.981 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.63 -33.58 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.76 -42.82 99.48 Favored 'General case' 0 N--CA 1.538 3.966 0 C-N-CA 123.245 0.618 . . . . 0.0 110.903 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.96 -32.63 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.955 0.502 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.23 -45.1 89.68 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 122.903 0.481 . . . . 0.0 111.401 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.67 -37.31 73.67 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.222 0.609 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.2 t -63.87 -28.77 70.07 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.414 0.686 . . . . 0.0 111.82 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 59.9 tp -73.74 -37.54 65.03 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 123.688 0.795 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 58.9 mt -88.28 -26.16 22.44 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -89.45 7.59 35.25 Favored 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 123.372 0.669 . . . . 0.0 110.274 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -77.96 -12.76 60.01 Favored 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.5 mttp 74.19 -18.12 0.42 Allowed 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 125.598 1.559 . . . . 0.0 111.105 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.87 130.54 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.74 141.89 24.39 Favored Pre-proline 0 N--CA 1.529 3.496 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 1 N--CA 1.54 4.211 0 CA-C-N 122.274 1.848 . . . . 0.0 110.591 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.586 2.356 0 CA-C-O 117.436 -1.268 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.82 88.99 1.05 Allowed 'Trans proline' 0 N--CA 1.535 3.964 0 CA-C-N 122.694 1.998 . . . . 0.0 110.803 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.03 -172.53 43.79 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.685 0.659 . . . . 0.0 111.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 26.2 t 61.62 149.23 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.687 1.195 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.55 30.23 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.341 1.057 . . . . 0.0 108.987 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 64.6 m -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 122.652 0.381 . . . . 0.0 111.067 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.44 -50.6 8.06 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.327 0.489 . . . . 0.0 113.912 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.87 -41.03 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.18 -34.04 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 118.874 0.761 . . . . 0.0 111.745 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.37 -44.83 99.63 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.085 0 CA-C-O 120.985 0.421 . . . . 0.0 110.174 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -61.22 -36.9 81.19 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.501 0.72 . . . . 0.0 111.983 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 -36.39 63.17 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.206 0 CA-C-N 118.343 0.52 . . . . 0.0 111.29 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' THR . . . . . 0.455 ' HG1' ' H ' ' B' ' 220' ' ' VAL . 10.2 p -66.67 -49.8 64.99 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . 0.455 ' H ' ' HG1' ' B' ' 219' ' ' THR . 8.3 p -71.34 -31.9 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.79 79.68 Favored 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 122.768 0.427 . . . . 0.0 111.217 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.36 69.31 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 122.936 0.494 . . . . 0.0 112.106 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.59 -43.07 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.493 0 C-N-CA 123.453 0.701 . . . . 0.0 111.973 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.88 -32.59 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 CA-C-N 118.7 0.682 . . . . 0.0 110.36 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.77 -38.7 75.91 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.172 0.589 . . . . 0.0 111.24 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.11 -52.09 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 CA-C-O 122.04 0.924 . . . . 0.0 109.621 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.59 -36.4 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 C-N-CA 126.02 1.728 . . . . 0.0 113.135 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.47 66.35 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.29 -38.1 76.98 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 118.971 0.805 . . . . 0.0 110.218 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.48 -41.98 75.41 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.112 0.565 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.46 -33.57 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 C-N-CA 122.914 0.486 . . . . 0.0 110.128 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.6 m -67.52 -44.38 78.53 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 121.576 0.703 . . . . 0.0 109.674 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.66 -27.07 65.66 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 124.59 1.156 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.5 t -67.51 -15.85 63.89 Favored 'General case' 0 N--CA 1.52 3.047 0 C-N-CA 123.138 0.575 . . . . 0.0 111.972 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.22 -37.31 13.4 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.57 0.748 . . . . 0.0 111.468 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.4 mp -80.7 -27.73 36.88 Favored 'General case' 0 N--CA 1.537 3.923 0 C-N-CA 123.025 0.53 . . . . 0.0 110.34 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -89.87 -2.69 58.25 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.591 0.757 . . . . 0.0 110.603 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.15 33.05 4.97 Favored 'General case' 0 N--CA 1.536 3.839 0 C-N-CA 124.488 1.115 . . . . 0.0 108.859 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -146.02 -52.3 0.25 Allowed 'General case' 0 N--CA 1.527 3.395 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.5 t -83.82 122.62 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.0 mp -93.77 141.72 24.15 Favored Pre-proline 0 N--CA 1.529 3.478 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 1 N--CA 1.539 4.167 0 CA-C-N 122.398 1.892 . . . . 0.0 110.684 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.574 1.868 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.9 164.63 35.03 Favored 'Trans proline' 1 N--CA 1.537 4.081 0 C-N-CA 122.286 1.991 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.54 33.5 0.08 OUTLIER Glycine 1 N--CA 1.519 4.168 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -166.76 45.1 0.06 Allowed 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.57 -8.77 36.85 Favored 'General case' 0 N--CA 1.528 3.43 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.908 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 -20.56 62.82 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.275 0.63 . . . . 0.0 109.91 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.29 58.6 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 124.053 0.835 . . . . 0.0 114.109 -177.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.5 tt -61.07 -35.57 66.38 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 CA-C-N 117.844 0.822 . . . . 0.0 110.513 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.4 mm -54.71 -33.96 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 C-N-CA 123.401 0.68 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 34.8 mm -69.26 -41.9 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 CA-C-O 121.262 0.553 . . . . 0.0 109.573 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -66.03 -42.45 89.59 Favored 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -57.94 -32.94 44.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.341 0 CA-C-N 119.354 0.979 . . . . 0.0 111.329 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 -48.45 72.36 Favored 'General case' 0 N--CA 1.531 3.608 0 C-N-CA 123.586 0.754 . . . . 0.0 110.979 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.18 -36.92 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.39 0 C-N-CA 123.781 0.832 . . . . 0.0 109.434 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.61 77.27 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 123.442 0.697 . . . . 0.0 111.221 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.97 -38.27 79.27 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 123.131 0.573 . . . . 0.0 112.099 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.19 -46.24 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 C-N-CA 122.729 0.411 . . . . 0.0 111.479 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.16 -32.51 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.643 0 CA-C-N 118.331 0.514 . . . . 0.0 110.305 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 55.0 tp -59.21 -43.59 92.26 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 122.983 0.513 . . . . 0.0 110.78 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.36 -54.13 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.12 -37.19 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.621 1.168 . . . . 0.0 114.082 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.0 71.82 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 119.223 0.92 . . . . 0.0 110.925 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.28 -41.93 72.76 Favored 'General case' 0 N--CA 1.53 3.568 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.01 -35.57 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.55 -48.09 67.97 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.139 0.576 . . . . 0.0 111.748 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.08 -24.88 67.38 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 123.485 0.714 . . . . 0.0 111.643 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 77.1 p -63.62 -19.52 64.93 Favored 'General case' 0 N--CA 1.53 3.529 0 C-N-CA 122.799 0.44 . . . . 0.0 111.515 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.27 -37.27 21.93 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -84.46 -24.7 29.36 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 123.875 0.87 . . . . 0.0 110.543 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -89.6 -0.24 57.39 Favored 'General case' 0 N--CA 1.538 3.948 0 C-N-CA 123.705 0.802 . . . . 0.0 109.866 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -124.5 33.77 5.17 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 124.809 1.244 . . . . 0.0 108.278 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.37 -67.99 0.09 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.55 133.12 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 50.6 mt -93.71 125.89 51.76 Favored Pre-proline 0 N--CA 1.524 3.247 0 CA-C-O 116.626 -1.654 . . . . 0.0 108.518 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 1 N--CA 1.538 4.102 0 CA-C-N 123.289 2.21 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 79.3 mmm . . . . . 0 CA--C 1.573 1.829 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.59 -166.17 0.26 Allowed 'Trans proline' 1 N--CA 1.541 4.271 0 C-N-CA 122.17 1.913 . . . . 0.0 109.84 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.1 13.23 Favored Glycine 1 N--CA 1.519 4.181 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.7 m -56.62 89.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.994 0.918 . . . . 0.0 111.616 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.07 8.48 2.96 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 124.732 1.213 . . . . 0.0 109.887 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.4 m -66.49 -40.04 89.06 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 123.213 0.605 . . . . 0.0 110.527 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.62 -37.4 77.3 Favored Glycine 1 N--CA 1.517 4.088 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.685 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.24 -38.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 C-N-CA 124.45 1.1 . . . . 0.0 110.593 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.08 -38.31 79.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.0 mt -70.11 -37.43 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.08 -47.92 83.47 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.46 -30.93 37.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.395 0 CA-C-N 118.41 0.55 . . . . 0.0 112.218 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -72.2 -48.11 45.62 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 123.47 0.708 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.45 -31.95 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.32 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.24 -34.96 64.45 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.96 -45.47 64.08 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-O 121.162 0.506 . . . . 0.0 111.887 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.15 -38.43 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.886 0.875 . . . . 0.0 112.693 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.44 -32.59 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 CA-C-N 119.334 0.97 . . . . 0.0 111.667 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.05 -47.83 75.97 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.92 -44.96 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.52 -41.08 85.52 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.25 0 CA-C-N 119.53 1.059 . . . . 0.0 112.986 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.34 -43.47 92.74 Favored 'General case' 0 N--CA 1.53 3.549 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.86 -34.54 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.16 -42.36 69.19 Favored 'General case' 1 N--CA 1.539 4.005 0 CA-C-N 118.831 0.741 . . . . 0.0 109.819 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.25 -34.96 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.572 0.749 . . . . 0.0 109.792 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.92 -43.13 84.07 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.282 0.633 . . . . 0.0 111.012 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 123.9 0.88 . . . . 0.0 111.273 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.76 -16.23 60.65 Favored 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 123.215 0.606 . . . . 0.0 111.814 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 mt -91.21 -37.59 13.23 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.854 0.861 . . . . 0.0 111.308 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.47 -27.39 27.53 Favored 'General case' 1 N--CA 1.541 4.086 0 C-N-CA 123.489 0.716 . . . . 0.0 110.589 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -100.09 13.17 35.02 Favored 'General case' 1 N--CA 1.54 4.027 0 C-N-CA 124.333 1.053 . . . . 0.0 109.223 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.01 -27.49 69.16 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.786 0.835 . . . . 0.0 110.372 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -167.12 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 123.226 0.61 . . . . 0.0 109.825 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.37 127.85 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.3 mt -118.3 141.81 30.19 Favored Pre-proline 0 N--CA 1.53 3.548 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.1 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 1 N--CA 1.541 4.281 0 CA-C-N 122.47 1.918 . . . . 0.0 110.837 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.581 2.152 0 CA-C-O 117.609 -1.186 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.63 -168.26 0.34 Allowed 'Trans proline' 0 N--CA 1.534 3.868 0 C-N-CA 122.593 2.195 . . . . 0.0 110.718 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.03 -141.24 3.4 Favored Glycine 1 N--CA 1.52 4.287 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t 61.4 47.68 6.59 Favored 'General case' 0 N--CA 1.519 2.982 0 C-N-CA 124.221 1.008 . . . . 0.0 111.535 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.36 18.16 0.57 Allowed 'General case' 0 N--CA 1.528 3.456 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.204 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.8 p -64.97 -20.7 66.62 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 121.887 -0.508 . . . . 0.0 110.508 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -49.23 14.87 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 124.202 0.906 . . . . 0.0 113.17 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -36.64 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.347 0 C-N-CA 123.262 0.625 . . . . 0.0 110.163 -177.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.41 -34.09 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 21.1 mm -67.29 -40.62 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 CA-C-O 121.386 0.612 . . . . 0.0 109.958 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -64.63 -46.42 82.64 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 m -62.56 -34.13 63.33 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 CA-C-N 118.495 0.589 . . . . 0.0 112.334 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 66.8 p -66.36 -49.22 67.65 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.119 0.568 . . . . 0.0 112.192 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.76 -37.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.62 88.09 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 122.582 0.353 . . . . 0.0 110.713 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.73 95.68 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 122.962 0.505 . . . . 0.0 111.817 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.3 -45.34 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.5 -32.93 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 C-N-CA 123.689 0.795 . . . . 0.0 109.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.8 tp -60.51 -40.82 92.83 Favored 'General case' 0 N--CA 1.535 3.783 0 C-N-CA 122.739 0.415 . . . . 0.0 110.577 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.46 -53.83 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.494 0.664 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.52 -37.96 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 124.208 1.003 . . . . 0.0 113.054 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.64 90.61 Favored 'General case' 1 N--CA 1.54 4.038 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.25 -34.34 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 C-N-CA 122.942 0.497 . . . . 0.0 109.883 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -43.25 79.87 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 122.657 0.383 . . . . 0.0 111.582 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.09 -31.65 51.03 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.47 0.577 . . . . 0.0 110.31 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.68 -45.03 93.31 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.152 0.581 . . . . 0.0 111.982 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -70.35 -24.87 63.05 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.169 0.587 . . . . 0.0 111.592 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.532 3.671 0 CA-C-N 118.413 0.552 . . . . 0.0 110.503 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.3 -14.33 31.03 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.645 1.178 . . . . 0.0 110.406 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.6 tp -80.16 -28.06 38.88 Favored 'General case' 0 N--CA 1.536 3.857 0 CA-C-N 118.405 0.548 . . . . 0.0 111.425 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -110.5 4.63 20.62 Favored 'General case' 1 N--CA 1.558 4.939 0 C-N-CA 122.993 0.517 . . . . 0.0 111.392 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.74 -19.85 62.69 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.037 0.535 . . . . 0.0 109.884 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 61.9 mttm 70.71 8.99 6.76 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 124.621 1.168 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.55 122.2 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.8 mp -94.05 141.74 24.06 Favored Pre-proline 0 N--CA 1.528 3.47 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 1 N--CA 1.539 4.187 0 CA-C-N 122.253 1.84 . . . . 0.0 110.603 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.575 1.918 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.93 -177.52 2.95 Favored 'Trans proline' 1 N--CA 1.538 4.119 0 C-N-CA 122.344 2.029 . . . . 0.0 110.337 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.55 170.59 27.11 Favored Glycine 1 N--CA 1.519 4.201 0 O-C-N 123.672 0.607 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -66.97 133.27 49.63 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.714 0.806 . . . . 0.0 110.374 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -166.48 -45.58 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -68.81 -34.14 75.03 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.931 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.53 -31.14 65.76 Favored Glycine 0 N--CA 1.514 3.897 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.406 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.86 -36.69 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 123.856 0.862 . . . . 0.0 110.46 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.06 -36.32 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 123.197 0.599 . . . . 0.0 109.649 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.51 -39.09 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -64.04 -41.75 97.3 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.45 -27.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-N 118.842 0.746 . . . . 0.0 111.486 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -68.54 -49.42 59.69 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.89 -38.44 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.75 68.29 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 123.038 0.535 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.41 91.67 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.155 0.582 . . . . 0.0 111.395 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.03 -43.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.723 0.809 . . . . 0.0 109.166 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -32.91 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 C-N-CA 123.953 0.901 . . . . 0.0 109.785 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -47.43 79.53 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.3 -55.86 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 19.9 m -68.35 -38.38 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.83 Favored 'General case' 0 N--CA 1.534 3.732 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.32 -34.73 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.884 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.87 -42.63 69.81 Favored 'General case' 1 N--CA 1.539 4.006 0 CA-C-N 119.559 1.072 . . . . 0.0 111.419 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 32.3 m -68.63 -31.24 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 122.066 -0.396 . . . . 0.0 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.21 -48.19 81.11 Favored 'General case' 0 N--CA 1.523 3.208 0 C-N-CA 123.203 0.601 . . . . 0.0 111.615 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.3 -29.06 63.5 Favored 'General case' 0 N--CA 1.527 3.396 0 C-N-CA 123.159 0.583 . . . . 0.0 110.709 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.68 -27.99 69.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.232 0.613 . . . . 0.0 111.556 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.2 tp -73.03 -37.54 66.87 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.65 0.78 . . . . 0.0 110.666 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.89 -27.13 22.37 Favored 'General case' 0 N--CA 1.539 3.994 0 C-N-CA 123.828 0.851 . . . . 0.0 109.861 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -88.9 13.64 12.25 Favored 'General case' 0 N--CA 1.536 3.867 0 C-N-CA 123.594 0.758 . . . . 0.0 109.92 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.479 ' C ' ' H ' ' C' ' 240' ' ' VAL . 63.4 tttp -132.36 -53.66 0.96 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 65.21 -19.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 125.053 1.341 . . . . 0.0 112.429 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' C' ' 238' ' ' LYS . 91.1 t -88.4 122.4 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -94.53 141.71 23.82 Favored Pre-proline 0 N--CA 1.525 3.296 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.301 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo . . . . . 1 N--CA 1.54 4.222 0 CA-C-N 122.389 1.889 . . . . 0.0 110.697 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 CA--C 1.576 1.952 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -52.17 -39.28 71.65 Favored 'Trans proline' 1 N--CA 1.548 4.725 0 CA-C-N 122.46 1.914 . . . . 0.0 113.264 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 176.88 172.27 41.32 Favored Glycine 1 N--CA 1.518 4.162 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.7 p -167.93 80.31 0.17 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.971 0.908 . . . . 0.0 108.79 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.63 -0.83 0.05 Allowed 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.432 0.693 . . . . 0.0 112.501 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.9 m -70.01 -40.23 75.38 Favored 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.477 0.711 . . . . 0.0 110.522 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.49 -29.53 74.97 Favored Glycine 1 N--CA 1.517 4.092 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.903 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.06 -36.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 123.62 0.768 . . . . 0.0 110.504 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.26 -36.64 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 C-N-CA 122.879 0.472 . . . . 0.0 110.383 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.18 -42.89 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 CA-C-O 121.802 0.811 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.99 -44.48 92.56 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.31 -33.27 53.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 CA-C-N 118.898 0.772 . . . . 0.0 112.117 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -66.82 -49.67 65.04 Favored 'General case' 0 N--CA 1.529 3.501 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.09 -37.24 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.82 -34.85 70.11 Favored 'General case' 0 N--CA 1.526 3.346 0 C-N-CA 122.664 0.386 . . . . 0.0 111.281 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.94 97.74 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 122.966 0.506 . . . . 0.0 111.727 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.05 -41.4 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.466 0 C-N-CA 123.538 0.735 . . . . 0.0 109.828 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.0 t -67.33 -32.82 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.791 0.836 . . . . 0.0 110.132 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.81 -48.05 73.02 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 18.6 tt -71.24 -44.46 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.8 m -66.86 -37.37 79.3 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.537 0 CA-C-N 120.447 1.476 . . . . 0.0 112.364 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.11 -31.84 69.29 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.62 -35.08 73.76 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.083 0.856 . . . . 0.0 111.011 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.89 -37.27 81.53 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-O 120.893 0.378 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.05 -40.66 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 C-N-CA 123.748 0.819 . . . . 0.0 109.792 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.79 -42.18 86.43 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.348 0.659 . . . . 0.0 110.472 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.566 ' HZ3' ' HE1' ' A' ' 237' ' ' TRP . 65.8 tttm -56.06 -29.39 60.44 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 124.46 1.104 . . . . 0.0 111.901 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.4 t -63.86 -22.79 67.08 Favored 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 122.914 0.485 . . . . 0.0 111.558 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -90.63 -18.18 25.59 Favored 'General case' 0 N--CA 1.534 3.733 0 C-N-CA 123.78 0.832 . . . . 0.0 109.956 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.23 -27.79 38.66 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.566 ' HE1' ' HZ3' ' A' ' 233' ' ' LYS . 92.7 m95 -89.25 13.57 13.06 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.028 0.531 . . . . 0.0 110.073 178.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -129.19 6.98 5.41 Favored 'General case' 0 N--CA 1.534 3.73 0 C-N-CA 125.007 1.323 . . . . 0.0 109.175 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.88 -31.99 70.11 Favored 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 124.098 0.959 . . . . 0.0 108.921 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.43 122.16 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.63 141.8 23.38 Favored Pre-proline 0 N--CA 1.532 3.664 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 1 N--CA 1.541 4.287 0 CA-C-N 122.296 1.856 . . . . 0.0 110.508 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 CA--C 1.57 1.712 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.14 71.19 3.64 Favored 'Trans proline' 1 N--CA 1.54 4.207 0 C-N-CA 122.1 1.867 . . . . 0.0 110.12 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.41 -150.51 51.76 Favored Glycine 1 N--CA 1.521 4.328 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -163.56 37.63 0.09 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-O 121.855 0.836 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 mt 54.7 9.07 0.25 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.207 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -43.07 98.94 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.986 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.03 60.45 Favored Glycine 1 N--CA 1.519 4.194 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.367 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.63 -45.97 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.245 0 C-N-CA 124.056 0.942 . . . . 0.0 111.255 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.24 -36.8 77.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.078 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.15 -39.52 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 123.335 0.654 . . . . 0.0 109.32 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -67.01 -44.31 80.63 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 23.5 m -57.71 -27.94 31.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 CA-C-N 118.984 0.811 . . . . 0.0 111.756 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' THR . . . . . 0.463 ' HG1' ' H ' ' B' ' 220' ' ' VAL . 26.4 p -71.9 -48.58 44.56 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.329 0.651 . . . . 0.0 110.301 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . 0.463 ' H ' ' HG1' ' B' ' 219' ' ' THR . 48.1 t -69.07 -31.81 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.306 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.56 81.56 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.409 0.683 . . . . 0.0 111.384 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.94 98.77 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 121.153 0.501 . . . . 0.0 111.499 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.08 -38.5 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 123.766 0.826 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -33.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.446 0.698 . . . . 0.0 111.394 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.58 -39.01 92.33 Favored 'General case' 0 N--CA 1.533 3.676 0 C-N-CA 122.454 0.302 . . . . 0.0 111.561 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.16 -55.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.77 -36.5 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.01 0.924 . . . . 0.0 113.237 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.39 67.72 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.35 -40.35 85.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 119.072 0.851 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -63.07 -38.97 93.3 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 122.641 0.376 . . . . 0.0 110.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.36 -39.8 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 C-N-CA 123.632 0.773 . . . . 0.0 109.703 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.81 -45.69 77.52 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.77 0.828 . . . . 0.0 110.995 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -70.49 -41.88 72.1 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.864 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 94.2 p -63.15 -27.05 69.11 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 122.834 0.454 . . . . 0.0 110.624 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -79.19 -31.16 43.74 Favored 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.7 tp -80.7 -28.23 36.77 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.07 0.548 . . . . 0.0 110.165 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -95.38 -4.71 44.8 Favored 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 123.525 0.73 . . . . 0.0 109.733 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 63.95 26.75 14.25 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 124.481 1.112 . . . . 0.0 112.418 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.3 -37.72 66.11 Favored 'General case' 0 N--CA 1.525 3.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.3 122.13 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.09 141.54 42.31 Favored Pre-proline 0 N--CA 1.527 3.387 0 CA-C-O 116.435 -1.745 . . . . 0.0 107.031 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 1 N--CA 1.55 4.82 0 CA-C-N 123.279 2.207 . . . . 0.0 114.542 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 CA--C 1.581 2.16 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.34 -23.07 22.59 Favored 'Trans proline' 1 N--CA 1.548 4.733 0 CA-C-N 122.26 1.843 . . . . 0.0 113.155 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.5 145.75 0.07 OUTLIER Glycine 1 N--CA 1.518 4.15 0 C-N-CA 123.871 0.748 . . . . 0.0 111.417 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 33.4 t -70.9 71.82 0.54 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 123.8 0.84 . . . . 0.0 110.448 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.19 -34.88 79.03 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 124.154 0.982 . . . . 0.0 110.1 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -70.91 -20.87 62.44 Favored 'General case' 0 N--CA 1.523 3.211 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.773 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.59 -50.03 16.61 Favored Glycine 0 N--CA 1.512 3.749 0 C-N-CA 124.201 0.905 . . . . 0.0 113.711 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.39 -35.65 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 CA-C-N 117.924 0.862 . . . . 0.0 111.364 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.08 -34.81 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 122.626 0.37 . . . . 0.0 110.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.23 -42.25 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.11 -40.45 97.66 Favored 'General case' 0 N--CA 1.526 3.364 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.57 -27.81 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 119.131 0.878 . . . . 0.0 111.906 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 33.8 p -69.13 -49.61 55.45 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.98 -39.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.57 -34.73 69.51 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 122.906 0.482 . . . . 0.0 111.268 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.26 99.38 Favored 'General case' 0 N--CA 1.522 3.161 0 C-N-CA 123.127 0.571 . . . . 0.0 111.604 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.16 -43.21 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.261 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.94 -32.22 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 123.883 0.873 . . . . 0.0 109.367 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -47.18 74.67 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 122.969 0.508 . . . . 0.0 109.824 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.76 -51.41 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.44 0.696 . . . . 0.0 110.404 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.44 -37.9 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.803 0.841 . . . . 0.0 112.748 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.09 82.85 Favored 'General case' 0 N--CA 1.539 3.977 0 CA-C-N 118.542 0.61 . . . . 0.0 112.186 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.17 -33.68 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.349 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.21 -43.18 99.41 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 123.246 0.618 . . . . 0.0 110.517 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.69 -34.75 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 C-N-CA 123.103 0.561 . . . . 0.0 109.674 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.15 -27.68 69.25 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.259 0.624 . . . . 0.0 111.233 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -62.0 -30.72 71.13 Favored 'General case' 0 N--CA 1.531 3.605 0 C-N-CA 123.527 0.731 . . . . 0.0 110.922 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.35 -24.96 68.08 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.09 0.556 . . . . 0.0 110.946 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.3 mt -91.32 -23.66 20.05 Favored 'General case' 0 N--CA 1.52 3.042 0 C-N-CA 124.218 1.007 . . . . 0.0 110.737 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -28.68 27.43 Favored 'General case' 1 N--CA 1.544 4.27 0 C-N-CA 123.115 0.566 . . . . 0.0 112.258 -176.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.09 14.37 17.05 Favored 'General case' 1 N--CA 1.553 4.691 0 C-N-CA 124.074 0.949 . . . . 0.0 111.747 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -52.5 -23.14 5.69 Favored 'General case' 0 N--CA 1.531 3.617 0 C-N-CA 124.439 1.096 . . . . 0.0 111.107 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -71.29 -35.28 71.25 Favored 'General case' 0 N--CA 1.513 2.678 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.5 122.07 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.512 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.56 114.32 59.1 Favored Pre-proline 0 N--CA 1.532 3.627 0 CA-C-O 116.599 -1.667 . . . . 0.0 107.104 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo . . . . . 1 N--CA 1.547 4.662 0 CA-C-N 123.028 2.117 . . . . 0.0 114.168 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 75.4 mmm . . . . . 0 CA--C 1.573 1.854 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.05 -171.07 0.8 Allowed 'Trans proline' 1 N--CA 1.539 4.168 0 C-N-CA 122.146 1.897 . . . . 0.0 110.006 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.42 159.47 29.47 Favored Glycine 1 N--CA 1.518 4.101 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 90.9 p -169.56 58.51 0.05 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.51 -9.91 0.55 Allowed 'General case' 0 N--CA 1.533 3.676 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.16 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -60.88 -20.35 61.74 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 121.254 0.549 . . . . 0.0 110.758 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.04 97.73 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.729 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.78 -36.03 63.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.127 0 CA-C-N 117.885 0.843 . . . . 0.0 111.679 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.58 -37.58 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.21 0.604 . . . . 0.0 109.708 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.05 -41.06 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -59.61 -48.47 81.52 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 124.5 1.12 . . . . 0.0 114.015 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.8 m -59.7 -32.36 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.914 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -72.15 -48.99 39.49 Favored 'General case' 0 N--CA 1.533 3.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.859 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.62 -32.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.696 0.398 . . . . 0.0 110.044 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.97 74.01 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.235 0.614 . . . . 0.0 111.332 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.44 77.49 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.396 0.278 . . . . 0.0 111.571 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.06 -43.62 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.512 0.725 . . . . 0.0 112.084 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.09 -32.86 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 CA-C-N 118.919 0.781 . . . . 0.0 111.931 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.1 mt -60.65 -36.92 79.87 Favored 'General case' 0 N--CA 1.537 3.898 0 CA-C-N 117.97 0.35 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.08 -47.72 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-O 121.489 0.662 . . . . 0.0 109.332 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.3 t -67.0 -37.73 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.263 0 C-N-CA 124.202 1.001 . . . . 0.0 111.606 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.11 90.25 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.94 -34.5 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 122.777 0.431 . . . . 0.0 109.943 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.81 -42.45 73.67 Favored 'General case' 1 N--CA 1.544 4.273 0 CA-C-N 118.875 0.762 . . . . 0.0 109.564 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.1 -31.66 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.13 -46.26 84.92 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.299 0.64 . . . . 0.0 111.472 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -69.0 -38.11 79.1 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.408 0.683 . . . . 0.0 110.772 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.6 p -63.77 -34.92 78.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 123.206 0.602 . . . . 0.0 110.668 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.78 -37.21 70.48 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 124.091 0.956 . . . . 0.0 109.731 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 59.1 tp -80.26 -27.03 38.7 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.925 0.89 . . . . 0.0 110.397 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -89.27 -1.16 57.96 Favored 'General case' 0 N--CA 1.535 3.818 0 C-N-CA 123.422 0.689 . . . . 0.0 110.549 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -81.4 -29.57 33.91 Favored 'General case' 0 N--CA 1.527 3.392 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -68.15 -40.17 82.44 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.306 1.042 . . . . 0.0 109.967 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.5 122.48 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.32 141.86 23.67 Favored Pre-proline 0 N--CA 1.53 3.54 0 C-N-CA 125.169 1.388 . . . . 0.0 107.284 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 1 N--CA 1.541 4.285 0 CA-C-N 122.235 1.834 . . . . 0.0 110.669 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 CA--C 1.583 2.239 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.86 -29.12 33.53 Favored 'Trans proline' 1 N--CA 1.548 4.703 0 CA-C-N 122.337 1.87 . . . . 0.0 113.515 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.68 53.82 29.2 Favored Glycine 1 N--CA 1.519 4.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 45.4 m 59.06 121.99 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 124.658 1.183 . . . . 0.0 112.006 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -165.39 -49.13 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' SER . . . . . 0.43 ' HG ' ' N ' ' B' ' 213' ' ' GLY . 98.7 p -68.21 -34.76 76.85 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.857 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . 0.43 ' N ' ' HG ' ' B' ' 212' ' ' SER . . . -73.55 -30.27 62.42 Favored Glycine 0 N--CA 1.515 3.917 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.237 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.01 -36.83 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.662 0.785 . . . . 0.0 110.662 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.02 -37.82 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 C-N-CA 123.068 0.547 . . . . 0.0 109.605 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.9 -37.89 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -62.7 -46.41 88.26 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.95 -38.86 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 118.583 0.629 . . . . 0.0 112.074 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -64.46 -48.96 73.3 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.72 -37.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.32 80.54 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.57 0.348 . . . . 0.0 111.097 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.39 70.85 Favored 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.86 -38.61 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 O-C-N 122.121 -0.362 . . . . 0.0 110.416 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.2 t -64.83 -32.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 123.495 0.718 . . . . 0.0 110.016 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.44 -36.91 76.81 Favored 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 122.615 0.366 . . . . 0.0 110.28 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.4 -52.28 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 123.327 0.651 . . . . 0.0 109.435 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.28 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 C-N-CA 124.322 1.049 . . . . 0.0 112.85 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.77 83.42 Favored 'General case' 0 N--CA 1.537 3.916 0 CA-C-N 118.607 0.64 . . . . 0.0 112.338 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -69.33 -33.83 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 C-N-CA 123.497 0.719 . . . . 0.0 109.091 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.56 -42.67 99.18 Favored 'General case' 0 N--CA 1.537 3.892 0 C-N-CA 123.498 0.719 . . . . 0.0 111.33 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.09 -31.76 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.126 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.22 -46.51 80.37 Favored 'General case' 0 N--CA 1.529 3.503 0 CA-C-O 120.776 0.322 . . . . 0.0 111.005 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.66 -25.21 59.04 Favored 'General case' 0 N--CA 1.525 3.308 0 C-N-CA 123.547 0.739 . . . . 0.0 111.021 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 60.5 p -65.17 -33.57 76.33 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.654 0.382 . . . . 0.0 111.065 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 66.5 mt -90.78 -21.1 21.69 Favored 'General case' 0 N--CA 1.531 3.598 0 C-N-CA 124.122 0.969 . . . . 0.0 111.0 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -22.75 40.51 Favored 'General case' 1 N--CA 1.543 4.213 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -88.91 -4.04 58.57 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.79 0.836 . . . . 0.0 110.262 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -76.55 -11.85 59.93 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 72.33 -7.87 1.28 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 124.676 1.19 . . . . 0.0 110.976 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.13 131.48 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.47 114.48 63.49 Favored Pre-proline 0 N--CA 1.525 3.294 0 CA-C-O 116.706 -1.616 . . . . 0.0 107.882 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 1 N--CA 1.548 4.715 0 C-N-CA 122.643 2.229 . . . . 0.0 114.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 CA--C 1.574 1.88 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.32 172.85 12.41 Favored 'Trans proline' 1 N--CA 1.54 4.256 0 C-N-CA 122.344 2.03 . . . . 0.0 110.518 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.9 163.87 31.33 Favored Glycine 1 N--CA 1.517 4.071 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.8 m 56.92 174.18 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 C-N-CA 124.256 1.023 . . . . 0.0 112.208 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt 76.23 -33.56 0.22 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 124.415 1.086 . . . . 0.0 109.566 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 88.2 p -66.63 -39.55 88.33 Favored 'General case' 0 N--CA 1.528 3.438 0 C-N-CA 123.289 0.636 . . . . 0.0 109.931 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.44 -32.79 82.33 Favored Glycine 1 N--CA 1.519 4.201 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.366 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.57 -36.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.73 -34.24 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 C-N-CA 123.713 0.805 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.48 -43.68 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 CA-C-O 121.774 0.797 . . . . 0.0 109.337 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -67.18 -43.51 82.03 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.62 -36.65 55.05 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.288 0 CA-C-N 118.934 0.788 . . . . 0.0 111.47 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -65.95 -48.46 71.26 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.435 0.694 . . . . 0.0 111.149 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.97 -34.76 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.524 0.73 . . . . 0.0 109.826 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.85 75.62 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.04 74.49 Favored 'General case' 0 N--CA 1.519 3.007 0 C-N-CA 122.511 0.324 . . . . 0.0 111.555 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.87 -44.89 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.164 0.586 . . . . 0.0 111.939 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -65.98 -32.85 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 CA-C-N 118.648 0.658 . . . . 0.0 110.834 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.88 -43.19 98.79 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.125 0.57 . . . . 0.0 111.181 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.33 -52.94 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.252 0.621 . . . . 0.0 110.156 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.48 -37.16 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 124.759 1.224 . . . . 0.0 113.726 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.12 -35.86 72.09 Favored 'General case' 0 N--CA 1.537 3.88 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.88 -34.88 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.972 0.806 . . . . 0.0 110.526 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -69.38 -42.3 75.35 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.22 -42.44 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 73.0 m -67.18 -48.07 69.05 Favored 'General case' 0 N--CA 1.528 3.453 0 CA-C-O 121.448 0.642 . . . . 0.0 110.542 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -67.69 -43.08 80.99 Favored 'General case' 0 N--CA 1.523 3.215 0 C-N-CA 124.256 1.022 . . . . 0.0 111.248 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 42.6 t -63.89 -26.26 68.52 Favored 'General case' 0 N--CA 1.53 3.549 0 CA-C-O 121.267 0.556 . . . . 0.0 110.221 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.9 tp -91.2 -14.83 30.31 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 125.016 1.326 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.0 -28.41 39.44 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.637 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -17.91 27.78 Favored 'General case' 1 N--CA 1.559 5.006 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 58.56 26.51 14.47 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.969 0.907 . . . . 0.0 111.473 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt 82.44 9.77 0.72 Allowed 'General case' 0 N--CA 1.532 3.63 0 C-N-CA 124.689 1.195 . . . . 0.0 111.213 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.36 130.3 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.908 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.65 134.59 26.24 Favored Pre-proline 0 N--CA 1.527 3.407 0 CA-C-O 116.779 -1.581 . . . . 0.0 108.482 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 1 N--CA 1.539 4.169 0 CA-C-N 122.999 2.107 . . . . 0.0 110.823 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.572 1.806 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.85 163.66 37.77 Favored 'Trans proline' 1 N--CA 1.539 4.163 0 C-N-CA 122.176 1.918 . . . . 0.0 110.049 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.96 154.85 53.51 Favored Glycine 1 N--CA 1.518 4.15 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.3 t -73.97 127.5 33.06 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 123.675 0.79 . . . . 0.0 110.21 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tp 65.31 -0.37 1.15 Allowed 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.952 0.901 . . . . 0.0 111.723 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -70.42 -23.1 62.68 Favored 'General case' 0 N--CA 1.524 3.24 0 C-N-CA 123.307 0.643 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.99 -50.29 8.79 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.491 0.567 . . . . 0.0 113.893 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.74 -36.92 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -59.24 -33.22 50.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 118.57 0.623 . . . . 0.0 111.022 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.65 -43.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.32 -34.73 77.96 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.48 -36.95 55.33 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.511 0 CA-C-N 119.906 1.23 . . . . 0.0 111.562 -175.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' THR . . . . . 0.468 ' HG1' ' H ' ' A' ' 220' ' ' VAL . 31.1 p -67.1 -48.58 67.74 Favored 'General case' 0 N--CA 1.525 3.312 0 C-N-CA 123.547 0.739 . . . . 0.0 110.358 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . 0.468 ' H ' ' HG1' ' A' ' 219' ' ' THR . 48.4 t -67.42 -31.87 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.92 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.94 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.115 0.566 . . . . 0.0 111.378 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.35 72.97 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 122.879 0.472 . . . . 0.0 111.689 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.95 -46.2 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.42 0 C-N-CA 123.377 0.671 . . . . 0.0 111.892 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.47 -32.42 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 CA-C-N 118.057 0.39 . . . . 0.0 111.074 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.02 -47.68 61.13 Favored 'General case' 0 N--CA 1.525 3.289 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.65 -41.53 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.7 -47.91 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.6 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.42 89.26 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.13 -37.61 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.612 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -34.09 65.56 Favored 'General case' 1 N--CA 1.549 4.512 0 CA-C-N 120.371 1.441 . . . . 0.0 109.991 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.78 -33.51 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.18 -33.15 74.87 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.77 27.66 Favored 'General case' 1 N--CA 1.541 4.105 0 CA-C-N 118.968 0.804 . . . . 0.0 110.443 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 33.7 t -63.03 -43.36 98.91 Favored 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -86.88 -14.67 41.3 Favored 'General case' 1 N--CA 1.549 4.515 0 CA-C-N 118.229 0.468 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.56 -28.63 37.19 Favored 'General case' 0 N--CA 1.538 3.964 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -114.34 -5.69 12.93 Favored 'General case' 1 N--CA 1.542 4.129 0 C-N-CA 124.515 1.126 . . . . 0.0 109.999 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 62.81 40.62 9.64 Favored 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 125.044 1.338 . . . . 0.0 112.314 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 65.18 3.18 2.11 Favored 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 122.75 64.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.6 mt -96.37 141.86 23.73 Favored Pre-proline 0 N--CA 1.525 3.279 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.83 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 1 N--CA 1.54 4.261 0 CA-C-N 122.4 1.893 . . . . 0.0 110.716 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 CA--C 1.585 2.315 0 CA-C-O 117.517 -1.23 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -88.24 74.54 2.07 Favored 'Trans proline' 0 N--CA 1.534 3.889 0 C-N-CA 122.642 2.228 . . . . 0.0 110.777 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.15 -176.81 44.66 Favored Glycine 1 N--CA 1.519 4.175 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -166.73 76.75 0.19 Allowed 'General case' 0 N--CA 1.521 3.088 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.94 -39.75 93.18 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 124.371 1.068 . . . . 0.0 110.222 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.5 m -58.91 -22.1 58.98 Favored 'General case' 0 N--CA 1.527 3.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.241 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.57 -40.92 31.02 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.718 0.675 . . . . 0.0 111.432 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.51 -43.63 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 124.583 1.153 . . . . 0.0 112.311 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.25 -33.71 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 C-N-CA 122.753 0.421 . . . . 0.0 111.002 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.4 -41.01 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.93 -45.49 89.01 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.69 -30.88 38.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.943 0.792 . . . . 0.0 111.782 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 29.6 p -69.69 -48.64 58.97 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.377 0.671 . . . . 0.0 110.606 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.87 -32.26 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.595 0.758 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.52 78.83 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.323 0.649 . . . . 0.0 111.817 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.37 71.66 Favored 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 122.854 0.461 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.37 -44.0 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.377 0.671 . . . . 0.0 111.591 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.88 -32.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.529 -0.732 . . . . 0.0 110.427 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.23 -47.58 76.33 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.86 -43.18 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.93 -37.4 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.117 0.872 . . . . 0.0 112.738 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.66 68.38 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -66.38 -34.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.984 0.811 . . . . 0.0 110.864 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -66.6 -33.8 76.47 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 122.682 0.393 . . . . 0.0 110.513 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.37 -42.56 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 123.25 0.62 . . . . 0.0 109.717 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.8 t -65.46 -45.61 83.08 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.489 0.716 . . . . 0.0 111.085 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.05 -47.03 60.82 Favored 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.68 0.792 . . . . 0.0 110.896 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 97.9 p -63.67 -13.68 45.04 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.846 0.458 . . . . 0.0 111.879 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.34 -34.68 15.6 Favored 'General case' 0 N--CA 1.531 3.58 0 C-N-CA 123.928 0.891 . . . . 0.0 110.512 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 53.4 tp -92.81 -27.41 17.18 Favored 'General case' 1 N--CA 1.539 4.019 0 C-N-CA 123.991 0.916 . . . . 0.0 112.296 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -99.45 13.22 34.07 Favored 'General case' 0 N--CA 1.537 3.882 0 C-N-CA 124.205 1.002 . . . . 0.0 111.043 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.42 -0.77 8.95 Favored 'General case' 0 N--CA 1.534 3.743 0 C-N-CA 122.604 0.361 . . . . 0.0 110.476 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 65.14 12.82 8.28 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 124.674 1.19 . . . . 0.0 112.902 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.68 122.77 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 44.3 mt -118.36 141.69 30.06 Favored Pre-proline 0 N--CA 1.531 3.621 0 CA-C-O 117.075 -1.44 . . . . 0.0 108.14 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 1 N--CA 1.539 4.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.784 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.574 1.874 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.71 -177.16 3.65 Favored 'Trans proline' 0 N--CA 1.533 3.845 0 C-N-CA 122.516 2.144 . . . . 0.0 110.474 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.25 173.82 6.53 Favored Glycine 1 N--CA 1.517 4.09 0 O-C-N 123.852 0.72 . . . . 0.0 111.924 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 95.2 p -169.12 179.69 3.92 Favored 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.255 1.022 . . . . 0.0 108.829 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.24 -40.47 97.52 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.7 p -61.5 -21.96 64.68 Favored 'General case' 0 N--CA 1.53 3.539 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.91 86.59 Favored Glycine 0 N--CA 1.509 3.528 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.782 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.58 71.46 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.082 0 CA-C-O 121.224 0.535 . . . . 0.0 109.651 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.55 -35.75 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 C-N-CA 123.07 0.548 . . . . 0.0 109.589 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 29.7 mm -69.99 -38.82 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -63.57 -45.55 89.94 Favored 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.94 -29.7 36.63 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.252 0 CA-C-N 118.929 0.786 . . . . 0.0 111.484 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 21.2 p -68.77 -48.71 63.01 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.2 0.6 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.41 -36.18 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.443 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.49 -37.56 74.22 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.762 0.425 . . . . 0.0 110.943 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.44 -45.52 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.366 0 C-N-CA 123.461 0.704 . . . . 0.0 111.5 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.29 -33.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 121.371 -0.831 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.83 -47.55 80.36 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 123.229 0.612 . . . . 0.0 112.402 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 7.9 tp -70.65 -38.86 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.78 -36.02 76.19 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 C-N-CA 124.022 0.929 . . . . 0.0 111.341 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.53 74.68 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 13.3 m -72.49 -35.8 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 CA-C-N 118.427 0.558 . . . . 0.0 111.761 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -70.98 -42.34 69.82 Favored 'General case' 0 N--CA 1.533 3.681 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.17 -35.93 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 CA-C-N 118.287 0.494 . . . . 0.0 110.985 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.6 m -66.6 -36.52 82.81 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-O 121.215 0.531 . . . . 0.0 109.929 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.26 -46.28 67.64 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.939 0.896 . . . . 0.0 109.908 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.6 t -67.02 -42.51 84.78 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.703 0.801 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.85 -36.96 81.24 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 124.305 1.042 . . . . 0.0 110.784 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.83 -27.83 40.17 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 122.832 0.453 . . . . 0.0 109.964 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -91.56 -17.66 25.28 Favored 'General case' 0 N--CA 1.536 3.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 65.6 pttt 33.7 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 126.843 2.057 . . . . 0.0 113.673 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 70.52 -7.37 1.04 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.172 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 91.8 t -92.07 123.32 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 47.5 mt -117.59 114.39 37.98 Favored Pre-proline 0 N--CA 1.526 3.33 0 CA-C-O 116.799 -1.572 . . . . 0.0 108.543 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo . . . . . 1 N--CA 1.548 4.713 0 CA-C-N 123.015 2.112 . . . . 0.0 114.161 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.571 1.775 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.66 -176.37 2.76 Favored 'Trans proline' 1 N--CA 1.537 4.048 0 C-N-CA 122.188 1.925 . . . . 0.0 110.096 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.64 -23.0 72.07 Favored Glycine 1 N--CA 1.521 4.33 0 O-C-N 123.712 0.633 . . . . 0.0 111.983 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.6 p 58.19 167.12 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 124.693 1.197 . . . . 0.0 112.426 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.2 mt -81.43 19.9 0.94 Allowed 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 124.162 0.985 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -63.06 -38.93 93.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.453 0.701 . . . . 0.0 111.276 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.61 -36.49 48.55 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.24 -47.75 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.299 1.04 . . . . 0.0 110.997 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.47 -34.54 70.17 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.993 0.361 . . . . 0.0 110.792 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.5 -48.16 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.32 -38.57 85.12 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.79 -36.89 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.43 0 CA-C-N 119.645 1.111 . . . . 0.0 111.339 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.0 p -66.9 -48.41 68.81 Favored 'General case' 0 N--CA 1.524 3.235 0 C-N-CA 123.665 0.786 . . . . 0.0 110.714 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.68 -31.68 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 C-N-CA 123.918 0.887 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.42 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.034 0.533 . . . . 0.0 111.147 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.04 68.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 122.929 0.492 . . . . 0.0 111.947 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.84 -44.05 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.548 0.739 . . . . 0.0 111.981 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.57 -32.56 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 CA-C-N 118.323 0.511 . . . . 0.0 110.766 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.81 -34.93 76.8 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.22 0.608 . . . . 0.0 112.513 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -69.82 -54.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 118.075 0.398 . . . . 0.0 111.326 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.15 -36.59 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.84 66.91 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.1 -34.85 73.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.075 0 CA-C-N 119.306 0.957 . . . . 0.0 110.816 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.69 -36.64 76.14 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 122.958 0.503 . . . . 0.0 110.021 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 80.9 t -67.35 -44.54 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.516 0.727 . . . . 0.0 109.444 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 86.3 m -61.74 -41.95 98.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.327 0.651 . . . . 0.0 110.746 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -68.11 -39.93 82.68 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.933 0.893 . . . . 0.0 109.911 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -64.97 -40.11 94.5 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.444 0.697 . . . . 0.0 110.393 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -37.2 82.63 Favored 'General case' 0 N--CA 1.533 3.717 0 C-N-CA 124.309 1.044 . . . . 0.0 110.068 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.4 tp -80.09 -27.66 39.22 Favored 'General case' 0 N--CA 1.53 3.56 0 C-N-CA 123.061 0.544 . . . . 0.0 110.248 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -90.26 -1.73 57.95 Favored 'General case' 0 N--CA 1.538 3.975 0 C-N-CA 123.656 0.783 . . . . 0.0 109.712 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -70.33 -5.07 25.39 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 123.388 0.675 . . . . 0.0 110.134 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp 71.72 -8.68 1.05 Allowed 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 125.027 1.331 . . . . 0.0 111.021 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.05 122.61 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 142.39 45.4 Favored Pre-proline 0 N--CA 1.526 3.343 0 C-N-CA 125.282 1.433 . . . . 0.0 108.115 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 1 N--CA 1.54 4.262 0 CA-C-N 122.175 1.813 . . . . 0.0 110.457 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.689 -1.148 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.84 146.6 48.31 Favored 'Trans proline' 1 N--CA 1.541 4.269 0 C-N-CA 122.035 1.823 . . . . 0.0 110.339 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.19 -41.63 0.21 Allowed Glycine 1 N--CA 1.516 4.004 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.4 p -70.43 -171.55 0.5 Allowed 'General case' 0 N--CA 1.52 3.069 0 C-N-CA 124.297 1.039 . . . . 0.0 110.429 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 82.7 -36.98 0.09 Allowed 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.307 1.443 . . . . 0.0 109.089 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 99.4 p -70.23 -33.41 71.63 Favored 'General case' 0 N--CA 1.526 3.359 0 CA-C-O 121.326 0.584 . . . . 0.0 109.821 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.97 -45.55 20.18 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.416 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -38.66 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.845 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -69.04 -34.78 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.709 -0.619 . . . . 0.0 110.975 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.25 -39.71 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -58.39 -49.08 78.52 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.8 -33.68 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -70.06 -49.17 53.78 Favored 'General case' 0 N--CA 1.529 3.502 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.18 -33.19 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 122.671 0.388 . . . . 0.0 110.372 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.32 78.08 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.09 0.556 . . . . 0.0 111.001 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.42 80.18 Favored 'General case' 0 N--CA 1.52 3.066 0 C-N-CA 122.777 0.431 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.22 -50.65 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 123.04 0.536 . . . . 0.0 111.09 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 m -62.88 -32.27 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 O-C-N 121.926 -0.484 . . . . 0.0 110.792 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.45 -43.02 88.67 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.334 0.654 . . . . 0.0 111.465 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -70.21 -48.01 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.24 -37.75 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 124.118 0.967 . . . . 0.0 112.584 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.539 3.994 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.86 -33.98 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.93 -43.34 93.07 Favored 'General case' 0 N--CA 1.535 3.789 0 C-N-CA 123.188 0.595 . . . . 0.0 112.532 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.9 -30.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 O-C-N 122.263 -0.273 . . . . 0.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 36.9 t -58.63 -46.0 88.04 Favored 'General case' 0 N--CA 1.526 3.337 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -74.09 -32.5 63.27 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 118.225 0.466 . . . . 0.0 111.187 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 83.4 p -63.22 -23.78 67.58 Favored 'General case' 0 N--CA 1.53 3.562 0 C-N-CA 122.717 0.407 . . . . 0.0 111.132 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.85 -23.13 22.87 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.886 0.874 . . . . 0.0 109.917 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.6 tp -80.61 -28.19 37.09 Favored 'General case' 0 N--CA 1.534 3.766 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -92.81 -3.02 55.42 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.523 0.729 . . . . 0.0 110.176 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -79.8 -20.26 46.58 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.118 0.567 . . . . 0.0 109.7 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 48.9 tttp 68.06 34.1 4.23 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 124.321 1.048 . . . . 0.0 110.617 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.4 p -95.41 122.61 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.9 141.53 31.52 Favored Pre-proline 0 N--CA 1.531 3.591 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 1 N--CA 1.539 4.192 0 CA-C-N 122.531 1.94 . . . . 0.0 110.697 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 CA--C 1.586 2.33 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -85.78 177.02 5.05 Favored 'Trans proline' 0 N--CA 1.535 3.963 0 C-N-CA 122.447 2.098 . . . . 0.0 111.088 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.78 82.59 0.05 OUTLIER Glycine 1 N--CA 1.517 4.091 0 C-N-CA 123.813 0.721 . . . . 0.0 112.281 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 93.0 p -67.61 105.92 2.02 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.843 0.857 . . . . 0.0 109.995 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 80.9 mt -77.12 1.58 17.74 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.587 0.755 . . . . 0.0 110.754 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 89.3 p -70.66 -30.9 67.63 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.203 0.601 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.01 9.86 Favored Glycine 1 N--CA 1.516 4.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.167 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.38 -42.08 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 C-N-CA 123.345 0.658 . . . . 0.0 111.759 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.96 -34.88 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.874 -0.516 . . . . 0.0 111.746 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.34 -43.95 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.74 -43.55 83.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.5 -38.48 63.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.132 0 CA-C-N 118.886 0.766 . . . . 0.0 111.987 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 31.3 p -66.08 -48.05 72.25 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.406 0.682 . . . . 0.0 111.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.1 -33.36 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 C-N-CA 123.638 0.775 . . . . 0.0 109.683 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.72 -34.61 76.09 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.73 73.99 Favored 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 122.603 0.361 . . . . 0.0 111.537 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.47 -44.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.332 0.653 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.13 -32.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 CA-C-N 118.61 0.641 . . . . 0.0 110.857 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.87 -42.12 93.04 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.216 0.606 . . . . 0.0 111.511 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 63.0 mt -70.14 -48.79 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.35 -36.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 124.972 1.309 . . . . 0.0 113.091 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.73 67.03 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.83 -36.79 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.918 0.781 . . . . 0.0 110.24 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -70.61 -42.25 71.21 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.977 0.511 . . . . 0.0 109.887 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.07 -35.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.24 -38.83 85.83 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 123.362 0.665 . . . . 0.0 110.323 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.99 -24.05 67.57 Favored 'General case' 0 N--CA 1.531 3.577 0 C-N-CA 124.954 1.301 . . . . 0.0 111.902 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 66.1 p -63.83 -28.76 70.08 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 36.9 mt -71.78 -27.95 63.3 Favored 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 124.118 0.967 . . . . 0.0 110.284 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.95 -18.76 36.2 Favored 'General case' 0 N--CA 1.533 3.717 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -89.02 -17.46 29.34 Favored 'General case' 1 N--CA 1.544 4.24 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.726 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -87.4 -22.92 24.73 Favored 'General case' 1 N--CA 1.547 4.384 0 CA-C-N 119.754 1.161 . . . . 0.0 109.808 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -69.41 -44.36 71.57 Favored 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.62 129.01 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.03 141.42 23.64 Favored Pre-proline 0 N--CA 1.527 3.393 0 CA-C-O 116.304 -1.808 . . . . 0.0 107.243 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 1 N--CA 1.549 4.735 0 C-N-CA 122.722 2.282 . . . . 0.0 114.74 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 CA--C 1.577 2.014 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.48 -29.83 19.83 Favored 'Trans proline' 1 N--CA 1.541 4.299 0 C-N-CA 122.28 1.987 . . . . 0.0 110.475 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.19 -178.47 23.81 Favored Glycine 1 N--CA 1.518 4.157 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.463 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 92.0 p -67.21 175.64 2.56 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.835 0.854 . . . . 0.0 110.42 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -163.08 -48.31 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 96.8 p -66.18 -34.16 77.4 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.335 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.94 -29.86 62.26 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.437 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.03 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.702 0.801 . . . . 0.0 110.499 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.19 -38.39 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.288 0.635 . . . . 0.0 109.93 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.16 -39.1 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -67.02 -46.71 73.65 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.06 -35.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.947 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.1 p -66.5 -49.49 66.39 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.84 -32.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.35 78.28 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 122.531 0.333 . . . . 0.0 111.665 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.49 73.98 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 122.628 0.371 . . . . 0.0 111.818 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.9 t -69.96 -43.46 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.324 0.649 . . . . 0.0 111.722 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.27 -32.6 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.581 0.628 . . . . 0.0 110.547 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.18 -34.63 72.35 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.19 -55.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 CA-C-N 117.868 0.304 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.87 -37.14 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.45 81.47 Favored 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.19 -34.78 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.453 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.397 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -69.56 -42.5 74.49 Favored 'General case' 1 N--CA 1.539 4.021 0 CA-C-N 119.407 1.003 . . . . 0.0 111.345 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.7 -31.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 O-C-N 121.981 -0.449 . . . . 0.0 110.303 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.96 -37.27 81.84 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.523 0.729 . . . . 0.0 111.696 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -82.84 -25.19 32.85 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.428 0.691 . . . . 0.0 110.449 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 m -68.02 -43.41 78.87 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.058 0.543 . . . . 0.0 111.828 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.1 -24.5 47.53 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.791 0.437 . . . . 0.0 111.143 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 57.9 tp -80.52 -27.83 37.54 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -89.91 -13.0 37.24 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 123.858 0.863 . . . . 0.0 110.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -73.03 -36.65 67.0 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 124.01 0.924 . . . . 0.0 109.432 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.5 -47.55 69.68 Favored 'General case' 0 N--CA 1.521 3.091 0 C-N-CA 123.998 0.919 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.54 122.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 124.23 1.012 . . . . 0.0 108.655 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.26 141.59 42.4 Favored Pre-proline 0 N--CA 1.526 3.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 1 N--CA 1.539 4.193 0 CA-C-N 122.603 1.965 . . . . 0.0 110.676 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.585 2.319 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -88.93 4.5 5.35 Favored 'Trans proline' 1 N--CA 1.536 4.025 0 C-N-CA 122.644 2.229 . . . . 0.0 111.87 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.98 -102.9 0.97 Allowed Glycine 1 N--CA 1.518 4.157 0 C-N-CA 123.685 0.659 . . . . 0.0 111.676 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 38.7 t -167.21 -179.18 4.42 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.776 0.831 . . . . 0.0 109.937 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.27 23.74 0.63 Allowed 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.993 0.917 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 67.5 m -69.12 -26.36 64.87 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 123.584 0.754 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.84 -50.12 9.39 Favored Glycine 0 N--CA 1.516 3.971 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.271 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.87 -36.71 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 122.984 0.514 . . . . 0.0 112.112 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 36.6 pt -62.9 -33.75 62.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 CA-C-N 119.185 0.902 . . . . 0.0 110.852 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 84.3 mt -69.67 -39.25 77.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -66.14 -43.34 87.35 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.84 -28.18 32.4 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.37 0.986 . . . . 0.0 111.345 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' THR . . . . . 0.41 ' HG1' ' N ' ' B' ' 220' ' ' VAL . 19.4 p -66.3 -48.52 70.1 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 123.509 0.723 . . . . 0.0 111.063 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . 0.41 ' N ' ' HG1' ' B' ' 219' ' ' THR . 51.5 t -69.85 -39.47 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 C-N-CA 123.694 0.797 . . . . 0.0 109.186 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.49 71.6 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.664 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.9 -33.21 75.31 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 122.712 0.405 . . . . 0.0 111.373 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.02 -48.54 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.334 0 C-N-CA 123.139 0.576 . . . . 0.0 111.102 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.55 -32.38 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 O-C-N 121.577 -0.702 . . . . 0.0 110.377 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.65 -47.78 83.28 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 123.424 0.689 . . . . 0.0 112.471 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -70.75 -37.48 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.879 0 CA-C-N 118.302 0.501 . . . . 0.0 110.085 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.92 -37.57 79.67 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 C-N-CA 123.155 0.582 . . . . 0.0 111.084 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.93 68.19 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.39 -37.08 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-N 118.893 0.769 . . . . 0.0 110.405 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -70.28 -42.08 72.56 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 122.739 0.416 . . . . 0.0 109.934 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.7 -42.63 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.26 -28.65 68.22 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 123.025 0.53 . . . . 0.0 111.062 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -68.18 -35.72 78.48 Favored 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 123.584 0.754 . . . . 0.0 110.617 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.7 m -63.59 -23.29 67.32 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.166 0.587 . . . . 0.0 109.828 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.6 -33.32 68.91 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.549 1.139 . . . . 0.0 108.299 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.25 -26.76 38.86 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 123.613 0.765 . . . . 0.0 110.149 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -88.64 13.17 12.83 Favored 'General case' 1 N--CA 1.547 4.395 0 C-N-CA 122.778 0.431 . . . . 0.0 110.072 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -136.74 -56.9 0.73 Allowed 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 71.25 -2.74 2.28 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 124.649 1.179 . . . . 0.0 110.459 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 99.2 t -98.77 122.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.05 141.69 23.99 Favored Pre-proline 0 N--CA 1.525 3.295 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 1 N--CA 1.54 4.264 0 CA-C-N 122.291 1.854 . . . . 0.0 110.699 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.57 1.735 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.66 -19.51 31.77 Favored 'Trans proline' 1 N--CA 1.541 4.271 0 C-N-CA 122.109 1.873 . . . . 0.0 110.801 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.55 -178.28 7.01 Favored Glycine 1 N--CA 1.518 4.161 0 C-N-CA 123.737 0.684 . . . . 0.0 112.39 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 46.0 t -168.44 176.16 5.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 124.001 0.92 . . . . 0.0 109.585 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.37 46.48 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.741 0.816 . . . . 0.0 109.474 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 36.4 t -69.62 -24.93 63.72 Favored 'General case' 0 N--CA 1.524 3.251 0 O-C-N 121.532 -0.73 . . . . 0.0 110.007 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.32 -46.19 57.88 Favored Glycine 0 N--CA 1.511 3.669 0 C-N-CA 124.513 1.054 . . . . 0.0 114.242 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 13.6 tt -59.14 -36.36 62.37 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.303 0 CA-C-N 118.233 1.016 . . . . 0.0 111.03 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.83 -34.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.391 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.22 -41.8 78.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-N 119.175 0.898 . . . . 0.0 108.73 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.54 -45.27 94.49 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.6 -37.26 78.47 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.658 0.663 . . . . 0.0 112.025 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 73.0 p -65.41 -48.85 71.39 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 123.201 0.6 . . . . 0.0 112.512 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.45 -32.09 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.26 80.32 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 122.766 0.426 . . . . 0.0 111.792 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.43 55.17 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.66 -38.37 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.23 -32.29 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.994 -0.441 . . . . 0.0 110.536 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.1 -34.88 75.65 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 122.966 0.506 . . . . 0.0 111.557 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.49 -54.78 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 122.899 0.479 . . . . 0.0 111.475 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.04 -35.86 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.853 0 C-N-CA 124.236 1.015 . . . . 0.0 112.893 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.36 66.19 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.47 -34.51 66.0 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.502 1.047 . . . . 0.0 110.487 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.83 -26.22 66.81 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 122.836 0.454 . . . . 0.0 110.871 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -37.74 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.83 -40.44 88.0 Favored 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 123.487 0.715 . . . . 0.0 109.577 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.38 -40.39 85.69 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 124.219 1.008 . . . . 0.0 109.782 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -64.59 -29.15 70.17 Favored 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 123.553 0.741 . . . . 0.0 111.588 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.6 tp -91.41 -23.75 19.95 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 124.502 1.121 . . . . 0.0 111.293 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.31 -27.89 38.33 Favored 'General case' 0 N--CA 1.536 3.84 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.981 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -113.6 13.76 18.78 Favored 'General case' 1 N--CA 1.555 4.784 0 CA-C-N 118.755 0.707 . . . . 0.0 112.184 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.46 -32.58 54.51 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -66.08 -41.7 90.33 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 124.16 0.984 . . . . 0.0 110.037 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 55.4 t -132.16 122.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.01 141.74 23.66 Favored Pre-proline 0 N--CA 1.528 3.425 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 1 N--CA 1.539 4.192 0 CA-C-N 122.296 1.856 . . . . 0.0 110.707 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.585 2.32 0 CA-C-O 117.474 -1.251 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -85.59 72.68 4.18 Favored 'Trans proline' 0 N--CA 1.535 3.966 0 CA-C-N 122.775 2.027 . . . . 0.0 110.146 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 88.28 -122.96 6.51 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m 57.32 49.52 13.03 Favored 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.052 0.941 . . . . 0.0 111.575 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.5 mp 56.94 9.14 0.58 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 124.616 1.166 . . . . 0.0 111.94 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 27.4 t -55.27 -34.4 64.04 Favored 'General case' 0 N--CA 1.534 3.734 0 CA-C-N 118.913 0.778 . . . . 0.0 112.241 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -42.11 40.79 Favored Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.097 0.873 . . . . 0.0 111.26 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.6 mm -57.96 -38.88 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 124.223 1.009 . . . . 0.0 110.861 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.86 -34.52 31.03 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 CA-C-O 119.458 -0.306 . . . . 0.0 111.029 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 1.6 mp -70.57 -49.13 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 CA-C-N 119.279 0.945 . . . . 0.0 108.804 179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -67.88 -27.55 66.76 Favored 'General case' 0 N--CA 1.53 3.564 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -56.46 -38.85 58.16 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.546 0 CA-C-N 120.109 1.322 . . . . 0.0 112.084 -174.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.3 p -64.05 -48.08 77.66 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 123.907 0.883 . . . . 0.0 110.769 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.87 -44.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.124 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.78 58.77 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.455 0.702 . . . . 0.0 111.812 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.64 95.89 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 122.998 0.519 . . . . 0.0 111.718 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -39.04 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.429 0.692 . . . . 0.0 109.719 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.82 -34.32 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.652 0.781 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -37.29 86.63 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.066 0.546 . . . . 0.0 111.881 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.13 -54.42 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 C-N-CA 122.911 0.484 . . . . 0.0 111.433 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.55 -36.3 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 C-N-CA 124.374 1.07 . . . . 0.0 113.747 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.68 -31.02 65.94 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.3 -38.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 119.036 0.834 . . . . 0.0 110.472 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.33 -32.76 73.11 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.899 0.48 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.61 -37.9 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.614 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.33 -46.67 72.78 Favored 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 123.397 0.679 . . . . 0.0 110.352 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.24 -26.64 65.8 Favored 'General case' 0 N--CA 1.524 3.265 0 C-N-CA 124.114 0.966 . . . . 0.0 110.915 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 68.9 m -63.33 -21.67 66.41 Favored 'General case' 0 N--CA 1.529 3.515 0 CA-C-N 118.133 0.424 . . . . 0.0 110.049 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 57.4 mt -91.44 -17.33 25.95 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 124.375 1.07 . . . . 0.0 110.592 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 53.1 tp -80.86 -28.41 36.07 Favored 'General case' 0 N--CA 1.537 3.904 0 CA-C-O 119.029 -0.51 . . . . 0.0 112.179 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -114.28 12.61 17.69 Favored 'General case' 1 N--CA 1.559 4.979 0 C-N-CA 123.221 0.609 . . . . 0.0 111.322 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -65.75 -10.24 35.37 Favored 'General case' 0 N--CA 1.535 3.79 0 C-N-CA 123.226 0.61 . . . . 0.0 110.313 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 92.07 -17.7 0.14 Allowed 'General case' 0 N--CA 1.536 3.863 0 C-N-CA 126.243 1.817 . . . . 0.0 110.286 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 135.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 42.2 mt -97.55 141.48 23.07 Favored Pre-proline 0 N--CA 1.527 3.397 0 CA-C-O 116.273 -1.822 . . . . 0.0 108.51 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 1 N--CA 1.55 4.806 0 C-N-CA 122.686 2.258 . . . . 0.0 114.723 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.576 1.96 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.85 -175.24 2.23 Favored 'Trans proline' 1 N--CA 1.537 4.036 0 C-N-CA 122.326 2.017 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -177.29 -13.59 0.02 OUTLIER Glycine 1 N--CA 1.524 4.505 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 72.32 0.12 Allowed 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.844 0.858 . . . . 0.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tt -162.6 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 29.6 t -55.49 -19.97 11.3 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 123.642 0.777 . . . . 0.0 111.634 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -24.79 75.56 Favored Glycine 0 N--CA 1.505 3.279 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.55 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -59.77 -48.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.982 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.14 -33.75 65.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 O-C-N 122.154 -0.341 . . . . 0.0 110.221 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.62 -38.93 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -67.12 -43.78 81.59 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.75 -32.72 43.48 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.367 0 CA-C-N 119.136 0.88 . . . . 0.0 111.645 -176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -64.93 -48.22 74.88 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.51 0.724 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.03 -46.14 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.477 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -34.88 58.76 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 123.123 0.569 . . . . 0.0 111.903 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.13 91.93 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.825 0.45 . . . . 0.0 111.955 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.14 -40.12 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.273 0.629 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.36 -33.0 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 123.667 0.787 . . . . 0.0 110.151 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.31 -47.48 73.42 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.3 tt -70.69 -41.71 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.02 -37.29 79.07 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.079 0.854 . . . . 0.0 112.257 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.85 68.64 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 m -64.38 -34.87 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.027 0.831 . . . . 0.0 110.613 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -68.94 -40.35 79.02 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.828 0.451 . . . . 0.0 109.858 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.55 -38.4 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.95 -42.22 97.37 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.688 0.795 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.57 -44.21 91.43 Favored 'General case' 0 N--CA 1.527 3.381 0 C-N-CA 124.269 1.028 . . . . 0.0 109.784 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.2 t -64.55 -27.13 68.75 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.274 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 50.8 tp -91.56 -25.32 19.27 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.422 1.089 . . . . 0.0 111.315 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.5 tp -80.6 -27.98 37.21 Favored 'General case' 0 N--CA 1.535 3.803 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -113.99 13.17 18.18 Favored 'General case' 1 N--CA 1.558 4.972 0 CA-C-N 119.064 0.847 . . . . 0.0 113.252 -178.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -92.3 -30.82 15.65 Favored 'General case' 0 N--CA 1.537 3.912 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.52 -45.99 81.37 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.99 0.916 . . . . 0.0 110.032 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.36 122.81 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 C-N-CA 124.715 1.206 . . . . 0.0 107.87 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.61 141.78 23.53 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 1 N--CA 1.54 4.227 0 CA-C-N 122.388 1.888 . . . . 0.0 110.734 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.55 156.98 12.99 Favored 'Trans proline' 1 N--CA 1.549 4.775 0 CA-C-N 122.017 1.756 . . . . 0.0 112.882 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.58 -179.34 18.9 Favored Glycine 1 N--CA 1.517 4.093 0 C-N-CA 123.678 0.656 . . . . 0.0 111.791 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t -169.2 166.07 10.81 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 124.031 0.932 . . . . 0.0 109.2 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 tt -165.12 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 61.0 m -57.93 -35.01 70.48 Favored 'General case' 0 N--CA 1.523 3.205 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.07 -38.21 40.94 Favored Glycine 0 N--CA 1.513 3.793 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.162 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.78 -44.34 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.874 0.87 . . . . 0.0 111.976 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.71 -33.82 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 C-N-CA 122.583 0.353 . . . . 0.0 110.919 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 89.3 mt -68.43 -38.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 O-C-N 121.79 -0.569 . . . . 0.0 109.54 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -67.04 -47.0 72.7 Favored 'General case' 0 N--CA 1.529 3.487 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.17 -34.8 58.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.145 0 CA-C-N 118.786 0.721 . . . . 0.0 111.926 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' THR . . . . . 0.43 ' HG1' ' H ' ' C' ' 220' ' ' VAL . 82.7 p -66.62 -48.65 68.82 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.596 0.758 . . . . 0.0 111.235 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . 0.43 ' H ' ' HG1' ' C' ' 219' ' ' THR . 89.1 t -68.11 -35.05 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.556 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.19 77.12 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.268 0.627 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.61 75.18 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 122.822 0.449 . . . . 0.0 111.632 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.93 -46.1 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.019 0.528 . . . . 0.0 111.64 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.83 -32.57 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 CA-C-N 118.697 0.68 . . . . 0.0 111.156 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.95 -41.5 99.52 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.21 0.604 . . . . 0.0 112.046 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 74.8 mt -70.56 -55.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 14.4 p -68.67 -41.73 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.36 82.14 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.15 -33.92 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 CA-C-N 118.101 0.41 . . . . 0.0 110.777 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -69.65 -27.11 64.77 Favored 'General case' 0 N--CA 1.536 3.864 0 CA-C-N 118.713 0.688 . . . . 0.0 110.539 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.26 -50.07 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 122.677 0.391 . . . . 0.0 110.508 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 31.3 p -63.81 -35.79 81.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 122.708 0.403 . . . . 0.0 111.2 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . 0.551 ' HZ3' ' HE1' ' C' ' 237' ' ' TRP . 64.9 tttm -65.96 -45.83 80.31 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.8 m -63.3 -25.66 68.41 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.348 0.659 . . . . 0.0 110.203 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -25.12 33.28 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.189 0.995 . . . . 0.0 108.344 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.05 -27.35 39.43 Favored 'General case' 0 N--CA 1.539 3.98 0 C-N-CA 123.574 0.75 . . . . 0.0 109.132 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . 0.551 ' HE1' ' HZ3' ' C' ' 233' ' ' LYS . 81.7 m95 -88.8 13.42 12.57 Favored 'General case' 1 N--CA 1.545 4.284 0 C-N-CA 122.939 0.496 . . . . 0.0 110.361 179.444 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' C' ' 240' ' ' VAL . 64.4 mttp -139.93 -62.77 0.51 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 70.77 -26.37 0.17 Allowed 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 125.008 1.323 . . . . 0.0 110.719 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . 0.501 ' H ' ' C ' ' C' ' 238' ' ' LYS . 19.1 m -136.86 136.67 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 C-N-CA 125.005 1.322 . . . . 0.0 107.592 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.85 141.65 24.02 Favored Pre-proline 0 N--CA 1.526 3.369 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 1 N--CA 1.538 4.114 0 CA-C-N 122.433 1.905 . . . . 0.0 110.659 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.2 128.28 24.73 Favored 'Trans proline' 1 N--CA 1.547 4.637 0 C-N-CA 122.328 2.019 . . . . 0.0 113.245 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.98 45.76 1.71 Allowed Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.819 0.723 . . . . 0.0 111.408 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 42.5 t -167.63 44.43 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.151 0 CA-C-O 121.922 0.868 . . . . 0.0 109.228 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.0 -9.44 45.68 Favored 'General case' 0 N--CA 1.529 3.506 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.746 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 42.8 t -71.14 -36.79 72.22 Favored 'General case' 0 N--CA 1.518 2.941 0 CA-C-O 121.597 0.713 . . . . 0.0 110.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.69 -49.63 68.89 Favored Glycine 0 N--CA 1.515 3.94 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.61 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.52 -35.97 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 CA-C-N 117.405 0.603 . . . . 0.0 110.753 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.4 mt -62.19 -36.66 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.975 0 C-N-CA 122.638 0.375 . . . . 0.0 110.44 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.91 -48.08 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 CA-C-O 121.584 0.707 . . . . 0.0 109.112 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -67.33 -41.2 85.63 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.42 -33.81 44.96 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.172 0.896 . . . . 0.0 112.082 -175.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 35.1 p -71.45 -48.56 48.64 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.338 0.655 . . . . 0.0 110.011 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.01 -31.71 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.288 0 C-N-CA 123.892 0.877 . . . . 0.0 109.621 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.66 Favored 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 123.455 0.702 . . . . 0.0 111.827 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.47 74.06 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 122.346 0.259 . . . . 0.0 111.174 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.97 -46.7 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 C-N-CA 123.411 0.684 . . . . 0.0 111.573 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.78 -32.11 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.411 0.55 . . . . 0.0 110.443 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -46.08 73.46 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.961 0.904 . . . . 0.0 111.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.13 -55.25 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.0 -36.41 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.19 66.4 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.65 -37.27 79.68 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.208 0.913 . . . . 0.0 110.59 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.79 -29.18 68.3 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 122.956 0.502 . . . . 0.0 110.732 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.52 -38.36 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.24 -47.23 71.39 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.349 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.44 -41.71 84.3 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.821 0.848 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -64.22 -31.45 72.66 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.022 0.529 . . . . 0.0 111.171 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.32 -37.65 74.78 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.461 0.704 . . . . 0.0 110.763 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 76.2 mt -83.77 -27.68 28.71 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 123.316 0.647 . . . . 0.0 109.909 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -89.71 5.81 44.26 Favored 'General case' 1 N--CA 1.54 4.045 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -66.19 -16.85 64.33 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.846 0.858 . . . . 0.0 109.968 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 73.09 -3.95 2.3 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 124.489 1.116 . . . . 0.0 110.24 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.01 122.43 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.94 141.78 43.21 Favored Pre-proline 0 N--CA 1.526 3.365 0 CA-C-O 116.509 -1.71 . . . . 0.0 107.346 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 1 N--CA 1.55 4.847 0 C-N-CA 122.911 2.407 . . . . 0.0 115.019 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.578 2.026 0 CA-C-O 117.482 -1.247 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -88.59 -16.37 2.5 Favored 'Trans proline' 0 N--CA 1.536 3.978 0 C-N-CA 122.503 2.136 . . . . 0.0 111.676 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.11 136.1 30.38 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 43.6 t -169.1 56.41 0.05 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.8 10.88 0.6 Allowed 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.537 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.1 m -70.32 -23.04 62.77 Favored 'General case' 0 N--CA 1.521 3.1 0 CA-C-N 118.052 0.387 . . . . 0.0 110.805 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.93 -50.88 7.39 Favored Glycine 1 N--CA 1.519 4.203 0 C-N-CA 123.439 0.543 . . . . 0.0 113.923 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.19 -39.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.66 -33.85 28.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.337 0.517 . . . . 0.0 111.007 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 23.5 mm -62.84 -42.99 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-O 121.278 0.561 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -64.38 -35.4 80.78 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.022 0.929 . . . . 0.0 112.717 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.47 -41.5 78.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-O 121.03 0.443 . . . . 0.0 110.476 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -65.03 -48.23 74.63 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.607 0.763 . . . . 0.0 111.271 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.72 -33.88 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.673 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.0 -35.19 80.41 Favored 'General case' 0 N--CA 1.523 3.217 0 C-N-CA 122.989 0.516 . . . . 0.0 111.56 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.33 63.3 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 122.832 0.453 . . . . 0.0 112.192 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.15 -43.63 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 123.107 0.563 . . . . 0.0 111.826 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.35 -32.82 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 CA-C-N 118.311 0.505 . . . . 0.0 110.713 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.64 -41.12 85.29 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.899 0.48 . . . . 0.0 111.339 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.09 -54.08 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 CA-C-O 121.686 0.755 . . . . 0.0 109.631 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.52 -35.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 125.788 1.635 . . . . 0.0 113.26 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.62 70.79 Favored 'General case' 0 N--CA 1.529 3.513 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.35 -41.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 CA-C-N 118.942 0.792 . . . . 0.0 111.454 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -65.15 -42.52 93.71 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.28 -36.97 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 CA-C-N 118.314 0.506 . . . . 0.0 110.822 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 97.0 m -67.75 -48.19 67.13 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 122.818 0.447 . . . . 0.0 111.346 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.2 -28.37 70.0 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.511 0.724 . . . . 0.0 111.411 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.65 -21.41 66.36 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 122.733 0.413 . . . . 0.0 110.88 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.1 mt -91.3 -30.4 16.61 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 124.197 0.999 . . . . 0.0 110.969 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 67.0 mt -80.3 -27.4 38.47 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.839 0.456 . . . . 0.0 112.13 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -99.15 6.81 46.3 Favored 'General case' 1 N--CA 1.543 4.181 0 C-N-CA 123.586 0.755 . . . . 0.0 110.936 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -143.07 31.51 1.39 Allowed 'General case' 0 N--CA 1.536 3.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.628 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -162.21 -60.94 0.05 OUTLIER 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 55.9 t -83.11 127.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.229 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.68 141.97 24.51 Favored Pre-proline 0 N--CA 1.524 3.261 0 CA-C-O 117.237 -1.363 . . . . 0.0 108.314 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo . . . . . 1 N--CA 1.54 4.263 0 CA-C-N 122.295 1.855 . . . . 0.0 110.815 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 CA--C 1.586 2.347 0 CA-C-O 117.557 -1.211 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -89.07 47.38 1.08 Allowed 'Trans proline' 0 N--CA 1.535 3.915 0 C-N-CA 122.682 2.254 . . . . 0.0 110.917 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.15 -70.67 0.45 Allowed Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.0 p -166.21 167.31 16.26 Favored 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 123.648 0.779 . . . . 0.0 109.263 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -80.73 20.24 0.76 Allowed 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 124.091 0.956 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -67.08 -24.68 65.98 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.343 0.657 . . . . 0.0 111.174 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.41 -51.04 7.65 Favored Glycine 0 N--CA 1.516 3.997 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.58 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 tp -66.71 -37.02 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.082 0.553 . . . . 0.0 112.367 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -62.77 -37.0 77.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.217 0 CA-C-N 118.256 0.48 . . . . 0.0 110.579 -177.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 87.4 mt -70.42 -48.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 CA-C-O 121.429 0.633 . . . . 0.0 109.595 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.36 -39.16 85.7 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.81 -39.04 68.98 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.251 0 CA-C-N 119.106 0.866 . . . . 0.0 111.914 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 20.1 p -63.75 -46.65 84.39 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.458 0.703 . . . . 0.0 110.756 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.65 -47.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.244 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.57 54.34 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.475 0.71 . . . . 0.0 111.902 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.61 95.9 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.95 0.5 . . . . 0.0 111.128 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.97 -40.43 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.5 -32.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 123.862 0.865 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -47.4 86.11 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-O 121.563 0.697 . . . . 0.0 110.797 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.11 -54.92 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.228 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.7 m -67.08 -37.03 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.73 68.04 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.1 m -65.06 -38.61 83.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 119.214 0.915 . . . . 0.0 110.558 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.53 -31.69 73.01 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 122.919 0.488 . . . . 0.0 110.878 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.89 -41.24 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 66.9 m -67.09 -39.91 86.87 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.627 0.771 . . . . 0.0 110.937 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.98 -42.68 57.1 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.626 0.771 . . . . 0.0 110.248 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 94.1 p -63.69 -12.75 37.02 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.024 0.53 . . . . 0.0 111.686 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -76.02 -37.75 58.05 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 122.609 0.364 . . . . 0.0 110.435 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 52.3 mt -107.78 -27.98 9.94 Favored 'General case' 1 N--CA 1.543 4.183 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.73 -9.64 48.63 Favored 'General case' 1 N--CA 1.547 4.397 0 CA-C-N 118.568 0.622 . . . . 0.0 112.404 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -81.62 -8.23 59.68 Favored 'General case' 0 N--CA 1.539 3.991 0 CA-C-N 118.62 0.646 . . . . 0.0 110.176 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 64.77 2.69 1.77 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 124.481 1.112 . . . . 0.0 112.49 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.69 122.65 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.47 141.42 22.79 Favored Pre-proline 0 N--CA 1.526 3.367 0 CA-C-O 116.125 -1.893 . . . . 0.0 108.539 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 1 N--CA 1.549 4.779 0 C-N-CA 122.58 2.186 . . . . 0.0 114.843 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 CA--C 1.586 2.351 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -89.22 -169.8 0.41 Allowed 'Trans proline' 0 N--CA 1.535 3.928 0 C-N-CA 122.611 2.207 . . . . 0.0 110.855 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.88 -2.68 0.03 OUTLIER Glycine 1 N--CA 1.521 4.362 0 O-C-N 123.695 0.622 . . . . 0.0 111.619 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p -66.92 110.0 3.16 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.731 0.812 . . . . 0.0 110.102 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.84 -3.26 4.74 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.884 0.874 . . . . 0.0 111.502 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.4 t -63.28 -41.62 99.01 Favored 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 123.377 0.671 . . . . 0.0 111.751 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.16 -34.22 55.56 Favored Glycine 1 N--CA 1.518 4.134 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.79 -49.64 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.904 0.882 . . . . 0.0 111.103 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -63.44 -33.68 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 122.172 -0.33 . . . . 0.0 110.789 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.1 mt -69.57 -41.6 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -66.14 -44.34 84.46 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.72 -37.6 60.33 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.226 0 CA-C-N 119.101 0.864 . . . . 0.0 111.723 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 p -63.99 -48.24 77.17 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 123.553 0.741 . . . . 0.0 111.158 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.97 -45.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.261 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.89 67.66 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.142 0.577 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.93 96.77 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 122.976 0.51 . . . . 0.0 111.401 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.05 -41.89 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 123.189 0.595 . . . . 0.0 109.723 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.04 -32.83 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.857 0.863 . . . . 0.0 110.235 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.41 -40.96 89.89 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.095 0.558 . . . . 0.0 111.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -70.04 -52.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 122.936 0.495 . . . . 0.0 111.614 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.2 m -66.28 -37.42 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.26 92.39 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.74 -33.87 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -63.17 -43.44 98.26 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.522 0.729 . . . . 0.0 112.446 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.05 -31.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 122.393 0.277 . . . . 0.0 110.488 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 44.7 t -62.44 -32.39 73.24 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 123.044 0.538 . . . . 0.0 111.037 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.32 -44.84 78.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.653 0.781 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.0 p -64.66 -41.31 96.19 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-O 121.465 0.65 . . . . 0.0 109.616 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.8 -34.44 78.17 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 124.538 1.135 . . . . 0.0 109.694 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp -80.03 -21.85 43.05 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.586 0.754 . . . . 0.0 110.041 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -89.03 13.07 13.8 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 123.599 0.759 . . . . 0.0 110.478 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -122.04 10.42 10.1 Favored 'General case' 1 N--CA 1.542 4.16 0 C-N-CA 124.556 1.142 . . . . 0.0 109.077 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 64.97 -24.1 0.08 Allowed 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 124.862 1.265 . . . . 0.0 113.637 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.64 122.5 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.09 142.11 23.98 Favored Pre-proline 0 N--CA 1.537 3.894 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo . . . . . 1 N--CA 1.54 4.245 0 CA-C-N 122.415 1.898 . . . . 0.0 110.769 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.576 1.973 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.28 120.01 6.69 Favored 'Trans proline' 1 N--CA 1.545 4.507 0 C-N-CA 122.278 1.986 . . . . 0.0 113.007 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.26 -172.41 22.07 Favored Glycine 1 N--CA 1.519 4.205 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p -167.69 171.19 10.34 Favored 'General case' 0 N--CA 1.521 3.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.44 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.51 -39.04 88.45 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.206 1.003 . . . . 0.0 109.667 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 93.0 p -55.58 -19.97 11.91 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 124.048 0.939 . . . . 0.0 111.438 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.99 -23.32 76.52 Favored Glycine 0 N--CA 1.511 3.683 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -51.27 74.0 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.72 -33.84 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 C-N-CA 122.778 0.431 . . . . 0.0 110.947 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.44 -38.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -66.78 -45.11 79.49 Favored 'General case' 0 N--CA 1.531 3.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.84 -34.06 47.27 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.992 0.815 . . . . 0.0 111.672 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.7 p -64.64 -48.43 74.86 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.233 0.613 . . . . 0.0 111.087 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.57 -41.01 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.33 -34.3 78.01 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.931 0.492 . . . . 0.0 111.576 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.03 67.55 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.26 -38.35 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.95 -32.64 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 CA-C-N 118.589 0.631 . . . . 0.0 110.55 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.7 tp -54.9 -34.7 63.34 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.145 0.578 . . . . 0.0 112.55 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.95 -55.74 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 CA-C-N 117.677 0.217 . . . . 0.0 111.382 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.5 -36.13 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 C-N-CA 124.33 1.052 . . . . 0.0 113.128 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.5 -31.02 65.61 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -58.32 -37.07 61.19 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.977 0.808 . . . . 0.0 110.641 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.21 -35.46 71.53 Favored 'General case' 0 N--CA 1.526 3.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.999 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.04 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.19 -41.87 85.12 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 123.481 0.712 . . . . 0.0 110.2 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -71.73 -37.01 70.66 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.851 0.86 . . . . 0.0 110.535 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 92.2 p -63.83 -17.68 63.36 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.027 0.531 . . . . 0.0 111.546 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.7 tp -83.57 -37.5 22.89 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.473 0.709 . . . . 0.0 110.338 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.83 -21.47 26.41 Favored 'General case' 1 N--CA 1.542 4.139 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -114.06 13.97 18.25 Favored 'General case' 0 N--CA 1.537 3.9 0 C-N-CA 124.967 1.307 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -56.91 -43.62 81.57 Favored 'General case' 0 N--CA 1.534 3.759 0 CA-C-O 121.941 0.877 . . . . 0.0 108.672 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? 178.01 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.469 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.2 p -84.53 128.25 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.87 0.868 . . . . 0.0 108.972 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.0 141.5 23.77 Favored Pre-proline 0 N--CA 1.529 3.501 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 1 N--CA 1.539 4.156 0 CA-C-N 122.427 1.902 . . . . 0.0 110.705 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.584 2.279 0 CA-C-O 117.553 -1.213 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -89.47 68.17 2.24 Favored 'Trans proline' 0 N--CA 1.534 3.9 0 C-N-CA 122.714 2.276 . . . . 0.0 110.835 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.0 -148.94 50.91 Favored Glycine 1 N--CA 1.521 4.306 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.416 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -164.45 144.49 7.71 Favored 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 123.667 0.787 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.05 -1.87 19.0 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.9 0.88 . . . . 0.0 110.46 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 91.9 p -68.19 -25.78 65.41 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 122.699 0.4 . . . . 0.0 110.758 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.02 -51.48 6.91 Favored Glycine 1 N--CA 1.518 4.16 0 O-C-N 123.117 0.261 . . . . 0.0 113.726 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 17.7 tt -67.18 -40.79 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 tp -54.45 -33.35 26.22 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.86 -42.05 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-O 121.458 0.647 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -64.87 -44.69 88.89 Favored 'General case' 0 N--CA 1.525 3.315 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 32.7 m -57.82 -35.15 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 CA-C-N 119.117 0.872 . . . . 0.0 111.95 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 36.7 p -62.83 -48.21 80.07 Favored 'General case' 0 N--CA 1.53 3.545 0 C-N-CA 123.527 0.731 . . . . 0.0 110.674 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.72 -48.76 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.346 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.97 -36.84 60.62 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 122.98 0.512 . . . . 0.0 111.882 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.81 94.61 Favored 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.077 0.551 . . . . 0.0 111.741 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.09 -41.36 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 C-N-CA 123.372 0.669 . . . . 0.0 109.571 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.15 -32.91 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.432 0.693 . . . . 0.0 109.495 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -47.3 79.19 Favored 'General case' 0 N--CA 1.539 3.985 0 CA-C-O 121.68 0.752 . . . . 0.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.34 -52.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.413 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.1 -36.05 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 124.875 1.27 . . . . 0.0 113.321 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.17 75.18 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.5 -37.98 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.639 0 CA-C-N 118.543 0.61 . . . . 0.0 111.732 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -69.31 -42.66 75.13 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 122.205 -0.31 . . . . 0.0 111.656 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.54 -32.11 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.41 0.55 . . . . 0.0 110.136 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.32 -39.25 85.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -67.7 -26.56 66.24 Favored 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 124.346 1.058 . . . . 0.0 111.557 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.54 -27.95 69.61 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 122.575 0.35 . . . . 0.0 110.785 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.3 -14.39 30.92 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 124.491 1.117 . . . . 0.0 110.345 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 50.8 tp -80.06 -28.39 39.22 Favored 'General case' 0 N--CA 1.538 3.939 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.654 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -108.87 1.36 20.79 Favored 'General case' 1 N--CA 1.559 5.003 0 C-N-CA 122.916 0.486 . . . . 0.0 111.447 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -75.76 -42.55 50.04 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -71.45 -57.6 4.28 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.279 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.64 121.87 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.81 141.55 22.98 Favored Pre-proline 0 N--CA 1.531 3.607 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 1 N--CA 1.538 4.113 0 CA-C-N 122.426 1.902 . . . . 0.0 110.668 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 CA--C 1.574 1.89 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.81 -20.89 10.13 Favored 'Trans proline' 1 N--CA 1.536 4.025 0 C-N-CA 122.415 2.077 . . . . 0.0 110.749 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.83 111.07 0.29 Allowed Glycine 1 N--CA 1.516 4.014 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.1 p 60.21 156.87 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 124.629 1.172 . . . . 0.0 111.8 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -165.47 -53.57 0.03 OUTLIER 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -55.65 -20.43 13.95 Favored 'General case' 0 N--CA 1.527 3.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.489 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.2 -26.89 67.27 Favored Glycine 0 N--CA 1.51 3.601 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -49.33 84.9 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 C-N-CA 123.219 0.608 . . . . 0.0 111.744 -177.666 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -67.15 -33.99 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.973 -0.455 . . . . 0.0 110.616 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.41 -38.84 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.8 -48.45 76.82 Favored 'General case' 0 N--CA 1.525 3.311 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.18 -36.12 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.933 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.8 p -66.85 -49.46 65.64 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.03 -33.09 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.33 77.6 Favored 'General case' 0 N--CA 1.523 3.189 0 C-N-CA 122.882 0.473 . . . . 0.0 111.211 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.5 83.35 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 122.759 0.424 . . . . 0.0 111.997 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.95 -45.23 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.406 0 C-N-CA 123.201 0.6 . . . . 0.0 111.263 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -67.66 -32.67 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 O-C-N 121.755 -0.591 . . . . 0.0 110.63 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -47.86 83.05 Favored 'General case' 0 N--CA 1.523 3.216 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.95 -44.62 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.82 -36.58 77.55 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 119.301 0.955 . . . . 0.0 112.448 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.11 67.19 Favored 'General case' 0 N--CA 1.526 3.338 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 4.3 m -70.24 -38.46 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 118.737 0.699 . . . . 0.0 111.543 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.23 -43.09 92.54 Favored 'General case' 0 N--CA 1.532 3.671 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.28 -31.9 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 CA-C-N 117.999 0.363 . . . . 0.0 110.03 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.9 t -66.5 -46.17 77.14 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.304 0.642 . . . . 0.0 110.712 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.09 -35.1 76.12 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.985 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 88.3 p -64.22 -34.93 79.23 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 122.791 0.436 . . . . 0.0 111.693 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.59 -20.07 25.47 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 124.035 0.934 . . . . 0.0 111.376 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.82 -27.84 36.42 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 122.713 0.405 . . . . 0.0 110.284 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -100.83 10.02 41.64 Favored 'General case' 1 N--CA 1.543 4.203 0 C-N-CA 124.116 0.966 . . . . 0.0 109.998 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.9 -21.91 26.02 Favored 'General case' 0 N--CA 1.531 3.588 0 C-N-CA 123.903 0.881 . . . . 0.0 108.73 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.83 -43.67 87.87 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 124.232 1.013 . . . . 0.0 108.766 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.0 m -136.33 125.12 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.93 141.4 23.23 Favored Pre-proline 0 N--CA 1.527 3.42 0 CA-C-O 116.272 -1.823 . . . . 0.0 107.153 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo . . . . . 1 N--CA 1.549 4.745 0 C-N-CA 122.948 2.432 . . . . 0.0 115.049 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.575 1.927 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.06 -51.53 11.01 Favored 'Trans proline' 1 N--CA 1.544 4.468 0 C-N-CA 122.404 2.069 . . . . 0.0 113.424 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.4 107.93 0.21 Allowed Glycine 1 N--CA 1.518 4.128 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 67.8 m -76.28 114.88 15.46 Favored 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.37 21.6 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.48 0.712 . . . . 0.0 110.296 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 122.798 0.439 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.54 -40.85 31.37 Favored Glycine 1 N--CA 1.52 4.24 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.18 -45.65 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.2 0 C-N-CA 124.443 1.097 . . . . 0.0 112.054 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 5.9 tp -55.58 -33.21 32.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 CA-C-N 118.529 0.604 . . . . 0.0 110.052 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.28 -46.5 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-O 121.822 0.82 . . . . 0.0 109.021 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.2 -41.9 85.04 Favored 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.74 -38.26 64.16 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 119.042 0.837 . . . . 0.0 111.776 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.9 p -64.04 -48.01 77.95 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.678 0.791 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.82 -45.74 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.07 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.44 54.07 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 123.372 0.669 . . . . 0.0 111.729 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -41.3 98.7 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-O 120.932 0.396 . . . . 0.0 111.384 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.11 -38.97 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.325 0 C-N-CA 123.558 0.743 . . . . 0.0 109.657 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.37 -33.1 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 123.617 0.767 . . . . 0.0 111.03 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.49 -43.47 93.29 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-N 118.594 0.634 . . . . 0.0 110.161 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.4 -54.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.36 0.664 . . . . 0.0 110.102 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.03 -37.82 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.301 1.04 . . . . 0.0 113.314 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.94 92.52 Favored 'General case' 1 N--CA 1.541 4.091 0 CA-C-N 118.575 0.625 . . . . 0.0 112.515 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.86 -34.1 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.21 -43.77 93.99 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.176 0.59 . . . . 0.0 112.051 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.29 -36.07 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 CA-C-O 120.818 0.342 . . . . 0.0 110.438 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.24 -39.44 86.18 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.297 0.639 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.44 -29.99 64.2 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 99.1 p -75.37 -43.15 51.92 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 122.748 0.419 . . . . 0.0 110.745 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.3 mt -77.27 -31.66 55.05 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.892 0.877 . . . . 0.0 111.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -80.67 -27.63 37.04 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 123.069 0.547 . . . . 0.0 111.662 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -92.01 0.65 57.47 Favored 'General case' 1 N--CA 1.545 4.283 0 C-N-CA 123.411 0.684 . . . . 0.0 110.509 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -104.84 -14.38 15.52 Favored 'General case' 1 N--CA 1.543 4.217 0 C-N-CA 124.117 0.967 . . . . 0.0 109.64 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? 62.85 52.24 2.75 Favored 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 124.679 1.191 . . . . 0.0 111.548 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 94.6 t -131.7 122.3 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -128.6 141.87 42.98 Favored Pre-proline 0 N--CA 1.533 3.715 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 1 N--CA 1.54 4.212 0 CA-C-N 122.322 1.865 . . . . 0.0 111.029 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.48 150.47 20.87 Favored 'Trans proline' 1 N--CA 1.547 4.661 0 CA-C-N 121.969 1.739 . . . . 0.0 113.258 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 172.3 -48.96 0.17 Allowed Glycine 1 N--CA 1.519 4.187 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p 58.38 159.54 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.783 1.233 . . . . 0.0 112.443 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.23 12.44 3.51 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 124.124 0.97 . . . . 0.0 109.943 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 24.4 t -62.27 -20.43 64.26 Favored 'General case' 0 N--CA 1.522 3.173 0 C-N-CA 123.829 0.851 . . . . 0.0 110.624 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.61 94.14 Favored Glycine 0 N--CA 1.508 3.488 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.184 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.3 pt -65.79 -35.39 75.05 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 CA-C-N 117.897 0.849 . . . . 0.0 111.265 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.14 -34.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 C-N-CA 123.203 0.601 . . . . 0.0 109.636 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.07 -44.31 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.421 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -67.02 -45.41 77.61 Favored 'General case' 0 N--CA 1.533 3.687 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.65 -35.85 52.15 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.3 p -66.06 -49.45 67.61 Favored 'General case' 0 N--CA 1.529 3.492 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.93 -37.82 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.14 72.76 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 122.64 0.376 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.23 94.87 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.938 0.495 . . . . 0.0 111.747 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.76 -42.12 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 123.322 0.649 . . . . 0.0 109.893 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.79 -32.97 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.547 0.739 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.87 -37.7 88.38 Favored 'General case' 0 N--CA 1.529 3.506 0 C-N-CA 122.89 0.476 . . . . 0.0 111.954 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.73 -54.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.707 0 C-N-CA 122.887 0.475 . . . . 0.0 111.624 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 22.7 m -66.86 -36.88 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.49 67.83 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.26 -36.55 77.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 119.393 0.997 . . . . 0.0 110.593 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.54 -30.27 71.0 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 122.784 0.434 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.16 -41.08 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.607 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.41 -48.31 67.7 Favored 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 123.465 0.706 . . . . 0.0 111.166 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.95 -25.07 67.97 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 124.068 0.947 . . . . 0.0 111.708 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 36.6 t -63.9 -40.96 97.72 Favored 'General case' 0 N--CA 1.524 3.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.8 -35.18 67.3 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.29 -20.85 43.44 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.18 0.592 . . . . 0.0 110.498 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -89.05 -18.08 28.04 Favored 'General case' 0 N--CA 1.538 3.932 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mttp 60.13 6.17 0.93 Allowed 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 124.414 1.086 . . . . 0.0 113.129 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -72.81 -38.42 67.19 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.5 t -135.99 123.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 30.3 mt -103.04 141.5 22.61 Favored Pre-proline 0 N--CA 1.527 3.404 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.286 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 1 N--CA 1.539 4.166 0 CA-C-N 122.62 1.972 . . . . 0.0 110.803 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.576 1.964 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.18 159.26 47.69 Favored 'Trans proline' 1 N--CA 1.54 4.256 0 C-N-CA 122.304 2.002 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.59 -43.1 69.85 Favored Glycine 1 N--CA 1.519 4.22 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 38.6 m 56.45 77.67 0.24 Allowed 'General case' 0 N--CA 1.521 3.084 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.3 21.32 0.12 Allowed 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m -69.89 -27.73 65.04 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 123.531 0.732 . . . . 0.0 110.989 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.36 -50.57 8.16 Favored Glycine 0 N--CA 1.512 3.734 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.805 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.35 -36.89 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 8.5 tp -60.12 -33.58 53.82 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.64 0.655 . . . . 0.0 110.42 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.13 -42.22 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -64.34 -29.23 70.31 Favored 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.22 -44.8 84.28 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.455 0 CA-C-N 119.673 1.124 . . . . 0.0 113.455 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.5 p -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.88 -36.76 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.142 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.6 70.41 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 122.616 0.366 . . . . 0.0 111.358 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.94 -43.68 98.13 Favored 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 122.651 0.38 . . . . 0.0 111.482 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.3 -42.77 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 C-N-CA 123.508 0.723 . . . . 0.0 110.003 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.42 -33.29 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.347 0 C-N-CA 123.407 0.683 . . . . 0.0 110.193 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.94 -38.57 91.55 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 122.813 0.445 . . . . 0.0 111.96 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.0 mt -70.34 -55.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 122.416 0.286 . . . . 0.0 111.546 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.7 -37.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.25 82.89 Favored 'General case' 0 N--CA 1.533 3.683 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.11 -34.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.622 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.0 -42.3 66.61 Favored 'General case' 1 N--CA 1.54 4.056 0 CA-C-N 119.504 1.047 . . . . 0.0 111.547 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.36 -32.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.4 p -67.27 -37.64 83.79 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-N 118.282 0.492 . . . . 0.0 111.103 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.61 -27.72 67.92 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.463 0.705 . . . . 0.0 111.452 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.6 p -72.21 -16.74 61.95 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 122.645 0.378 . . . . 0.0 111.32 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.4 -37.7 13.05 Favored 'General case' 0 N--CA 1.535 3.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.268 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.67 -27.88 26.78 Favored 'General case' 1 N--CA 1.545 4.298 0 C-N-CA 122.916 0.487 . . . . 0.0 111.152 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.94 -16.89 18.6 Favored 'General case' 1 N--CA 1.544 4.264 0 C-N-CA 123.587 0.755 . . . . 0.0 109.631 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.93 39.53 20.12 Favored 'General case' 0 N--CA 1.516 2.834 0 C-N-CA 125.195 1.398 . . . . 0.0 112.212 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 60.53 8.73 1.79 Allowed 'General case' 0 N--CA 1.516 2.872 0 C-N-CA 124.433 1.093 . . . . 0.0 112.652 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.39 123.0 66.55 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.11 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.78 113.98 63.75 Favored Pre-proline 0 N--CA 1.517 2.914 0 CA-C-O 116.659 -1.638 . . . . 0.0 107.096 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo . . . . . 1 N--CA 1.547 4.646 0 C-N-CA 122.511 2.141 . . . . 0.0 114.396 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.572 1.797 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.98 68.38 3.94 Favored 'Trans proline' 1 N--CA 1.539 4.167 0 C-N-CA 122.171 1.914 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.47 84.13 0.26 Allowed Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 32.7 t 58.96 30.78 20.66 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 124.179 0.992 . . . . 0.0 111.829 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.99 -17.79 61.42 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.524 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.5 p -65.18 -39.52 93.01 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.712 0.805 . . . . 0.0 111.131 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.99 81.19 Favored Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.271 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.05 -36.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 C-N-CA 124.026 0.93 . . . . 0.0 110.533 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.42 -35.93 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 C-N-CA 122.966 0.506 . . . . 0.0 110.151 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.98 -38.13 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.54 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -65.21 -47.01 78.41 Favored 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.82 -29.92 41.44 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 118.699 0.682 . . . . 0.0 112.335 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.5 p -69.57 -49.9 49.75 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.55 -31.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.098 0.559 . . . . 0.0 111.238 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.04 79.39 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 122.855 0.462 . . . . 0.0 111.626 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.4 t -70.05 -48.26 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 123.268 0.627 . . . . 0.0 111.212 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.0 -32.02 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 CA-C-N 118.251 0.478 . . . . 0.0 110.106 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -46.98 62.93 Favored 'General case' 0 N--CA 1.535 3.776 0 C-N-CA 123.667 0.787 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.33 -54.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.81 -37.03 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 124.768 1.227 . . . . 0.0 113.818 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.43 -31.92 68.2 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.7 m -69.45 -36.09 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 119.332 0.969 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.92 -42.44 66.7 Favored 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.22 -38.36 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.24 -38.93 86.0 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 124.004 0.921 . . . . 0.0 111.039 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 22.1 t -70.08 -32.47 70.55 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 122.947 0.499 . . . . 0.0 110.108 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.31 -32.21 62.76 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.939 0.896 . . . . 0.0 109.904 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.22 -16.06 55.62 Favored 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -88.85 -17.44 29.67 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 55.09 13.22 0.75 Allowed 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -74.63 -11.68 60.25 Favored 'General case' 0 N--CA 1.536 3.843 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.43 125.19 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 47.0 mt -118.36 141.93 30.46 Favored Pre-proline 0 N--CA 1.529 3.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.729 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo . . . . . 1 N--CA 1.541 4.276 0 CA-C-N 122.374 1.883 . . . . 0.0 110.801 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 17.5 ptm . . . . . 0 CA--C 1.576 1.963 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.91 159.77 52.07 Favored 'Trans proline' 1 N--CA 1.542 4.325 0 C-N-CA 122.298 1.998 . . . . 0.0 110.371 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.62 -10.69 58.54 Favored Glycine 1 N--CA 1.518 4.165 0 C-N-CA 123.643 0.64 . . . . 0.0 112.167 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 210' ' ' SER . . . . . 0.411 ' C ' ' H ' ' C' ' 212' ' ' SER . 46.6 m 57.28 176.89 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 124.277 1.031 . . . . 0.0 112.209 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 69.92 -32.3 0.23 Allowed 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.513 1.525 . . . . 0.0 111.366 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 212' ' ' SER . . . . . 0.411 ' H ' ' C ' ' C' ' 210' ' ' SER . 70.0 m -70.65 -23.79 62.58 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.706 -0.621 . . . . 0.0 109.85 176.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.88 -50.09 55.04 Favored Glycine 0 N--CA 1.512 3.718 0 C-N-CA 124.264 0.935 . . . . 0.0 114.616 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.15 -36.03 60.69 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.094 0.947 . . . . 0.0 110.748 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.03 -34.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 122.871 0.468 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.4 -41.09 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.872 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -56.72 -41.8 78.09 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.512 0.725 . . . . 0.0 111.867 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 50.5 t -57.76 -45.88 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 19.3 p -62.87 -49.28 75.45 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.05 -38.45 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.133 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.8 78.79 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.46 64.39 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.99 -38.39 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.32 -32.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.551 0.614 . . . . 0.0 110.668 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.73 -36.02 71.48 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.149 0.58 . . . . 0.0 112.371 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -69.57 -54.85 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 122.763 0.425 . . . . 0.0 111.193 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.14 -35.99 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 C-N-CA 124.236 1.014 . . . . 0.0 113.227 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -31.11 65.9 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.27 -35.21 74.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.077 0 CA-C-N 119.401 1.001 . . . . 0.0 110.594 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.79 -33.79 75.51 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 122.887 0.475 . . . . 0.0 110.422 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.58 -43.0 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 C-N-CA 123.29 0.636 . . . . 0.0 109.8 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 61.7 m -65.47 -48.45 72.62 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.155 0.582 . . . . 0.0 110.891 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -68.42 -41.04 80.97 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 124.06 0.944 . . . . 0.0 111.487 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -70.1 -29.19 66.1 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 122.881 0.472 . . . . 0.0 110.654 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.07 -34.87 24.1 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.687 0.795 . . . . 0.0 111.124 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 53.5 tp -81.05 -27.74 35.63 Favored 'General case' 0 N--CA 1.538 3.955 0 C-N-CA 123.804 0.841 . . . . 0.0 113.052 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -103.21 13.99 32.69 Favored 'General case' 1 N--CA 1.548 4.447 0 C-N-CA 124.424 1.09 . . . . 0.0 111.321 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -119.16 -7.84 10.25 Favored 'General case' 1 N--CA 1.541 4.121 0 C-N-CA 124.198 0.999 . . . . 0.0 110.983 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -68.37 -43.95 76.23 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.79 122.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.7 mp -109.41 141.6 23.9 Favored Pre-proline 0 N--CA 1.534 3.757 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 1 N--CA 1.541 4.275 0 CA-C-N 122.474 1.919 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.571 1.767 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.6 81.09 1.61 Allowed 'Trans proline' 1 N--CA 1.538 4.125 0 C-N-CA 122.184 1.923 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.17 173.2 19.93 Favored Glycine 1 N--CA 1.519 4.201 0 C-N-CA 123.664 0.65 . . . . 0.0 111.605 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -167.64 179.75 4.71 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 123.714 0.806 . . . . 0.0 109.777 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.6 mt 66.6 -9.81 0.31 Allowed 'General case' 0 N--CA 1.518 2.953 0 C-N-CA 124.849 1.26 . . . . 0.0 112.912 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 56.7 m -70.4 -38.11 74.59 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 123.309 0.644 . . . . 0.0 111.071 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.21 -41.38 31.59 Favored Glycine 1 N--CA 1.517 4.082 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.716 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.48 -47.62 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.974 0.91 . . . . 0.0 110.886 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.2 -34.2 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 O-C-N 121.939 -0.475 . . . . 0.0 111.576 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.84 -43.13 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -67.05 -40.93 87.24 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.79 -33.28 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.151 0 CA-C-N 119.347 0.976 . . . . 0.0 112.791 -175.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -49.72 61.24 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.07 -31.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.435 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.24 -41.29 77.18 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.643 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.22 -43.66 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.505 0.722 . . . . 0.0 111.793 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.91 -32.26 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 CA-C-N 118.332 0.514 . . . . 0.0 110.791 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.11 -38.34 79.35 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.115 0.566 . . . . 0.0 112.317 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.23 -55.14 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.84 -37.41 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.09 89.19 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.8 -34.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.11 -43.82 97.99 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.413 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.59 -36.0 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 CA-C-O 120.987 0.422 . . . . 0.0 110.211 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.34 -48.33 67.83 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.375 0.67 . . . . 0.0 111.687 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -72.28 -45.16 61.26 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.871 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' SER . . . . . 0.411 ' HG ' ' N ' ' A' ' 235' ' ' LEU . 94.8 p -65.04 -39.42 93.29 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . 0.411 ' N ' ' HG ' ' A' ' 234' ' ' SER . 53.5 tp -72.89 -37.69 67.2 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 122.682 0.393 . . . . 0.0 111.909 -177.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.76 -24.29 31.19 Favored 'General case' 0 N--CA 1.539 3.987 0 C-N-CA 123.612 0.765 . . . . 0.0 111.247 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -89.05 -7.13 56.48 Favored 'General case' 1 N--CA 1.541 4.112 0 CA-C-N 118.259 0.481 . . . . 0.0 110.357 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -81.47 -38.39 26.46 Favored 'General case' 0 N--CA 1.528 3.45 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.75 -57.31 4.46 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.791 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.08 122.16 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -96.43 141.79 23.61 Favored Pre-proline 0 N--CA 1.527 3.424 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 1 N--CA 1.54 4.226 0 CA-C-N 122.32 1.864 . . . . 0.0 110.682 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -51.39 175.12 0.06 OUTLIER 'Trans proline' 1 N--CA 1.545 4.552 0 C-N-CA 122.454 2.102 . . . . 0.0 113.621 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.11 172.5 45.03 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 m 56.25 53.02 9.36 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 124.007 0.923 . . . . 0.0 111.614 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -165.63 -48.2 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.28 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -61.07 -26.27 67.52 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.918 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.71 -44.74 19.44 Favored Glycine 0 N--CA 1.515 3.954 0 O-C-N 123.849 0.718 . . . . 0.0 111.48 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.72 -46.24 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 C-N-CA 124.708 1.203 . . . . 0.0 111.585 -176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.9 -32.62 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 O-C-N 122.143 -0.348 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.72 -48.57 87.52 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.73 -0.606 . . . . 0.0 110.62 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -67.85 -40.04 83.74 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 20.1 m -57.52 -38.58 64.36 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 CA-C-N 119.929 1.24 . . . . 0.0 112.067 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -61.34 -48.1 82.85 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.694 0.798 . . . . 0.0 111.266 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.67 -44.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.479 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 -34.78 75.42 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 122.994 0.518 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.0 94.12 Favored 'General case' 0 N--CA 1.523 3.195 0 C-N-CA 123.017 0.527 . . . . 0.0 111.902 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.4 -44.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.49 -35.03 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.045 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.34 -38.06 79.39 Favored 'General case' 0 N--CA 1.532 3.629 0 C-N-CA 123.123 0.569 . . . . 0.0 111.327 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.98 -48.81 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.0 -35.53 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 C-N-CA 125.442 1.497 . . . . 0.0 112.158 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.85 68.57 Favored 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -173.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.01 -44.19 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.662 0.664 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -63.77 -42.11 97.84 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.93 -33.62 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.589 0.632 . . . . 0.0 110.798 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.9 m -67.22 -43.64 81.52 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.026 0.53 . . . . 0.0 110.611 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.49 -31.13 65.14 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.711 0.804 . . . . 0.0 110.249 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.92 -43.01 97.22 Favored 'General case' 0 N--CA 1.522 3.143 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.8 -14.76 41.28 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.683 0.793 . . . . 0.0 112.543 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.8 tp -90.07 -27.71 19.5 Favored 'General case' 1 N--CA 1.542 4.133 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 14.15 25.75 Favored 'General case' 1 N--CA 1.556 4.835 0 CA-C-N 119.665 1.121 . . . . 0.0 113.917 -177.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -63.73 -3.55 2.42 Favored 'General case' 1 N--CA 1.54 4.031 0 CA-C-N 118.557 0.617 . . . . 0.0 110.842 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp 82.87 48.65 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.854 0 C-N-CA 125.2 1.4 . . . . 0.0 109.372 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.35 122.4 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.55 141.64 23.46 Favored Pre-proline 0 N--CA 1.528 3.445 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 1 N--CA 1.539 4.203 0 CA-C-N 122.524 1.937 . . . . 0.0 110.725 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.576 1.965 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.27 145.51 54.4 Favored 'Trans proline' 1 N--CA 1.541 4.307 0 C-N-CA 122.2 1.933 . . . . 0.0 110.334 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.23 71.63 Favored Glycine 1 N--CA 1.517 4.058 0 C-N-CA 123.777 0.704 . . . . 0.0 111.716 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.4 m 56.57 100.47 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 124.167 0.987 . . . . 0.0 111.31 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -148.62 -5.43 0.42 Allowed 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 123.783 0.833 . . . . 0.0 110.708 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -55.75 -20.88 16.28 Favored 'General case' 0 N--CA 1.528 3.461 0 O-C-N 121.781 -0.574 . . . . 0.0 111.493 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.95 -39.79 93.34 Favored Glycine 0 N--CA 1.51 3.594 0 O-C-N 124.112 0.883 . . . . 0.0 113.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -38.05 80.25 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 CA-C-N 117.524 0.662 . . . . 0.0 109.866 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 50.7 mt -56.74 -34.36 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.389 0.675 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 25.8 mm -69.6 -44.26 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.614 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.44 -36.81 75.5 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.276 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 40.5 p -63.77 -49.26 73.68 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.9 -38.88 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.78 73.71 Favored 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 122.718 0.407 . . . . 0.0 110.972 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.52 85.42 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.087 0.555 . . . . 0.0 112.04 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.291 0.636 . . . . 0.0 109.839 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.95 -32.48 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 123.592 0.757 . . . . 0.0 110.291 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.6 tp -64.23 -48.53 75.46 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 tt -71.95 -52.08 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.06 -37.01 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -31.78 68.9 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.18 -34.9 66.09 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.251 0.932 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -68.86 -38.62 79.86 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.046 0.451 . . . . 0.0 109.807 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.1 -41.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 C-N-CA 123.91 0.884 . . . . 0.0 109.599 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.21 -38.79 92.31 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.526 0.73 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.0 -47.02 54.97 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.47 0.708 . . . . 0.0 109.481 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.66 -12.81 37.09 Favored 'General case' 0 N--CA 1.519 2.975 0 C-N-CA 123.702 0.801 . . . . 0.0 112.391 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 59.1 tp -91.0 -37.52 13.41 Favored 'General case' 0 N--CA 1.533 3.695 0 C-N-CA 123.925 0.89 . . . . 0.0 111.801 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.79 -27.57 17.92 Favored 'General case' 1 N--CA 1.54 4.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.474 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -98.15 13.47 31.05 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.284 1.034 . . . . 0.0 109.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.74 -21.25 66.31 Favored 'General case' 0 N--CA 1.527 3.393 0 C-N-CA 124.447 1.099 . . . . 0.0 109.685 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.33 -21.08 66.49 Favored 'General case' 0 N--CA 1.522 3.146 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.307 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.98 123.01 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 38.7 mt -116.71 141.73 28.61 Favored Pre-proline 0 N--CA 1.532 3.636 0 CA-C-O 117.049 -1.453 . . . . 0.0 108.329 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 1 N--CA 1.54 4.213 0 CA-C-N 122.533 1.94 . . . . 0.0 110.772 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 CA--C 1.585 2.316 0 CA-C-O 117.468 -1.254 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -88.92 22.53 0.83 Allowed 'Trans proline' 0 N--CA 1.535 3.952 0 C-N-CA 122.608 2.205 . . . . 0.0 111.397 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.69 159.19 46.03 Favored Glycine 1 N--CA 1.519 4.201 0 C-N-CA 123.608 0.623 . . . . 0.0 111.561 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.4 p -72.29 64.87 0.59 Allowed 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 123.84 0.856 . . . . 0.0 109.881 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.92 -36.42 83.33 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.989 0.915 . . . . 0.0 109.889 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.1 m -70.55 -20.88 62.77 Favored 'General case' 0 N--CA 1.521 3.098 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.983 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.24 -50.28 8.58 Favored Glycine 0 N--CA 1.513 3.8 0 C-N-CA 123.984 0.802 . . . . 0.0 113.78 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.84 -36.91 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 42.5 pt -57.96 -33.81 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 118.951 0.796 . . . . 0.0 110.667 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.65 -41.19 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.66 -34.48 77.17 Favored 'General case' 0 N--CA 1.529 3.493 0 C-N-CA 123.471 0.708 . . . . 0.0 111.687 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.89 -38.03 63.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 CA-C-O 120.921 0.391 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.5 p -66.02 -49.15 68.74 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.302 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.02 -44.93 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.022 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.061 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.75 -34.57 67.68 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.351 0.66 . . . . 0.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.24 98.57 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 122.904 0.482 . . . . 0.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.1 t -69.94 -39.06 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.397 0.679 . . . . 0.0 109.627 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.7 -32.87 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 123.755 0.822 . . . . 0.0 109.869 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -47.21 84.89 Favored 'General case' 0 N--CA 1.535 3.794 0 CA-C-O 121.58 0.705 . . . . 0.0 110.748 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.06 -54.11 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.926 0.89 . . . . 0.0 112.702 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.63 -36.79 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.57 -31.73 68.27 Favored 'General case' 0 N--CA 1.528 3.455 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.09 -34.93 73.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.104 0 CA-C-N 119.348 0.976 . . . . 0.0 110.581 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -65.12 -36.08 83.15 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 122.561 0.344 . . . . 0.0 110.297 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.03 -37.43 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.633 0.773 . . . . 0.0 109.764 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 66.6 m -67.11 -48.33 68.45 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.236 0.614 . . . . 0.0 111.002 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -70.38 -27.72 64.53 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 123.784 0.834 . . . . 0.0 110.351 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.9 t -63.92 -37.9 89.09 Favored 'General case' 0 N--CA 1.528 3.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.546 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.79 -37.23 76.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 123.971 0.908 . . . . 0.0 110.505 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.65 -23.44 39.69 Favored 'General case' 0 N--CA 1.531 3.625 0 C-N-CA 123.586 0.754 . . . . 0.0 110.384 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -89.68 -8.75 51.7 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 123.864 0.866 . . . . 0.0 109.921 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -126.62 44.3 2.91 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.842 1.257 . . . . 0.0 108.168 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.28 -22.75 0.06 Allowed 'General case' 0 N--CA 1.526 3.373 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.582 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 p -83.5 124.78 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.47 114.45 18.21 Favored Pre-proline 0 N--CA 1.526 3.367 0 CA-C-O 116.818 -1.563 . . . . 0.0 108.455 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 1 N--CA 1.548 4.712 0 CA-C-N 122.941 2.086 . . . . 0.0 114.416 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.53 142.49 30.62 Favored 'Trans proline' 1 N--CA 1.549 4.761 0 CA-C-N 122.02 1.757 . . . . 0.0 113.491 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 173.96 -161.79 32.22 Favored Glycine 1 N--CA 1.517 4.058 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.3 m 58.19 58.84 3.31 Favored 'General case' 0 N--CA 1.52 3.035 0 C-N-CA 124.207 1.003 . . . . 0.0 111.753 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.44 13.04 0.82 Allowed 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.755 0.822 . . . . 0.0 110.66 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.7 m -71.46 -43.15 67.17 Favored 'General case' 0 N--CA 1.519 2.979 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.46 93.28 Favored Glycine 1 N--CA 1.518 4.158 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.272 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.9 tp -57.6 -36.38 53.92 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 118.116 0.958 . . . . 0.0 110.785 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.98 -40.17 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.781 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 1.5 mp -66.72 -41.3 87.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.144 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -59.25 -36.47 75.54 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.334 0.654 . . . . 0.0 112.042 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.21 -42.27 83.03 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.154 0 CA-C-O 121.023 0.439 . . . . 0.0 110.029 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 5.5 p -63.21 -48.39 78.5 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.602 0.761 . . . . 0.0 110.974 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.6 -42.94 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.441 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.87 75.86 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 122.885 0.474 . . . . 0.0 111.066 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.36 -48.99 68.42 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.05 0.54 . . . . 0.0 111.513 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -38.84 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 C-N-CA 123.248 0.619 . . . . 0.0 110.055 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.15 -32.91 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 C-N-CA 123.099 0.56 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.05 -34.89 79.51 Favored 'General case' 0 N--CA 1.534 3.76 0 C-N-CA 122.83 0.452 . . . . 0.0 111.83 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.66 -54.62 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 C-N-CA 122.804 0.442 . . . . 0.0 111.039 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -36.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.78 82.35 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.5 -34.78 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.215 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.86 -40.18 79.48 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 119.197 0.908 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.01 -31.62 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.808 0 CA-C-N 118.435 0.561 . . . . 0.0 110.964 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.25 -40.72 95.11 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 122.818 0.447 . . . . 0.0 111.345 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.27 -45.43 32.71 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.271 0.628 . . . . 0.0 109.973 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.8 t -63.16 -12.82 30.55 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 122.804 0.442 . . . . 0.0 111.68 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 64.3 tp -89.1 -35.92 16.02 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 124.308 1.043 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -27.59 26.87 Favored 'General case' 1 N--CA 1.543 4.179 0 C-N-CA 123.979 0.912 . . . . 0.0 110.703 -177.59 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -108.63 13.69 25.02 Favored 'General case' 0 N--CA 1.536 3.826 0 C-N-CA 125.063 1.345 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -50.86 -29.23 11.33 Favored 'General case' 0 N--CA 1.524 3.233 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.79 -11.58 0.02 OUTLIER 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 122.886 0.474 . . . . 0.0 110.638 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.01 122.15 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.38 142.16 24.12 Favored Pre-proline 0 N--CA 1.534 3.736 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 1 N--CA 1.541 4.296 0 CA-C-N 122.218 1.828 . . . . 0.0 110.83 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.579 2.088 0 CA-C-O 117.629 -1.177 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -51.06 104.08 0.08 OUTLIER 'Trans proline' 1 N--CA 1.548 4.729 0 CA-C-N 122.442 1.908 . . . . 0.0 113.579 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.01 152.72 50.51 Favored Glycine 1 N--CA 1.518 4.131 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m 55.56 -177.62 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.954 0.902 . . . . 0.0 112.006 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 6.7 tp 66.85 -1.22 1.42 Allowed 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.161 0.985 . . . . 0.0 111.503 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -70.5 -21.03 62.8 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 122.968 0.507 . . . . 0.0 110.857 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.43 -50.14 22.36 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 123.614 0.626 . . . . 0.0 113.814 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.24 -36.65 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 CA-C-N 117.432 0.616 . . . . 0.0 111.149 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.74 -35.1 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 117.942 0.337 . . . . 0.0 110.832 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.37 -42.56 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.737 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -66.58 -42.75 86.52 Favored 'General case' 0 N--CA 1.527 3.414 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.41 -33.47 47.95 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.847 0.749 . . . . 0.0 112.287 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 25.3 p -66.97 -50.27 62.82 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.98 -39.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.74 68.89 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.967 0.507 . . . . 0.0 111.306 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.21 94.06 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 122.841 0.457 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 51.3 t -70.05 -41.17 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 123.622 0.769 . . . . 0.0 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.81 -34.14 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.876 0.871 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.44 -36.76 83.61 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.125 0.57 . . . . 0.0 111.588 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.83 -54.24 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 C-N-CA 123.109 0.564 . . . . 0.0 111.085 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 m -67.76 -42.02 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.34 92.35 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.07 -37.02 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 CA-C-O 118.047 -0.977 . . . . 0.0 112.218 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -73.32 -36.57 66.25 Favored 'General case' 1 N--CA 1.548 4.443 0 CA-C-N 120.631 1.559 . . . . 0.0 109.801 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.86 -32.03 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 C-N-CA 123.188 0.595 . . . . 0.0 109.713 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.56 -38.12 83.51 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 123.304 0.642 . . . . 0.0 111.192 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -51.16 -24.39 4.13 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 124.362 1.065 . . . . 0.0 111.633 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 35.4 t -63.72 -39.81 95.22 Favored 'General case' 0 N--CA 1.52 3.065 0 C-N-CA 122.814 0.446 . . . . 0.0 110.89 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.88 -31.49 69.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.21 -27.75 38.76 Favored 'General case' 0 N--CA 1.537 3.89 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -89.66 -14.6 34.47 Favored 'General case' 1 N--CA 1.542 4.152 0 C-N-CA 123.342 0.657 . . . . 0.0 109.968 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 50.8 tttm 95.19 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.538 3.928 0 C-N-CA 126.09 1.756 . . . . 0.0 113.073 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 80.4 tttt 52.57 54.4 10.67 Favored 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 124.329 1.052 . . . . 0.0 112.812 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m -92.17 122.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.778 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -129.61 134.33 26.09 Favored Pre-proline 0 N--CA 1.536 3.84 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 1 N--CA 1.539 4.171 0 CA-C-N 122.924 2.08 . . . . 0.0 110.652 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.521 3.085 0 N-CA-C 109.979 -0.378 . . . . 422.23 109.979 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.41 -50.64 9.53 Favored Glycine 0 N--CA 1.511 3.681 0 CA-C-N 115.78 -0.645 . . . . 182.12 113.236 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -66.48 -37.48 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.596 0.698 . . . . 429.52 111.002 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.89 -41.86 92.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 C-N-CA 122.59 0.356 . . . . 386.43 110.488 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.58 -45.02 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 O-C-N 121.665 -0.647 . . . . 161.88 109.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.17 -40.56 86.61 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 114.482 1.29 . . . . 999.99 114.482 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.7 -31.57 40.2 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.227 0 CA-C-N 119.076 0.853 . . . . 168.06 111.209 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.6 p -69.52 -48.63 59.85 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.419 0.688 . . . . 21.5 110.282 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.89 -34.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.192 0 CA-C-N 115.296 -0.865 . . . . 220.71 109.09 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.83 72.88 Favored 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 123.278 0.631 . . . . 59.04 111.039 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.68 68.88 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 115.801 -0.636 . . . . 25.92 111.121 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.62 -45.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 C-N-CA 123.422 0.689 . . . . 37.84 111.716 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.78 -32.83 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 CA-C-N 118.332 0.514 . . . . 282.57 110.432 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 49.6 tp -63.98 -36.16 83.06 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.482 0.713 . . . . 170.35 112.194 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.8 -52.64 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 122.838 0.455 . . . . 145.71 110.357 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.2 -37.5 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 O-C-N 121.807 -0.558 . . . . 205.37 112.162 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.23 85.35 Favored 'General case' 0 N--CA 1.536 3.836 0 N-CA-C 112.818 0.673 . . . . 54.0 112.818 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 -34.28 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.648 0 N-CA-C 109.838 -0.431 . . . . 167.28 109.838 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -69.76 -42.59 73.65 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 109.647 -0.501 . . . . 382.56 109.647 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.46 -31.96 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.3 0.64 . . . . 396.06 109.474 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.7 t -65.07 -39.37 93.13 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.188 0.595 . . . . 241.93 110.467 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.67 -33.02 53.52 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.645 0.778 . . . . 962.6 110.328 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 77.8 p -63.42 -24.1 67.69 Favored 'General case' 0 N--CA 1.533 3.698 0 CA-C-O 120.9 0.381 . . . . 329.86 110.409 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.93 -33.16 30.49 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 124.094 0.958 . . . . 647.43 109.577 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 47.0 tp . . . . . 1 N--CA 1.54 4.026 0 C-N-CA 124.619 1.167 . . . . 658.92 111.832 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.524 3.234 0 CA-C-O 120.843 0.354 . . . . 322.12 111.41 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.3 -35.82 56.22 Favored Glycine 1 N--CA 1.517 4.047 0 CA-C-N 115.444 -0.798 . . . . 118.7 111.417 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.6 mm -65.87 -36.92 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.747 0.819 . . . . 351.56 110.187 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -65.72 -40.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.59 0 C-N-CA 123.151 0.58 . . . . 318.28 109.834 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 83.4 mt -70.08 -38.33 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.421 0.688 . . . . 156.48 109.302 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -62.04 -47.44 84.72 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.504 0.927 . . . . 999.99 113.504 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 15.2 m -59.24 -27.86 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 O-C-N 122.28 -0.262 . . . . 221.17 111.223 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.0 p -66.23 -48.22 71.26 Favored 'General case' 0 N--CA 1.535 3.816 0 CA-C-O 121.39 0.614 . . . . 21.87 110.368 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.13 -51.61 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 CA-C-N 115.281 -0.872 . . . . 176.34 109.076 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.23 -34.69 61.27 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 122.889 0.476 . . . . 36.92 111.545 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.86 92.38 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 122.717 0.407 . . . . 26.88 111.166 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 80.5 t -69.75 -46.74 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 N-CA-C 109.471 -0.566 . . . . 93.61 109.471 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.5 -33.81 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.281 0.632 . . . . 229.62 110.192 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.27 -39.46 92.64 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.778 0.431 . . . . 164.04 110.632 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.01 -46.91 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 109.042 -0.725 . . . . 134.42 109.042 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.25 -36.73 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.199 1.0 . . . . 189.86 111.344 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.0 -31.59 67.08 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.72 0.637 . . . . 50.32 112.72 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.97 -44.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 CA-C-N 118.473 0.579 . . . . 179.11 109.661 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -66.06 -42.62 89.21 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 122.842 0.457 . . . . 336.07 110.202 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.08 -38.73 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 N-CA-C 109.509 -0.552 . . . . 298.7 109.509 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.13 -48.48 67.97 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.003 0.521 . . . . 272.98 111.418 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.73 -42.12 70.97 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.601 0.76 . . . . 892.98 111.112 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 98.4 p -63.8 -13.33 43.29 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 119.228 -0.415 . . . . 295.12 111.308 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -37.94 12.99 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.704 0.801 . . . . 751.54 109.214 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.531 3.623 0 C-N-CA 123.329 0.652 . . . . 539.81 110.728 -178.614 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 N--CA 1.525 3.306 0 CA-C-O 120.472 0.177 . . . . 581.98 110.887 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -70.2 -22.52 62.93 Favored 'General case' 0 N--CA 1.52 3.033 0 C-N-CA 122.889 0.476 . . . . 487.96 109.996 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.4 -50.73 9.39 Favored Glycine 0 N--CA 1.512 3.751 0 CA-C-N 115.926 -0.579 . . . . 126.84 113.157 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.0 tp -66.41 -37.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 117.481 0.641 . . . . 390.09 110.918 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.62 -41.08 88.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 C-N-CA 122.617 0.367 . . . . 395.7 110.189 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.42 -38.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 109.37 -0.604 . . . . 188.96 109.37 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.49 -46.38 83.25 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.995 1.109 . . . . 999.99 113.995 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.85 -27.89 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.966 0 CA-C-N 118.133 0.424 . . . . 199.57 111.424 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 23.9 p -69.79 -48.22 59.99 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-O 121.401 0.62 . . . . 22.73 110.227 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.96 -47.72 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 CA-C-N 115.321 -0.854 . . . . 203.96 108.967 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.62 56.12 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.246 0.618 . . . . 49.7 111.504 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.21 -44.01 85.08 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 122.969 0.508 . . . . 25.3 110.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.11 -41.55 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.323 0.649 . . . . 93.88 109.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.58 -35.28 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.396 0.678 . . . . 243.0 109.935 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.4 -42.41 96.12 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.989 0.516 . . . . 85.12 111.953 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.27 -51.3 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 C-N-CA 123.186 0.594 . . . . 125.46 111.196 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.31 -36.85 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 112.751 0.648 . . . . 188.14 112.751 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.11 -44.71 87.84 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.281 0.845 . . . . 48.46 113.281 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 30.0 m -59.45 -34.69 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 CA-C-N 118.69 0.677 . . . . 139.07 110.594 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -71.32 -42.26 68.82 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 109.615 -0.513 . . . . 304.14 109.615 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.82 -40.03 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 N-CA-C 109.153 -0.684 . . . . 256.41 109.153 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.4 m -67.09 -40.25 86.92 Favored 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 109.525 -0.546 . . . . 224.28 109.525 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.528 3.448 0 C-N-CA 123.71 0.804 . . . . 901.13 110.139 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.524 3.272 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.54 -50.07 70.3 Favored Glycine 0 N--CA 1.514 3.899 0 CA-C-N 114.808 -1.087 . . . . 0.0 114.477 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.7 tp -58.72 -35.91 57.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 CA-C-N 117.863 0.831 . . . . 0.0 110.61 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.64 -34.48 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.077 0.551 . . . . 0.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.69 -45.11 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -67.19 -46.36 74.15 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.71 -40.63 76.56 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 49.9 p -64.75 -49.22 71.64 Favored 'General case' 0 N--CA 1.528 3.43 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.24 -31.59 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.71 71.59 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.825 0.45 . . . . 0.0 111.928 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.88 70.87 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.48 0.312 . . . . 0.0 111.418 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -68.68 -50.93 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 123.514 0.726 . . . . 0.0 111.502 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.29 -31.89 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 122.064 -0.397 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -47.14 66.4 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 123.561 0.744 . . . . 0.0 110.889 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.5 mm -67.77 -42.95 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 C-N-CA 122.794 0.438 . . . . 0.0 110.437 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.4 -39.69 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.576 0.75 . . . . 0.0 111.756 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.27 85.86 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.71 0.404 . . . . 0.0 111.981 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.63 -33.58 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.76 -42.82 99.48 Favored 'General case' 0 N--CA 1.538 3.966 0 C-N-CA 123.245 0.618 . . . . 0.0 110.903 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.96 -32.63 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.955 0.502 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.23 -45.1 89.68 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 122.903 0.481 . . . . 0.0 111.401 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.67 -37.31 73.67 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.222 0.609 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.2 t -63.87 -28.77 70.07 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.414 0.686 . . . . 0.0 111.82 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 59.9 tp -73.74 -37.54 65.03 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 123.688 0.795 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.528 3.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.864 -178.289 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.518 2.934 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.44 -50.6 8.06 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.327 0.489 . . . . 0.0 113.912 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.87 -41.03 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.18 -34.04 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 118.874 0.761 . . . . 0.0 111.745 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.37 -44.83 99.63 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.085 0 CA-C-O 120.985 0.421 . . . . 0.0 110.174 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -61.22 -36.9 81.19 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.501 0.72 . . . . 0.0 111.983 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 -36.39 63.17 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.206 0 CA-C-N 118.343 0.52 . . . . 0.0 111.29 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 10.2 p -66.67 -49.8 64.99 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 8.3 p -71.34 -31.9 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.79 79.68 Favored 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 122.768 0.427 . . . . 0.0 111.217 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.36 69.31 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 122.936 0.494 . . . . 0.0 112.106 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.59 -43.07 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.493 0 C-N-CA 123.453 0.701 . . . . 0.0 111.973 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.88 -32.59 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 CA-C-N 118.7 0.682 . . . . 0.0 110.36 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.77 -38.7 75.91 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.172 0.589 . . . . 0.0 111.24 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.11 -52.09 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 CA-C-O 122.04 0.924 . . . . 0.0 109.621 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.59 -36.4 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 C-N-CA 126.02 1.728 . . . . 0.0 113.135 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.47 66.35 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.29 -38.1 76.98 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 118.971 0.805 . . . . 0.0 110.218 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.48 -41.98 75.41 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.112 0.565 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.46 -33.57 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 C-N-CA 122.914 0.486 . . . . 0.0 110.128 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.6 m -67.52 -44.38 78.53 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 121.576 0.703 . . . . 0.0 109.674 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.66 -27.07 65.66 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 124.59 1.156 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.5 t -67.51 -15.85 63.89 Favored 'General case' 0 N--CA 1.52 3.047 0 C-N-CA 123.138 0.575 . . . . 0.0 111.972 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.22 -37.31 13.4 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.57 0.748 . . . . 0.0 111.468 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.537 3.923 0 C-N-CA 123.025 0.53 . . . . 0.0 110.34 -177.664 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.528 3.43 0 CA-C-O 120.572 0.225 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 -20.56 62.82 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.275 0.63 . . . . 0.0 109.91 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.29 58.6 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 124.053 0.835 . . . . 0.0 114.109 -177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.5 tt -61.07 -35.57 66.38 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 CA-C-N 117.844 0.822 . . . . 0.0 110.513 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.4 mm -54.71 -33.96 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 C-N-CA 123.401 0.68 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 34.8 mm -69.26 -41.9 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 CA-C-O 121.262 0.553 . . . . 0.0 109.573 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -66.03 -42.45 89.59 Favored 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -57.94 -32.94 44.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.341 0 CA-C-N 119.354 0.979 . . . . 0.0 111.329 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 -48.45 72.36 Favored 'General case' 0 N--CA 1.531 3.608 0 C-N-CA 123.586 0.754 . . . . 0.0 110.979 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.18 -36.92 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.39 0 C-N-CA 123.781 0.832 . . . . 0.0 109.434 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.61 77.27 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 123.442 0.697 . . . . 0.0 111.221 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.97 -38.27 79.27 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 123.131 0.573 . . . . 0.0 112.099 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.19 -46.24 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 C-N-CA 122.729 0.411 . . . . 0.0 111.479 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.16 -32.51 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.643 0 CA-C-N 118.331 0.514 . . . . 0.0 110.305 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 55.0 tp -59.21 -43.59 92.26 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 122.983 0.513 . . . . 0.0 110.78 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.36 -54.13 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.12 -37.19 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.621 1.168 . . . . 0.0 114.082 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.0 71.82 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 119.223 0.92 . . . . 0.0 110.925 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.28 -41.93 72.76 Favored 'General case' 0 N--CA 1.53 3.568 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.01 -35.57 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.55 -48.09 67.97 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.139 0.576 . . . . 0.0 111.748 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 28.7 pttt . . . . . 0 N--CA 1.537 3.88 0 C-N-CA 123.485 0.714 . . . . 0.0 111.643 -177.467 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.522 3.141 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.62 -37.4 77.3 Favored Glycine 1 N--CA 1.517 4.088 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.685 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.24 -38.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 C-N-CA 124.45 1.1 . . . . 0.0 110.593 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.08 -38.31 79.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.0 mt -70.11 -37.43 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.08 -47.92 83.47 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.46 -30.93 37.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.395 0 CA-C-N 118.41 0.55 . . . . 0.0 112.218 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -72.2 -48.11 45.62 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 123.47 0.708 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.45 -31.95 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.32 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.24 -34.96 64.45 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.96 -45.47 64.08 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-O 121.162 0.506 . . . . 0.0 111.887 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.15 -38.43 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.886 0.875 . . . . 0.0 112.693 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.44 -32.59 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 CA-C-N 119.334 0.97 . . . . 0.0 111.667 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.05 -47.83 75.97 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.92 -44.96 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.52 -41.08 85.52 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.25 0 CA-C-N 119.53 1.059 . . . . 0.0 112.986 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.34 -43.47 92.74 Favored 'General case' 0 N--CA 1.53 3.549 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.86 -34.54 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.16 -42.36 69.19 Favored 'General case' 1 N--CA 1.539 4.005 0 CA-C-N 118.831 0.741 . . . . 0.0 109.819 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.25 -34.96 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.572 0.749 . . . . 0.0 109.792 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.92 -43.13 84.07 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.282 0.633 . . . . 0.0 111.012 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 123.9 0.88 . . . . 0.0 111.273 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.76 -16.23 60.65 Favored 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 123.215 0.606 . . . . 0.0 111.814 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 mt -91.21 -37.59 13.23 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.854 0.861 . . . . 0.0 111.308 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 1 N--CA 1.541 4.086 0 C-N-CA 123.489 0.716 . . . . 0.0 110.589 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 N--CA 1.528 3.437 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -49.23 14.87 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 124.202 0.906 . . . . 0.0 113.17 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -36.64 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.347 0 C-N-CA 123.262 0.625 . . . . 0.0 110.163 -177.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.41 -34.09 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 21.1 mm -67.29 -40.62 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 CA-C-O 121.386 0.612 . . . . 0.0 109.958 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -64.63 -46.42 82.64 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 m -62.56 -34.13 63.33 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 CA-C-N 118.495 0.589 . . . . 0.0 112.334 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 66.8 p -66.36 -49.22 67.65 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.119 0.568 . . . . 0.0 112.192 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.76 -37.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.62 88.09 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 122.582 0.353 . . . . 0.0 110.713 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.73 95.68 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 122.962 0.505 . . . . 0.0 111.817 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.3 -45.34 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.5 -32.93 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 C-N-CA 123.689 0.795 . . . . 0.0 109.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.8 tp -60.51 -40.82 92.83 Favored 'General case' 0 N--CA 1.535 3.783 0 C-N-CA 122.739 0.415 . . . . 0.0 110.577 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.46 -53.83 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.494 0.664 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.52 -37.96 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 124.208 1.003 . . . . 0.0 113.054 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.64 90.61 Favored 'General case' 1 N--CA 1.54 4.038 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.25 -34.34 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 C-N-CA 122.942 0.497 . . . . 0.0 109.883 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -43.25 79.87 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 122.657 0.383 . . . . 0.0 111.582 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.09 -31.65 51.03 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.47 0.577 . . . . 0.0 110.31 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.68 -45.03 93.31 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.152 0.581 . . . . 0.0 111.982 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -70.35 -24.87 63.05 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.169 0.587 . . . . 0.0 111.592 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.532 3.671 0 CA-C-N 118.413 0.552 . . . . 0.0 110.503 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.3 -14.33 31.03 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.645 1.178 . . . . 0.0 110.406 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.6 tp . . . . . 0 N--CA 1.536 3.857 0 CA-C-N 118.405 0.548 . . . . 0.0 111.425 -176.941 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.523 3.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -68.81 -34.14 75.03 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.931 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.53 -31.14 65.76 Favored Glycine 0 N--CA 1.514 3.897 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.406 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.86 -36.69 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 123.856 0.862 . . . . 0.0 110.46 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.06 -36.32 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 123.197 0.599 . . . . 0.0 109.649 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.51 -39.09 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -64.04 -41.75 97.3 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.45 -27.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-N 118.842 0.746 . . . . 0.0 111.486 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -68.54 -49.42 59.69 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.89 -38.44 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.75 68.29 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 123.038 0.535 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.41 91.67 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.155 0.582 . . . . 0.0 111.395 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.03 -43.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.723 0.809 . . . . 0.0 109.166 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -32.91 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 C-N-CA 123.953 0.901 . . . . 0.0 109.785 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -47.43 79.53 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.3 -55.86 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 19.9 m -68.35 -38.38 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.83 Favored 'General case' 0 N--CA 1.534 3.732 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.32 -34.73 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.884 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.87 -42.63 69.81 Favored 'General case' 1 N--CA 1.539 4.006 0 CA-C-N 119.559 1.072 . . . . 0.0 111.419 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 32.3 m -68.63 -31.24 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 122.066 -0.396 . . . . 0.0 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.21 -48.19 81.11 Favored 'General case' 0 N--CA 1.523 3.208 0 C-N-CA 123.203 0.601 . . . . 0.0 111.615 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.527 3.396 0 C-N-CA 123.159 0.583 . . . . 0.0 110.709 -179.11 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.525 3.294 0 CA-C-O 121.375 0.607 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.49 -29.53 74.97 Favored Glycine 1 N--CA 1.517 4.092 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.903 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.06 -36.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 123.62 0.768 . . . . 0.0 110.504 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.26 -36.64 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 C-N-CA 122.879 0.472 . . . . 0.0 110.383 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.18 -42.89 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 CA-C-O 121.802 0.811 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.99 -44.48 92.56 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.31 -33.27 53.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 CA-C-N 118.898 0.772 . . . . 0.0 112.117 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -66.82 -49.67 65.04 Favored 'General case' 0 N--CA 1.529 3.501 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.09 -37.24 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.82 -34.85 70.11 Favored 'General case' 0 N--CA 1.526 3.346 0 C-N-CA 122.664 0.386 . . . . 0.0 111.281 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.94 97.74 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 122.966 0.506 . . . . 0.0 111.727 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.05 -41.4 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.466 0 C-N-CA 123.538 0.735 . . . . 0.0 109.828 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.0 t -67.33 -32.82 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.791 0.836 . . . . 0.0 110.132 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.81 -48.05 73.02 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 18.6 tt -71.24 -44.46 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.8 m -66.86 -37.37 79.3 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.537 0 CA-C-N 120.447 1.476 . . . . 0.0 112.364 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.11 -31.84 69.29 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.62 -35.08 73.76 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.083 0.856 . . . . 0.0 111.011 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.89 -37.27 81.53 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-O 120.893 0.378 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.05 -40.66 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 C-N-CA 123.748 0.819 . . . . 0.0 109.792 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.79 -42.18 86.43 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.348 0.659 . . . . 0.0 110.472 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.06 -29.39 60.44 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 124.46 1.104 . . . . 0.0 111.901 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.4 t -63.86 -22.79 67.08 Favored 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 122.914 0.485 . . . . 0.0 111.558 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -90.63 -18.18 25.59 Favored 'General case' 0 N--CA 1.534 3.733 0 C-N-CA 123.78 0.832 . . . . 0.0 109.956 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 1 N--CA 1.54 4.063 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.526 3.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.03 60.45 Favored Glycine 1 N--CA 1.519 4.194 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.367 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.63 -45.97 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.245 0 C-N-CA 124.056 0.942 . . . . 0.0 111.255 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.24 -36.8 77.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.078 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.15 -39.52 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 123.335 0.654 . . . . 0.0 109.32 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -67.01 -44.31 80.63 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 23.5 m -57.71 -27.94 31.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 CA-C-N 118.984 0.811 . . . . 0.0 111.756 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 26.4 p -71.9 -48.58 44.56 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.329 0.651 . . . . 0.0 110.301 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 -31.81 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.306 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.56 81.56 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.409 0.683 . . . . 0.0 111.384 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.94 98.77 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 121.153 0.501 . . . . 0.0 111.499 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.08 -38.5 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 123.766 0.826 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -33.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.446 0.698 . . . . 0.0 111.394 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.58 -39.01 92.33 Favored 'General case' 0 N--CA 1.533 3.676 0 C-N-CA 122.454 0.302 . . . . 0.0 111.561 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.16 -55.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.77 -36.5 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.01 0.924 . . . . 0.0 113.237 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.39 67.72 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.35 -40.35 85.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 119.072 0.851 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -63.07 -38.97 93.3 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 122.641 0.376 . . . . 0.0 110.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.36 -39.8 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 C-N-CA 123.632 0.773 . . . . 0.0 109.703 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.81 -45.69 77.52 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.77 0.828 . . . . 0.0 110.995 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -70.49 -41.88 72.1 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.864 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 94.2 p -63.15 -27.05 69.11 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 122.834 0.454 . . . . 0.0 110.624 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -79.19 -31.16 43.74 Favored 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 N--CA 1.528 3.454 0 C-N-CA 123.07 0.548 . . . . 0.0 110.165 -178.571 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.53 3.563 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -70.91 -20.87 62.44 Favored 'General case' 0 N--CA 1.523 3.211 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.773 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.59 -50.03 16.61 Favored Glycine 0 N--CA 1.512 3.749 0 C-N-CA 124.201 0.905 . . . . 0.0 113.711 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.39 -35.65 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 CA-C-N 117.924 0.862 . . . . 0.0 111.364 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.08 -34.81 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 122.626 0.37 . . . . 0.0 110.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.23 -42.25 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.11 -40.45 97.66 Favored 'General case' 0 N--CA 1.526 3.364 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.57 -27.81 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 119.131 0.878 . . . . 0.0 111.906 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 33.8 p -69.13 -49.61 55.45 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.98 -39.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.57 -34.73 69.51 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 122.906 0.482 . . . . 0.0 111.268 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.26 99.38 Favored 'General case' 0 N--CA 1.522 3.161 0 C-N-CA 123.127 0.571 . . . . 0.0 111.604 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.16 -43.21 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.261 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.94 -32.22 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 123.883 0.873 . . . . 0.0 109.367 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -47.18 74.67 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 122.969 0.508 . . . . 0.0 109.824 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.76 -51.41 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.44 0.696 . . . . 0.0 110.404 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.44 -37.9 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.803 0.841 . . . . 0.0 112.748 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.09 82.85 Favored 'General case' 0 N--CA 1.539 3.977 0 CA-C-N 118.542 0.61 . . . . 0.0 112.186 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.17 -33.68 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.349 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.21 -43.18 99.41 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 123.246 0.618 . . . . 0.0 110.517 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.69 -34.75 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 C-N-CA 123.103 0.561 . . . . 0.0 109.674 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.15 -27.68 69.25 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.259 0.624 . . . . 0.0 111.233 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm . . . . . 0 N--CA 1.531 3.605 0 C-N-CA 123.527 0.731 . . . . 0.0 110.922 -179.716 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.531 3.577 0 CA-C-O 121.254 0.549 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.04 97.73 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.729 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.78 -36.03 63.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.127 0 CA-C-N 117.885 0.843 . . . . 0.0 111.679 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.58 -37.58 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.21 0.604 . . . . 0.0 109.708 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.05 -41.06 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -59.61 -48.47 81.52 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 124.5 1.12 . . . . 0.0 114.015 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.8 m -59.7 -32.36 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.914 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -72.15 -48.99 39.49 Favored 'General case' 0 N--CA 1.533 3.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.859 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.62 -32.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.696 0.398 . . . . 0.0 110.044 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.97 74.01 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.235 0.614 . . . . 0.0 111.332 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.44 77.49 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.396 0.278 . . . . 0.0 111.571 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.06 -43.62 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.512 0.725 . . . . 0.0 112.084 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.09 -32.86 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 CA-C-N 118.919 0.781 . . . . 0.0 111.931 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.1 mt -60.65 -36.92 79.87 Favored 'General case' 0 N--CA 1.537 3.898 0 CA-C-N 117.97 0.35 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.08 -47.72 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-O 121.489 0.662 . . . . 0.0 109.332 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.3 t -67.0 -37.73 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.263 0 C-N-CA 124.202 1.001 . . . . 0.0 111.606 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.11 90.25 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.94 -34.5 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 122.777 0.431 . . . . 0.0 109.943 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.81 -42.45 73.67 Favored 'General case' 1 N--CA 1.544 4.273 0 CA-C-N 118.875 0.762 . . . . 0.0 109.564 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.1 -31.66 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.13 -46.26 84.92 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.299 0.64 . . . . 0.0 111.472 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -69.0 -38.11 79.1 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.408 0.683 . . . . 0.0 110.772 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.6 p -63.77 -34.92 78.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 123.206 0.602 . . . . 0.0 110.668 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.78 -37.21 70.48 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 124.091 0.956 . . . . 0.0 109.731 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 N--CA 1.528 3.426 0 C-N-CA 123.925 0.89 . . . . 0.0 110.397 -179.308 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.525 3.321 0 CA-C-O 121.286 0.565 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.55 -30.27 62.42 Favored Glycine 0 N--CA 1.515 3.917 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.01 -36.83 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.662 0.785 . . . . 0.0 110.662 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.02 -37.82 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 C-N-CA 123.068 0.547 . . . . 0.0 109.605 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.9 -37.89 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -62.7 -46.41 88.26 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.95 -38.86 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 118.583 0.629 . . . . 0.0 112.074 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -64.46 -48.96 73.3 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.72 -37.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.32 80.54 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.57 0.348 . . . . 0.0 111.097 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.39 70.85 Favored 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.86 -38.61 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 O-C-N 122.121 -0.362 . . . . 0.0 110.416 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.2 t -64.83 -32.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 123.495 0.718 . . . . 0.0 110.016 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.44 -36.91 76.81 Favored 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 122.615 0.366 . . . . 0.0 110.28 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.4 -52.28 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 123.327 0.651 . . . . 0.0 109.435 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.28 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 C-N-CA 124.322 1.049 . . . . 0.0 112.85 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.77 83.42 Favored 'General case' 0 N--CA 1.537 3.916 0 CA-C-N 118.607 0.64 . . . . 0.0 112.338 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -69.33 -33.83 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 C-N-CA 123.497 0.719 . . . . 0.0 109.091 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.56 -42.67 99.18 Favored 'General case' 0 N--CA 1.537 3.892 0 C-N-CA 123.498 0.719 . . . . 0.0 111.33 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.09 -31.76 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.126 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.22 -46.51 80.37 Favored 'General case' 0 N--CA 1.529 3.503 0 CA-C-O 120.776 0.322 . . . . 0.0 111.005 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.66 -25.21 59.04 Favored 'General case' 0 N--CA 1.525 3.308 0 C-N-CA 123.547 0.739 . . . . 0.0 111.021 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 60.5 p -65.17 -33.57 76.33 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.654 0.382 . . . . 0.0 111.065 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 66.5 mt -90.78 -21.1 21.69 Favored 'General case' 0 N--CA 1.531 3.598 0 C-N-CA 124.122 0.969 . . . . 0.0 111.0 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 1 N--CA 1.543 4.213 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.53 3.549 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 88.2 p -66.63 -39.55 88.33 Favored 'General case' 0 N--CA 1.528 3.438 0 C-N-CA 123.289 0.636 . . . . 0.0 109.931 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.44 -32.79 82.33 Favored Glycine 1 N--CA 1.519 4.201 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.366 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.57 -36.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.73 -34.24 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 C-N-CA 123.713 0.805 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.48 -43.68 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 CA-C-O 121.774 0.797 . . . . 0.0 109.337 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -67.18 -43.51 82.03 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.62 -36.65 55.05 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.288 0 CA-C-N 118.934 0.788 . . . . 0.0 111.47 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -65.95 -48.46 71.26 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.435 0.694 . . . . 0.0 111.149 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.97 -34.76 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.524 0.73 . . . . 0.0 109.826 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.85 75.62 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.04 74.49 Favored 'General case' 0 N--CA 1.519 3.007 0 C-N-CA 122.511 0.324 . . . . 0.0 111.555 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.87 -44.89 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.164 0.586 . . . . 0.0 111.939 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -65.98 -32.85 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 CA-C-N 118.648 0.658 . . . . 0.0 110.834 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.88 -43.19 98.79 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.125 0.57 . . . . 0.0 111.181 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.33 -52.94 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.252 0.621 . . . . 0.0 110.156 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.48 -37.16 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 124.759 1.224 . . . . 0.0 113.726 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.12 -35.86 72.09 Favored 'General case' 0 N--CA 1.537 3.88 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.88 -34.88 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.972 0.806 . . . . 0.0 110.526 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -69.38 -42.3 75.35 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.22 -42.44 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 73.0 m -67.18 -48.07 69.05 Favored 'General case' 0 N--CA 1.528 3.453 0 CA-C-O 121.448 0.642 . . . . 0.0 110.542 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 N--CA 1.523 3.215 0 C-N-CA 124.256 1.022 . . . . 0.0 111.248 -178.884 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.524 3.24 0 CA-C-O 120.451 0.167 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.99 -50.29 8.79 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.491 0.567 . . . . 0.0 113.893 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.74 -36.92 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -59.24 -33.22 50.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 118.57 0.623 . . . . 0.0 111.022 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.65 -43.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.32 -34.73 77.96 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.48 -36.95 55.33 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.511 0 CA-C-N 119.906 1.23 . . . . 0.0 111.562 -175.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.1 p -67.1 -48.58 67.74 Favored 'General case' 0 N--CA 1.525 3.312 0 C-N-CA 123.547 0.739 . . . . 0.0 110.358 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.42 -31.87 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.92 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.94 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.115 0.566 . . . . 0.0 111.378 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.35 72.97 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 122.879 0.472 . . . . 0.0 111.689 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.95 -46.2 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.42 0 C-N-CA 123.377 0.671 . . . . 0.0 111.892 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.47 -32.42 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 CA-C-N 118.057 0.39 . . . . 0.0 111.074 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.02 -47.68 61.13 Favored 'General case' 0 N--CA 1.525 3.289 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.65 -41.53 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.7 -47.91 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.6 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.42 89.26 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.13 -37.61 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.612 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -34.09 65.56 Favored 'General case' 1 N--CA 1.549 4.512 0 CA-C-N 120.371 1.441 . . . . 0.0 109.991 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.78 -33.51 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.18 -33.15 74.87 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.77 27.66 Favored 'General case' 1 N--CA 1.541 4.105 0 CA-C-N 118.968 0.804 . . . . 0.0 110.443 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 33.7 t -63.03 -43.36 98.91 Favored 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -86.88 -14.67 41.3 Favored 'General case' 1 N--CA 1.549 4.515 0 CA-C-N 118.229 0.468 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.538 3.964 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.42 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.527 3.392 0 N-CA-C 111.241 0.089 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.57 -40.92 31.02 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.718 0.675 . . . . 0.0 111.432 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.51 -43.63 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 124.583 1.153 . . . . 0.0 112.311 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.25 -33.71 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 C-N-CA 122.753 0.421 . . . . 0.0 111.002 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.4 -41.01 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.93 -45.49 89.01 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.69 -30.88 38.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.943 0.792 . . . . 0.0 111.782 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 29.6 p -69.69 -48.64 58.97 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.377 0.671 . . . . 0.0 110.606 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.87 -32.26 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.595 0.758 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.52 78.83 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.323 0.649 . . . . 0.0 111.817 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.37 71.66 Favored 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 122.854 0.461 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.37 -44.0 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.377 0.671 . . . . 0.0 111.591 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.88 -32.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.529 -0.732 . . . . 0.0 110.427 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.23 -47.58 76.33 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.86 -43.18 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.93 -37.4 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.117 0.872 . . . . 0.0 112.738 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.66 68.38 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -66.38 -34.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.984 0.811 . . . . 0.0 110.864 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -66.6 -33.8 76.47 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 122.682 0.393 . . . . 0.0 110.513 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.37 -42.56 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 123.25 0.62 . . . . 0.0 109.717 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.8 t -65.46 -45.61 83.08 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.489 0.716 . . . . 0.0 111.085 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.05 -47.03 60.82 Favored 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.68 0.792 . . . . 0.0 110.896 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 97.9 p -63.67 -13.68 45.04 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.846 0.458 . . . . 0.0 111.879 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.34 -34.68 15.6 Favored 'General case' 0 N--CA 1.531 3.58 0 C-N-CA 123.928 0.891 . . . . 0.0 110.512 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 1 N--CA 1.539 4.019 0 C-N-CA 123.991 0.916 . . . . 0.0 112.296 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.53 3.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.7 p -61.5 -21.96 64.68 Favored 'General case' 0 N--CA 1.53 3.539 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.91 86.59 Favored Glycine 0 N--CA 1.509 3.528 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.782 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.58 71.46 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.082 0 CA-C-O 121.224 0.535 . . . . 0.0 109.651 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.55 -35.75 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 C-N-CA 123.07 0.548 . . . . 0.0 109.589 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 29.7 mm -69.99 -38.82 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -63.57 -45.55 89.94 Favored 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.94 -29.7 36.63 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.252 0 CA-C-N 118.929 0.786 . . . . 0.0 111.484 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 21.2 p -68.77 -48.71 63.01 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.2 0.6 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.41 -36.18 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.443 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.49 -37.56 74.22 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.762 0.425 . . . . 0.0 110.943 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.44 -45.52 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.366 0 C-N-CA 123.461 0.704 . . . . 0.0 111.5 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.29 -33.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 121.371 -0.831 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.83 -47.55 80.36 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 123.229 0.612 . . . . 0.0 112.402 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 7.9 tp -70.65 -38.86 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.78 -36.02 76.19 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 C-N-CA 124.022 0.929 . . . . 0.0 111.341 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.53 74.68 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 13.3 m -72.49 -35.8 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 CA-C-N 118.427 0.558 . . . . 0.0 111.761 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -70.98 -42.34 69.82 Favored 'General case' 0 N--CA 1.533 3.681 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.17 -35.93 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 CA-C-N 118.287 0.494 . . . . 0.0 110.985 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.6 m -66.6 -36.52 82.81 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-O 121.215 0.531 . . . . 0.0 109.929 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.523 3.202 0 C-N-CA 123.939 0.896 . . . . 0.0 109.908 179.657 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.524 3.258 0 CA-C-O 121.266 0.555 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.61 -36.49 48.55 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.24 -47.75 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.299 1.04 . . . . 0.0 110.997 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.47 -34.54 70.17 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.993 0.361 . . . . 0.0 110.792 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.5 -48.16 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.32 -38.57 85.12 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.79 -36.89 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.43 0 CA-C-N 119.645 1.111 . . . . 0.0 111.339 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.0 p -66.9 -48.41 68.81 Favored 'General case' 0 N--CA 1.524 3.235 0 C-N-CA 123.665 0.786 . . . . 0.0 110.714 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.68 -31.68 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 C-N-CA 123.918 0.887 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.42 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.034 0.533 . . . . 0.0 111.147 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.04 68.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 122.929 0.492 . . . . 0.0 111.947 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.84 -44.05 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.548 0.739 . . . . 0.0 111.981 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.57 -32.56 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 CA-C-N 118.323 0.511 . . . . 0.0 110.766 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.81 -34.93 76.8 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.22 0.608 . . . . 0.0 112.513 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -69.82 -54.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 118.075 0.398 . . . . 0.0 111.326 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.15 -36.59 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.84 66.91 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.1 -34.85 73.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.075 0 CA-C-N 119.306 0.957 . . . . 0.0 110.816 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.69 -36.64 76.14 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 122.958 0.503 . . . . 0.0 110.021 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 80.9 t -67.35 -44.54 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.516 0.727 . . . . 0.0 109.444 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 86.3 m -61.74 -41.95 98.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.327 0.651 . . . . 0.0 110.746 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -68.11 -39.93 82.68 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.933 0.893 . . . . 0.0 109.911 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -64.97 -40.11 94.5 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.444 0.697 . . . . 0.0 110.393 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -37.2 82.63 Favored 'General case' 0 N--CA 1.533 3.717 0 C-N-CA 124.309 1.044 . . . . 0.0 110.068 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.4 tp . . . . . 0 N--CA 1.53 3.56 0 C-N-CA 123.061 0.544 . . . . 0.0 110.248 -178.876 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.526 3.359 0 CA-C-O 121.326 0.584 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.97 -45.55 20.18 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.416 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -38.66 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.845 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -69.04 -34.78 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.709 -0.619 . . . . 0.0 110.975 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.25 -39.71 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -58.39 -49.08 78.52 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.8 -33.68 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -70.06 -49.17 53.78 Favored 'General case' 0 N--CA 1.529 3.502 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.18 -33.19 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 122.671 0.388 . . . . 0.0 110.372 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.32 78.08 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.09 0.556 . . . . 0.0 111.001 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.42 80.18 Favored 'General case' 0 N--CA 1.52 3.066 0 C-N-CA 122.777 0.431 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.22 -50.65 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 123.04 0.536 . . . . 0.0 111.09 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 m -62.88 -32.27 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 O-C-N 121.926 -0.484 . . . . 0.0 110.792 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.45 -43.02 88.67 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.334 0.654 . . . . 0.0 111.465 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -70.21 -48.01 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.24 -37.75 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 124.118 0.967 . . . . 0.0 112.584 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.539 3.994 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.86 -33.98 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.93 -43.34 93.07 Favored 'General case' 0 N--CA 1.535 3.789 0 C-N-CA 123.188 0.595 . . . . 0.0 112.532 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.9 -30.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 O-C-N 122.263 -0.273 . . . . 0.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 36.9 t -58.63 -46.0 88.04 Favored 'General case' 0 N--CA 1.526 3.337 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -74.09 -32.5 63.27 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 118.225 0.466 . . . . 0.0 111.187 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 83.4 p -63.22 -23.78 67.58 Favored 'General case' 0 N--CA 1.53 3.562 0 C-N-CA 122.717 0.407 . . . . 0.0 111.132 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.85 -23.13 22.87 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.886 0.874 . . . . 0.0 109.917 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.534 3.766 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.888 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.524 3.248 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 89.3 p -70.66 -30.9 67.63 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.203 0.601 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.01 9.86 Favored Glycine 1 N--CA 1.516 4.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.167 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 214' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 214' ' ' ILE . 0.2 OUTLIER -63.38 -42.08 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 C-N-CA 123.345 0.658 . . . . 0.0 111.759 -176.562 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.96 -34.88 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.874 -0.516 . . . . 0.0 111.746 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.34 -43.95 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.74 -43.55 83.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.5 -38.48 63.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.132 0 CA-C-N 118.886 0.766 . . . . 0.0 111.987 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 31.3 p -66.08 -48.05 72.25 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.406 0.682 . . . . 0.0 111.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.1 -33.36 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 C-N-CA 123.638 0.775 . . . . 0.0 109.683 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.72 -34.61 76.09 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.73 73.99 Favored 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 122.603 0.361 . . . . 0.0 111.537 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.47 -44.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.332 0.653 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.13 -32.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 CA-C-N 118.61 0.641 . . . . 0.0 110.857 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.87 -42.12 93.04 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.216 0.606 . . . . 0.0 111.511 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 63.0 mt -70.14 -48.79 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.35 -36.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 124.972 1.309 . . . . 0.0 113.091 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.73 67.03 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.83 -36.79 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.918 0.781 . . . . 0.0 110.24 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -70.61 -42.25 71.21 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.977 0.511 . . . . 0.0 109.887 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.07 -35.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.24 -38.83 85.83 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 123.362 0.665 . . . . 0.0 110.323 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.531 3.577 0 C-N-CA 124.954 1.301 . . . . 0.0 111.902 -179.097 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 96.8 p . . . . . 0 N--CA 1.526 3.354 0 CA-C-O 121.183 0.516 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.94 -29.86 62.26 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.437 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.03 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.702 0.801 . . . . 0.0 110.499 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.19 -38.39 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.288 0.635 . . . . 0.0 109.93 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.16 -39.1 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -67.02 -46.71 73.65 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.06 -35.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.947 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.1 p -66.5 -49.49 66.39 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.84 -32.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.35 78.28 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 122.531 0.333 . . . . 0.0 111.665 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.49 73.98 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 122.628 0.371 . . . . 0.0 111.818 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.9 t -69.96 -43.46 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.324 0.649 . . . . 0.0 111.722 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.27 -32.6 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.581 0.628 . . . . 0.0 110.547 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.18 -34.63 72.35 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.19 -55.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 CA-C-N 117.868 0.304 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.87 -37.14 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.45 81.47 Favored 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.19 -34.78 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.453 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.397 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -69.56 -42.5 74.49 Favored 'General case' 1 N--CA 1.539 4.021 0 CA-C-N 119.407 1.003 . . . . 0.0 111.345 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.7 -31.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 O-C-N 121.981 -0.449 . . . . 0.0 110.303 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.96 -37.27 81.84 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.523 0.729 . . . . 0.0 111.696 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -82.84 -25.19 32.85 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.428 0.691 . . . . 0.0 110.449 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 m -68.02 -43.41 78.87 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.058 0.543 . . . . 0.0 111.828 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.1 -24.5 47.53 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.791 0.437 . . . . 0.0 111.143 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.532 3.661 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.196 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.518 2.942 0 CA-C-O 120.727 0.299 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.84 -50.12 9.39 Favored Glycine 0 N--CA 1.516 3.971 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.271 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.87 -36.71 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 122.984 0.514 . . . . 0.0 112.112 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 36.6 pt -62.9 -33.75 62.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 CA-C-N 119.185 0.902 . . . . 0.0 110.852 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 84.3 mt -69.67 -39.25 77.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -66.14 -43.34 87.35 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.84 -28.18 32.4 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.37 0.986 . . . . 0.0 111.345 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 19.4 p -66.3 -48.52 70.1 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 123.509 0.723 . . . . 0.0 111.063 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -39.47 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 C-N-CA 123.694 0.797 . . . . 0.0 109.186 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.49 71.6 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.664 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.9 -33.21 75.31 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 122.712 0.405 . . . . 0.0 111.373 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.02 -48.54 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.334 0 C-N-CA 123.139 0.576 . . . . 0.0 111.102 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.55 -32.38 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 O-C-N 121.577 -0.702 . . . . 0.0 110.377 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.65 -47.78 83.28 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 123.424 0.689 . . . . 0.0 112.471 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -70.75 -37.48 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.879 0 CA-C-N 118.302 0.501 . . . . 0.0 110.085 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.92 -37.57 79.67 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 C-N-CA 123.155 0.582 . . . . 0.0 111.084 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.93 68.19 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.39 -37.08 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-N 118.893 0.769 . . . . 0.0 110.405 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -70.28 -42.08 72.56 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 122.739 0.416 . . . . 0.0 109.934 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.7 -42.63 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.26 -28.65 68.22 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 123.025 0.53 . . . . 0.0 111.062 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -68.18 -35.72 78.48 Favored 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 123.584 0.754 . . . . 0.0 110.617 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.7 m -63.59 -23.29 67.32 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.166 0.587 . . . . 0.0 109.828 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.6 -33.32 68.91 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.549 1.139 . . . . 0.0 108.299 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.524 3.273 0 C-N-CA 123.613 0.765 . . . . 0.0 110.149 -179.291 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.518 2.973 0 CA-C-O 121.615 0.722 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 36.4 t -69.62 -24.93 63.72 Favored 'General case' 0 N--CA 1.524 3.251 0 O-C-N 121.532 -0.73 . . . . 0.0 110.007 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.32 -46.19 57.88 Favored Glycine 0 N--CA 1.511 3.669 0 C-N-CA 124.513 1.054 . . . . 0.0 114.242 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 13.6 tt -59.14 -36.36 62.37 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.303 0 CA-C-N 118.233 1.016 . . . . 0.0 111.03 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.83 -34.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.391 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 216' ' ' ILE . 1.6 mp -70.22 -41.8 78.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-N 119.175 0.898 . . . . 0.0 108.73 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.54 -45.27 94.49 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.6 -37.26 78.47 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.658 0.663 . . . . 0.0 112.025 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 73.0 p -65.41 -48.85 71.39 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 123.201 0.6 . . . . 0.0 112.512 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.45 -32.09 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.26 80.32 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 122.766 0.426 . . . . 0.0 111.792 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.43 55.17 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.66 -38.37 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.23 -32.29 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.994 -0.441 . . . . 0.0 110.536 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.1 -34.88 75.65 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 122.966 0.506 . . . . 0.0 111.557 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.49 -54.78 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 122.899 0.479 . . . . 0.0 111.475 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.04 -35.86 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.853 0 C-N-CA 124.236 1.015 . . . . 0.0 112.893 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.36 66.19 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.47 -34.51 66.0 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.502 1.047 . . . . 0.0 110.487 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.83 -26.22 66.81 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 122.836 0.454 . . . . 0.0 110.871 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -37.74 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.83 -40.44 88.0 Favored 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 123.487 0.715 . . . . 0.0 109.577 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 N--CA 1.525 3.285 0 C-N-CA 124.219 1.008 . . . . 0.0 109.782 179.244 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.534 3.734 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -42.11 40.79 Favored Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.097 0.873 . . . . 0.0 111.26 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.6 mm -57.96 -38.88 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 124.223 1.009 . . . . 0.0 110.861 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.86 -34.52 31.03 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 CA-C-O 119.458 -0.306 . . . . 0.0 111.029 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.6 mp -70.57 -49.13 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 CA-C-N 119.279 0.945 . . . . 0.0 108.804 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -67.88 -27.55 66.76 Favored 'General case' 0 N--CA 1.53 3.564 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -56.46 -38.85 58.16 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.546 0 CA-C-N 120.109 1.322 . . . . 0.0 112.084 -174.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.3 p -64.05 -48.08 77.66 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 123.907 0.883 . . . . 0.0 110.769 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.87 -44.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.124 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.78 58.77 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.455 0.702 . . . . 0.0 111.812 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.64 95.89 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 122.998 0.519 . . . . 0.0 111.718 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -39.04 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.429 0.692 . . . . 0.0 109.719 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.82 -34.32 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.652 0.781 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -37.29 86.63 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.066 0.546 . . . . 0.0 111.881 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.13 -54.42 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 C-N-CA 122.911 0.484 . . . . 0.0 111.433 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.55 -36.3 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 C-N-CA 124.374 1.07 . . . . 0.0 113.747 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.68 -31.02 65.94 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.3 -38.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 119.036 0.834 . . . . 0.0 110.472 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.33 -32.76 73.11 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.899 0.48 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.61 -37.9 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.614 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.33 -46.67 72.78 Favored 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 123.397 0.679 . . . . 0.0 110.352 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.24 -26.64 65.8 Favored 'General case' 0 N--CA 1.524 3.265 0 C-N-CA 124.114 0.966 . . . . 0.0 110.915 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 68.9 m -63.33 -21.67 66.41 Favored 'General case' 0 N--CA 1.529 3.515 0 CA-C-N 118.133 0.424 . . . . 0.0 110.049 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 57.4 mt -91.44 -17.33 25.95 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 124.375 1.07 . . . . 0.0 110.592 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.537 3.904 0 CA-C-O 119.029 -0.51 . . . . 0.0 112.179 -176.816 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.531 3.602 0 CA-C-O 121.106 0.479 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -24.79 75.56 Favored Glycine 0 N--CA 1.505 3.279 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.55 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -59.77 -48.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.982 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.14 -33.75 65.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 O-C-N 122.154 -0.341 . . . . 0.0 110.221 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.62 -38.93 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -67.12 -43.78 81.59 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.75 -32.72 43.48 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.367 0 CA-C-N 119.136 0.88 . . . . 0.0 111.645 -176.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -64.93 -48.22 74.88 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.51 0.724 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.03 -46.14 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.477 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -34.88 58.76 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 123.123 0.569 . . . . 0.0 111.903 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.13 91.93 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.825 0.45 . . . . 0.0 111.955 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.14 -40.12 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.273 0.629 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.36 -33.0 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 123.667 0.787 . . . . 0.0 110.151 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.31 -47.48 73.42 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.3 tt -70.69 -41.71 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.02 -37.29 79.07 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.079 0.854 . . . . 0.0 112.257 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.85 68.64 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 m -64.38 -34.87 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.027 0.831 . . . . 0.0 110.613 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -68.94 -40.35 79.02 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.828 0.451 . . . . 0.0 109.858 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.55 -38.4 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.95 -42.22 97.37 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.688 0.795 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.57 -44.21 91.43 Favored 'General case' 0 N--CA 1.527 3.381 0 C-N-CA 124.269 1.028 . . . . 0.0 109.784 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.2 t -64.55 -27.13 68.75 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.274 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 50.8 tp -91.56 -25.32 19.27 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.422 1.089 . . . . 0.0 111.315 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.5 tp . . . . . 0 N--CA 1.535 3.803 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.816 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.53 3.526 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 61.0 m -57.93 -35.01 70.48 Favored 'General case' 0 N--CA 1.523 3.205 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.07 -38.21 40.94 Favored Glycine 0 N--CA 1.513 3.793 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.162 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.78 -44.34 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.874 0.87 . . . . 0.0 111.976 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.71 -33.82 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 C-N-CA 122.583 0.353 . . . . 0.0 110.919 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 89.3 mt -68.43 -38.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 O-C-N 121.79 -0.569 . . . . 0.0 109.54 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -67.04 -47.0 72.7 Favored 'General case' 0 N--CA 1.529 3.487 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.17 -34.8 58.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.145 0 CA-C-N 118.786 0.721 . . . . 0.0 111.926 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 82.7 p -66.62 -48.65 68.82 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.596 0.758 . . . . 0.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.11 -35.05 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.556 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.19 77.12 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.268 0.627 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.61 75.18 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 122.822 0.449 . . . . 0.0 111.632 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.93 -46.1 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.019 0.528 . . . . 0.0 111.64 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.83 -32.57 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 CA-C-N 118.697 0.68 . . . . 0.0 111.156 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.95 -41.5 99.52 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.21 0.604 . . . . 0.0 112.046 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 74.8 mt -70.56 -55.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 14.4 p -68.67 -41.73 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.36 82.14 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.15 -33.92 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 CA-C-N 118.101 0.41 . . . . 0.0 110.777 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -69.65 -27.11 64.77 Favored 'General case' 0 N--CA 1.536 3.864 0 CA-C-N 118.713 0.688 . . . . 0.0 110.539 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.26 -50.07 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 122.677 0.391 . . . . 0.0 110.508 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 31.3 p -63.81 -35.79 81.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 122.708 0.403 . . . . 0.0 111.2 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 tttm . . . . . 0 N--CA 1.525 3.307 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 179.431 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.518 2.941 0 CA-C-O 121.597 0.713 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.69 -49.63 68.89 Favored Glycine 0 N--CA 1.515 3.94 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.61 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.52 -35.97 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 CA-C-N 117.405 0.603 . . . . 0.0 110.753 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.4 mt -62.19 -36.66 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.975 0 C-N-CA 122.638 0.375 . . . . 0.0 110.44 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.91 -48.08 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 CA-C-O 121.584 0.707 . . . . 0.0 109.112 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -67.33 -41.2 85.63 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.42 -33.81 44.96 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.172 0.896 . . . . 0.0 112.082 -175.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 35.1 p -71.45 -48.56 48.64 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.338 0.655 . . . . 0.0 110.011 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.01 -31.71 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.288 0 C-N-CA 123.892 0.877 . . . . 0.0 109.621 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.66 Favored 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 123.455 0.702 . . . . 0.0 111.827 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.47 74.06 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 122.346 0.259 . . . . 0.0 111.174 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.97 -46.7 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 C-N-CA 123.411 0.684 . . . . 0.0 111.573 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.78 -32.11 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.411 0.55 . . . . 0.0 110.443 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -46.08 73.46 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.961 0.904 . . . . 0.0 111.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.13 -55.25 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.0 -36.41 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.19 66.4 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.65 -37.27 79.68 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.208 0.913 . . . . 0.0 110.59 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.79 -29.18 68.3 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 122.956 0.502 . . . . 0.0 110.732 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.52 -38.36 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.24 -47.23 71.39 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.349 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.44 -41.71 84.3 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.821 0.848 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -64.22 -31.45 72.66 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.022 0.529 . . . . 0.0 111.171 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.32 -37.65 74.78 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.461 0.704 . . . . 0.0 110.763 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.531 3.622 0 C-N-CA 123.316 0.647 . . . . 0.0 109.909 -179.638 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.521 3.1 0 CA-C-O 119.919 -0.086 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.93 -50.88 7.39 Favored Glycine 1 N--CA 1.519 4.203 0 C-N-CA 123.439 0.543 . . . . 0.0 113.923 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.19 -39.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.66 -33.85 28.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.337 0.517 . . . . 0.0 111.007 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 23.5 mm -62.84 -42.99 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-O 121.278 0.561 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -64.38 -35.4 80.78 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.022 0.929 . . . . 0.0 112.717 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.47 -41.5 78.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-O 121.03 0.443 . . . . 0.0 110.476 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -65.03 -48.23 74.63 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.607 0.763 . . . . 0.0 111.271 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.72 -33.88 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.673 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.0 -35.19 80.41 Favored 'General case' 0 N--CA 1.523 3.217 0 C-N-CA 122.989 0.516 . . . . 0.0 111.56 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.33 63.3 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 122.832 0.453 . . . . 0.0 112.192 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.15 -43.63 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 123.107 0.563 . . . . 0.0 111.826 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.35 -32.82 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 CA-C-N 118.311 0.505 . . . . 0.0 110.713 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.64 -41.12 85.29 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.899 0.48 . . . . 0.0 111.339 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.09 -54.08 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 CA-C-O 121.686 0.755 . . . . 0.0 109.631 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.52 -35.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 125.788 1.635 . . . . 0.0 113.26 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.62 70.79 Favored 'General case' 0 N--CA 1.529 3.513 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.35 -41.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 CA-C-N 118.942 0.792 . . . . 0.0 111.454 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -65.15 -42.52 93.71 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.28 -36.97 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 CA-C-N 118.314 0.506 . . . . 0.0 110.822 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 97.0 m -67.75 -48.19 67.13 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 122.818 0.447 . . . . 0.0 111.346 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.2 -28.37 70.0 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.511 0.724 . . . . 0.0 111.411 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.65 -21.41 66.36 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 122.733 0.413 . . . . 0.0 110.88 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.1 mt -91.3 -30.4 16.61 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 124.197 0.999 . . . . 0.0 110.969 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.534 3.75 0 C-N-CA 122.839 0.456 . . . . 0.0 112.13 -177.365 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.531 3.586 0 CA-C-O 120.8 0.333 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -67.08 -24.68 65.98 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.343 0.657 . . . . 0.0 111.174 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.41 -51.04 7.65 Favored Glycine 0 N--CA 1.516 3.997 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.58 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 tp -66.71 -37.02 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.082 0.553 . . . . 0.0 112.367 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 215' ' ' ILE . . . . . 0.452 ' O ' HD13 ' C' ' 215' ' ' ILE . 0.2 OUTLIER -62.77 -37.0 77.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.217 0 CA-C-N 118.256 0.48 . . . . 0.0 110.579 -177.64 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 87.4 mt -70.42 -48.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 CA-C-O 121.429 0.633 . . . . 0.0 109.595 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.36 -39.16 85.7 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.81 -39.04 68.98 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.251 0 CA-C-N 119.106 0.866 . . . . 0.0 111.914 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 20.1 p -63.75 -46.65 84.39 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.458 0.703 . . . . 0.0 110.756 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.65 -47.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.244 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.57 54.34 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.475 0.71 . . . . 0.0 111.902 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.61 95.9 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.95 0.5 . . . . 0.0 111.128 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.97 -40.43 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.5 -32.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 123.862 0.865 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -47.4 86.11 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-O 121.563 0.697 . . . . 0.0 110.797 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.11 -54.92 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.228 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.7 m -67.08 -37.03 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.73 68.04 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.1 m -65.06 -38.61 83.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 119.214 0.915 . . . . 0.0 110.558 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.53 -31.69 73.01 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 122.919 0.488 . . . . 0.0 110.878 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.89 -41.24 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 66.9 m -67.09 -39.91 86.87 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.627 0.771 . . . . 0.0 110.937 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.523 3.2 0 C-N-CA 123.626 0.771 . . . . 0.0 110.248 -179.278 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.523 3.182 0 CA-C-O 121.109 0.48 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.16 -34.22 55.56 Favored Glycine 1 N--CA 1.518 4.134 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.79 -49.64 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.904 0.882 . . . . 0.0 111.103 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -63.44 -33.68 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 122.172 -0.33 . . . . 0.0 110.789 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.1 mt -69.57 -41.6 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -66.14 -44.34 84.46 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.72 -37.6 60.33 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.226 0 CA-C-N 119.101 0.864 . . . . 0.0 111.723 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 p -63.99 -48.24 77.17 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 123.553 0.741 . . . . 0.0 111.158 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.97 -45.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.261 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.89 67.66 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.142 0.577 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.93 96.77 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 122.976 0.51 . . . . 0.0 111.401 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.05 -41.89 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 123.189 0.595 . . . . 0.0 109.723 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.04 -32.83 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.857 0.863 . . . . 0.0 110.235 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.41 -40.96 89.89 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.095 0.558 . . . . 0.0 111.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -70.04 -52.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 122.936 0.495 . . . . 0.0 111.614 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.2 m -66.28 -37.42 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.26 92.39 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.74 -33.87 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -63.17 -43.44 98.26 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.522 0.729 . . . . 0.0 112.446 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.05 -31.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 122.393 0.277 . . . . 0.0 110.488 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 44.7 t -62.44 -32.39 73.24 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 123.044 0.538 . . . . 0.0 111.037 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.32 -44.84 78.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.653 0.781 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.0 p -64.66 -41.31 96.19 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-O 121.465 0.65 . . . . 0.0 109.616 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.8 -34.44 78.17 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 124.538 1.135 . . . . 0.0 109.694 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 N--CA 1.531 3.603 0 C-N-CA 123.586 0.754 . . . . 0.0 110.041 -179.097 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.53 3.537 0 CA-C-O 120.706 0.288 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.99 -23.32 76.52 Favored Glycine 0 N--CA 1.511 3.683 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -51.27 74.0 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.72 -33.84 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 C-N-CA 122.778 0.431 . . . . 0.0 110.947 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.44 -38.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -66.78 -45.11 79.49 Favored 'General case' 0 N--CA 1.531 3.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.84 -34.06 47.27 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.992 0.815 . . . . 0.0 111.672 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.7 p -64.64 -48.43 74.86 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.233 0.613 . . . . 0.0 111.087 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.57 -41.01 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.33 -34.3 78.01 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.931 0.492 . . . . 0.0 111.576 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.03 67.55 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.26 -38.35 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.95 -32.64 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 CA-C-N 118.589 0.631 . . . . 0.0 110.55 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.7 tp -54.9 -34.7 63.34 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.145 0.578 . . . . 0.0 112.55 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.95 -55.74 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 CA-C-N 117.677 0.217 . . . . 0.0 111.382 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.5 -36.13 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 C-N-CA 124.33 1.052 . . . . 0.0 113.128 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.5 -31.02 65.61 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -58.32 -37.07 61.19 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.977 0.808 . . . . 0.0 110.641 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.21 -35.46 71.53 Favored 'General case' 0 N--CA 1.526 3.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.999 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.04 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.19 -41.87 85.12 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 123.481 0.712 . . . . 0.0 110.2 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -71.73 -37.01 70.66 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.851 0.86 . . . . 0.0 110.535 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 92.2 p -63.83 -17.68 63.36 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.027 0.531 . . . . 0.0 111.546 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.7 tp -83.57 -37.5 22.89 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.473 0.709 . . . . 0.0 110.338 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 1 N--CA 1.542 4.139 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.53 3.532 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 91.9 p -68.19 -25.78 65.41 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 122.699 0.4 . . . . 0.0 110.758 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.02 -51.48 6.91 Favored Glycine 1 N--CA 1.518 4.16 0 O-C-N 123.117 0.261 . . . . 0.0 113.726 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 17.7 tt -67.18 -40.79 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 tp -54.45 -33.35 26.22 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.86 -42.05 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-O 121.458 0.647 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -64.87 -44.69 88.89 Favored 'General case' 0 N--CA 1.525 3.315 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 32.7 m -57.82 -35.15 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 CA-C-N 119.117 0.872 . . . . 0.0 111.95 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 36.7 p -62.83 -48.21 80.07 Favored 'General case' 0 N--CA 1.53 3.545 0 C-N-CA 123.527 0.731 . . . . 0.0 110.674 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.72 -48.76 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.346 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.97 -36.84 60.62 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 122.98 0.512 . . . . 0.0 111.882 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.81 94.61 Favored 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.077 0.551 . . . . 0.0 111.741 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.09 -41.36 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 C-N-CA 123.372 0.669 . . . . 0.0 109.571 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.15 -32.91 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.432 0.693 . . . . 0.0 109.495 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -47.3 79.19 Favored 'General case' 0 N--CA 1.539 3.985 0 CA-C-O 121.68 0.752 . . . . 0.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.34 -52.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.413 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.1 -36.05 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 124.875 1.27 . . . . 0.0 113.321 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.17 75.18 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.5 -37.98 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.639 0 CA-C-N 118.543 0.61 . . . . 0.0 111.732 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -69.31 -42.66 75.13 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 122.205 -0.31 . . . . 0.0 111.656 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.54 -32.11 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.41 0.55 . . . . 0.0 110.136 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.32 -39.25 85.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 N--CA 1.523 3.182 0 C-N-CA 124.346 1.058 . . . . 0.0 111.557 -178.701 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.527 3.416 0 CA-C-O 120.796 0.332 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.2 -26.89 67.27 Favored Glycine 0 N--CA 1.51 3.601 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -49.33 84.9 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 C-N-CA 123.219 0.608 . . . . 0.0 111.744 -177.666 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -67.15 -33.99 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.973 -0.455 . . . . 0.0 110.616 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.41 -38.84 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.8 -48.45 76.82 Favored 'General case' 0 N--CA 1.525 3.311 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.18 -36.12 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.933 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.8 p -66.85 -49.46 65.64 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.03 -33.09 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.33 77.6 Favored 'General case' 0 N--CA 1.523 3.189 0 C-N-CA 122.882 0.473 . . . . 0.0 111.211 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.5 83.35 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 122.759 0.424 . . . . 0.0 111.997 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.95 -45.23 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.406 0 C-N-CA 123.201 0.6 . . . . 0.0 111.263 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -67.66 -32.67 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 O-C-N 121.755 -0.591 . . . . 0.0 110.63 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -47.86 83.05 Favored 'General case' 0 N--CA 1.523 3.216 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.95 -44.62 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.82 -36.58 77.55 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 119.301 0.955 . . . . 0.0 112.448 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.11 67.19 Favored 'General case' 0 N--CA 1.526 3.338 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 4.3 m -70.24 -38.46 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 118.737 0.699 . . . . 0.0 111.543 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.23 -43.09 92.54 Favored 'General case' 0 N--CA 1.532 3.671 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.28 -31.9 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 CA-C-N 117.999 0.363 . . . . 0.0 110.03 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.9 t -66.5 -46.17 77.14 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.304 0.642 . . . . 0.0 110.712 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.09 -35.1 76.12 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.985 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 88.3 p -64.22 -34.93 79.23 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 122.791 0.436 . . . . 0.0 111.693 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.59 -20.07 25.47 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 124.035 0.934 . . . . 0.0 111.376 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 N--CA 1.535 3.801 0 C-N-CA 122.713 0.405 . . . . 0.0 110.284 -178.788 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.528 3.458 0 CA-C-O 120.262 0.077 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.54 -40.85 31.37 Favored Glycine 1 N--CA 1.52 4.24 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.18 -45.65 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.2 0 C-N-CA 124.443 1.097 . . . . 0.0 112.054 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 5.9 tp -55.58 -33.21 32.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 CA-C-N 118.529 0.604 . . . . 0.0 110.052 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.28 -46.5 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-O 121.822 0.82 . . . . 0.0 109.021 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.2 -41.9 85.04 Favored 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.74 -38.26 64.16 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 119.042 0.837 . . . . 0.0 111.776 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.9 p -64.04 -48.01 77.95 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.678 0.791 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.82 -45.74 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.07 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.44 54.07 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 123.372 0.669 . . . . 0.0 111.729 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -41.3 98.7 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-O 120.932 0.396 . . . . 0.0 111.384 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.11 -38.97 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.325 0 C-N-CA 123.558 0.743 . . . . 0.0 109.657 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.37 -33.1 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 123.617 0.767 . . . . 0.0 111.03 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.49 -43.47 93.29 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-N 118.594 0.634 . . . . 0.0 110.161 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.4 -54.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.36 0.664 . . . . 0.0 110.102 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.03 -37.82 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.301 1.04 . . . . 0.0 113.314 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.94 92.52 Favored 'General case' 1 N--CA 1.541 4.091 0 CA-C-N 118.575 0.625 . . . . 0.0 112.515 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.86 -34.1 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.21 -43.77 93.99 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.176 0.59 . . . . 0.0 112.051 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.29 -36.07 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 CA-C-O 120.818 0.342 . . . . 0.0 110.438 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.24 -39.44 86.18 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.297 0.639 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.44 -29.99 64.2 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 99.1 p -75.37 -43.15 51.92 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 122.748 0.419 . . . . 0.0 110.745 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.3 mt -77.27 -31.66 55.05 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.892 0.877 . . . . 0.0 111.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.536 3.829 0 C-N-CA 123.069 0.547 . . . . 0.0 111.662 -176.977 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.532 3.642 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 24.4 t -62.27 -20.43 64.26 Favored 'General case' 0 N--CA 1.522 3.173 0 C-N-CA 123.829 0.851 . . . . 0.0 110.624 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.61 94.14 Favored Glycine 0 N--CA 1.508 3.488 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.184 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.3 pt -65.79 -35.39 75.05 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 CA-C-N 117.897 0.849 . . . . 0.0 111.265 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.14 -34.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 C-N-CA 123.203 0.601 . . . . 0.0 109.636 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.07 -44.31 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.421 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -67.02 -45.41 77.61 Favored 'General case' 0 N--CA 1.533 3.687 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.65 -35.85 52.15 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.3 p -66.06 -49.45 67.61 Favored 'General case' 0 N--CA 1.529 3.492 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.93 -37.82 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.14 72.76 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 122.64 0.376 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.23 94.87 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.938 0.495 . . . . 0.0 111.747 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.76 -42.12 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 123.322 0.649 . . . . 0.0 109.893 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.79 -32.97 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.547 0.739 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.87 -37.7 88.38 Favored 'General case' 0 N--CA 1.529 3.506 0 C-N-CA 122.89 0.476 . . . . 0.0 111.954 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.73 -54.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.707 0 C-N-CA 122.887 0.475 . . . . 0.0 111.624 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 22.7 m -66.86 -36.88 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.49 67.83 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.26 -36.55 77.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 119.393 0.997 . . . . 0.0 110.593 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.54 -30.27 71.0 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 122.784 0.434 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.16 -41.08 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.607 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.41 -48.31 67.7 Favored 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 123.465 0.706 . . . . 0.0 111.166 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.53 3.531 0 C-N-CA 124.068 0.947 . . . . 0.0 111.708 -178.933 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.517 2.912 0 CA-C-O 120.684 0.278 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.36 -50.57 8.16 Favored Glycine 0 N--CA 1.512 3.734 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.805 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.35 -36.89 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 8.5 tp -60.12 -33.58 53.82 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.64 0.655 . . . . 0.0 110.42 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.13 -42.22 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -64.34 -29.23 70.31 Favored 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.22 -44.8 84.28 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.455 0 CA-C-N 119.673 1.124 . . . . 0.0 113.455 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.5 p -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.88 -36.76 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.142 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.6 70.41 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 122.616 0.366 . . . . 0.0 111.358 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.94 -43.68 98.13 Favored 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 122.651 0.38 . . . . 0.0 111.482 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.3 -42.77 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 C-N-CA 123.508 0.723 . . . . 0.0 110.003 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.42 -33.29 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.347 0 C-N-CA 123.407 0.683 . . . . 0.0 110.193 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.94 -38.57 91.55 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 122.813 0.445 . . . . 0.0 111.96 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.0 mt -70.34 -55.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 122.416 0.286 . . . . 0.0 111.546 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.7 -37.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.25 82.89 Favored 'General case' 0 N--CA 1.533 3.683 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.11 -34.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.622 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.0 -42.3 66.61 Favored 'General case' 1 N--CA 1.54 4.056 0 CA-C-N 119.504 1.047 . . . . 0.0 111.547 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.36 -32.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.4 p -67.27 -37.64 83.79 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-N 118.282 0.492 . . . . 0.0 111.103 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.61 -27.72 67.92 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.463 0.705 . . . . 0.0 111.452 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.6 p -72.21 -16.74 61.95 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 122.645 0.378 . . . . 0.0 111.32 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.4 -37.7 13.05 Favored 'General case' 0 N--CA 1.535 3.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.268 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 1 N--CA 1.545 4.298 0 C-N-CA 122.916 0.487 . . . . 0.0 111.152 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.526 3.351 0 CA-C-O 121.122 0.487 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.99 81.19 Favored Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.271 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.05 -36.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 C-N-CA 124.026 0.93 . . . . 0.0 110.533 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.42 -35.93 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 C-N-CA 122.966 0.506 . . . . 0.0 110.151 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.98 -38.13 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.54 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -65.21 -47.01 78.41 Favored 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.82 -29.92 41.44 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 118.699 0.682 . . . . 0.0 112.335 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.5 p -69.57 -49.9 49.75 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.55 -31.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.098 0.559 . . . . 0.0 111.238 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.04 79.39 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 122.855 0.462 . . . . 0.0 111.626 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.4 t -70.05 -48.26 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 123.268 0.627 . . . . 0.0 111.212 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.0 -32.02 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 CA-C-N 118.251 0.478 . . . . 0.0 110.106 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -46.98 62.93 Favored 'General case' 0 N--CA 1.535 3.776 0 C-N-CA 123.667 0.787 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.33 -54.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.81 -37.03 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 124.768 1.227 . . . . 0.0 113.818 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.43 -31.92 68.2 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.7 m -69.45 -36.09 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 119.332 0.969 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.92 -42.44 66.7 Favored 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.22 -38.36 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.24 -38.93 86.0 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 124.004 0.921 . . . . 0.0 111.039 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 22.1 t -70.08 -32.47 70.55 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 122.947 0.499 . . . . 0.0 110.108 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.31 -32.21 62.76 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.939 0.896 . . . . 0.0 109.904 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.533 3.71 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.528 3.439 0 CA-C-O 121.054 0.454 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.0 m -70.65 -23.79 62.58 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.706 -0.621 . . . . 0.0 109.85 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.88 -50.09 55.04 Favored Glycine 0 N--CA 1.512 3.718 0 C-N-CA 124.264 0.935 . . . . 0.0 114.616 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.15 -36.03 60.69 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.094 0.947 . . . . 0.0 110.748 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.03 -34.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 122.871 0.468 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.4 -41.09 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.872 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -56.72 -41.8 78.09 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.512 0.725 . . . . 0.0 111.867 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 50.5 t -57.76 -45.88 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 19.3 p -62.87 -49.28 75.45 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.05 -38.45 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.133 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.8 78.79 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.46 64.39 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.99 -38.39 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.32 -32.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.551 0.614 . . . . 0.0 110.668 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.73 -36.02 71.48 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.149 0.58 . . . . 0.0 112.371 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -69.57 -54.85 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 122.763 0.425 . . . . 0.0 111.193 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.14 -35.99 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 C-N-CA 124.236 1.014 . . . . 0.0 113.227 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -31.11 65.9 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.27 -35.21 74.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.077 0 CA-C-N 119.401 1.001 . . . . 0.0 110.594 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.79 -33.79 75.51 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 122.887 0.475 . . . . 0.0 110.422 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.58 -43.0 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 C-N-CA 123.29 0.636 . . . . 0.0 109.8 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 61.7 m -65.47 -48.45 72.62 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.155 0.582 . . . . 0.0 110.891 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 N--CA 1.522 3.152 0 C-N-CA 124.06 0.944 . . . . 0.0 111.487 -179.285 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.525 3.301 0 CA-C-O 121.237 0.541 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.21 -41.38 31.59 Favored Glycine 1 N--CA 1.517 4.082 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.716 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 214' ' ' ILE . 1.4 mp -64.48 -47.62 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.974 0.91 . . . . 0.0 110.886 -176.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.2 -34.2 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 O-C-N 121.939 -0.475 . . . . 0.0 111.576 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.84 -43.13 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -67.05 -40.93 87.24 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.79 -33.28 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.151 0 CA-C-N 119.347 0.976 . . . . 0.0 112.791 -175.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -49.72 61.24 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.07 -31.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.435 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.24 -41.29 77.18 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.643 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.22 -43.66 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.505 0.722 . . . . 0.0 111.793 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.91 -32.26 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 CA-C-N 118.332 0.514 . . . . 0.0 110.791 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.11 -38.34 79.35 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.115 0.566 . . . . 0.0 112.317 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.23 -55.14 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.84 -37.41 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.09 89.19 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.8 -34.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.11 -43.82 97.99 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.413 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.59 -36.0 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 CA-C-O 120.987 0.422 . . . . 0.0 110.211 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.34 -48.33 67.83 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.375 0.67 . . . . 0.0 111.687 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -72.28 -45.16 61.26 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.871 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 94.8 p -65.04 -39.42 93.29 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 tp -72.89 -37.69 67.2 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 122.682 0.393 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 N--CA 1.539 3.987 0 C-N-CA 123.612 0.765 . . . . 0.0 111.247 -177.926 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.526 3.363 0 CA-C-O 120.324 0.106 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.71 -44.74 19.44 Favored Glycine 0 N--CA 1.515 3.954 0 O-C-N 123.849 0.718 . . . . 0.0 111.48 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 214' ' ' ILE . . . . . 0.402 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -58.72 -46.24 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 C-N-CA 124.708 1.203 . . . . 0.0 111.585 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.9 -32.62 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 O-C-N 122.143 -0.348 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.72 -48.57 87.52 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.73 -0.606 . . . . 0.0 110.62 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -67.85 -40.04 83.74 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 20.1 m -57.52 -38.58 64.36 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 CA-C-N 119.929 1.24 . . . . 0.0 112.067 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -61.34 -48.1 82.85 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.694 0.798 . . . . 0.0 111.266 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.67 -44.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.479 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 -34.78 75.42 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 122.994 0.518 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.0 94.12 Favored 'General case' 0 N--CA 1.523 3.195 0 C-N-CA 123.017 0.527 . . . . 0.0 111.902 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.4 -44.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.49 -35.03 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.045 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.34 -38.06 79.39 Favored 'General case' 0 N--CA 1.532 3.629 0 C-N-CA 123.123 0.569 . . . . 0.0 111.327 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.98 -48.81 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.0 -35.53 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 C-N-CA 125.442 1.497 . . . . 0.0 112.158 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.85 68.57 Favored 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.01 -44.19 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.662 0.664 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -63.77 -42.11 97.84 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.93 -33.62 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.589 0.632 . . . . 0.0 110.798 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.9 m -67.22 -43.64 81.52 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.026 0.53 . . . . 0.0 110.611 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.49 -31.13 65.14 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.711 0.804 . . . . 0.0 110.249 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.92 -43.01 97.22 Favored 'General case' 0 N--CA 1.522 3.143 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.8 -14.76 41.28 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.683 0.793 . . . . 0.0 112.543 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 1 N--CA 1.542 4.133 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.534 3.748 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -55.75 -20.88 16.28 Favored 'General case' 0 N--CA 1.528 3.461 0 O-C-N 121.781 -0.574 . . . . 0.0 111.493 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.95 -39.79 93.34 Favored Glycine 0 N--CA 1.51 3.594 0 O-C-N 124.112 0.883 . . . . 0.0 113.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -38.05 80.25 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 CA-C-N 117.524 0.662 . . . . 0.0 109.866 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 50.7 mt -56.74 -34.36 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.389 0.675 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 25.8 mm -69.6 -44.26 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.614 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.44 -36.81 75.5 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.276 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 40.5 p -63.77 -49.26 73.68 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.9 -38.88 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.78 73.71 Favored 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 122.718 0.407 . . . . 0.0 110.972 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.52 85.42 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.087 0.555 . . . . 0.0 112.04 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.291 0.636 . . . . 0.0 109.839 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.95 -32.48 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 123.592 0.757 . . . . 0.0 110.291 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.6 tp -64.23 -48.53 75.46 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 tt -71.95 -52.08 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.06 -37.01 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -31.78 68.9 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.18 -34.9 66.09 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.251 0.932 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -68.86 -38.62 79.86 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.046 0.451 . . . . 0.0 109.807 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.1 -41.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 C-N-CA 123.91 0.884 . . . . 0.0 109.599 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.21 -38.79 92.31 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.526 0.73 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.6 tttm . . . . . 0 N--CA 1.524 3.245 0 C-N-CA 123.47 0.708 . . . . 0.0 109.481 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.521 3.098 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.24 -50.28 8.58 Favored Glycine 0 N--CA 1.513 3.8 0 C-N-CA 123.984 0.802 . . . . 0.0 113.78 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.84 -36.91 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 42.5 pt -57.96 -33.81 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 118.951 0.796 . . . . 0.0 110.667 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.65 -41.19 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.66 -34.48 77.17 Favored 'General case' 0 N--CA 1.529 3.493 0 C-N-CA 123.471 0.708 . . . . 0.0 111.687 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.89 -38.03 63.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 CA-C-O 120.921 0.391 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.5 p -66.02 -49.15 68.74 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.302 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.02 -44.93 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.022 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.061 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.75 -34.57 67.68 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.351 0.66 . . . . 0.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.24 98.57 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 122.904 0.482 . . . . 0.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.1 t -69.94 -39.06 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.397 0.679 . . . . 0.0 109.627 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.7 -32.87 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 123.755 0.822 . . . . 0.0 109.869 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -47.21 84.89 Favored 'General case' 0 N--CA 1.535 3.794 0 CA-C-O 121.58 0.705 . . . . 0.0 110.748 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.06 -54.11 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.926 0.89 . . . . 0.0 112.702 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.63 -36.79 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.57 -31.73 68.27 Favored 'General case' 0 N--CA 1.528 3.455 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.09 -34.93 73.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.104 0 CA-C-N 119.348 0.976 . . . . 0.0 110.581 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -65.12 -36.08 83.15 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 122.561 0.344 . . . . 0.0 110.297 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.03 -37.43 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.633 0.773 . . . . 0.0 109.764 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 66.6 m -67.11 -48.33 68.45 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.236 0.614 . . . . 0.0 111.002 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -70.38 -27.72 64.53 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 123.784 0.834 . . . . 0.0 110.351 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.9 t -63.92 -37.9 89.09 Favored 'General case' 0 N--CA 1.528 3.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.546 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.79 -37.23 76.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 123.971 0.908 . . . . 0.0 110.505 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.531 3.625 0 C-N-CA 123.586 0.754 . . . . 0.0 110.384 -179.022 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.519 2.979 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.46 93.28 Favored Glycine 1 N--CA 1.518 4.158 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.272 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.9 tp -57.6 -36.38 53.92 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 118.116 0.958 . . . . 0.0 110.785 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.98 -40.17 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.781 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 216' ' ' ILE . . . . . 0.416 ' N ' HD12 ' B' ' 216' ' ' ILE . 1.5 mp -66.72 -41.3 87.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.144 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -59.25 -36.47 75.54 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.334 0.654 . . . . 0.0 112.042 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.21 -42.27 83.03 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.154 0 CA-C-O 121.023 0.439 . . . . 0.0 110.029 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 5.5 p -63.21 -48.39 78.5 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.602 0.761 . . . . 0.0 110.974 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.6 -42.94 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.441 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.87 75.86 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 122.885 0.474 . . . . 0.0 111.066 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.36 -48.99 68.42 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.05 0.54 . . . . 0.0 111.513 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -38.84 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 C-N-CA 123.248 0.619 . . . . 0.0 110.055 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.15 -32.91 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 C-N-CA 123.099 0.56 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.05 -34.89 79.51 Favored 'General case' 0 N--CA 1.534 3.76 0 C-N-CA 122.83 0.452 . . . . 0.0 111.83 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.66 -54.62 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 C-N-CA 122.804 0.442 . . . . 0.0 111.039 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -36.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.78 82.35 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.5 -34.78 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.215 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.86 -40.18 79.48 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 119.197 0.908 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.01 -31.62 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.808 0 CA-C-N 118.435 0.561 . . . . 0.0 110.964 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.25 -40.72 95.11 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 122.818 0.447 . . . . 0.0 111.345 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.27 -45.43 32.71 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.271 0.628 . . . . 0.0 109.973 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.8 t -63.16 -12.82 30.55 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 122.804 0.442 . . . . 0.0 111.68 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 64.3 tp -89.1 -35.92 16.02 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 124.308 1.043 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 1 N--CA 1.543 4.179 0 C-N-CA 123.979 0.912 . . . . 0.0 110.703 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.528 3.441 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -70.5 -21.03 62.8 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 122.968 0.507 . . . . 0.0 110.857 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.43 -50.14 22.36 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 123.614 0.626 . . . . 0.0 113.814 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.24 -36.65 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 CA-C-N 117.432 0.616 . . . . 0.0 111.149 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.74 -35.1 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 117.942 0.337 . . . . 0.0 110.832 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.37 -42.56 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.737 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -66.58 -42.75 86.52 Favored 'General case' 0 N--CA 1.527 3.414 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.41 -33.47 47.95 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.847 0.749 . . . . 0.0 112.287 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 25.3 p -66.97 -50.27 62.82 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.98 -39.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.74 68.89 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.967 0.507 . . . . 0.0 111.306 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.21 94.06 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 122.841 0.457 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 51.3 t -70.05 -41.17 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 123.622 0.769 . . . . 0.0 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.81 -34.14 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.876 0.871 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.44 -36.76 83.61 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.125 0.57 . . . . 0.0 111.588 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.83 -54.24 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 C-N-CA 123.109 0.564 . . . . 0.0 111.085 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 m -67.76 -42.02 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.34 92.35 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.07 -37.02 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 CA-C-O 118.047 -0.977 . . . . 0.0 112.218 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -73.32 -36.57 66.25 Favored 'General case' 1 N--CA 1.548 4.443 0 CA-C-N 120.631 1.559 . . . . 0.0 109.801 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.86 -32.03 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 C-N-CA 123.188 0.595 . . . . 0.0 109.713 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.56 -38.12 83.51 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 123.304 0.642 . . . . 0.0 111.192 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 N--CA 1.531 3.586 0 C-N-CA 124.362 1.065 . . . . 0.0 111.633 179.613 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.574 1.867 0 N-CA-C 108.561 -0.903 . . . . 999.99 108.561 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.7 -34.77 8.6 Favored 'Trans proline' 1 N--CA 1.538 4.124 0 C-N-CA 122.153 1.902 . . . . 999.99 110.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 64.58 145.88 0.03 OUTLIER Glycine 1 N--CA 1.519 4.22 0 CA-C-N 115.449 -0.796 . . . . 891.5 111.367 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.8 p -166.46 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.576 0.75 . . . . 999.99 109.114 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.2 mt -72.9 -24.79 60.88 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 115.099 -0.955 . . . . 872.26 110.203 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -70.24 -23.61 62.94 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.819 0.448 . . . . 422.23 109.979 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.41 -50.64 9.53 Favored Glycine 0 N--CA 1.511 3.681 0 CA-C-N 115.78 -0.645 . . . . 182.12 113.236 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -66.48 -37.48 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.596 0.698 . . . . 429.52 111.002 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.89 -41.86 92.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 C-N-CA 122.59 0.356 . . . . 386.43 110.488 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.58 -45.02 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 O-C-N 121.665 -0.647 . . . . 161.88 109.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.17 -40.56 86.61 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 114.482 1.29 . . . . 999.99 114.482 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.7 -31.57 40.2 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.227 0 CA-C-N 119.076 0.853 . . . . 168.06 111.209 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.6 p -69.52 -48.63 59.85 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.419 0.688 . . . . 21.5 110.282 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.89 -34.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.192 0 CA-C-N 115.296 -0.865 . . . . 220.71 109.09 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.83 72.88 Favored 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 123.278 0.631 . . . . 59.04 111.039 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.68 68.88 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 115.801 -0.636 . . . . 25.92 111.121 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.62 -45.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 C-N-CA 123.422 0.689 . . . . 37.84 111.716 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.78 -32.83 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 CA-C-N 118.332 0.514 . . . . 282.57 110.432 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 49.6 tp -63.98 -36.16 83.06 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.482 0.713 . . . . 170.35 112.194 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.8 -52.64 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 122.838 0.455 . . . . 145.71 110.357 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.2 -37.5 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 O-C-N 121.807 -0.558 . . . . 205.37 112.162 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.23 85.35 Favored 'General case' 0 N--CA 1.536 3.836 0 N-CA-C 112.818 0.673 . . . . 54.0 112.818 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 -34.28 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.648 0 N-CA-C 109.838 -0.431 . . . . 167.28 109.838 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -69.76 -42.59 73.65 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 109.647 -0.501 . . . . 382.56 109.647 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.46 -31.96 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.3 0.64 . . . . 396.06 109.474 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.7 t -65.07 -39.37 93.13 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.188 0.595 . . . . 241.93 110.467 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.67 -33.02 53.52 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.645 0.778 . . . . 962.6 110.328 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 77.8 p -63.42 -24.1 67.69 Favored 'General case' 0 N--CA 1.533 3.698 0 CA-C-O 120.9 0.381 . . . . 329.86 110.409 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.93 -33.16 30.49 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 124.094 0.958 . . . . 647.43 109.577 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 47.0 tp -93.71 -8.25 41.36 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 124.619 1.167 . . . . 658.92 111.832 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -115.24 13.3 16.68 Favored 'General case' 0 N--CA 1.536 3.85 0 N-CA-C 105.935 -1.876 . . . . 999.99 105.935 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -64.06 169.85 4.06 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.832 1.253 . . . . 999.99 108.075 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -53.17 -9.54 0.16 Allowed 'General case' 0 N--CA 1.537 3.889 0 CA-C-N 114.498 -1.228 . . . . 999.99 111.545 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 85.6 t -134.11 120.77 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 N-CA-C 104.399 -2.445 . . . . 999.99 104.399 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.05 142.21 44.27 Favored Pre-proline 0 N--CA 1.521 3.083 0 C-N-CA 125.731 1.612 . . . . 999.99 107.531 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 1 N--CA 1.54 4.239 0 CA-C-N 122.487 1.924 . . . . 999.99 110.588 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 CA--C 1.58 2.124 0 N-CA-C 108.579 -0.897 . . . . 999.99 108.579 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -59.74 -76.95 0.02 OUTLIER 'Trans proline' 1 N--CA 1.544 4.487 0 C-N-CA 121.823 1.682 . . . . 999.99 111.233 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 58.78 73.3 0.48 Allowed Glycine 1 N--CA 1.518 4.15 0 C-N-CA 123.602 0.62 . . . . 999.99 112.223 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 67.9 m -158.9 21.03 0.2 Allowed 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 123.611 0.764 . . . . 999.99 110.374 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.21 -38.87 50.52 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 124.827 1.251 . . . . 695.35 107.766 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 63.4 m -55.81 -29.29 59.52 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 114.978 -1.01 . . . . 322.12 111.41 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.3 -35.82 56.22 Favored Glycine 1 N--CA 1.517 4.047 0 CA-C-N 115.444 -0.798 . . . . 118.7 111.417 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.6 mm -65.87 -36.92 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.747 0.819 . . . . 351.56 110.187 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -65.72 -40.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.59 0 C-N-CA 123.151 0.58 . . . . 318.28 109.834 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 83.4 mt -70.08 -38.33 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.421 0.688 . . . . 156.48 109.302 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -62.04 -47.44 84.72 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.504 0.927 . . . . 999.99 113.504 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 15.2 m -59.24 -27.86 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 O-C-N 122.28 -0.262 . . . . 221.17 111.223 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.0 p -66.23 -48.22 71.26 Favored 'General case' 0 N--CA 1.535 3.816 0 CA-C-O 121.39 0.614 . . . . 21.87 110.368 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.13 -51.61 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 CA-C-N 115.281 -0.872 . . . . 176.34 109.076 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.23 -34.69 61.27 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 122.889 0.476 . . . . 36.92 111.545 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.86 92.38 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 122.717 0.407 . . . . 26.88 111.166 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 80.5 t -69.75 -46.74 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 N-CA-C 109.471 -0.566 . . . . 93.61 109.471 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.5 -33.81 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.281 0.632 . . . . 229.62 110.192 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.27 -39.46 92.64 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.778 0.431 . . . . 164.04 110.632 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.01 -46.91 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 109.042 -0.725 . . . . 134.42 109.042 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.25 -36.73 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.199 1.0 . . . . 189.86 111.344 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.0 -31.59 67.08 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.72 0.637 . . . . 50.32 112.72 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.97 -44.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 CA-C-N 118.473 0.579 . . . . 179.11 109.661 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -66.06 -42.62 89.21 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 122.842 0.457 . . . . 336.07 110.202 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.08 -38.73 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 N-CA-C 109.509 -0.552 . . . . 298.7 109.509 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.13 -48.48 67.97 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.003 0.521 . . . . 272.98 111.418 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.73 -42.12 70.97 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.601 0.76 . . . . 892.98 111.112 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 98.4 p -63.8 -13.33 43.29 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 119.228 -0.415 . . . . 295.12 111.308 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -37.94 12.99 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.704 0.801 . . . . 751.54 109.214 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.9 tp -80.88 -27.77 36.22 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.329 0.652 . . . . 539.81 110.728 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -90.27 -3.81 57.57 Favored 'General case' 0 N--CA 1.539 3.983 0 C-N-CA 123.738 0.815 . . . . 999.99 110.314 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.23 -6.42 28.96 Favored 'General case' 0 N--CA 1.535 3.795 0 C-N-CA 122.866 0.466 . . . . 999.99 109.82 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.0 6.1 5.74 Favored 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 124.721 1.208 . . . . 999.99 111.236 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.82 122.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 107.47 -1.307 . . . . 999.99 107.47 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.33 114.16 64.37 Favored Pre-proline 0 N--CA 1.527 3.402 0 CA-C-O 116.822 -1.561 . . . . 999.99 107.083 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 1 N--CA 1.547 4.644 0 C-N-CA 122.465 2.11 . . . . 999.99 114.26 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 2.001 0 N-CA-C 109.366 -0.605 . . . . 999.99 109.366 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.31 42.03 0.96 Allowed 'Trans proline' 1 N--CA 1.541 4.309 0 C-N-CA 122.416 2.077 . . . . 999.99 110.271 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.23 28.09 Favored Glycine 1 N--CA 1.519 4.208 0 N-CA-C 110.976 -0.849 . . . . 999.99 110.976 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.0 t -167.77 71.14 0.1 Allowed 'General case' 0 N--CA 1.517 2.924 0 C-N-CA 123.787 0.835 . . . . 997.01 108.999 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.92 -18.2 65.02 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 123.416 0.686 . . . . 581.98 110.887 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -70.2 -22.52 62.93 Favored 'General case' 0 N--CA 1.52 3.033 0 C-N-CA 122.889 0.476 . . . . 487.96 109.996 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.4 -50.73 9.39 Favored Glycine 0 N--CA 1.512 3.751 0 CA-C-N 115.926 -0.579 . . . . 126.84 113.157 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.0 tp -66.41 -37.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 117.481 0.641 . . . . 390.09 110.918 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.62 -41.08 88.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 C-N-CA 122.617 0.367 . . . . 395.7 110.189 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.42 -38.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 109.37 -0.604 . . . . 188.96 109.37 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.49 -46.38 83.25 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.995 1.109 . . . . 999.99 113.995 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.85 -27.89 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.966 0 CA-C-N 118.133 0.424 . . . . 199.57 111.424 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 23.9 p -69.79 -48.22 59.99 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-O 121.401 0.62 . . . . 22.73 110.227 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.96 -47.72 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 CA-C-N 115.321 -0.854 . . . . 203.96 108.967 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.62 56.12 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.246 0.618 . . . . 49.7 111.504 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.21 -44.01 85.08 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 122.969 0.508 . . . . 25.3 110.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.11 -41.55 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.323 0.649 . . . . 93.88 109.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.58 -35.28 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.396 0.678 . . . . 243.0 109.935 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.4 -42.41 96.12 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.989 0.516 . . . . 85.12 111.953 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.27 -51.3 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 C-N-CA 123.186 0.594 . . . . 125.46 111.196 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.31 -36.85 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 112.751 0.648 . . . . 188.14 112.751 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.11 -44.71 87.84 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.281 0.845 . . . . 48.46 113.281 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 30.0 m -59.45 -34.69 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 CA-C-N 118.69 0.677 . . . . 139.07 110.594 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -71.32 -42.26 68.82 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 109.615 -0.513 . . . . 304.14 109.615 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.82 -40.03 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 N-CA-C 109.153 -0.684 . . . . 256.41 109.153 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.4 m -67.09 -40.25 86.92 Favored 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 109.525 -0.546 . . . . 224.28 109.525 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.16 -28.89 62.48 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.71 0.804 . . . . 901.13 110.139 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.6 t -69.16 -37.91 78.46 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 122.788 0.435 . . . . 340.59 110.233 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.03 -37.56 83.02 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.103 0.961 . . . . 572.01 112.156 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.52 -27.5 37.62 Favored 'General case' 0 N--CA 1.538 3.954 0 N-CA-C 108.831 -0.803 . . . . 669.34 108.831 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -89.26 -4.2 58.25 Favored 'General case' 0 N--CA 1.537 3.92 0 C-N-CA 123.375 0.67 . . . . 999.99 110.002 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -86.09 -25.88 25.59 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.582 0.753 . . . . 999.99 109.09 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -66.02 -33.23 75.34 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 124.217 1.007 . . . . 999.99 110.088 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.2 122.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 N-CA-C 107.418 -1.327 . . . . 999.99 107.418 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.04 141.92 23.91 Favored Pre-proline 0 N--CA 1.527 3.398 0 N-CA-C 107.408 -1.33 . . . . 999.99 107.408 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 1 N--CA 1.539 4.199 0 C-N-CA 122.006 1.804 . . . . 999.99 110.688 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.572 1.804 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.96 -167.55 0.36 Allowed 'Trans proline' 1 N--CA 1.54 4.222 0 C-N-CA 122.223 1.949 . . . . 0.0 110.257 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -165.08 33.91 0.25 Allowed Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.9 p -167.47 179.69 4.82 Favored 'General case' 0 N--CA 1.52 3.058 0 C-N-CA 124.34 1.056 . . . . 0.0 108.735 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt -159.98 -37.71 0.05 Allowed 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.6 m -70.74 -30.43 66.94 Favored 'General case' 0 N--CA 1.524 3.272 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.54 -50.07 70.3 Favored Glycine 0 N--CA 1.514 3.899 0 CA-C-N 114.808 -1.087 . . . . 0.0 114.477 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.7 tp -58.72 -35.91 57.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 CA-C-N 117.863 0.831 . . . . 0.0 110.61 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.64 -34.48 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.077 0.551 . . . . 0.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.69 -45.11 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -67.19 -46.36 74.15 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.71 -40.63 76.56 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 49.9 p -64.75 -49.22 71.64 Favored 'General case' 0 N--CA 1.528 3.43 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.24 -31.59 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.71 71.59 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.825 0.45 . . . . 0.0 111.928 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.88 70.87 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.48 0.312 . . . . 0.0 111.418 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -68.68 -50.93 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 123.514 0.726 . . . . 0.0 111.502 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.29 -31.89 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 122.064 -0.397 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -47.14 66.4 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 123.561 0.744 . . . . 0.0 110.889 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.5 mm -67.77 -42.95 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 C-N-CA 122.794 0.438 . . . . 0.0 110.437 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.4 -39.69 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.576 0.75 . . . . 0.0 111.756 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.27 85.86 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.71 0.404 . . . . 0.0 111.981 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.63 -33.58 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.76 -42.82 99.48 Favored 'General case' 0 N--CA 1.538 3.966 0 C-N-CA 123.245 0.618 . . . . 0.0 110.903 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.96 -32.63 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.955 0.502 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.23 -45.1 89.68 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 122.903 0.481 . . . . 0.0 111.401 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.67 -37.31 73.67 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.222 0.609 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.2 t -63.87 -28.77 70.07 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.414 0.686 . . . . 0.0 111.82 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 59.9 tp -73.74 -37.54 65.03 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 123.688 0.795 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 58.9 mt -88.28 -26.16 22.44 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -89.45 7.59 35.25 Favored 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 123.372 0.669 . . . . 0.0 110.274 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -77.96 -12.76 60.01 Favored 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.5 mttp 74.19 -18.12 0.42 Allowed 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 125.598 1.559 . . . . 0.0 111.105 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.87 130.54 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.74 141.89 24.39 Favored Pre-proline 0 N--CA 1.529 3.496 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 1 N--CA 1.54 4.211 0 CA-C-N 122.274 1.848 . . . . 0.0 110.591 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.586 2.356 0 CA-C-O 117.436 -1.268 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.82 88.99 1.05 Allowed 'Trans proline' 0 N--CA 1.535 3.964 0 CA-C-N 122.694 1.998 . . . . 0.0 110.803 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.03 -172.53 43.79 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.685 0.659 . . . . 0.0 111.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 26.2 t 61.62 149.23 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.687 1.195 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.55 30.23 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.341 1.057 . . . . 0.0 108.987 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 64.6 m -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 122.652 0.381 . . . . 0.0 111.067 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.44 -50.6 8.06 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.327 0.489 . . . . 0.0 113.912 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.87 -41.03 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.18 -34.04 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 118.874 0.761 . . . . 0.0 111.745 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.37 -44.83 99.63 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.085 0 CA-C-O 120.985 0.421 . . . . 0.0 110.174 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -61.22 -36.9 81.19 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.501 0.72 . . . . 0.0 111.983 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 -36.39 63.17 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.206 0 CA-C-N 118.343 0.52 . . . . 0.0 111.29 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 10.2 p -66.67 -49.8 64.99 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 8.3 p -71.34 -31.9 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.79 79.68 Favored 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 122.768 0.427 . . . . 0.0 111.217 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.36 69.31 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 122.936 0.494 . . . . 0.0 112.106 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.59 -43.07 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.493 0 C-N-CA 123.453 0.701 . . . . 0.0 111.973 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.88 -32.59 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 CA-C-N 118.7 0.682 . . . . 0.0 110.36 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.77 -38.7 75.91 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.172 0.589 . . . . 0.0 111.24 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.11 -52.09 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 CA-C-O 122.04 0.924 . . . . 0.0 109.621 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.59 -36.4 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 C-N-CA 126.02 1.728 . . . . 0.0 113.135 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.47 66.35 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.29 -38.1 76.98 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 118.971 0.805 . . . . 0.0 110.218 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.48 -41.98 75.41 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.112 0.565 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.46 -33.57 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 C-N-CA 122.914 0.486 . . . . 0.0 110.128 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.6 m -67.52 -44.38 78.53 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 121.576 0.703 . . . . 0.0 109.674 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.66 -27.07 65.66 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 124.59 1.156 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.5 t -67.51 -15.85 63.89 Favored 'General case' 0 N--CA 1.52 3.047 0 C-N-CA 123.138 0.575 . . . . 0.0 111.972 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.22 -37.31 13.4 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.57 0.748 . . . . 0.0 111.468 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.4 mp -80.7 -27.73 36.88 Favored 'General case' 0 N--CA 1.537 3.923 0 C-N-CA 123.025 0.53 . . . . 0.0 110.34 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -89.87 -2.69 58.25 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.591 0.757 . . . . 0.0 110.603 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.15 33.05 4.97 Favored 'General case' 0 N--CA 1.536 3.839 0 C-N-CA 124.488 1.115 . . . . 0.0 108.859 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -146.02 -52.3 0.25 Allowed 'General case' 0 N--CA 1.527 3.395 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.5 t -83.82 122.62 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.0 mp -93.77 141.72 24.15 Favored Pre-proline 0 N--CA 1.529 3.478 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 1 N--CA 1.539 4.167 0 CA-C-N 122.398 1.892 . . . . 0.0 110.684 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.574 1.868 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.9 164.63 35.03 Favored 'Trans proline' 1 N--CA 1.537 4.081 0 C-N-CA 122.286 1.991 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.54 33.5 0.08 OUTLIER Glycine 1 N--CA 1.519 4.168 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -166.76 45.1 0.06 Allowed 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.57 -8.77 36.85 Favored 'General case' 0 N--CA 1.528 3.43 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.908 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 -20.56 62.82 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.275 0.63 . . . . 0.0 109.91 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.29 58.6 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 124.053 0.835 . . . . 0.0 114.109 -177.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.5 tt -61.07 -35.57 66.38 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 CA-C-N 117.844 0.822 . . . . 0.0 110.513 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.4 mm -54.71 -33.96 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 C-N-CA 123.401 0.68 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 34.8 mm -69.26 -41.9 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 CA-C-O 121.262 0.553 . . . . 0.0 109.573 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -66.03 -42.45 89.59 Favored 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -57.94 -32.94 44.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.341 0 CA-C-N 119.354 0.979 . . . . 0.0 111.329 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 -48.45 72.36 Favored 'General case' 0 N--CA 1.531 3.608 0 C-N-CA 123.586 0.754 . . . . 0.0 110.979 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.18 -36.92 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.39 0 C-N-CA 123.781 0.832 . . . . 0.0 109.434 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.61 77.27 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 123.442 0.697 . . . . 0.0 111.221 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.97 -38.27 79.27 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 123.131 0.573 . . . . 0.0 112.099 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.19 -46.24 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 C-N-CA 122.729 0.411 . . . . 0.0 111.479 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.16 -32.51 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.643 0 CA-C-N 118.331 0.514 . . . . 0.0 110.305 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 55.0 tp -59.21 -43.59 92.26 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 122.983 0.513 . . . . 0.0 110.78 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.36 -54.13 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.12 -37.19 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.621 1.168 . . . . 0.0 114.082 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.0 71.82 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 119.223 0.92 . . . . 0.0 110.925 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.28 -41.93 72.76 Favored 'General case' 0 N--CA 1.53 3.568 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.01 -35.57 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.55 -48.09 67.97 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.139 0.576 . . . . 0.0 111.748 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.08 -24.88 67.38 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 123.485 0.714 . . . . 0.0 111.643 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 77.1 p -63.62 -19.52 64.93 Favored 'General case' 0 N--CA 1.53 3.529 0 C-N-CA 122.799 0.44 . . . . 0.0 111.515 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.27 -37.27 21.93 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -84.46 -24.7 29.36 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 123.875 0.87 . . . . 0.0 110.543 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -89.6 -0.24 57.39 Favored 'General case' 0 N--CA 1.538 3.948 0 C-N-CA 123.705 0.802 . . . . 0.0 109.866 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -124.5 33.77 5.17 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 124.809 1.244 . . . . 0.0 108.278 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.37 -67.99 0.09 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.55 133.12 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 50.6 mt -93.71 125.89 51.76 Favored Pre-proline 0 N--CA 1.524 3.247 0 CA-C-O 116.626 -1.654 . . . . 0.0 108.518 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 1 N--CA 1.538 4.102 0 CA-C-N 123.289 2.21 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 79.3 mmm . . . . . 0 CA--C 1.573 1.829 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.59 -166.17 0.26 Allowed 'Trans proline' 1 N--CA 1.541 4.271 0 C-N-CA 122.17 1.913 . . . . 0.0 109.84 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.1 13.23 Favored Glycine 1 N--CA 1.519 4.181 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.7 m -56.62 89.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.994 0.918 . . . . 0.0 111.616 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.07 8.48 2.96 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 124.732 1.213 . . . . 0.0 109.887 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.4 m -66.49 -40.04 89.06 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 123.213 0.605 . . . . 0.0 110.527 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.62 -37.4 77.3 Favored Glycine 1 N--CA 1.517 4.088 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.685 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.24 -38.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 C-N-CA 124.45 1.1 . . . . 0.0 110.593 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.08 -38.31 79.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.0 mt -70.11 -37.43 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.08 -47.92 83.47 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.46 -30.93 37.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.395 0 CA-C-N 118.41 0.55 . . . . 0.0 112.218 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -72.2 -48.11 45.62 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 123.47 0.708 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.45 -31.95 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.32 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.24 -34.96 64.45 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.96 -45.47 64.08 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-O 121.162 0.506 . . . . 0.0 111.887 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.15 -38.43 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.886 0.875 . . . . 0.0 112.693 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.44 -32.59 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 CA-C-N 119.334 0.97 . . . . 0.0 111.667 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.05 -47.83 75.97 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.92 -44.96 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.52 -41.08 85.52 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.25 0 CA-C-N 119.53 1.059 . . . . 0.0 112.986 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.34 -43.47 92.74 Favored 'General case' 0 N--CA 1.53 3.549 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.86 -34.54 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.16 -42.36 69.19 Favored 'General case' 1 N--CA 1.539 4.005 0 CA-C-N 118.831 0.741 . . . . 0.0 109.819 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.25 -34.96 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.572 0.749 . . . . 0.0 109.792 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.92 -43.13 84.07 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.282 0.633 . . . . 0.0 111.012 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 123.9 0.88 . . . . 0.0 111.273 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.76 -16.23 60.65 Favored 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 123.215 0.606 . . . . 0.0 111.814 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 mt -91.21 -37.59 13.23 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.854 0.861 . . . . 0.0 111.308 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.47 -27.39 27.53 Favored 'General case' 1 N--CA 1.541 4.086 0 C-N-CA 123.489 0.716 . . . . 0.0 110.589 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -100.09 13.17 35.02 Favored 'General case' 1 N--CA 1.54 4.027 0 C-N-CA 124.333 1.053 . . . . 0.0 109.223 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.01 -27.49 69.16 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.786 0.835 . . . . 0.0 110.372 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -167.12 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 123.226 0.61 . . . . 0.0 109.825 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.37 127.85 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.3 mt -118.3 141.81 30.19 Favored Pre-proline 0 N--CA 1.53 3.548 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.1 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 1 N--CA 1.541 4.281 0 CA-C-N 122.47 1.918 . . . . 0.0 110.837 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.581 2.152 0 CA-C-O 117.609 -1.186 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.63 -168.26 0.34 Allowed 'Trans proline' 0 N--CA 1.534 3.868 0 C-N-CA 122.593 2.195 . . . . 0.0 110.718 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.03 -141.24 3.4 Favored Glycine 1 N--CA 1.52 4.287 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t 61.4 47.68 6.59 Favored 'General case' 0 N--CA 1.519 2.982 0 C-N-CA 124.221 1.008 . . . . 0.0 111.535 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.36 18.16 0.57 Allowed 'General case' 0 N--CA 1.528 3.456 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.204 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.8 p -64.97 -20.7 66.62 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 121.887 -0.508 . . . . 0.0 110.508 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -49.23 14.87 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 124.202 0.906 . . . . 0.0 113.17 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -36.64 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.347 0 C-N-CA 123.262 0.625 . . . . 0.0 110.163 -177.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.41 -34.09 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 21.1 mm -67.29 -40.62 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 CA-C-O 121.386 0.612 . . . . 0.0 109.958 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -64.63 -46.42 82.64 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 m -62.56 -34.13 63.33 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 CA-C-N 118.495 0.589 . . . . 0.0 112.334 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 66.8 p -66.36 -49.22 67.65 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.119 0.568 . . . . 0.0 112.192 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.76 -37.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.62 88.09 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 122.582 0.353 . . . . 0.0 110.713 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.73 95.68 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 122.962 0.505 . . . . 0.0 111.817 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.3 -45.34 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.5 -32.93 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 C-N-CA 123.689 0.795 . . . . 0.0 109.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.8 tp -60.51 -40.82 92.83 Favored 'General case' 0 N--CA 1.535 3.783 0 C-N-CA 122.739 0.415 . . . . 0.0 110.577 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.46 -53.83 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.494 0.664 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.52 -37.96 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 124.208 1.003 . . . . 0.0 113.054 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.64 90.61 Favored 'General case' 1 N--CA 1.54 4.038 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.25 -34.34 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 C-N-CA 122.942 0.497 . . . . 0.0 109.883 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -43.25 79.87 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 122.657 0.383 . . . . 0.0 111.582 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.09 -31.65 51.03 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.47 0.577 . . . . 0.0 110.31 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.68 -45.03 93.31 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.152 0.581 . . . . 0.0 111.982 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -70.35 -24.87 63.05 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.169 0.587 . . . . 0.0 111.592 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.532 3.671 0 CA-C-N 118.413 0.552 . . . . 0.0 110.503 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.3 -14.33 31.03 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.645 1.178 . . . . 0.0 110.406 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.6 tp -80.16 -28.06 38.88 Favored 'General case' 0 N--CA 1.536 3.857 0 CA-C-N 118.405 0.548 . . . . 0.0 111.425 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -110.5 4.63 20.62 Favored 'General case' 1 N--CA 1.558 4.939 0 C-N-CA 122.993 0.517 . . . . 0.0 111.392 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.74 -19.85 62.69 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.037 0.535 . . . . 0.0 109.884 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 61.9 mttm 70.71 8.99 6.76 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 124.621 1.168 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.55 122.2 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.8 mp -94.05 141.74 24.06 Favored Pre-proline 0 N--CA 1.528 3.47 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 1 N--CA 1.539 4.187 0 CA-C-N 122.253 1.84 . . . . 0.0 110.603 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.575 1.918 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.93 -177.52 2.95 Favored 'Trans proline' 1 N--CA 1.538 4.119 0 C-N-CA 122.344 2.029 . . . . 0.0 110.337 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.55 170.59 27.11 Favored Glycine 1 N--CA 1.519 4.201 0 O-C-N 123.672 0.607 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -66.97 133.27 49.63 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.714 0.806 . . . . 0.0 110.374 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -166.48 -45.58 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -68.81 -34.14 75.03 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.931 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.53 -31.14 65.76 Favored Glycine 0 N--CA 1.514 3.897 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.406 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.86 -36.69 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 123.856 0.862 . . . . 0.0 110.46 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.06 -36.32 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 123.197 0.599 . . . . 0.0 109.649 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.51 -39.09 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -64.04 -41.75 97.3 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.45 -27.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-N 118.842 0.746 . . . . 0.0 111.486 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -68.54 -49.42 59.69 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.89 -38.44 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.75 68.29 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 123.038 0.535 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.41 91.67 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.155 0.582 . . . . 0.0 111.395 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.03 -43.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.723 0.809 . . . . 0.0 109.166 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -32.91 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 C-N-CA 123.953 0.901 . . . . 0.0 109.785 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -47.43 79.53 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.3 -55.86 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 19.9 m -68.35 -38.38 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.83 Favored 'General case' 0 N--CA 1.534 3.732 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.32 -34.73 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.884 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.87 -42.63 69.81 Favored 'General case' 1 N--CA 1.539 4.006 0 CA-C-N 119.559 1.072 . . . . 0.0 111.419 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 32.3 m -68.63 -31.24 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 122.066 -0.396 . . . . 0.0 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.21 -48.19 81.11 Favored 'General case' 0 N--CA 1.523 3.208 0 C-N-CA 123.203 0.601 . . . . 0.0 111.615 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.3 -29.06 63.5 Favored 'General case' 0 N--CA 1.527 3.396 0 C-N-CA 123.159 0.583 . . . . 0.0 110.709 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.68 -27.99 69.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.232 0.613 . . . . 0.0 111.556 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.2 tp -73.03 -37.54 66.87 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.65 0.78 . . . . 0.0 110.666 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.89 -27.13 22.37 Favored 'General case' 0 N--CA 1.539 3.994 0 C-N-CA 123.828 0.851 . . . . 0.0 109.861 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -88.9 13.64 12.25 Favored 'General case' 0 N--CA 1.536 3.867 0 C-N-CA 123.594 0.758 . . . . 0.0 109.92 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' C' ' 240' ' ' VAL . 63.4 tttp -132.36 -53.66 0.96 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 65.21 -19.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 125.053 1.341 . . . . 0.0 112.429 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 240' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' C' ' 238' ' ' LYS . 91.1 t -88.4 122.4 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -94.53 141.71 23.82 Favored Pre-proline 0 N--CA 1.525 3.296 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.301 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo . . . . . 1 N--CA 1.54 4.222 0 CA-C-N 122.389 1.889 . . . . 0.0 110.697 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 CA--C 1.576 1.952 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -52.17 -39.28 71.65 Favored 'Trans proline' 1 N--CA 1.548 4.725 0 CA-C-N 122.46 1.914 . . . . 0.0 113.264 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 176.88 172.27 41.32 Favored Glycine 1 N--CA 1.518 4.162 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.7 p -167.93 80.31 0.17 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.971 0.908 . . . . 0.0 108.79 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.63 -0.83 0.05 Allowed 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.432 0.693 . . . . 0.0 112.501 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.9 m -70.01 -40.23 75.38 Favored 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.477 0.711 . . . . 0.0 110.522 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.49 -29.53 74.97 Favored Glycine 1 N--CA 1.517 4.092 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.903 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.06 -36.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 123.62 0.768 . . . . 0.0 110.504 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.26 -36.64 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 C-N-CA 122.879 0.472 . . . . 0.0 110.383 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.18 -42.89 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 CA-C-O 121.802 0.811 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.99 -44.48 92.56 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.31 -33.27 53.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 CA-C-N 118.898 0.772 . . . . 0.0 112.117 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -66.82 -49.67 65.04 Favored 'General case' 0 N--CA 1.529 3.501 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.09 -37.24 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.82 -34.85 70.11 Favored 'General case' 0 N--CA 1.526 3.346 0 C-N-CA 122.664 0.386 . . . . 0.0 111.281 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.94 97.74 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 122.966 0.506 . . . . 0.0 111.727 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.05 -41.4 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.466 0 C-N-CA 123.538 0.735 . . . . 0.0 109.828 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.0 t -67.33 -32.82 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.791 0.836 . . . . 0.0 110.132 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.81 -48.05 73.02 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 18.6 tt -71.24 -44.46 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.8 m -66.86 -37.37 79.3 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.537 0 CA-C-N 120.447 1.476 . . . . 0.0 112.364 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.11 -31.84 69.29 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.62 -35.08 73.76 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.083 0.856 . . . . 0.0 111.011 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.89 -37.27 81.53 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-O 120.893 0.378 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.05 -40.66 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 C-N-CA 123.748 0.819 . . . . 0.0 109.792 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.79 -42.18 86.43 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.348 0.659 . . . . 0.0 110.472 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.63 ' HZ3' ' HE1' ' A' ' 237' ' ' TRP . 65.8 tttm -56.06 -29.39 60.44 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 124.46 1.104 . . . . 0.0 111.901 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.4 t -63.86 -22.79 67.08 Favored 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 122.914 0.485 . . . . 0.0 111.558 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -90.63 -18.18 25.59 Favored 'General case' 0 N--CA 1.534 3.733 0 C-N-CA 123.78 0.832 . . . . 0.0 109.956 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.23 -27.79 38.66 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.63 ' HE1' ' HZ3' ' A' ' 233' ' ' LYS . 92.7 m95 -89.25 13.57 13.06 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.028 0.531 . . . . 0.0 110.073 178.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -129.19 6.98 5.41 Favored 'General case' 0 N--CA 1.534 3.73 0 C-N-CA 125.007 1.323 . . . . 0.0 109.175 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.88 -31.99 70.11 Favored 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 124.098 0.959 . . . . 0.0 108.921 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.43 122.16 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.63 141.8 23.38 Favored Pre-proline 0 N--CA 1.532 3.664 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 1 N--CA 1.541 4.287 0 CA-C-N 122.296 1.856 . . . . 0.0 110.508 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 CA--C 1.57 1.712 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.14 71.19 3.64 Favored 'Trans proline' 1 N--CA 1.54 4.207 0 C-N-CA 122.1 1.867 . . . . 0.0 110.12 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.41 -150.51 51.76 Favored Glycine 1 N--CA 1.521 4.328 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -163.56 37.63 0.09 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-O 121.855 0.836 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 mt 54.7 9.07 0.25 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.207 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -43.07 98.94 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.986 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.03 60.45 Favored Glycine 1 N--CA 1.519 4.194 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.367 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.63 -45.97 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.245 0 C-N-CA 124.056 0.942 . . . . 0.0 111.255 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.24 -36.8 77.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.078 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.15 -39.52 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 123.335 0.654 . . . . 0.0 109.32 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -67.01 -44.31 80.63 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 23.5 m -57.71 -27.94 31.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 CA-C-N 118.984 0.811 . . . . 0.0 111.756 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 26.4 p -71.9 -48.58 44.56 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.329 0.651 . . . . 0.0 110.301 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 -31.81 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.306 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.56 81.56 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.409 0.683 . . . . 0.0 111.384 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.94 98.77 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 121.153 0.501 . . . . 0.0 111.499 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.08 -38.5 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 123.766 0.826 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -33.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.446 0.698 . . . . 0.0 111.394 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.58 -39.01 92.33 Favored 'General case' 0 N--CA 1.533 3.676 0 C-N-CA 122.454 0.302 . . . . 0.0 111.561 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.16 -55.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.77 -36.5 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.01 0.924 . . . . 0.0 113.237 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.39 67.72 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.35 -40.35 85.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 119.072 0.851 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -63.07 -38.97 93.3 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 122.641 0.376 . . . . 0.0 110.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.36 -39.8 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 C-N-CA 123.632 0.773 . . . . 0.0 109.703 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.81 -45.69 77.52 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.77 0.828 . . . . 0.0 110.995 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -70.49 -41.88 72.1 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.864 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 94.2 p -63.15 -27.05 69.11 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 122.834 0.454 . . . . 0.0 110.624 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -79.19 -31.16 43.74 Favored 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.7 tp -80.7 -28.23 36.77 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.07 0.548 . . . . 0.0 110.165 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -95.38 -4.71 44.8 Favored 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 123.525 0.73 . . . . 0.0 109.733 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 63.95 26.75 14.25 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 124.481 1.112 . . . . 0.0 112.418 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.3 -37.72 66.11 Favored 'General case' 0 N--CA 1.525 3.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.3 122.13 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.09 141.54 42.31 Favored Pre-proline 0 N--CA 1.527 3.387 0 CA-C-O 116.435 -1.745 . . . . 0.0 107.031 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 1 N--CA 1.55 4.82 0 CA-C-N 123.279 2.207 . . . . 0.0 114.542 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 CA--C 1.581 2.16 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.34 -23.07 22.59 Favored 'Trans proline' 1 N--CA 1.548 4.733 0 CA-C-N 122.26 1.843 . . . . 0.0 113.155 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.5 145.75 0.07 OUTLIER Glycine 1 N--CA 1.518 4.15 0 C-N-CA 123.871 0.748 . . . . 0.0 111.417 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 33.4 t -70.9 71.82 0.54 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 123.8 0.84 . . . . 0.0 110.448 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.19 -34.88 79.03 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 124.154 0.982 . . . . 0.0 110.1 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -70.91 -20.87 62.44 Favored 'General case' 0 N--CA 1.523 3.211 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.773 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.59 -50.03 16.61 Favored Glycine 0 N--CA 1.512 3.749 0 C-N-CA 124.201 0.905 . . . . 0.0 113.711 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.39 -35.65 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 CA-C-N 117.924 0.862 . . . . 0.0 111.364 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.08 -34.81 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 122.626 0.37 . . . . 0.0 110.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.23 -42.25 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.11 -40.45 97.66 Favored 'General case' 0 N--CA 1.526 3.364 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.57 -27.81 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 119.131 0.878 . . . . 0.0 111.906 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 33.8 p -69.13 -49.61 55.45 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.98 -39.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.57 -34.73 69.51 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 122.906 0.482 . . . . 0.0 111.268 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.26 99.38 Favored 'General case' 0 N--CA 1.522 3.161 0 C-N-CA 123.127 0.571 . . . . 0.0 111.604 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.16 -43.21 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.261 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.94 -32.22 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 123.883 0.873 . . . . 0.0 109.367 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -47.18 74.67 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 122.969 0.508 . . . . 0.0 109.824 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.76 -51.41 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.44 0.696 . . . . 0.0 110.404 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.44 -37.9 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.803 0.841 . . . . 0.0 112.748 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.09 82.85 Favored 'General case' 0 N--CA 1.539 3.977 0 CA-C-N 118.542 0.61 . . . . 0.0 112.186 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.17 -33.68 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.349 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.21 -43.18 99.41 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 123.246 0.618 . . . . 0.0 110.517 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.69 -34.75 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 C-N-CA 123.103 0.561 . . . . 0.0 109.674 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.15 -27.68 69.25 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.259 0.624 . . . . 0.0 111.233 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -62.0 -30.72 71.13 Favored 'General case' 0 N--CA 1.531 3.605 0 C-N-CA 123.527 0.731 . . . . 0.0 110.922 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.35 -24.96 68.08 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.09 0.556 . . . . 0.0 110.946 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.3 mt -91.32 -23.66 20.05 Favored 'General case' 0 N--CA 1.52 3.042 0 C-N-CA 124.218 1.007 . . . . 0.0 110.737 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -28.68 27.43 Favored 'General case' 1 N--CA 1.544 4.27 0 C-N-CA 123.115 0.566 . . . . 0.0 112.258 -176.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.09 14.37 17.05 Favored 'General case' 1 N--CA 1.553 4.691 0 C-N-CA 124.074 0.949 . . . . 0.0 111.747 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -52.5 -23.14 5.69 Favored 'General case' 0 N--CA 1.531 3.617 0 C-N-CA 124.439 1.096 . . . . 0.0 111.107 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -71.29 -35.28 71.25 Favored 'General case' 0 N--CA 1.513 2.678 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.5 122.07 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.512 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.56 114.32 59.1 Favored Pre-proline 0 N--CA 1.532 3.627 0 CA-C-O 116.599 -1.667 . . . . 0.0 107.104 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo . . . . . 1 N--CA 1.547 4.662 0 CA-C-N 123.028 2.117 . . . . 0.0 114.168 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 75.4 mmm . . . . . 0 CA--C 1.573 1.854 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.05 -171.07 0.8 Allowed 'Trans proline' 1 N--CA 1.539 4.168 0 C-N-CA 122.146 1.897 . . . . 0.0 110.006 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.42 159.47 29.47 Favored Glycine 1 N--CA 1.518 4.101 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 90.9 p -169.56 58.51 0.05 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.51 -9.91 0.55 Allowed 'General case' 0 N--CA 1.533 3.676 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.16 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -60.88 -20.35 61.74 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 121.254 0.549 . . . . 0.0 110.758 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.04 97.73 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.729 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.78 -36.03 63.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.127 0 CA-C-N 117.885 0.843 . . . . 0.0 111.679 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.58 -37.58 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.21 0.604 . . . . 0.0 109.708 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.05 -41.06 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -59.61 -48.47 81.52 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 124.5 1.12 . . . . 0.0 114.015 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.8 m -59.7 -32.36 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.914 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -72.15 -48.99 39.49 Favored 'General case' 0 N--CA 1.533 3.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.859 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.62 -32.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.696 0.398 . . . . 0.0 110.044 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.97 74.01 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.235 0.614 . . . . 0.0 111.332 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.44 77.49 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.396 0.278 . . . . 0.0 111.571 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.06 -43.62 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.512 0.725 . . . . 0.0 112.084 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.09 -32.86 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 CA-C-N 118.919 0.781 . . . . 0.0 111.931 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.1 mt -60.65 -36.92 79.87 Favored 'General case' 0 N--CA 1.537 3.898 0 CA-C-N 117.97 0.35 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.08 -47.72 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-O 121.489 0.662 . . . . 0.0 109.332 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.3 t -67.0 -37.73 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.263 0 C-N-CA 124.202 1.001 . . . . 0.0 111.606 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.11 90.25 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.94 -34.5 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 122.777 0.431 . . . . 0.0 109.943 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.81 -42.45 73.67 Favored 'General case' 1 N--CA 1.544 4.273 0 CA-C-N 118.875 0.762 . . . . 0.0 109.564 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.1 -31.66 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.13 -46.26 84.92 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.299 0.64 . . . . 0.0 111.472 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -69.0 -38.11 79.1 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.408 0.683 . . . . 0.0 110.772 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.6 p -63.77 -34.92 78.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 123.206 0.602 . . . . 0.0 110.668 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.78 -37.21 70.48 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 124.091 0.956 . . . . 0.0 109.731 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 59.1 tp -80.26 -27.03 38.7 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.925 0.89 . . . . 0.0 110.397 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -89.27 -1.16 57.96 Favored 'General case' 0 N--CA 1.535 3.818 0 C-N-CA 123.422 0.689 . . . . 0.0 110.549 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -81.4 -29.57 33.91 Favored 'General case' 0 N--CA 1.527 3.392 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -68.15 -40.17 82.44 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.306 1.042 . . . . 0.0 109.967 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.5 122.48 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.32 141.86 23.67 Favored Pre-proline 0 N--CA 1.53 3.54 0 C-N-CA 125.169 1.388 . . . . 0.0 107.284 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 1 N--CA 1.541 4.285 0 CA-C-N 122.235 1.834 . . . . 0.0 110.669 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 CA--C 1.583 2.239 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.86 -29.12 33.53 Favored 'Trans proline' 1 N--CA 1.548 4.703 0 CA-C-N 122.337 1.87 . . . . 0.0 113.515 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.68 53.82 29.2 Favored Glycine 1 N--CA 1.519 4.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 45.4 m 59.06 121.99 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 124.658 1.183 . . . . 0.0 112.006 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -165.39 -49.13 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.7 p -68.21 -34.76 76.85 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.857 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.55 -30.27 62.42 Favored Glycine 0 N--CA 1.515 3.917 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.01 -36.83 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.662 0.785 . . . . 0.0 110.662 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.02 -37.82 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 C-N-CA 123.068 0.547 . . . . 0.0 109.605 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.9 -37.89 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -62.7 -46.41 88.26 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.95 -38.86 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 118.583 0.629 . . . . 0.0 112.074 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -64.46 -48.96 73.3 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.72 -37.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.32 80.54 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.57 0.348 . . . . 0.0 111.097 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.39 70.85 Favored 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.86 -38.61 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 O-C-N 122.121 -0.362 . . . . 0.0 110.416 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.2 t -64.83 -32.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 123.495 0.718 . . . . 0.0 110.016 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.44 -36.91 76.81 Favored 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 122.615 0.366 . . . . 0.0 110.28 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.4 -52.28 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 123.327 0.651 . . . . 0.0 109.435 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.28 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 C-N-CA 124.322 1.049 . . . . 0.0 112.85 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.77 83.42 Favored 'General case' 0 N--CA 1.537 3.916 0 CA-C-N 118.607 0.64 . . . . 0.0 112.338 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -69.33 -33.83 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 C-N-CA 123.497 0.719 . . . . 0.0 109.091 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.56 -42.67 99.18 Favored 'General case' 0 N--CA 1.537 3.892 0 C-N-CA 123.498 0.719 . . . . 0.0 111.33 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.09 -31.76 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.126 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.22 -46.51 80.37 Favored 'General case' 0 N--CA 1.529 3.503 0 CA-C-O 120.776 0.322 . . . . 0.0 111.005 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.66 -25.21 59.04 Favored 'General case' 0 N--CA 1.525 3.308 0 C-N-CA 123.547 0.739 . . . . 0.0 111.021 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 60.5 p -65.17 -33.57 76.33 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.654 0.382 . . . . 0.0 111.065 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 66.5 mt -90.78 -21.1 21.69 Favored 'General case' 0 N--CA 1.531 3.598 0 C-N-CA 124.122 0.969 . . . . 0.0 111.0 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -22.75 40.51 Favored 'General case' 1 N--CA 1.543 4.213 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -88.91 -4.04 58.57 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.79 0.836 . . . . 0.0 110.262 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -76.55 -11.85 59.93 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 72.33 -7.87 1.28 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 124.676 1.19 . . . . 0.0 110.976 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.13 131.48 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.47 114.48 63.49 Favored Pre-proline 0 N--CA 1.525 3.294 0 CA-C-O 116.706 -1.616 . . . . 0.0 107.882 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 1 N--CA 1.548 4.715 0 C-N-CA 122.643 2.229 . . . . 0.0 114.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 CA--C 1.574 1.88 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.32 172.85 12.41 Favored 'Trans proline' 1 N--CA 1.54 4.256 0 C-N-CA 122.344 2.03 . . . . 0.0 110.518 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.9 163.87 31.33 Favored Glycine 1 N--CA 1.517 4.071 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.8 m 56.92 174.18 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 C-N-CA 124.256 1.023 . . . . 0.0 112.208 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt 76.23 -33.56 0.22 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 124.415 1.086 . . . . 0.0 109.566 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 88.2 p -66.63 -39.55 88.33 Favored 'General case' 0 N--CA 1.528 3.438 0 C-N-CA 123.289 0.636 . . . . 0.0 109.931 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.44 -32.79 82.33 Favored Glycine 1 N--CA 1.519 4.201 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.366 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.57 -36.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.73 -34.24 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 C-N-CA 123.713 0.805 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.48 -43.68 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 CA-C-O 121.774 0.797 . . . . 0.0 109.337 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -67.18 -43.51 82.03 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.62 -36.65 55.05 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.288 0 CA-C-N 118.934 0.788 . . . . 0.0 111.47 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -65.95 -48.46 71.26 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.435 0.694 . . . . 0.0 111.149 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.97 -34.76 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.524 0.73 . . . . 0.0 109.826 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.85 75.62 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.04 74.49 Favored 'General case' 0 N--CA 1.519 3.007 0 C-N-CA 122.511 0.324 . . . . 0.0 111.555 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.87 -44.89 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.164 0.586 . . . . 0.0 111.939 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -65.98 -32.85 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 CA-C-N 118.648 0.658 . . . . 0.0 110.834 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.88 -43.19 98.79 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.125 0.57 . . . . 0.0 111.181 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.33 -52.94 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.252 0.621 . . . . 0.0 110.156 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.48 -37.16 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 124.759 1.224 . . . . 0.0 113.726 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.12 -35.86 72.09 Favored 'General case' 0 N--CA 1.537 3.88 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.88 -34.88 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.972 0.806 . . . . 0.0 110.526 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -69.38 -42.3 75.35 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.22 -42.44 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 73.0 m -67.18 -48.07 69.05 Favored 'General case' 0 N--CA 1.528 3.453 0 CA-C-O 121.448 0.642 . . . . 0.0 110.542 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -67.69 -43.08 80.99 Favored 'General case' 0 N--CA 1.523 3.215 0 C-N-CA 124.256 1.022 . . . . 0.0 111.248 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 42.6 t -63.89 -26.26 68.52 Favored 'General case' 0 N--CA 1.53 3.549 0 CA-C-O 121.267 0.556 . . . . 0.0 110.221 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.9 tp -91.2 -14.83 30.31 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 125.016 1.326 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.0 -28.41 39.44 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.637 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -17.91 27.78 Favored 'General case' 1 N--CA 1.559 5.006 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 58.56 26.51 14.47 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.969 0.907 . . . . 0.0 111.473 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt 82.44 9.77 0.72 Allowed 'General case' 0 N--CA 1.532 3.63 0 C-N-CA 124.689 1.195 . . . . 0.0 111.213 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.36 130.3 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.908 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.65 134.59 26.24 Favored Pre-proline 0 N--CA 1.527 3.407 0 CA-C-O 116.779 -1.581 . . . . 0.0 108.482 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 1 N--CA 1.539 4.169 0 CA-C-N 122.999 2.107 . . . . 0.0 110.823 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.572 1.806 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.85 163.66 37.77 Favored 'Trans proline' 1 N--CA 1.539 4.163 0 C-N-CA 122.176 1.918 . . . . 0.0 110.049 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.96 154.85 53.51 Favored Glycine 1 N--CA 1.518 4.15 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.3 t -73.97 127.5 33.06 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 123.675 0.79 . . . . 0.0 110.21 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tp 65.31 -0.37 1.15 Allowed 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.952 0.901 . . . . 0.0 111.723 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -70.42 -23.1 62.68 Favored 'General case' 0 N--CA 1.524 3.24 0 C-N-CA 123.307 0.643 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.99 -50.29 8.79 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.491 0.567 . . . . 0.0 113.893 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.74 -36.92 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -59.24 -33.22 50.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 118.57 0.623 . . . . 0.0 111.022 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.65 -43.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.32 -34.73 77.96 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.48 -36.95 55.33 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.511 0 CA-C-N 119.906 1.23 . . . . 0.0 111.562 -175.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.1 p -67.1 -48.58 67.74 Favored 'General case' 0 N--CA 1.525 3.312 0 C-N-CA 123.547 0.739 . . . . 0.0 110.358 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.42 -31.87 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.92 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.94 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.115 0.566 . . . . 0.0 111.378 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.35 72.97 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 122.879 0.472 . . . . 0.0 111.689 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.95 -46.2 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.42 0 C-N-CA 123.377 0.671 . . . . 0.0 111.892 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.47 -32.42 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 CA-C-N 118.057 0.39 . . . . 0.0 111.074 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.02 -47.68 61.13 Favored 'General case' 0 N--CA 1.525 3.289 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.65 -41.53 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.7 -47.91 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.6 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.42 89.26 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.13 -37.61 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.612 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -34.09 65.56 Favored 'General case' 1 N--CA 1.549 4.512 0 CA-C-N 120.371 1.441 . . . . 0.0 109.991 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.78 -33.51 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.18 -33.15 74.87 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.77 27.66 Favored 'General case' 1 N--CA 1.541 4.105 0 CA-C-N 118.968 0.804 . . . . 0.0 110.443 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 33.7 t -63.03 -43.36 98.91 Favored 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -86.88 -14.67 41.3 Favored 'General case' 1 N--CA 1.549 4.515 0 CA-C-N 118.229 0.468 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.56 -28.63 37.19 Favored 'General case' 0 N--CA 1.538 3.964 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -114.34 -5.69 12.93 Favored 'General case' 1 N--CA 1.542 4.129 0 C-N-CA 124.515 1.126 . . . . 0.0 109.999 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 62.81 40.62 9.64 Favored 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 125.044 1.338 . . . . 0.0 112.314 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 65.18 3.18 2.11 Favored 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 122.75 64.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.6 mt -96.37 141.86 23.73 Favored Pre-proline 0 N--CA 1.525 3.279 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.83 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 1 N--CA 1.54 4.261 0 CA-C-N 122.4 1.893 . . . . 0.0 110.716 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 CA--C 1.585 2.315 0 CA-C-O 117.517 -1.23 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -88.24 74.54 2.07 Favored 'Trans proline' 0 N--CA 1.534 3.889 0 C-N-CA 122.642 2.228 . . . . 0.0 110.777 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.15 -176.81 44.66 Favored Glycine 1 N--CA 1.519 4.175 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -166.73 76.75 0.19 Allowed 'General case' 0 N--CA 1.521 3.088 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.94 -39.75 93.18 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 124.371 1.068 . . . . 0.0 110.222 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.5 m -58.91 -22.1 58.98 Favored 'General case' 0 N--CA 1.527 3.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.241 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.57 -40.92 31.02 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.718 0.675 . . . . 0.0 111.432 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.51 -43.63 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 124.583 1.153 . . . . 0.0 112.311 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.25 -33.71 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 C-N-CA 122.753 0.421 . . . . 0.0 111.002 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.4 -41.01 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.93 -45.49 89.01 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.69 -30.88 38.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.943 0.792 . . . . 0.0 111.782 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 29.6 p -69.69 -48.64 58.97 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.377 0.671 . . . . 0.0 110.606 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.87 -32.26 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.595 0.758 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.52 78.83 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.323 0.649 . . . . 0.0 111.817 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.37 71.66 Favored 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 122.854 0.461 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.37 -44.0 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.377 0.671 . . . . 0.0 111.591 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.88 -32.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.529 -0.732 . . . . 0.0 110.427 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.23 -47.58 76.33 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.86 -43.18 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.93 -37.4 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.117 0.872 . . . . 0.0 112.738 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.66 68.38 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -66.38 -34.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.984 0.811 . . . . 0.0 110.864 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -66.6 -33.8 76.47 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 122.682 0.393 . . . . 0.0 110.513 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.37 -42.56 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 123.25 0.62 . . . . 0.0 109.717 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.8 t -65.46 -45.61 83.08 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.489 0.716 . . . . 0.0 111.085 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.05 -47.03 60.82 Favored 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.68 0.792 . . . . 0.0 110.896 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 97.9 p -63.67 -13.68 45.04 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.846 0.458 . . . . 0.0 111.879 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.34 -34.68 15.6 Favored 'General case' 0 N--CA 1.531 3.58 0 C-N-CA 123.928 0.891 . . . . 0.0 110.512 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 53.4 tp -92.81 -27.41 17.18 Favored 'General case' 1 N--CA 1.539 4.019 0 C-N-CA 123.991 0.916 . . . . 0.0 112.296 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -99.45 13.22 34.07 Favored 'General case' 0 N--CA 1.537 3.882 0 C-N-CA 124.205 1.002 . . . . 0.0 111.043 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.42 -0.77 8.95 Favored 'General case' 0 N--CA 1.534 3.743 0 C-N-CA 122.604 0.361 . . . . 0.0 110.476 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 65.14 12.82 8.28 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 124.674 1.19 . . . . 0.0 112.902 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.68 122.77 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 44.3 mt -118.36 141.69 30.06 Favored Pre-proline 0 N--CA 1.531 3.621 0 CA-C-O 117.075 -1.44 . . . . 0.0 108.14 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 1 N--CA 1.539 4.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.784 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.574 1.874 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.71 -177.16 3.65 Favored 'Trans proline' 0 N--CA 1.533 3.845 0 C-N-CA 122.516 2.144 . . . . 0.0 110.474 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.25 173.82 6.53 Favored Glycine 1 N--CA 1.517 4.09 0 O-C-N 123.852 0.72 . . . . 0.0 111.924 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 95.2 p -169.12 179.69 3.92 Favored 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.255 1.022 . . . . 0.0 108.829 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.24 -40.47 97.52 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.7 p -61.5 -21.96 64.68 Favored 'General case' 0 N--CA 1.53 3.539 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.91 86.59 Favored Glycine 0 N--CA 1.509 3.528 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.782 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.58 71.46 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.082 0 CA-C-O 121.224 0.535 . . . . 0.0 109.651 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.55 -35.75 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 C-N-CA 123.07 0.548 . . . . 0.0 109.589 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 29.7 mm -69.99 -38.82 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -63.57 -45.55 89.94 Favored 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.94 -29.7 36.63 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.252 0 CA-C-N 118.929 0.786 . . . . 0.0 111.484 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 21.2 p -68.77 -48.71 63.01 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.2 0.6 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.41 -36.18 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.443 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.49 -37.56 74.22 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.762 0.425 . . . . 0.0 110.943 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.44 -45.52 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.366 0 C-N-CA 123.461 0.704 . . . . 0.0 111.5 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.29 -33.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 121.371 -0.831 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.83 -47.55 80.36 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 123.229 0.612 . . . . 0.0 112.402 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 7.9 tp -70.65 -38.86 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.78 -36.02 76.19 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 C-N-CA 124.022 0.929 . . . . 0.0 111.341 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.53 74.68 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 13.3 m -72.49 -35.8 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 CA-C-N 118.427 0.558 . . . . 0.0 111.761 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -70.98 -42.34 69.82 Favored 'General case' 0 N--CA 1.533 3.681 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.17 -35.93 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 CA-C-N 118.287 0.494 . . . . 0.0 110.985 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.6 m -66.6 -36.52 82.81 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-O 121.215 0.531 . . . . 0.0 109.929 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.26 -46.28 67.64 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.939 0.896 . . . . 0.0 109.908 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.6 t -67.02 -42.51 84.78 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.703 0.801 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.85 -36.96 81.24 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 124.305 1.042 . . . . 0.0 110.784 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.83 -27.83 40.17 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 122.832 0.453 . . . . 0.0 109.964 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -91.56 -17.66 25.28 Favored 'General case' 0 N--CA 1.536 3.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 65.6 pttt 33.7 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 126.843 2.057 . . . . 0.0 113.673 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 70.52 -7.37 1.04 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.172 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 91.8 t -92.07 123.32 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 47.5 mt -117.59 114.39 37.98 Favored Pre-proline 0 N--CA 1.526 3.33 0 CA-C-O 116.799 -1.572 . . . . 0.0 108.543 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo . . . . . 1 N--CA 1.548 4.713 0 CA-C-N 123.015 2.112 . . . . 0.0 114.161 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.571 1.775 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.66 -176.37 2.76 Favored 'Trans proline' 1 N--CA 1.537 4.048 0 C-N-CA 122.188 1.925 . . . . 0.0 110.096 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.64 -23.0 72.07 Favored Glycine 1 N--CA 1.521 4.33 0 O-C-N 123.712 0.633 . . . . 0.0 111.983 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.6 p 58.19 167.12 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 124.693 1.197 . . . . 0.0 112.426 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.2 mt -81.43 19.9 0.94 Allowed 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 124.162 0.985 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -63.06 -38.93 93.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.453 0.701 . . . . 0.0 111.276 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.61 -36.49 48.55 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.24 -47.75 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.299 1.04 . . . . 0.0 110.997 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.47 -34.54 70.17 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.993 0.361 . . . . 0.0 110.792 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.5 -48.16 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.32 -38.57 85.12 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.79 -36.89 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.43 0 CA-C-N 119.645 1.111 . . . . 0.0 111.339 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.0 p -66.9 -48.41 68.81 Favored 'General case' 0 N--CA 1.524 3.235 0 C-N-CA 123.665 0.786 . . . . 0.0 110.714 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.68 -31.68 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 C-N-CA 123.918 0.887 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.42 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.034 0.533 . . . . 0.0 111.147 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.04 68.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 122.929 0.492 . . . . 0.0 111.947 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.84 -44.05 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.548 0.739 . . . . 0.0 111.981 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.57 -32.56 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 CA-C-N 118.323 0.511 . . . . 0.0 110.766 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.81 -34.93 76.8 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.22 0.608 . . . . 0.0 112.513 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -69.82 -54.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 118.075 0.398 . . . . 0.0 111.326 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.15 -36.59 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.84 66.91 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.1 -34.85 73.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.075 0 CA-C-N 119.306 0.957 . . . . 0.0 110.816 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.69 -36.64 76.14 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 122.958 0.503 . . . . 0.0 110.021 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 80.9 t -67.35 -44.54 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.516 0.727 . . . . 0.0 109.444 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 86.3 m -61.74 -41.95 98.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.327 0.651 . . . . 0.0 110.746 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -68.11 -39.93 82.68 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.933 0.893 . . . . 0.0 109.911 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -64.97 -40.11 94.5 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.444 0.697 . . . . 0.0 110.393 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -37.2 82.63 Favored 'General case' 0 N--CA 1.533 3.717 0 C-N-CA 124.309 1.044 . . . . 0.0 110.068 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.4 tp -80.09 -27.66 39.22 Favored 'General case' 0 N--CA 1.53 3.56 0 C-N-CA 123.061 0.544 . . . . 0.0 110.248 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -90.26 -1.73 57.95 Favored 'General case' 0 N--CA 1.538 3.975 0 C-N-CA 123.656 0.783 . . . . 0.0 109.712 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -70.33 -5.07 25.39 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 123.388 0.675 . . . . 0.0 110.134 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp 71.72 -8.68 1.05 Allowed 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 125.027 1.331 . . . . 0.0 111.021 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.05 122.61 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 142.39 45.4 Favored Pre-proline 0 N--CA 1.526 3.343 0 C-N-CA 125.282 1.433 . . . . 0.0 108.115 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 1 N--CA 1.54 4.262 0 CA-C-N 122.175 1.813 . . . . 0.0 110.457 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.689 -1.148 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.84 146.6 48.31 Favored 'Trans proline' 1 N--CA 1.541 4.269 0 C-N-CA 122.035 1.823 . . . . 0.0 110.339 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.19 -41.63 0.21 Allowed Glycine 1 N--CA 1.516 4.004 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.4 p -70.43 -171.55 0.5 Allowed 'General case' 0 N--CA 1.52 3.069 0 C-N-CA 124.297 1.039 . . . . 0.0 110.429 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 82.7 -36.98 0.09 Allowed 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.307 1.443 . . . . 0.0 109.089 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 99.4 p -70.23 -33.41 71.63 Favored 'General case' 0 N--CA 1.526 3.359 0 CA-C-O 121.326 0.584 . . . . 0.0 109.821 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.97 -45.55 20.18 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.416 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -38.66 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.845 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -69.04 -34.78 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.709 -0.619 . . . . 0.0 110.975 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.25 -39.71 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -58.39 -49.08 78.52 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.8 -33.68 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -70.06 -49.17 53.78 Favored 'General case' 0 N--CA 1.529 3.502 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.18 -33.19 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 122.671 0.388 . . . . 0.0 110.372 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.32 78.08 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.09 0.556 . . . . 0.0 111.001 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.42 80.18 Favored 'General case' 0 N--CA 1.52 3.066 0 C-N-CA 122.777 0.431 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.22 -50.65 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 123.04 0.536 . . . . 0.0 111.09 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 m -62.88 -32.27 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 O-C-N 121.926 -0.484 . . . . 0.0 110.792 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.45 -43.02 88.67 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.334 0.654 . . . . 0.0 111.465 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -70.21 -48.01 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.24 -37.75 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 124.118 0.967 . . . . 0.0 112.584 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.539 3.994 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.86 -33.98 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.93 -43.34 93.07 Favored 'General case' 0 N--CA 1.535 3.789 0 C-N-CA 123.188 0.595 . . . . 0.0 112.532 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.9 -30.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 O-C-N 122.263 -0.273 . . . . 0.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 36.9 t -58.63 -46.0 88.04 Favored 'General case' 0 N--CA 1.526 3.337 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -74.09 -32.5 63.27 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 118.225 0.466 . . . . 0.0 111.187 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 83.4 p -63.22 -23.78 67.58 Favored 'General case' 0 N--CA 1.53 3.562 0 C-N-CA 122.717 0.407 . . . . 0.0 111.132 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.85 -23.13 22.87 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.886 0.874 . . . . 0.0 109.917 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.6 tp -80.61 -28.19 37.09 Favored 'General case' 0 N--CA 1.534 3.766 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -92.81 -3.02 55.42 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.523 0.729 . . . . 0.0 110.176 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -79.8 -20.26 46.58 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.118 0.567 . . . . 0.0 109.7 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 48.9 tttp 68.06 34.1 4.23 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 124.321 1.048 . . . . 0.0 110.617 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.401 ' C ' HD22 ' B' ' 241' ' ' LEU . 9.4 p -95.41 122.61 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.401 HD22 ' C ' ' B' ' 240' ' ' VAL . 2.5 mm? -119.9 141.53 31.52 Favored Pre-proline 0 N--CA 1.531 3.591 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 1 N--CA 1.539 4.192 0 CA-C-N 122.531 1.94 . . . . 0.0 110.697 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 CA--C 1.586 2.33 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -85.78 177.02 5.05 Favored 'Trans proline' 0 N--CA 1.535 3.963 0 C-N-CA 122.447 2.098 . . . . 0.0 111.088 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.78 82.59 0.05 OUTLIER Glycine 1 N--CA 1.517 4.091 0 C-N-CA 123.813 0.721 . . . . 0.0 112.281 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 93.0 p -67.61 105.92 2.02 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.843 0.857 . . . . 0.0 109.995 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 80.9 mt -77.12 1.58 17.74 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.587 0.755 . . . . 0.0 110.754 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 89.3 p -70.66 -30.9 67.63 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.203 0.601 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.01 9.86 Favored Glycine 1 N--CA 1.516 4.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.167 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 214' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 214' ' ' ILE . 0.2 OUTLIER -63.38 -42.08 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 C-N-CA 123.345 0.658 . . . . 0.0 111.759 -176.562 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.96 -34.88 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.874 -0.516 . . . . 0.0 111.746 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.34 -43.95 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.74 -43.55 83.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.5 -38.48 63.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.132 0 CA-C-N 118.886 0.766 . . . . 0.0 111.987 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 31.3 p -66.08 -48.05 72.25 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.406 0.682 . . . . 0.0 111.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.1 -33.36 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 C-N-CA 123.638 0.775 . . . . 0.0 109.683 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.72 -34.61 76.09 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.73 73.99 Favored 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 122.603 0.361 . . . . 0.0 111.537 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.47 -44.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.332 0.653 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.13 -32.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 CA-C-N 118.61 0.641 . . . . 0.0 110.857 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.87 -42.12 93.04 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.216 0.606 . . . . 0.0 111.511 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 63.0 mt -70.14 -48.79 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.35 -36.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 124.972 1.309 . . . . 0.0 113.091 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.73 67.03 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.83 -36.79 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.918 0.781 . . . . 0.0 110.24 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -70.61 -42.25 71.21 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.977 0.511 . . . . 0.0 109.887 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.07 -35.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.24 -38.83 85.83 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 123.362 0.665 . . . . 0.0 110.323 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.99 -24.05 67.57 Favored 'General case' 0 N--CA 1.531 3.577 0 C-N-CA 124.954 1.301 . . . . 0.0 111.902 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 66.1 p -63.83 -28.76 70.08 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 36.9 mt -71.78 -27.95 63.3 Favored 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 124.118 0.967 . . . . 0.0 110.284 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.95 -18.76 36.2 Favored 'General case' 0 N--CA 1.533 3.717 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -89.02 -17.46 29.34 Favored 'General case' 1 N--CA 1.544 4.24 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.726 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -87.4 -22.92 24.73 Favored 'General case' 1 N--CA 1.547 4.384 0 CA-C-N 119.754 1.161 . . . . 0.0 109.808 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -69.41 -44.36 71.57 Favored 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.62 129.01 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.03 141.42 23.64 Favored Pre-proline 0 N--CA 1.527 3.393 0 CA-C-O 116.304 -1.808 . . . . 0.0 107.243 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 1 N--CA 1.549 4.735 0 C-N-CA 122.722 2.282 . . . . 0.0 114.74 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 CA--C 1.577 2.014 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.48 -29.83 19.83 Favored 'Trans proline' 1 N--CA 1.541 4.299 0 C-N-CA 122.28 1.987 . . . . 0.0 110.475 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.19 -178.47 23.81 Favored Glycine 1 N--CA 1.518 4.157 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.463 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 92.0 p -67.21 175.64 2.56 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.835 0.854 . . . . 0.0 110.42 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -163.08 -48.31 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 96.8 p -66.18 -34.16 77.4 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.335 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.94 -29.86 62.26 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.437 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.03 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.702 0.801 . . . . 0.0 110.499 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.19 -38.39 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.288 0.635 . . . . 0.0 109.93 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.16 -39.1 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -67.02 -46.71 73.65 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.06 -35.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.947 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.1 p -66.5 -49.49 66.39 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.84 -32.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.35 78.28 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 122.531 0.333 . . . . 0.0 111.665 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.49 73.98 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 122.628 0.371 . . . . 0.0 111.818 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.9 t -69.96 -43.46 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.324 0.649 . . . . 0.0 111.722 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.27 -32.6 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.581 0.628 . . . . 0.0 110.547 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.18 -34.63 72.35 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.19 -55.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 CA-C-N 117.868 0.304 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.87 -37.14 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.45 81.47 Favored 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.19 -34.78 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.453 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.397 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -69.56 -42.5 74.49 Favored 'General case' 1 N--CA 1.539 4.021 0 CA-C-N 119.407 1.003 . . . . 0.0 111.345 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.7 -31.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 O-C-N 121.981 -0.449 . . . . 0.0 110.303 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.96 -37.27 81.84 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.523 0.729 . . . . 0.0 111.696 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -82.84 -25.19 32.85 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.428 0.691 . . . . 0.0 110.449 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 m -68.02 -43.41 78.87 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.058 0.543 . . . . 0.0 111.828 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.1 -24.5 47.53 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.791 0.437 . . . . 0.0 111.143 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 57.9 tp -80.52 -27.83 37.54 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -89.91 -13.0 37.24 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 123.858 0.863 . . . . 0.0 110.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -73.03 -36.65 67.0 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 124.01 0.924 . . . . 0.0 109.432 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.5 -47.55 69.68 Favored 'General case' 0 N--CA 1.521 3.091 0 C-N-CA 123.998 0.919 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.54 122.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 124.23 1.012 . . . . 0.0 108.655 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.26 141.59 42.4 Favored Pre-proline 0 N--CA 1.526 3.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 1 N--CA 1.539 4.193 0 CA-C-N 122.603 1.965 . . . . 0.0 110.676 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.585 2.319 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -88.93 4.5 5.35 Favored 'Trans proline' 1 N--CA 1.536 4.025 0 C-N-CA 122.644 2.229 . . . . 0.0 111.87 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.98 -102.9 0.97 Allowed Glycine 1 N--CA 1.518 4.157 0 C-N-CA 123.685 0.659 . . . . 0.0 111.676 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 38.7 t -167.21 -179.18 4.42 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.776 0.831 . . . . 0.0 109.937 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.27 23.74 0.63 Allowed 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.993 0.917 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 67.5 m -69.12 -26.36 64.87 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 123.584 0.754 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.84 -50.12 9.39 Favored Glycine 0 N--CA 1.516 3.971 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.271 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.87 -36.71 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 122.984 0.514 . . . . 0.0 112.112 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 36.6 pt -62.9 -33.75 62.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 CA-C-N 119.185 0.902 . . . . 0.0 110.852 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 84.3 mt -69.67 -39.25 77.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -66.14 -43.34 87.35 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.84 -28.18 32.4 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.37 0.986 . . . . 0.0 111.345 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 19.4 p -66.3 -48.52 70.1 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 123.509 0.723 . . . . 0.0 111.063 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -39.47 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 C-N-CA 123.694 0.797 . . . . 0.0 109.186 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.49 71.6 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.664 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.9 -33.21 75.31 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 122.712 0.405 . . . . 0.0 111.373 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.02 -48.54 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.334 0 C-N-CA 123.139 0.576 . . . . 0.0 111.102 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.55 -32.38 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 O-C-N 121.577 -0.702 . . . . 0.0 110.377 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.65 -47.78 83.28 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 123.424 0.689 . . . . 0.0 112.471 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -70.75 -37.48 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.879 0 CA-C-N 118.302 0.501 . . . . 0.0 110.085 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.92 -37.57 79.67 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 C-N-CA 123.155 0.582 . . . . 0.0 111.084 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.93 68.19 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.39 -37.08 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-N 118.893 0.769 . . . . 0.0 110.405 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -70.28 -42.08 72.56 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 122.739 0.416 . . . . 0.0 109.934 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.7 -42.63 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.26 -28.65 68.22 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 123.025 0.53 . . . . 0.0 111.062 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -68.18 -35.72 78.48 Favored 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 123.584 0.754 . . . . 0.0 110.617 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.7 m -63.59 -23.29 67.32 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.166 0.587 . . . . 0.0 109.828 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.6 -33.32 68.91 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.549 1.139 . . . . 0.0 108.299 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.25 -26.76 38.86 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 123.613 0.765 . . . . 0.0 110.149 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -88.64 13.17 12.83 Favored 'General case' 1 N--CA 1.547 4.395 0 C-N-CA 122.778 0.431 . . . . 0.0 110.072 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -136.74 -56.9 0.73 Allowed 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 71.25 -2.74 2.28 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 124.649 1.179 . . . . 0.0 110.459 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 99.2 t -98.77 122.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.05 141.69 23.99 Favored Pre-proline 0 N--CA 1.525 3.295 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 1 N--CA 1.54 4.264 0 CA-C-N 122.291 1.854 . . . . 0.0 110.699 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.57 1.735 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.66 -19.51 31.77 Favored 'Trans proline' 1 N--CA 1.541 4.271 0 C-N-CA 122.109 1.873 . . . . 0.0 110.801 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.55 -178.28 7.01 Favored Glycine 1 N--CA 1.518 4.161 0 C-N-CA 123.737 0.684 . . . . 0.0 112.39 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 46.0 t -168.44 176.16 5.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 124.001 0.92 . . . . 0.0 109.585 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.37 46.48 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.741 0.816 . . . . 0.0 109.474 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 36.4 t -69.62 -24.93 63.72 Favored 'General case' 0 N--CA 1.524 3.251 0 O-C-N 121.532 -0.73 . . . . 0.0 110.007 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.32 -46.19 57.88 Favored Glycine 0 N--CA 1.511 3.669 0 C-N-CA 124.513 1.054 . . . . 0.0 114.242 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 13.6 tt -59.14 -36.36 62.37 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.303 0 CA-C-N 118.233 1.016 . . . . 0.0 111.03 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.83 -34.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.391 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 216' ' ' ILE . 1.6 mp -70.22 -41.8 78.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-N 119.175 0.898 . . . . 0.0 108.73 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.54 -45.27 94.49 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.6 -37.26 78.47 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.658 0.663 . . . . 0.0 112.025 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 73.0 p -65.41 -48.85 71.39 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 123.201 0.6 . . . . 0.0 112.512 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.45 -32.09 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.26 80.32 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 122.766 0.426 . . . . 0.0 111.792 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.43 55.17 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.66 -38.37 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.23 -32.29 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.994 -0.441 . . . . 0.0 110.536 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.1 -34.88 75.65 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 122.966 0.506 . . . . 0.0 111.557 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.49 -54.78 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 122.899 0.479 . . . . 0.0 111.475 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.04 -35.86 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.853 0 C-N-CA 124.236 1.015 . . . . 0.0 112.893 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.36 66.19 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.47 -34.51 66.0 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.502 1.047 . . . . 0.0 110.487 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.83 -26.22 66.81 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 122.836 0.454 . . . . 0.0 110.871 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -37.74 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.83 -40.44 88.0 Favored 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 123.487 0.715 . . . . 0.0 109.577 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.38 -40.39 85.69 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 124.219 1.008 . . . . 0.0 109.782 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -64.59 -29.15 70.17 Favored 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 123.553 0.741 . . . . 0.0 111.588 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.6 tp -91.41 -23.75 19.95 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 124.502 1.121 . . . . 0.0 111.293 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.31 -27.89 38.33 Favored 'General case' 0 N--CA 1.536 3.84 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.981 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -113.6 13.76 18.78 Favored 'General case' 1 N--CA 1.555 4.784 0 CA-C-N 118.755 0.707 . . . . 0.0 112.184 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.46 -32.58 54.51 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -66.08 -41.7 90.33 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 124.16 0.984 . . . . 0.0 110.037 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 55.4 t -132.16 122.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.01 141.74 23.66 Favored Pre-proline 0 N--CA 1.528 3.425 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 1 N--CA 1.539 4.192 0 CA-C-N 122.296 1.856 . . . . 0.0 110.707 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.585 2.32 0 CA-C-O 117.474 -1.251 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -85.59 72.68 4.18 Favored 'Trans proline' 0 N--CA 1.535 3.966 0 CA-C-N 122.775 2.027 . . . . 0.0 110.146 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 88.28 -122.96 6.51 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m 57.32 49.52 13.03 Favored 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.052 0.941 . . . . 0.0 111.575 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.5 mp 56.94 9.14 0.58 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 124.616 1.166 . . . . 0.0 111.94 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 27.4 t -55.27 -34.4 64.04 Favored 'General case' 0 N--CA 1.534 3.734 0 CA-C-N 118.913 0.778 . . . . 0.0 112.241 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -42.11 40.79 Favored Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.097 0.873 . . . . 0.0 111.26 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.6 mm -57.96 -38.88 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 124.223 1.009 . . . . 0.0 110.861 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.86 -34.52 31.03 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 CA-C-O 119.458 -0.306 . . . . 0.0 111.029 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.6 mp -70.57 -49.13 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 CA-C-N 119.279 0.945 . . . . 0.0 108.804 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -67.88 -27.55 66.76 Favored 'General case' 0 N--CA 1.53 3.564 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -56.46 -38.85 58.16 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.546 0 CA-C-N 120.109 1.322 . . . . 0.0 112.084 -174.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.3 p -64.05 -48.08 77.66 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 123.907 0.883 . . . . 0.0 110.769 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.87 -44.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.124 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.78 58.77 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.455 0.702 . . . . 0.0 111.812 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.64 95.89 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 122.998 0.519 . . . . 0.0 111.718 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -39.04 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.429 0.692 . . . . 0.0 109.719 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.82 -34.32 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.652 0.781 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -37.29 86.63 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.066 0.546 . . . . 0.0 111.881 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.13 -54.42 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 C-N-CA 122.911 0.484 . . . . 0.0 111.433 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.55 -36.3 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 C-N-CA 124.374 1.07 . . . . 0.0 113.747 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.68 -31.02 65.94 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.3 -38.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 119.036 0.834 . . . . 0.0 110.472 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.33 -32.76 73.11 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.899 0.48 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.61 -37.9 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.614 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.33 -46.67 72.78 Favored 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 123.397 0.679 . . . . 0.0 110.352 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.24 -26.64 65.8 Favored 'General case' 0 N--CA 1.524 3.265 0 C-N-CA 124.114 0.966 . . . . 0.0 110.915 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 68.9 m -63.33 -21.67 66.41 Favored 'General case' 0 N--CA 1.529 3.515 0 CA-C-N 118.133 0.424 . . . . 0.0 110.049 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 57.4 mt -91.44 -17.33 25.95 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 124.375 1.07 . . . . 0.0 110.592 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 53.1 tp -80.86 -28.41 36.07 Favored 'General case' 0 N--CA 1.537 3.904 0 CA-C-O 119.029 -0.51 . . . . 0.0 112.179 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -114.28 12.61 17.69 Favored 'General case' 1 N--CA 1.559 4.979 0 C-N-CA 123.221 0.609 . . . . 0.0 111.322 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -65.75 -10.24 35.37 Favored 'General case' 0 N--CA 1.535 3.79 0 C-N-CA 123.226 0.61 . . . . 0.0 110.313 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 92.07 -17.7 0.14 Allowed 'General case' 0 N--CA 1.536 3.863 0 C-N-CA 126.243 1.817 . . . . 0.0 110.286 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 135.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 42.2 mt -97.55 141.48 23.07 Favored Pre-proline 0 N--CA 1.527 3.397 0 CA-C-O 116.273 -1.822 . . . . 0.0 108.51 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 1 N--CA 1.55 4.806 0 C-N-CA 122.686 2.258 . . . . 0.0 114.723 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.576 1.96 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.85 -175.24 2.23 Favored 'Trans proline' 1 N--CA 1.537 4.036 0 C-N-CA 122.326 2.017 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -177.29 -13.59 0.02 OUTLIER Glycine 1 N--CA 1.524 4.505 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 72.32 0.12 Allowed 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.844 0.858 . . . . 0.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tt -162.6 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 29.6 t -55.49 -19.97 11.3 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 123.642 0.777 . . . . 0.0 111.634 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -24.79 75.56 Favored Glycine 0 N--CA 1.505 3.279 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.55 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -59.77 -48.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.982 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.14 -33.75 65.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 O-C-N 122.154 -0.341 . . . . 0.0 110.221 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.62 -38.93 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -67.12 -43.78 81.59 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.75 -32.72 43.48 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.367 0 CA-C-N 119.136 0.88 . . . . 0.0 111.645 -176.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -64.93 -48.22 74.88 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.51 0.724 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.03 -46.14 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.477 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -34.88 58.76 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 123.123 0.569 . . . . 0.0 111.903 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.13 91.93 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.825 0.45 . . . . 0.0 111.955 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.14 -40.12 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.273 0.629 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.36 -33.0 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 123.667 0.787 . . . . 0.0 110.151 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.31 -47.48 73.42 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.3 tt -70.69 -41.71 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.02 -37.29 79.07 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.079 0.854 . . . . 0.0 112.257 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.85 68.64 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 m -64.38 -34.87 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.027 0.831 . . . . 0.0 110.613 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -68.94 -40.35 79.02 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.828 0.451 . . . . 0.0 109.858 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.55 -38.4 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.95 -42.22 97.37 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.688 0.795 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.57 -44.21 91.43 Favored 'General case' 0 N--CA 1.527 3.381 0 C-N-CA 124.269 1.028 . . . . 0.0 109.784 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.2 t -64.55 -27.13 68.75 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.274 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 50.8 tp -91.56 -25.32 19.27 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.422 1.089 . . . . 0.0 111.315 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.5 tp -80.6 -27.98 37.21 Favored 'General case' 0 N--CA 1.535 3.803 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -113.99 13.17 18.18 Favored 'General case' 1 N--CA 1.558 4.972 0 CA-C-N 119.064 0.847 . . . . 0.0 113.252 -178.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -92.3 -30.82 15.65 Favored 'General case' 0 N--CA 1.537 3.912 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.52 -45.99 81.37 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.99 0.916 . . . . 0.0 110.032 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.36 122.81 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 C-N-CA 124.715 1.206 . . . . 0.0 107.87 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.61 141.78 23.53 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 1 N--CA 1.54 4.227 0 CA-C-N 122.388 1.888 . . . . 0.0 110.734 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.55 156.98 12.99 Favored 'Trans proline' 1 N--CA 1.549 4.775 0 CA-C-N 122.017 1.756 . . . . 0.0 112.882 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.58 -179.34 18.9 Favored Glycine 1 N--CA 1.517 4.093 0 C-N-CA 123.678 0.656 . . . . 0.0 111.791 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t -169.2 166.07 10.81 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 124.031 0.932 . . . . 0.0 109.2 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 tt -165.12 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 61.0 m -57.93 -35.01 70.48 Favored 'General case' 0 N--CA 1.523 3.205 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.07 -38.21 40.94 Favored Glycine 0 N--CA 1.513 3.793 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.162 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.78 -44.34 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.874 0.87 . . . . 0.0 111.976 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.71 -33.82 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 C-N-CA 122.583 0.353 . . . . 0.0 110.919 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 89.3 mt -68.43 -38.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 O-C-N 121.79 -0.569 . . . . 0.0 109.54 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -67.04 -47.0 72.7 Favored 'General case' 0 N--CA 1.529 3.487 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.17 -34.8 58.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.145 0 CA-C-N 118.786 0.721 . . . . 0.0 111.926 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 82.7 p -66.62 -48.65 68.82 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.596 0.758 . . . . 0.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.11 -35.05 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.556 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.19 77.12 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.268 0.627 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.61 75.18 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 122.822 0.449 . . . . 0.0 111.632 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.93 -46.1 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.019 0.528 . . . . 0.0 111.64 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.83 -32.57 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 CA-C-N 118.697 0.68 . . . . 0.0 111.156 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.95 -41.5 99.52 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.21 0.604 . . . . 0.0 112.046 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 74.8 mt -70.56 -55.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 14.4 p -68.67 -41.73 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.36 82.14 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.15 -33.92 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 CA-C-N 118.101 0.41 . . . . 0.0 110.777 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -69.65 -27.11 64.77 Favored 'General case' 0 N--CA 1.536 3.864 0 CA-C-N 118.713 0.688 . . . . 0.0 110.539 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.26 -50.07 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 122.677 0.391 . . . . 0.0 110.508 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 31.3 p -63.81 -35.79 81.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 122.708 0.403 . . . . 0.0 111.2 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -65.96 -45.83 80.31 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.8 m -63.3 -25.66 68.41 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.348 0.659 . . . . 0.0 110.203 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -25.12 33.28 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.189 0.995 . . . . 0.0 108.344 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.05 -27.35 39.43 Favored 'General case' 0 N--CA 1.539 3.98 0 C-N-CA 123.574 0.75 . . . . 0.0 109.132 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -88.8 13.42 12.57 Favored 'General case' 1 N--CA 1.545 4.284 0 C-N-CA 122.939 0.496 . . . . 0.0 110.361 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 238' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' C' ' 240' ' ' VAL . 64.4 mttp -139.93 -62.77 0.51 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 70.77 -26.37 0.17 Allowed 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 125.008 1.323 . . . . 0.0 110.719 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 240' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' C' ' 238' ' ' LYS . 19.1 m -136.86 136.67 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 C-N-CA 125.005 1.322 . . . . 0.0 107.592 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.85 141.65 24.02 Favored Pre-proline 0 N--CA 1.526 3.369 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 1 N--CA 1.538 4.114 0 CA-C-N 122.433 1.905 . . . . 0.0 110.659 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.2 128.28 24.73 Favored 'Trans proline' 1 N--CA 1.547 4.637 0 C-N-CA 122.328 2.019 . . . . 0.0 113.245 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.98 45.76 1.71 Allowed Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.819 0.723 . . . . 0.0 111.408 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 42.5 t -167.63 44.43 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.151 0 CA-C-O 121.922 0.868 . . . . 0.0 109.228 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.41 ' CD1' ' H ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -68.0 -9.44 45.68 Favored 'General case' 0 N--CA 1.529 3.506 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.746 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 42.8 t -71.14 -36.79 72.22 Favored 'General case' 0 N--CA 1.518 2.941 0 CA-C-O 121.597 0.713 . . . . 0.0 110.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.69 -49.63 68.89 Favored Glycine 0 N--CA 1.515 3.94 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.61 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.52 -35.97 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 CA-C-N 117.405 0.603 . . . . 0.0 110.753 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.4 mt -62.19 -36.66 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.975 0 C-N-CA 122.638 0.375 . . . . 0.0 110.44 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.91 -48.08 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 CA-C-O 121.584 0.707 . . . . 0.0 109.112 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -67.33 -41.2 85.63 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.42 -33.81 44.96 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.172 0.896 . . . . 0.0 112.082 -175.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 35.1 p -71.45 -48.56 48.64 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.338 0.655 . . . . 0.0 110.011 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.01 -31.71 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.288 0 C-N-CA 123.892 0.877 . . . . 0.0 109.621 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.66 Favored 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 123.455 0.702 . . . . 0.0 111.827 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.47 74.06 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 122.346 0.259 . . . . 0.0 111.174 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.97 -46.7 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 C-N-CA 123.411 0.684 . . . . 0.0 111.573 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.78 -32.11 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.411 0.55 . . . . 0.0 110.443 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -46.08 73.46 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.961 0.904 . . . . 0.0 111.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.13 -55.25 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.0 -36.41 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.19 66.4 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.65 -37.27 79.68 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.208 0.913 . . . . 0.0 110.59 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.79 -29.18 68.3 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 122.956 0.502 . . . . 0.0 110.732 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.52 -38.36 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.24 -47.23 71.39 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.349 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.44 -41.71 84.3 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.821 0.848 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -64.22 -31.45 72.66 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.022 0.529 . . . . 0.0 111.171 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.32 -37.65 74.78 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.461 0.704 . . . . 0.0 110.763 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 76.2 mt -83.77 -27.68 28.71 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 123.316 0.647 . . . . 0.0 109.909 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -89.71 5.81 44.26 Favored 'General case' 1 N--CA 1.54 4.045 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -66.19 -16.85 64.33 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.846 0.858 . . . . 0.0 109.968 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 73.09 -3.95 2.3 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 124.489 1.116 . . . . 0.0 110.24 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.01 122.43 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.94 141.78 43.21 Favored Pre-proline 0 N--CA 1.526 3.365 0 CA-C-O 116.509 -1.71 . . . . 0.0 107.346 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 1 N--CA 1.55 4.847 0 C-N-CA 122.911 2.407 . . . . 0.0 115.019 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.578 2.026 0 CA-C-O 117.482 -1.247 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -88.59 -16.37 2.5 Favored 'Trans proline' 0 N--CA 1.536 3.978 0 C-N-CA 122.503 2.136 . . . . 0.0 111.676 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.11 136.1 30.38 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 43.6 t -169.1 56.41 0.05 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.8 10.88 0.6 Allowed 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.537 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.1 m -70.32 -23.04 62.77 Favored 'General case' 0 N--CA 1.521 3.1 0 CA-C-N 118.052 0.387 . . . . 0.0 110.805 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.93 -50.88 7.39 Favored Glycine 1 N--CA 1.519 4.203 0 C-N-CA 123.439 0.543 . . . . 0.0 113.923 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.19 -39.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.66 -33.85 28.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.337 0.517 . . . . 0.0 111.007 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 23.5 mm -62.84 -42.99 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-O 121.278 0.561 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -64.38 -35.4 80.78 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.022 0.929 . . . . 0.0 112.717 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.47 -41.5 78.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-O 121.03 0.443 . . . . 0.0 110.476 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -65.03 -48.23 74.63 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.607 0.763 . . . . 0.0 111.271 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.72 -33.88 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.673 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.0 -35.19 80.41 Favored 'General case' 0 N--CA 1.523 3.217 0 C-N-CA 122.989 0.516 . . . . 0.0 111.56 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.33 63.3 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 122.832 0.453 . . . . 0.0 112.192 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.15 -43.63 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 123.107 0.563 . . . . 0.0 111.826 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.35 -32.82 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 CA-C-N 118.311 0.505 . . . . 0.0 110.713 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.64 -41.12 85.29 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.899 0.48 . . . . 0.0 111.339 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.09 -54.08 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 CA-C-O 121.686 0.755 . . . . 0.0 109.631 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.52 -35.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 125.788 1.635 . . . . 0.0 113.26 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.62 70.79 Favored 'General case' 0 N--CA 1.529 3.513 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.35 -41.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 CA-C-N 118.942 0.792 . . . . 0.0 111.454 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -65.15 -42.52 93.71 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.28 -36.97 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 CA-C-N 118.314 0.506 . . . . 0.0 110.822 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 97.0 m -67.75 -48.19 67.13 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 122.818 0.447 . . . . 0.0 111.346 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.2 -28.37 70.0 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.511 0.724 . . . . 0.0 111.411 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.65 -21.41 66.36 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 122.733 0.413 . . . . 0.0 110.88 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.1 mt -91.3 -30.4 16.61 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 124.197 0.999 . . . . 0.0 110.969 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 67.0 mt -80.3 -27.4 38.47 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.839 0.456 . . . . 0.0 112.13 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -99.15 6.81 46.3 Favored 'General case' 1 N--CA 1.543 4.181 0 C-N-CA 123.586 0.755 . . . . 0.0 110.936 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -143.07 31.51 1.39 Allowed 'General case' 0 N--CA 1.536 3.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.628 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -162.21 -60.94 0.05 OUTLIER 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 55.9 t -83.11 127.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.229 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.68 141.97 24.51 Favored Pre-proline 0 N--CA 1.524 3.261 0 CA-C-O 117.237 -1.363 . . . . 0.0 108.314 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo . . . . . 1 N--CA 1.54 4.263 0 CA-C-N 122.295 1.855 . . . . 0.0 110.815 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 CA--C 1.586 2.347 0 CA-C-O 117.557 -1.211 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -89.07 47.38 1.08 Allowed 'Trans proline' 0 N--CA 1.535 3.915 0 C-N-CA 122.682 2.254 . . . . 0.0 110.917 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.15 -70.67 0.45 Allowed Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.0 p -166.21 167.31 16.26 Favored 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 123.648 0.779 . . . . 0.0 109.263 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -80.73 20.24 0.76 Allowed 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 124.091 0.956 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -67.08 -24.68 65.98 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.343 0.657 . . . . 0.0 111.174 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.41 -51.04 7.65 Favored Glycine 0 N--CA 1.516 3.997 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.58 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 tp -66.71 -37.02 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.082 0.553 . . . . 0.0 112.367 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 215' ' ' ILE . . . . . 0.452 ' O ' HD13 ' C' ' 215' ' ' ILE . 0.2 OUTLIER -62.77 -37.0 77.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.217 0 CA-C-N 118.256 0.48 . . . . 0.0 110.579 -177.64 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 87.4 mt -70.42 -48.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 CA-C-O 121.429 0.633 . . . . 0.0 109.595 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.36 -39.16 85.7 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.81 -39.04 68.98 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.251 0 CA-C-N 119.106 0.866 . . . . 0.0 111.914 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 20.1 p -63.75 -46.65 84.39 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.458 0.703 . . . . 0.0 110.756 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.65 -47.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.244 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.57 54.34 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.475 0.71 . . . . 0.0 111.902 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.61 95.9 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.95 0.5 . . . . 0.0 111.128 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.97 -40.43 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.5 -32.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 123.862 0.865 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -47.4 86.11 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-O 121.563 0.697 . . . . 0.0 110.797 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.11 -54.92 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.228 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.7 m -67.08 -37.03 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.73 68.04 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.1 m -65.06 -38.61 83.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 119.214 0.915 . . . . 0.0 110.558 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.53 -31.69 73.01 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 122.919 0.488 . . . . 0.0 110.878 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.89 -41.24 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 66.9 m -67.09 -39.91 86.87 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.627 0.771 . . . . 0.0 110.937 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.98 -42.68 57.1 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.626 0.771 . . . . 0.0 110.248 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 94.1 p -63.69 -12.75 37.02 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.024 0.53 . . . . 0.0 111.686 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -76.02 -37.75 58.05 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 122.609 0.364 . . . . 0.0 110.435 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 52.3 mt -107.78 -27.98 9.94 Favored 'General case' 1 N--CA 1.543 4.183 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.73 -9.64 48.63 Favored 'General case' 1 N--CA 1.547 4.397 0 CA-C-N 118.568 0.622 . . . . 0.0 112.404 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -81.62 -8.23 59.68 Favored 'General case' 0 N--CA 1.539 3.991 0 CA-C-N 118.62 0.646 . . . . 0.0 110.176 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 64.77 2.69 1.77 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 124.481 1.112 . . . . 0.0 112.49 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.69 122.65 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.47 141.42 22.79 Favored Pre-proline 0 N--CA 1.526 3.367 0 CA-C-O 116.125 -1.893 . . . . 0.0 108.539 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 1 N--CA 1.549 4.779 0 C-N-CA 122.58 2.186 . . . . 0.0 114.843 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 CA--C 1.586 2.351 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -89.22 -169.8 0.41 Allowed 'Trans proline' 0 N--CA 1.535 3.928 0 C-N-CA 122.611 2.207 . . . . 0.0 110.855 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.88 -2.68 0.03 OUTLIER Glycine 1 N--CA 1.521 4.362 0 O-C-N 123.695 0.622 . . . . 0.0 111.619 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p -66.92 110.0 3.16 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.731 0.812 . . . . 0.0 110.102 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.84 -3.26 4.74 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.884 0.874 . . . . 0.0 111.502 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.4 t -63.28 -41.62 99.01 Favored 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 123.377 0.671 . . . . 0.0 111.751 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.16 -34.22 55.56 Favored Glycine 1 N--CA 1.518 4.134 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.79 -49.64 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.904 0.882 . . . . 0.0 111.103 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -63.44 -33.68 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 122.172 -0.33 . . . . 0.0 110.789 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.1 mt -69.57 -41.6 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -66.14 -44.34 84.46 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.72 -37.6 60.33 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.226 0 CA-C-N 119.101 0.864 . . . . 0.0 111.723 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 p -63.99 -48.24 77.17 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 123.553 0.741 . . . . 0.0 111.158 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.97 -45.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.261 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.89 67.66 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.142 0.577 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.93 96.77 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 122.976 0.51 . . . . 0.0 111.401 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.05 -41.89 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 123.189 0.595 . . . . 0.0 109.723 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.04 -32.83 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.857 0.863 . . . . 0.0 110.235 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.41 -40.96 89.89 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.095 0.558 . . . . 0.0 111.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -70.04 -52.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 122.936 0.495 . . . . 0.0 111.614 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.2 m -66.28 -37.42 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.26 92.39 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.74 -33.87 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -63.17 -43.44 98.26 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.522 0.729 . . . . 0.0 112.446 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.05 -31.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 122.393 0.277 . . . . 0.0 110.488 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 44.7 t -62.44 -32.39 73.24 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 123.044 0.538 . . . . 0.0 111.037 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.32 -44.84 78.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.653 0.781 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.0 p -64.66 -41.31 96.19 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-O 121.465 0.65 . . . . 0.0 109.616 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.8 -34.44 78.17 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 124.538 1.135 . . . . 0.0 109.694 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp -80.03 -21.85 43.05 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.586 0.754 . . . . 0.0 110.041 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -89.03 13.07 13.8 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 123.599 0.759 . . . . 0.0 110.478 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -122.04 10.42 10.1 Favored 'General case' 1 N--CA 1.542 4.16 0 C-N-CA 124.556 1.142 . . . . 0.0 109.077 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 64.97 -24.1 0.08 Allowed 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 124.862 1.265 . . . . 0.0 113.637 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.64 122.5 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.09 142.11 23.98 Favored Pre-proline 0 N--CA 1.537 3.894 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo . . . . . 1 N--CA 1.54 4.245 0 CA-C-N 122.415 1.898 . . . . 0.0 110.769 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.576 1.973 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.28 120.01 6.69 Favored 'Trans proline' 1 N--CA 1.545 4.507 0 C-N-CA 122.278 1.986 . . . . 0.0 113.007 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.26 -172.41 22.07 Favored Glycine 1 N--CA 1.519 4.205 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p -167.69 171.19 10.34 Favored 'General case' 0 N--CA 1.521 3.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.44 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.51 -39.04 88.45 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.206 1.003 . . . . 0.0 109.667 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 93.0 p -55.58 -19.97 11.91 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 124.048 0.939 . . . . 0.0 111.438 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.99 -23.32 76.52 Favored Glycine 0 N--CA 1.511 3.683 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -51.27 74.0 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.72 -33.84 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 C-N-CA 122.778 0.431 . . . . 0.0 110.947 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.44 -38.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -66.78 -45.11 79.49 Favored 'General case' 0 N--CA 1.531 3.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.84 -34.06 47.27 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.992 0.815 . . . . 0.0 111.672 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.7 p -64.64 -48.43 74.86 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.233 0.613 . . . . 0.0 111.087 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.57 -41.01 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.33 -34.3 78.01 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.931 0.492 . . . . 0.0 111.576 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.03 67.55 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.26 -38.35 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.95 -32.64 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 CA-C-N 118.589 0.631 . . . . 0.0 110.55 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.7 tp -54.9 -34.7 63.34 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.145 0.578 . . . . 0.0 112.55 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.95 -55.74 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 CA-C-N 117.677 0.217 . . . . 0.0 111.382 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.5 -36.13 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 C-N-CA 124.33 1.052 . . . . 0.0 113.128 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.5 -31.02 65.61 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -58.32 -37.07 61.19 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.977 0.808 . . . . 0.0 110.641 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.21 -35.46 71.53 Favored 'General case' 0 N--CA 1.526 3.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.999 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.04 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.19 -41.87 85.12 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 123.481 0.712 . . . . 0.0 110.2 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -71.73 -37.01 70.66 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.851 0.86 . . . . 0.0 110.535 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 92.2 p -63.83 -17.68 63.36 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.027 0.531 . . . . 0.0 111.546 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.7 tp -83.57 -37.5 22.89 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.473 0.709 . . . . 0.0 110.338 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.83 -21.47 26.41 Favored 'General case' 1 N--CA 1.542 4.139 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -114.06 13.97 18.25 Favored 'General case' 0 N--CA 1.537 3.9 0 C-N-CA 124.967 1.307 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -56.91 -43.62 81.57 Favored 'General case' 0 N--CA 1.534 3.759 0 CA-C-O 121.941 0.877 . . . . 0.0 108.672 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? 178.01 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.469 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.2 p -84.53 128.25 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.87 0.868 . . . . 0.0 108.972 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.0 141.5 23.77 Favored Pre-proline 0 N--CA 1.529 3.501 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 1 N--CA 1.539 4.156 0 CA-C-N 122.427 1.902 . . . . 0.0 110.705 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.584 2.279 0 CA-C-O 117.553 -1.213 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -89.47 68.17 2.24 Favored 'Trans proline' 0 N--CA 1.534 3.9 0 C-N-CA 122.714 2.276 . . . . 0.0 110.835 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.0 -148.94 50.91 Favored Glycine 1 N--CA 1.521 4.306 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.416 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -164.45 144.49 7.71 Favored 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 123.667 0.787 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.05 -1.87 19.0 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.9 0.88 . . . . 0.0 110.46 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 91.9 p -68.19 -25.78 65.41 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 122.699 0.4 . . . . 0.0 110.758 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.02 -51.48 6.91 Favored Glycine 1 N--CA 1.518 4.16 0 O-C-N 123.117 0.261 . . . . 0.0 113.726 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 17.7 tt -67.18 -40.79 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 tp -54.45 -33.35 26.22 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.86 -42.05 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-O 121.458 0.647 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -64.87 -44.69 88.89 Favored 'General case' 0 N--CA 1.525 3.315 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 32.7 m -57.82 -35.15 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 CA-C-N 119.117 0.872 . . . . 0.0 111.95 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 36.7 p -62.83 -48.21 80.07 Favored 'General case' 0 N--CA 1.53 3.545 0 C-N-CA 123.527 0.731 . . . . 0.0 110.674 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.72 -48.76 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.346 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.97 -36.84 60.62 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 122.98 0.512 . . . . 0.0 111.882 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.81 94.61 Favored 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.077 0.551 . . . . 0.0 111.741 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.09 -41.36 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 C-N-CA 123.372 0.669 . . . . 0.0 109.571 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.15 -32.91 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.432 0.693 . . . . 0.0 109.495 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -47.3 79.19 Favored 'General case' 0 N--CA 1.539 3.985 0 CA-C-O 121.68 0.752 . . . . 0.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.34 -52.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.413 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.1 -36.05 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 124.875 1.27 . . . . 0.0 113.321 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.17 75.18 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.5 -37.98 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.639 0 CA-C-N 118.543 0.61 . . . . 0.0 111.732 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -69.31 -42.66 75.13 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 122.205 -0.31 . . . . 0.0 111.656 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.54 -32.11 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.41 0.55 . . . . 0.0 110.136 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.32 -39.25 85.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -67.7 -26.56 66.24 Favored 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 124.346 1.058 . . . . 0.0 111.557 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.54 -27.95 69.61 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 122.575 0.35 . . . . 0.0 110.785 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.3 -14.39 30.92 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 124.491 1.117 . . . . 0.0 110.345 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 50.8 tp -80.06 -28.39 39.22 Favored 'General case' 0 N--CA 1.538 3.939 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.654 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -108.87 1.36 20.79 Favored 'General case' 1 N--CA 1.559 5.003 0 C-N-CA 122.916 0.486 . . . . 0.0 111.447 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -75.76 -42.55 50.04 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -71.45 -57.6 4.28 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.279 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.64 121.87 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.81 141.55 22.98 Favored Pre-proline 0 N--CA 1.531 3.607 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 1 N--CA 1.538 4.113 0 CA-C-N 122.426 1.902 . . . . 0.0 110.668 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 CA--C 1.574 1.89 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.81 -20.89 10.13 Favored 'Trans proline' 1 N--CA 1.536 4.025 0 C-N-CA 122.415 2.077 . . . . 0.0 110.749 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.83 111.07 0.29 Allowed Glycine 1 N--CA 1.516 4.014 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.1 p 60.21 156.87 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 124.629 1.172 . . . . 0.0 111.8 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -165.47 -53.57 0.03 OUTLIER 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -55.65 -20.43 13.95 Favored 'General case' 0 N--CA 1.527 3.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.489 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.2 -26.89 67.27 Favored Glycine 0 N--CA 1.51 3.601 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -49.33 84.9 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 C-N-CA 123.219 0.608 . . . . 0.0 111.744 -177.666 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -67.15 -33.99 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.973 -0.455 . . . . 0.0 110.616 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.41 -38.84 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.8 -48.45 76.82 Favored 'General case' 0 N--CA 1.525 3.311 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.18 -36.12 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.933 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.8 p -66.85 -49.46 65.64 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.03 -33.09 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.33 77.6 Favored 'General case' 0 N--CA 1.523 3.189 0 C-N-CA 122.882 0.473 . . . . 0.0 111.211 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.5 83.35 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 122.759 0.424 . . . . 0.0 111.997 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.95 -45.23 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.406 0 C-N-CA 123.201 0.6 . . . . 0.0 111.263 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -67.66 -32.67 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 O-C-N 121.755 -0.591 . . . . 0.0 110.63 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -47.86 83.05 Favored 'General case' 0 N--CA 1.523 3.216 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.95 -44.62 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.82 -36.58 77.55 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 119.301 0.955 . . . . 0.0 112.448 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.11 67.19 Favored 'General case' 0 N--CA 1.526 3.338 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 4.3 m -70.24 -38.46 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 118.737 0.699 . . . . 0.0 111.543 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.23 -43.09 92.54 Favored 'General case' 0 N--CA 1.532 3.671 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.28 -31.9 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 CA-C-N 117.999 0.363 . . . . 0.0 110.03 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.9 t -66.5 -46.17 77.14 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.304 0.642 . . . . 0.0 110.712 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.09 -35.1 76.12 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.985 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 88.3 p -64.22 -34.93 79.23 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 122.791 0.436 . . . . 0.0 111.693 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.59 -20.07 25.47 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 124.035 0.934 . . . . 0.0 111.376 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.82 -27.84 36.42 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 122.713 0.405 . . . . 0.0 110.284 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -100.83 10.02 41.64 Favored 'General case' 1 N--CA 1.543 4.203 0 C-N-CA 124.116 0.966 . . . . 0.0 109.998 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.9 -21.91 26.02 Favored 'General case' 0 N--CA 1.531 3.588 0 C-N-CA 123.903 0.881 . . . . 0.0 108.73 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.83 -43.67 87.87 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 124.232 1.013 . . . . 0.0 108.766 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.0 m -136.33 125.12 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.93 141.4 23.23 Favored Pre-proline 0 N--CA 1.527 3.42 0 CA-C-O 116.272 -1.823 . . . . 0.0 107.153 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo . . . . . 1 N--CA 1.549 4.745 0 C-N-CA 122.948 2.432 . . . . 0.0 115.049 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.575 1.927 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.06 -51.53 11.01 Favored 'Trans proline' 1 N--CA 1.544 4.468 0 C-N-CA 122.404 2.069 . . . . 0.0 113.424 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.4 107.93 0.21 Allowed Glycine 1 N--CA 1.518 4.128 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 67.8 m -76.28 114.88 15.46 Favored 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.37 21.6 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.48 0.712 . . . . 0.0 110.296 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 122.798 0.439 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.54 -40.85 31.37 Favored Glycine 1 N--CA 1.52 4.24 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.18 -45.65 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.2 0 C-N-CA 124.443 1.097 . . . . 0.0 112.054 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 5.9 tp -55.58 -33.21 32.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 CA-C-N 118.529 0.604 . . . . 0.0 110.052 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.28 -46.5 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-O 121.822 0.82 . . . . 0.0 109.021 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.2 -41.9 85.04 Favored 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.74 -38.26 64.16 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 119.042 0.837 . . . . 0.0 111.776 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.9 p -64.04 -48.01 77.95 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.678 0.791 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.82 -45.74 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.07 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.44 54.07 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 123.372 0.669 . . . . 0.0 111.729 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -41.3 98.7 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-O 120.932 0.396 . . . . 0.0 111.384 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.11 -38.97 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.325 0 C-N-CA 123.558 0.743 . . . . 0.0 109.657 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.37 -33.1 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 123.617 0.767 . . . . 0.0 111.03 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.49 -43.47 93.29 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-N 118.594 0.634 . . . . 0.0 110.161 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.4 -54.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.36 0.664 . . . . 0.0 110.102 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.03 -37.82 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.301 1.04 . . . . 0.0 113.314 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.94 92.52 Favored 'General case' 1 N--CA 1.541 4.091 0 CA-C-N 118.575 0.625 . . . . 0.0 112.515 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.86 -34.1 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.21 -43.77 93.99 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.176 0.59 . . . . 0.0 112.051 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.29 -36.07 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 CA-C-O 120.818 0.342 . . . . 0.0 110.438 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.24 -39.44 86.18 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.297 0.639 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.44 -29.99 64.2 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 99.1 p -75.37 -43.15 51.92 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 122.748 0.419 . . . . 0.0 110.745 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.3 mt -77.27 -31.66 55.05 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.892 0.877 . . . . 0.0 111.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -80.67 -27.63 37.04 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 123.069 0.547 . . . . 0.0 111.662 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -92.01 0.65 57.47 Favored 'General case' 1 N--CA 1.545 4.283 0 C-N-CA 123.411 0.684 . . . . 0.0 110.509 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -104.84 -14.38 15.52 Favored 'General case' 1 N--CA 1.543 4.217 0 C-N-CA 124.117 0.967 . . . . 0.0 109.64 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? 62.85 52.24 2.75 Favored 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 124.679 1.191 . . . . 0.0 111.548 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 240' ' ' VAL . . . . . 0.534 ' C ' HD23 ' B' ' 241' ' ' LEU . 94.6 t -131.7 122.3 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 241' ' ' LEU . . . . . 0.534 HD23 ' C ' ' B' ' 240' ' ' VAL . 0.0 OUTLIER -128.6 141.87 42.98 Favored Pre-proline 0 N--CA 1.533 3.715 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 1 N--CA 1.54 4.212 0 CA-C-N 122.322 1.865 . . . . 0.0 111.029 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.48 150.47 20.87 Favored 'Trans proline' 1 N--CA 1.547 4.661 0 CA-C-N 121.969 1.739 . . . . 0.0 113.258 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 172.3 -48.96 0.17 Allowed Glycine 1 N--CA 1.519 4.187 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p 58.38 159.54 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.783 1.233 . . . . 0.0 112.443 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.23 12.44 3.51 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 124.124 0.97 . . . . 0.0 109.943 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 24.4 t -62.27 -20.43 64.26 Favored 'General case' 0 N--CA 1.522 3.173 0 C-N-CA 123.829 0.851 . . . . 0.0 110.624 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.61 94.14 Favored Glycine 0 N--CA 1.508 3.488 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.184 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.3 pt -65.79 -35.39 75.05 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 CA-C-N 117.897 0.849 . . . . 0.0 111.265 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.14 -34.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 C-N-CA 123.203 0.601 . . . . 0.0 109.636 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.07 -44.31 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.421 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -67.02 -45.41 77.61 Favored 'General case' 0 N--CA 1.533 3.687 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.65 -35.85 52.15 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.3 p -66.06 -49.45 67.61 Favored 'General case' 0 N--CA 1.529 3.492 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.93 -37.82 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.14 72.76 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 122.64 0.376 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.23 94.87 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.938 0.495 . . . . 0.0 111.747 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.76 -42.12 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 123.322 0.649 . . . . 0.0 109.893 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.79 -32.97 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.547 0.739 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.87 -37.7 88.38 Favored 'General case' 0 N--CA 1.529 3.506 0 C-N-CA 122.89 0.476 . . . . 0.0 111.954 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.73 -54.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.707 0 C-N-CA 122.887 0.475 . . . . 0.0 111.624 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 22.7 m -66.86 -36.88 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.49 67.83 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.26 -36.55 77.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 119.393 0.997 . . . . 0.0 110.593 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.54 -30.27 71.0 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 122.784 0.434 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.16 -41.08 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.607 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.41 -48.31 67.7 Favored 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 123.465 0.706 . . . . 0.0 111.166 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.95 -25.07 67.97 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 124.068 0.947 . . . . 0.0 111.708 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 36.6 t -63.9 -40.96 97.72 Favored 'General case' 0 N--CA 1.524 3.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.8 -35.18 67.3 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.29 -20.85 43.44 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.18 0.592 . . . . 0.0 110.498 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -89.05 -18.08 28.04 Favored 'General case' 0 N--CA 1.538 3.932 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mttp 60.13 6.17 0.93 Allowed 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 124.414 1.086 . . . . 0.0 113.129 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -72.81 -38.42 67.19 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.5 t -135.99 123.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 30.3 mt -103.04 141.5 22.61 Favored Pre-proline 0 N--CA 1.527 3.404 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.286 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 1 N--CA 1.539 4.166 0 CA-C-N 122.62 1.972 . . . . 0.0 110.803 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.576 1.964 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.18 159.26 47.69 Favored 'Trans proline' 1 N--CA 1.54 4.256 0 C-N-CA 122.304 2.002 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.59 -43.1 69.85 Favored Glycine 1 N--CA 1.519 4.22 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 38.6 m 56.45 77.67 0.24 Allowed 'General case' 0 N--CA 1.521 3.084 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.3 21.32 0.12 Allowed 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m -69.89 -27.73 65.04 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 123.531 0.732 . . . . 0.0 110.989 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.36 -50.57 8.16 Favored Glycine 0 N--CA 1.512 3.734 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.805 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.35 -36.89 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 8.5 tp -60.12 -33.58 53.82 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.64 0.655 . . . . 0.0 110.42 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.13 -42.22 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -64.34 -29.23 70.31 Favored 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.22 -44.8 84.28 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.455 0 CA-C-N 119.673 1.124 . . . . 0.0 113.455 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.5 p -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.88 -36.76 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.142 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.6 70.41 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 122.616 0.366 . . . . 0.0 111.358 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.94 -43.68 98.13 Favored 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 122.651 0.38 . . . . 0.0 111.482 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.3 -42.77 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 C-N-CA 123.508 0.723 . . . . 0.0 110.003 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.42 -33.29 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.347 0 C-N-CA 123.407 0.683 . . . . 0.0 110.193 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.94 -38.57 91.55 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 122.813 0.445 . . . . 0.0 111.96 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.0 mt -70.34 -55.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 122.416 0.286 . . . . 0.0 111.546 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.7 -37.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.25 82.89 Favored 'General case' 0 N--CA 1.533 3.683 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.11 -34.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.622 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.0 -42.3 66.61 Favored 'General case' 1 N--CA 1.54 4.056 0 CA-C-N 119.504 1.047 . . . . 0.0 111.547 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.36 -32.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.4 p -67.27 -37.64 83.79 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-N 118.282 0.492 . . . . 0.0 111.103 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.61 -27.72 67.92 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.463 0.705 . . . . 0.0 111.452 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.6 p -72.21 -16.74 61.95 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 122.645 0.378 . . . . 0.0 111.32 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.4 -37.7 13.05 Favored 'General case' 0 N--CA 1.535 3.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.268 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.67 -27.88 26.78 Favored 'General case' 1 N--CA 1.545 4.298 0 C-N-CA 122.916 0.487 . . . . 0.0 111.152 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.94 -16.89 18.6 Favored 'General case' 1 N--CA 1.544 4.264 0 C-N-CA 123.587 0.755 . . . . 0.0 109.631 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.93 39.53 20.12 Favored 'General case' 0 N--CA 1.516 2.834 0 C-N-CA 125.195 1.398 . . . . 0.0 112.212 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 60.53 8.73 1.79 Allowed 'General case' 0 N--CA 1.516 2.872 0 C-N-CA 124.433 1.093 . . . . 0.0 112.652 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.39 123.0 66.55 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.11 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.78 113.98 63.75 Favored Pre-proline 0 N--CA 1.517 2.914 0 CA-C-O 116.659 -1.638 . . . . 0.0 107.096 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo . . . . . 1 N--CA 1.547 4.646 0 C-N-CA 122.511 2.141 . . . . 0.0 114.396 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.572 1.797 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.98 68.38 3.94 Favored 'Trans proline' 1 N--CA 1.539 4.167 0 C-N-CA 122.171 1.914 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.47 84.13 0.26 Allowed Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 32.7 t 58.96 30.78 20.66 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 124.179 0.992 . . . . 0.0 111.829 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.99 -17.79 61.42 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.524 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.5 p -65.18 -39.52 93.01 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.712 0.805 . . . . 0.0 111.131 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.99 81.19 Favored Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.271 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.05 -36.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 C-N-CA 124.026 0.93 . . . . 0.0 110.533 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.42 -35.93 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 C-N-CA 122.966 0.506 . . . . 0.0 110.151 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.98 -38.13 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.54 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -65.21 -47.01 78.41 Favored 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.82 -29.92 41.44 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 118.699 0.682 . . . . 0.0 112.335 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.5 p -69.57 -49.9 49.75 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.55 -31.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.098 0.559 . . . . 0.0 111.238 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.04 79.39 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 122.855 0.462 . . . . 0.0 111.626 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.4 t -70.05 -48.26 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 123.268 0.627 . . . . 0.0 111.212 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.0 -32.02 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 CA-C-N 118.251 0.478 . . . . 0.0 110.106 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -46.98 62.93 Favored 'General case' 0 N--CA 1.535 3.776 0 C-N-CA 123.667 0.787 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.33 -54.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.81 -37.03 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 124.768 1.227 . . . . 0.0 113.818 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.43 -31.92 68.2 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.7 m -69.45 -36.09 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 119.332 0.969 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.92 -42.44 66.7 Favored 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.22 -38.36 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.24 -38.93 86.0 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 124.004 0.921 . . . . 0.0 111.039 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 22.1 t -70.08 -32.47 70.55 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 122.947 0.499 . . . . 0.0 110.108 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.31 -32.21 62.76 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.939 0.896 . . . . 0.0 109.904 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.22 -16.06 55.62 Favored 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -88.85 -17.44 29.67 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 55.09 13.22 0.75 Allowed 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -74.63 -11.68 60.25 Favored 'General case' 0 N--CA 1.536 3.843 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.43 125.19 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 47.0 mt -118.36 141.93 30.46 Favored Pre-proline 0 N--CA 1.529 3.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.729 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo . . . . . 1 N--CA 1.541 4.276 0 CA-C-N 122.374 1.883 . . . . 0.0 110.801 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 17.5 ptm . . . . . 0 CA--C 1.576 1.963 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.91 159.77 52.07 Favored 'Trans proline' 1 N--CA 1.542 4.325 0 C-N-CA 122.298 1.998 . . . . 0.0 110.371 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.62 -10.69 58.54 Favored Glycine 1 N--CA 1.518 4.165 0 C-N-CA 123.643 0.64 . . . . 0.0 112.167 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 46.6 m 57.28 176.89 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 124.277 1.031 . . . . 0.0 112.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 69.92 -32.3 0.23 Allowed 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.513 1.525 . . . . 0.0 111.366 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.0 m -70.65 -23.79 62.58 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.706 -0.621 . . . . 0.0 109.85 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.88 -50.09 55.04 Favored Glycine 0 N--CA 1.512 3.718 0 C-N-CA 124.264 0.935 . . . . 0.0 114.616 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.15 -36.03 60.69 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.094 0.947 . . . . 0.0 110.748 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.03 -34.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 122.871 0.468 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.4 -41.09 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.872 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -56.72 -41.8 78.09 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.512 0.725 . . . . 0.0 111.867 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 50.5 t -57.76 -45.88 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 19.3 p -62.87 -49.28 75.45 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.05 -38.45 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.133 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.8 78.79 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.46 64.39 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.99 -38.39 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.32 -32.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.551 0.614 . . . . 0.0 110.668 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.73 -36.02 71.48 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.149 0.58 . . . . 0.0 112.371 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -69.57 -54.85 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 122.763 0.425 . . . . 0.0 111.193 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.14 -35.99 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 C-N-CA 124.236 1.014 . . . . 0.0 113.227 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -31.11 65.9 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.27 -35.21 74.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.077 0 CA-C-N 119.401 1.001 . . . . 0.0 110.594 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.79 -33.79 75.51 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 122.887 0.475 . . . . 0.0 110.422 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.58 -43.0 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 C-N-CA 123.29 0.636 . . . . 0.0 109.8 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 61.7 m -65.47 -48.45 72.62 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.155 0.582 . . . . 0.0 110.891 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -68.42 -41.04 80.97 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 124.06 0.944 . . . . 0.0 111.487 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -70.1 -29.19 66.1 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 122.881 0.472 . . . . 0.0 110.654 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.07 -34.87 24.1 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.687 0.795 . . . . 0.0 111.124 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 53.5 tp -81.05 -27.74 35.63 Favored 'General case' 0 N--CA 1.538 3.955 0 C-N-CA 123.804 0.841 . . . . 0.0 113.052 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -103.21 13.99 32.69 Favored 'General case' 1 N--CA 1.548 4.447 0 C-N-CA 124.424 1.09 . . . . 0.0 111.321 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -119.16 -7.84 10.25 Favored 'General case' 1 N--CA 1.541 4.121 0 C-N-CA 124.198 0.999 . . . . 0.0 110.983 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -68.37 -43.95 76.23 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.79 122.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.7 mp -109.41 141.6 23.9 Favored Pre-proline 0 N--CA 1.534 3.757 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 1 N--CA 1.541 4.275 0 CA-C-N 122.474 1.919 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.571 1.767 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.6 81.09 1.61 Allowed 'Trans proline' 1 N--CA 1.538 4.125 0 C-N-CA 122.184 1.923 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.17 173.2 19.93 Favored Glycine 1 N--CA 1.519 4.201 0 C-N-CA 123.664 0.65 . . . . 0.0 111.605 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -167.64 179.75 4.71 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 123.714 0.806 . . . . 0.0 109.777 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.6 mt 66.6 -9.81 0.31 Allowed 'General case' 0 N--CA 1.518 2.953 0 C-N-CA 124.849 1.26 . . . . 0.0 112.912 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 56.7 m -70.4 -38.11 74.59 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 123.309 0.644 . . . . 0.0 111.071 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.21 -41.38 31.59 Favored Glycine 1 N--CA 1.517 4.082 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.716 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 214' ' ' ILE . 1.4 mp -64.48 -47.62 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.974 0.91 . . . . 0.0 110.886 -176.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.2 -34.2 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 O-C-N 121.939 -0.475 . . . . 0.0 111.576 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.84 -43.13 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -67.05 -40.93 87.24 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.79 -33.28 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.151 0 CA-C-N 119.347 0.976 . . . . 0.0 112.791 -175.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -49.72 61.24 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.07 -31.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.435 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.24 -41.29 77.18 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.643 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.22 -43.66 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.505 0.722 . . . . 0.0 111.793 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.91 -32.26 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 CA-C-N 118.332 0.514 . . . . 0.0 110.791 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.11 -38.34 79.35 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.115 0.566 . . . . 0.0 112.317 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.23 -55.14 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.84 -37.41 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.09 89.19 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.8 -34.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.11 -43.82 97.99 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.413 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.59 -36.0 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 CA-C-O 120.987 0.422 . . . . 0.0 110.211 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.34 -48.33 67.83 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.375 0.67 . . . . 0.0 111.687 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -72.28 -45.16 61.26 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.871 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 94.8 p -65.04 -39.42 93.29 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 tp -72.89 -37.69 67.2 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 122.682 0.393 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.76 -24.29 31.19 Favored 'General case' 0 N--CA 1.539 3.987 0 C-N-CA 123.612 0.765 . . . . 0.0 111.247 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -89.05 -7.13 56.48 Favored 'General case' 1 N--CA 1.541 4.112 0 CA-C-N 118.259 0.481 . . . . 0.0 110.357 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -81.47 -38.39 26.46 Favored 'General case' 0 N--CA 1.528 3.45 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.75 -57.31 4.46 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.791 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.08 122.16 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -96.43 141.79 23.61 Favored Pre-proline 0 N--CA 1.527 3.424 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 1 N--CA 1.54 4.226 0 CA-C-N 122.32 1.864 . . . . 0.0 110.682 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -51.39 175.12 0.06 OUTLIER 'Trans proline' 1 N--CA 1.545 4.552 0 C-N-CA 122.454 2.102 . . . . 0.0 113.621 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.11 172.5 45.03 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 m 56.25 53.02 9.36 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 124.007 0.923 . . . . 0.0 111.614 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -165.63 -48.2 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.28 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -61.07 -26.27 67.52 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.918 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.71 -44.74 19.44 Favored Glycine 0 N--CA 1.515 3.954 0 O-C-N 123.849 0.718 . . . . 0.0 111.48 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 214' ' ' ILE . . . . . 0.402 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -58.72 -46.24 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 C-N-CA 124.708 1.203 . . . . 0.0 111.585 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.9 -32.62 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 O-C-N 122.143 -0.348 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.72 -48.57 87.52 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.73 -0.606 . . . . 0.0 110.62 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -67.85 -40.04 83.74 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 20.1 m -57.52 -38.58 64.36 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 CA-C-N 119.929 1.24 . . . . 0.0 112.067 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -61.34 -48.1 82.85 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.694 0.798 . . . . 0.0 111.266 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.67 -44.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.479 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 -34.78 75.42 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 122.994 0.518 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.0 94.12 Favored 'General case' 0 N--CA 1.523 3.195 0 C-N-CA 123.017 0.527 . . . . 0.0 111.902 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.4 -44.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.49 -35.03 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.045 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.34 -38.06 79.39 Favored 'General case' 0 N--CA 1.532 3.629 0 C-N-CA 123.123 0.569 . . . . 0.0 111.327 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.98 -48.81 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.0 -35.53 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 C-N-CA 125.442 1.497 . . . . 0.0 112.158 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.85 68.57 Favored 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -173.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.01 -44.19 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.662 0.664 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -63.77 -42.11 97.84 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.93 -33.62 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.589 0.632 . . . . 0.0 110.798 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.9 m -67.22 -43.64 81.52 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.026 0.53 . . . . 0.0 110.611 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.49 -31.13 65.14 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.711 0.804 . . . . 0.0 110.249 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.92 -43.01 97.22 Favored 'General case' 0 N--CA 1.522 3.143 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.8 -14.76 41.28 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.683 0.793 . . . . 0.0 112.543 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.8 tp -90.07 -27.71 19.5 Favored 'General case' 1 N--CA 1.542 4.133 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 14.15 25.75 Favored 'General case' 1 N--CA 1.556 4.835 0 CA-C-N 119.665 1.121 . . . . 0.0 113.917 -177.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -63.73 -3.55 2.42 Favored 'General case' 1 N--CA 1.54 4.031 0 CA-C-N 118.557 0.617 . . . . 0.0 110.842 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp 82.87 48.65 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.854 0 C-N-CA 125.2 1.4 . . . . 0.0 109.372 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.35 122.4 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.55 141.64 23.46 Favored Pre-proline 0 N--CA 1.528 3.445 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 1 N--CA 1.539 4.203 0 CA-C-N 122.524 1.937 . . . . 0.0 110.725 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.576 1.965 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.27 145.51 54.4 Favored 'Trans proline' 1 N--CA 1.541 4.307 0 C-N-CA 122.2 1.933 . . . . 0.0 110.334 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.23 71.63 Favored Glycine 1 N--CA 1.517 4.058 0 C-N-CA 123.777 0.704 . . . . 0.0 111.716 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.4 m 56.57 100.47 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 124.167 0.987 . . . . 0.0 111.31 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -148.62 -5.43 0.42 Allowed 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 123.783 0.833 . . . . 0.0 110.708 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -55.75 -20.88 16.28 Favored 'General case' 0 N--CA 1.528 3.461 0 O-C-N 121.781 -0.574 . . . . 0.0 111.493 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.95 -39.79 93.34 Favored Glycine 0 N--CA 1.51 3.594 0 O-C-N 124.112 0.883 . . . . 0.0 113.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -38.05 80.25 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 CA-C-N 117.524 0.662 . . . . 0.0 109.866 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 50.7 mt -56.74 -34.36 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.389 0.675 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 25.8 mm -69.6 -44.26 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.614 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.44 -36.81 75.5 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.276 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 40.5 p -63.77 -49.26 73.68 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.9 -38.88 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.78 73.71 Favored 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 122.718 0.407 . . . . 0.0 110.972 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.52 85.42 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.087 0.555 . . . . 0.0 112.04 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.291 0.636 . . . . 0.0 109.839 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.95 -32.48 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 123.592 0.757 . . . . 0.0 110.291 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.6 tp -64.23 -48.53 75.46 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 tt -71.95 -52.08 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.06 -37.01 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -31.78 68.9 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.18 -34.9 66.09 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.251 0.932 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -68.86 -38.62 79.86 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.046 0.451 . . . . 0.0 109.807 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.1 -41.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 C-N-CA 123.91 0.884 . . . . 0.0 109.599 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.21 -38.79 92.31 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.526 0.73 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.0 -47.02 54.97 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.47 0.708 . . . . 0.0 109.481 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.66 -12.81 37.09 Favored 'General case' 0 N--CA 1.519 2.975 0 C-N-CA 123.702 0.801 . . . . 0.0 112.391 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 59.1 tp -91.0 -37.52 13.41 Favored 'General case' 0 N--CA 1.533 3.695 0 C-N-CA 123.925 0.89 . . . . 0.0 111.801 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.79 -27.57 17.92 Favored 'General case' 1 N--CA 1.54 4.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.474 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -98.15 13.47 31.05 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.284 1.034 . . . . 0.0 109.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.74 -21.25 66.31 Favored 'General case' 0 N--CA 1.527 3.393 0 C-N-CA 124.447 1.099 . . . . 0.0 109.685 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.33 -21.08 66.49 Favored 'General case' 0 N--CA 1.522 3.146 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.307 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.98 123.01 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 38.7 mt -116.71 141.73 28.61 Favored Pre-proline 0 N--CA 1.532 3.636 0 CA-C-O 117.049 -1.453 . . . . 0.0 108.329 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 1 N--CA 1.54 4.213 0 CA-C-N 122.533 1.94 . . . . 0.0 110.772 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 CA--C 1.585 2.316 0 CA-C-O 117.468 -1.254 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -88.92 22.53 0.83 Allowed 'Trans proline' 0 N--CA 1.535 3.952 0 C-N-CA 122.608 2.205 . . . . 0.0 111.397 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.69 159.19 46.03 Favored Glycine 1 N--CA 1.519 4.201 0 C-N-CA 123.608 0.623 . . . . 0.0 111.561 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.4 p -72.29 64.87 0.59 Allowed 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 123.84 0.856 . . . . 0.0 109.881 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.92 -36.42 83.33 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.989 0.915 . . . . 0.0 109.889 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.1 m -70.55 -20.88 62.77 Favored 'General case' 0 N--CA 1.521 3.098 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.983 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.24 -50.28 8.58 Favored Glycine 0 N--CA 1.513 3.8 0 C-N-CA 123.984 0.802 . . . . 0.0 113.78 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.84 -36.91 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 42.5 pt -57.96 -33.81 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 118.951 0.796 . . . . 0.0 110.667 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.65 -41.19 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.66 -34.48 77.17 Favored 'General case' 0 N--CA 1.529 3.493 0 C-N-CA 123.471 0.708 . . . . 0.0 111.687 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.89 -38.03 63.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 CA-C-O 120.921 0.391 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.5 p -66.02 -49.15 68.74 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.302 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.02 -44.93 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.022 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.061 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.75 -34.57 67.68 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.351 0.66 . . . . 0.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.24 98.57 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 122.904 0.482 . . . . 0.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.1 t -69.94 -39.06 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.397 0.679 . . . . 0.0 109.627 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.7 -32.87 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 123.755 0.822 . . . . 0.0 109.869 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -47.21 84.89 Favored 'General case' 0 N--CA 1.535 3.794 0 CA-C-O 121.58 0.705 . . . . 0.0 110.748 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.06 -54.11 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.926 0.89 . . . . 0.0 112.702 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.63 -36.79 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.57 -31.73 68.27 Favored 'General case' 0 N--CA 1.528 3.455 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.09 -34.93 73.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.104 0 CA-C-N 119.348 0.976 . . . . 0.0 110.581 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -65.12 -36.08 83.15 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 122.561 0.344 . . . . 0.0 110.297 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.03 -37.43 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.633 0.773 . . . . 0.0 109.764 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 66.6 m -67.11 -48.33 68.45 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.236 0.614 . . . . 0.0 111.002 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -70.38 -27.72 64.53 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 123.784 0.834 . . . . 0.0 110.351 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.9 t -63.92 -37.9 89.09 Favored 'General case' 0 N--CA 1.528 3.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.546 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.79 -37.23 76.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 123.971 0.908 . . . . 0.0 110.505 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.65 -23.44 39.69 Favored 'General case' 0 N--CA 1.531 3.625 0 C-N-CA 123.586 0.754 . . . . 0.0 110.384 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -89.68 -8.75 51.7 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 123.864 0.866 . . . . 0.0 109.921 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -126.62 44.3 2.91 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.842 1.257 . . . . 0.0 108.168 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.28 -22.75 0.06 Allowed 'General case' 0 N--CA 1.526 3.373 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.582 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 p -83.5 124.78 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.47 114.45 18.21 Favored Pre-proline 0 N--CA 1.526 3.367 0 CA-C-O 116.818 -1.563 . . . . 0.0 108.455 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 1 N--CA 1.548 4.712 0 CA-C-N 122.941 2.086 . . . . 0.0 114.416 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.53 142.49 30.62 Favored 'Trans proline' 1 N--CA 1.549 4.761 0 CA-C-N 122.02 1.757 . . . . 0.0 113.491 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 173.96 -161.79 32.22 Favored Glycine 1 N--CA 1.517 4.058 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.3 m 58.19 58.84 3.31 Favored 'General case' 0 N--CA 1.52 3.035 0 C-N-CA 124.207 1.003 . . . . 0.0 111.753 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.44 13.04 0.82 Allowed 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.755 0.822 . . . . 0.0 110.66 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.7 m -71.46 -43.15 67.17 Favored 'General case' 0 N--CA 1.519 2.979 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.46 93.28 Favored Glycine 1 N--CA 1.518 4.158 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.272 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.9 tp -57.6 -36.38 53.92 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 118.116 0.958 . . . . 0.0 110.785 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.98 -40.17 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.781 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 216' ' ' ILE . . . . . 0.416 ' N ' HD12 ' B' ' 216' ' ' ILE . 1.5 mp -66.72 -41.3 87.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.144 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -59.25 -36.47 75.54 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.334 0.654 . . . . 0.0 112.042 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.21 -42.27 83.03 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.154 0 CA-C-O 121.023 0.439 . . . . 0.0 110.029 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 5.5 p -63.21 -48.39 78.5 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.602 0.761 . . . . 0.0 110.974 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.6 -42.94 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.441 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.87 75.86 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 122.885 0.474 . . . . 0.0 111.066 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.36 -48.99 68.42 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.05 0.54 . . . . 0.0 111.513 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -38.84 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 C-N-CA 123.248 0.619 . . . . 0.0 110.055 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.15 -32.91 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 C-N-CA 123.099 0.56 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.05 -34.89 79.51 Favored 'General case' 0 N--CA 1.534 3.76 0 C-N-CA 122.83 0.452 . . . . 0.0 111.83 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.66 -54.62 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 C-N-CA 122.804 0.442 . . . . 0.0 111.039 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -36.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.78 82.35 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.5 -34.78 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.215 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.86 -40.18 79.48 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 119.197 0.908 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.01 -31.62 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.808 0 CA-C-N 118.435 0.561 . . . . 0.0 110.964 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.25 -40.72 95.11 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 122.818 0.447 . . . . 0.0 111.345 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.27 -45.43 32.71 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.271 0.628 . . . . 0.0 109.973 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.8 t -63.16 -12.82 30.55 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 122.804 0.442 . . . . 0.0 111.68 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 64.3 tp -89.1 -35.92 16.02 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 124.308 1.043 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -27.59 26.87 Favored 'General case' 1 N--CA 1.543 4.179 0 C-N-CA 123.979 0.912 . . . . 0.0 110.703 -177.59 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -108.63 13.69 25.02 Favored 'General case' 0 N--CA 1.536 3.826 0 C-N-CA 125.063 1.345 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -50.86 -29.23 11.33 Favored 'General case' 0 N--CA 1.524 3.233 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.79 -11.58 0.02 OUTLIER 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 122.886 0.474 . . . . 0.0 110.638 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.01 122.15 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.38 142.16 24.12 Favored Pre-proline 0 N--CA 1.534 3.736 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 1 N--CA 1.541 4.296 0 CA-C-N 122.218 1.828 . . . . 0.0 110.83 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.579 2.088 0 CA-C-O 117.629 -1.177 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -51.06 104.08 0.08 OUTLIER 'Trans proline' 1 N--CA 1.548 4.729 0 CA-C-N 122.442 1.908 . . . . 0.0 113.579 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.01 152.72 50.51 Favored Glycine 1 N--CA 1.518 4.131 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m 55.56 -177.62 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.954 0.902 . . . . 0.0 112.006 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 6.7 tp 66.85 -1.22 1.42 Allowed 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.161 0.985 . . . . 0.0 111.503 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -70.5 -21.03 62.8 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 122.968 0.507 . . . . 0.0 110.857 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.43 -50.14 22.36 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 123.614 0.626 . . . . 0.0 113.814 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.24 -36.65 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 CA-C-N 117.432 0.616 . . . . 0.0 111.149 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.74 -35.1 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 117.942 0.337 . . . . 0.0 110.832 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.37 -42.56 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.737 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -66.58 -42.75 86.52 Favored 'General case' 0 N--CA 1.527 3.414 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.41 -33.47 47.95 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.847 0.749 . . . . 0.0 112.287 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 25.3 p -66.97 -50.27 62.82 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.98 -39.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.74 68.89 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.967 0.507 . . . . 0.0 111.306 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.21 94.06 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 122.841 0.457 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 51.3 t -70.05 -41.17 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 123.622 0.769 . . . . 0.0 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.81 -34.14 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.876 0.871 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.44 -36.76 83.61 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.125 0.57 . . . . 0.0 111.588 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.83 -54.24 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 C-N-CA 123.109 0.564 . . . . 0.0 111.085 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 m -67.76 -42.02 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.34 92.35 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.07 -37.02 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 CA-C-O 118.047 -0.977 . . . . 0.0 112.218 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -73.32 -36.57 66.25 Favored 'General case' 1 N--CA 1.548 4.443 0 CA-C-N 120.631 1.559 . . . . 0.0 109.801 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.86 -32.03 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 C-N-CA 123.188 0.595 . . . . 0.0 109.713 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.56 -38.12 83.51 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 123.304 0.642 . . . . 0.0 111.192 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -51.16 -24.39 4.13 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 124.362 1.065 . . . . 0.0 111.633 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 35.4 t -63.72 -39.81 95.22 Favored 'General case' 0 N--CA 1.52 3.065 0 C-N-CA 122.814 0.446 . . . . 0.0 110.89 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.88 -31.49 69.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.21 -27.75 38.76 Favored 'General case' 0 N--CA 1.537 3.89 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -89.66 -14.6 34.47 Favored 'General case' 1 N--CA 1.542 4.152 0 C-N-CA 123.342 0.657 . . . . 0.0 109.968 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 50.8 tttm 95.19 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.538 3.928 0 C-N-CA 126.09 1.756 . . . . 0.0 113.073 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 80.4 tttt 52.57 54.4 10.67 Favored 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 124.329 1.052 . . . . 0.0 112.812 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 240' ' ' VAL . . . . . 0.465 ' C ' HD22 ' C' ' 241' ' ' LEU . 21.7 m -92.17 122.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.778 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 241' ' ' LEU . . . . . 0.465 HD22 ' C ' ' C' ' 240' ' ' VAL . 3.6 mm? -129.61 134.33 26.09 Favored Pre-proline 0 N--CA 1.536 3.84 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 1 N--CA 1.539 4.171 0 CA-C-N 122.924 2.08 . . . . 0.0 110.652 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m . . . . . 0 N--CA 1.521 3.085 0 N-CA-C 109.979 -0.378 . . . . 422.23000000000002 109.979 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.41 -50.64 9.53 Favored Glycine 0 N--CA 1.511 3.681 0 CA-C-N 115.78 -0.645 . . . . 182.12 113.236 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -66.48 -37.48 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.596 0.698 . . . . 429.51999999999998 111.002 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.89 -41.86 92.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 C-N-CA 122.59 0.356 . . . . 386.43000000000001 110.488 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.58 -45.02 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 O-C-N 121.665 -0.647 . . . . 161.88 109.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.17 -40.56 86.61 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 114.482 1.29 . . . . 999.99000000000001 114.482 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.7 -31.57 40.2 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.227 0 CA-C-N 119.076 0.853 . . . . 168.06 111.209 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.6 p -69.52 -48.63 59.85 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.419 0.688 . . . . 21.5 110.282 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.89 -34.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.192 0 CA-C-N 115.296 -0.865 . . . . 220.71000000000001 109.09 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.83 72.88 Favored 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 123.278 0.631 . . . . 59.039999999999999 111.039 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.68 68.88 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 115.801 -0.636 . . . . 25.920000000000002 111.121 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.62 -45.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 C-N-CA 123.422 0.689 . . . . 37.840000000000003 111.716 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.78 -32.83 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 CA-C-N 118.332 0.514 . . . . 282.56999999999999 110.432 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 49.6 tp -63.98 -36.16 83.06 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.482 0.713 . . . . 170.34999999999999 112.194 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.8 -52.64 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 122.838 0.455 . . . . 145.71000000000001 110.357 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.2 -37.5 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 O-C-N 121.807 -0.558 . . . . 205.37 112.162 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.23 85.35 Favored 'General case' 0 N--CA 1.536 3.836 0 N-CA-C 112.818 0.673 . . . . 54.0 112.818 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 -34.28 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.648 0 N-CA-C 109.838 -0.431 . . . . 167.28 109.838 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -69.76 -42.59 73.65 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 109.647 -0.501 . . . . 382.56 109.647 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.46 -31.96 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.3 0.64 . . . . 396.06 109.474 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.7 t -65.07 -39.37 93.13 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.188 0.595 . . . . 241.93000000000001 110.467 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.67 -33.02 53.52 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.645 0.778 . . . . 962.60000000000002 110.328 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 77.8 p -63.42 -24.1 67.69 Favored 'General case' 0 N--CA 1.533 3.698 0 CA-C-O 120.9 0.381 . . . . 329.86000000000001 110.409 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.93 -33.16 30.49 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 124.094 0.958 . . . . 647.42999999999995 109.577 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 47.0 tp . . . . . 1 N--CA 1.54 4.026 0 C-N-CA 124.619 1.167 . . . . 658.91999999999996 111.832 -177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 63.4 m . . . . . 0 N--CA 1.524 3.234 0 CA-C-O 120.843 0.354 . . . . 322.12 111.41 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.3 -35.82 56.22 Favored Glycine 1 N--CA 1.517 4.047 0 CA-C-N 115.444 -0.798 . . . . 118.7 111.417 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.6 mm -65.87 -36.92 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.747 0.819 . . . . 351.56 110.187 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -65.72 -40.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.59 0 C-N-CA 123.151 0.58 . . . . 318.27999999999997 109.834 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 83.4 mt -70.08 -38.33 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.421 0.688 . . . . 156.47999999999999 109.302 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -62.04 -47.44 84.72 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.504 0.927 . . . . 999.99000000000001 113.504 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 15.2 m -59.24 -27.86 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 O-C-N 122.28 -0.262 . . . . 221.16999999999999 111.223 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.0 p -66.23 -48.22 71.26 Favored 'General case' 0 N--CA 1.535 3.816 0 CA-C-O 121.39 0.614 . . . . 21.870000000000001 110.368 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.13 -51.61 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 CA-C-N 115.281 -0.872 . . . . 176.34 109.076 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.23 -34.69 61.27 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 122.889 0.476 . . . . 36.920000000000002 111.545 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.86 92.38 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 122.717 0.407 . . . . 26.879999999999999 111.166 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 80.5 t -69.75 -46.74 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 N-CA-C 109.471 -0.566 . . . . 93.609999999999999 109.471 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.5 -33.81 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.281 0.632 . . . . 229.62 110.192 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.27 -39.46 92.64 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.778 0.431 . . . . 164.03999999999999 110.632 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.01 -46.91 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 109.042 -0.725 . . . . 134.41999999999999 109.042 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.25 -36.73 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.199 1.0 . . . . 189.86000000000001 111.344 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.0 -31.59 67.08 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.72 0.637 . . . . 50.32 112.72 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.97 -44.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 CA-C-N 118.473 0.579 . . . . 179.11000000000001 109.661 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -66.06 -42.62 89.21 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 122.842 0.457 . . . . 336.06999999999999 110.202 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.08 -38.73 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 N-CA-C 109.509 -0.552 . . . . 298.69999999999999 109.509 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.13 -48.48 67.97 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.003 0.521 . . . . 272.98000000000002 111.418 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.73 -42.12 70.97 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.601 0.76 . . . . 892.98000000000002 111.112 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 98.4 p -63.8 -13.33 43.29 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 119.228 -0.415 . . . . 295.12 111.308 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -37.94 12.99 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.704 0.801 . . . . 751.53999999999996 109.214 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.9 tp . . . . . 0 N--CA 1.531 3.623 0 C-N-CA 123.329 0.652 . . . . 539.80999999999995 110.728 -178.614 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt . . . . . 0 N--CA 1.525 3.306 0 CA-C-O 120.472 0.177 . . . . 581.98000000000002 110.887 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -70.2 -22.52 62.93 Favored 'General case' 0 N--CA 1.52 3.033 0 C-N-CA 122.889 0.476 . . . . 487.95999999999998 109.996 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.4 -50.73 9.39 Favored Glycine 0 N--CA 1.512 3.751 0 CA-C-N 115.926 -0.579 . . . . 126.84 113.157 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.0 tp -66.41 -37.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 117.481 0.641 . . . . 390.08999999999997 110.918 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.62 -41.08 88.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 C-N-CA 122.617 0.367 . . . . 395.69999999999999 110.189 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.42 -38.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 109.37 -0.604 . . . . 188.96000000000001 109.37 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.49 -46.38 83.25 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.995 1.109 . . . . 999.99000000000001 113.995 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.85 -27.89 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.966 0 CA-C-N 118.133 0.424 . . . . 199.56999999999999 111.424 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 23.9 p -69.79 -48.22 59.99 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-O 121.401 0.62 . . . . 22.73 110.227 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.96 -47.72 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 CA-C-N 115.321 -0.854 . . . . 203.96000000000001 108.967 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.62 56.12 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.246 0.618 . . . . 49.700000000000003 111.504 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.21 -44.01 85.08 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 122.969 0.508 . . . . 25.300000000000001 110.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.11 -41.55 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.323 0.649 . . . . 93.879999999999995 109.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.58 -35.28 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.396 0.678 . . . . 243.0 109.935 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.4 -42.41 96.12 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.989 0.516 . . . . 85.120000000000005 111.953 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.27 -51.3 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 C-N-CA 123.186 0.594 . . . . 125.45999999999999 111.196 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.31 -36.85 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 112.751 0.648 . . . . 188.13999999999999 112.751 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.11 -44.71 87.84 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.281 0.845 . . . . 48.460000000000001 113.281 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 30.0 m -59.45 -34.69 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 CA-C-N 118.69 0.677 . . . . 139.06999999999999 110.594 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -71.32 -42.26 68.82 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 109.615 -0.513 . . . . 304.13999999999999 109.615 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.82 -40.03 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 N-CA-C 109.153 -0.684 . . . . 256.41000000000003 109.153 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.4 m -67.09 -40.25 86.92 Favored 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 109.525 -0.546 . . . . 224.28 109.525 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 N--CA 1.528 3.448 0 C-N-CA 123.71 0.804 . . . . 901.13 110.139 179.71 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.6 m . . . . . 0 N--CA 1.524 3.272 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.54 -50.07 70.3 Favored Glycine 0 N--CA 1.514 3.899 0 CA-C-N 114.808 -1.087 . . . . 0.0 114.477 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.7 tp -58.72 -35.91 57.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 CA-C-N 117.863 0.831 . . . . 0.0 110.61 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.64 -34.48 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.077 0.551 . . . . 0.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.69 -45.11 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -67.19 -46.36 74.15 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.71 -40.63 76.56 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 49.9 p -64.75 -49.22 71.64 Favored 'General case' 0 N--CA 1.528 3.43 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.24 -31.59 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.71 71.59 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.825 0.45 . . . . 0.0 111.928 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.88 70.87 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.48 0.312 . . . . 0.0 111.418 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -68.68 -50.93 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 123.514 0.726 . . . . 0.0 111.502 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.29 -31.89 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 122.064 -0.397 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -47.14 66.4 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 123.561 0.744 . . . . 0.0 110.889 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.5 mm -67.77 -42.95 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 C-N-CA 122.794 0.438 . . . . 0.0 110.437 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.4 -39.69 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.576 0.75 . . . . 0.0 111.756 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.27 85.86 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.71 0.404 . . . . 0.0 111.981 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.63 -33.58 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.76 -42.82 99.48 Favored 'General case' 0 N--CA 1.538 3.966 0 C-N-CA 123.245 0.618 . . . . 0.0 110.903 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.96 -32.63 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.955 0.502 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.23 -45.1 89.68 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 122.903 0.481 . . . . 0.0 111.401 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.67 -37.31 73.67 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.222 0.609 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.2 t -63.87 -28.77 70.07 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.414 0.686 . . . . 0.0 111.82 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 59.9 tp -73.74 -37.54 65.03 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 123.688 0.795 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 58.9 mt . . . . . 0 N--CA 1.528 3.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.864 -178.289 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.518 2.934 0 CA-C-O 119.673 -0.203 . . . . 0.0 111.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.44 -50.6 8.06 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.327 0.489 . . . . 0.0 113.912 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.87 -41.03 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.18 -34.04 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 118.874 0.761 . . . . 0.0 111.745 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.37 -44.83 99.63 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.085 0 CA-C-O 120.985 0.421 . . . . 0.0 110.174 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -61.22 -36.9 81.19 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.501 0.72 . . . . 0.0 111.983 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 -36.39 63.17 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.206 0 CA-C-N 118.343 0.52 . . . . 0.0 111.29 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 10.2 p -66.67 -49.8 64.99 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 8.3 p -71.34 -31.9 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.79 79.68 Favored 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 122.768 0.427 . . . . 0.0 111.217 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.36 69.31 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 122.936 0.494 . . . . 0.0 112.106 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.59 -43.07 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.493 0 C-N-CA 123.453 0.701 . . . . 0.0 111.973 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.88 -32.59 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 CA-C-N 118.7 0.682 . . . . 0.0 110.36 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.77 -38.7 75.91 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.172 0.589 . . . . 0.0 111.24 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.11 -52.09 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 CA-C-O 122.04 0.924 . . . . 0.0 109.621 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.59 -36.4 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 C-N-CA 126.02 1.728 . . . . 0.0 113.135 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.47 66.35 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.29 -38.1 76.98 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 118.971 0.805 . . . . 0.0 110.218 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.48 -41.98 75.41 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.112 0.565 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.46 -33.57 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 C-N-CA 122.914 0.486 . . . . 0.0 110.128 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.6 m -67.52 -44.38 78.53 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 121.576 0.703 . . . . 0.0 109.674 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.66 -27.07 65.66 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 124.59 1.156 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.5 t -67.51 -15.85 63.89 Favored 'General case' 0 N--CA 1.52 3.047 0 C-N-CA 123.138 0.575 . . . . 0.0 111.972 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.22 -37.31 13.4 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.57 0.748 . . . . 0.0 111.468 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 N--CA 1.537 3.923 0 C-N-CA 123.025 0.53 . . . . 0.0 110.34 -177.664 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 N--CA 1.528 3.43 0 CA-C-O 120.572 0.225 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 -20.56 62.82 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.275 0.63 . . . . 0.0 109.91 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.29 58.6 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 124.053 0.835 . . . . 0.0 114.109 -177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.5 tt -61.07 -35.57 66.38 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 CA-C-N 117.844 0.822 . . . . 0.0 110.513 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.4 mm -54.71 -33.96 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 C-N-CA 123.401 0.68 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 34.8 mm -69.26 -41.9 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 CA-C-O 121.262 0.553 . . . . 0.0 109.573 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -66.03 -42.45 89.59 Favored 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -57.94 -32.94 44.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.341 0 CA-C-N 119.354 0.979 . . . . 0.0 111.329 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 -48.45 72.36 Favored 'General case' 0 N--CA 1.531 3.608 0 C-N-CA 123.586 0.754 . . . . 0.0 110.979 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.18 -36.92 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.39 0 C-N-CA 123.781 0.832 . . . . 0.0 109.434 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.61 77.27 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 123.442 0.697 . . . . 0.0 111.221 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.97 -38.27 79.27 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 123.131 0.573 . . . . 0.0 112.099 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.19 -46.24 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 C-N-CA 122.729 0.411 . . . . 0.0 111.479 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.16 -32.51 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.643 0 CA-C-N 118.331 0.514 . . . . 0.0 110.305 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 55.0 tp -59.21 -43.59 92.26 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 122.983 0.513 . . . . 0.0 110.78 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.36 -54.13 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.12 -37.19 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.621 1.168 . . . . 0.0 114.082 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.0 71.82 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 119.223 0.92 . . . . 0.0 110.925 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.28 -41.93 72.76 Favored 'General case' 0 N--CA 1.53 3.568 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.01 -35.57 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.55 -48.09 67.97 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.139 0.576 . . . . 0.0 111.748 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 28.7 pttt . . . . . 0 N--CA 1.537 3.88 0 C-N-CA 123.485 0.714 . . . . 0.0 111.643 -177.467 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.522 3.141 0 CA-C-O 121.16 0.505 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.62 -37.4 77.3 Favored Glycine 1 N--CA 1.517 4.088 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.685 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.24 -38.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 C-N-CA 124.45 1.1 . . . . 0.0 110.593 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.08 -38.31 79.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.0 mt -70.11 -37.43 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.08 -47.92 83.47 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.46 -30.93 37.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.395 0 CA-C-N 118.41 0.55 . . . . 0.0 112.218 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -72.2 -48.11 45.62 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 123.47 0.708 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.45 -31.95 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.32 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.24 -34.96 64.45 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.96 -45.47 64.08 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-O 121.162 0.506 . . . . 0.0 111.887 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.15 -38.43 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.886 0.875 . . . . 0.0 112.693 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.44 -32.59 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 CA-C-N 119.334 0.97 . . . . 0.0 111.667 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.05 -47.83 75.97 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.92 -44.96 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.52 -41.08 85.52 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.25 0 CA-C-N 119.53 1.059 . . . . 0.0 112.986 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.34 -43.47 92.74 Favored 'General case' 0 N--CA 1.53 3.549 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.86 -34.54 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.16 -42.36 69.19 Favored 'General case' 1 N--CA 1.539 4.005 0 CA-C-N 118.831 0.741 . . . . 0.0 109.819 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.25 -34.96 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.572 0.749 . . . . 0.0 109.792 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.92 -43.13 84.07 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.282 0.633 . . . . 0.0 111.012 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 123.9 0.88 . . . . 0.0 111.273 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.76 -16.23 60.65 Favored 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 123.215 0.606 . . . . 0.0 111.814 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 mt -91.21 -37.59 13.23 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.854 0.861 . . . . 0.0 111.308 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? . . . . . 1 N--CA 1.541 4.086 0 C-N-CA 123.489 0.716 . . . . 0.0 110.589 -178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.8 p . . . . . 0 N--CA 1.528 3.437 0 N-CA-C 110.508 -0.182 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -49.23 14.87 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 124.202 0.906 . . . . 0.0 113.17 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -36.64 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.347 0 C-N-CA 123.262 0.625 . . . . 0.0 110.163 -177.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.41 -34.09 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 21.1 mm -67.29 -40.62 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 CA-C-O 121.386 0.612 . . . . 0.0 109.958 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -64.63 -46.42 82.64 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 m -62.56 -34.13 63.33 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 CA-C-N 118.495 0.589 . . . . 0.0 112.334 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 66.8 p -66.36 -49.22 67.65 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.119 0.568 . . . . 0.0 112.192 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.76 -37.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.62 88.09 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 122.582 0.353 . . . . 0.0 110.713 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.73 95.68 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 122.962 0.505 . . . . 0.0 111.817 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.3 -45.34 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.5 -32.93 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 C-N-CA 123.689 0.795 . . . . 0.0 109.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.8 tp -60.51 -40.82 92.83 Favored 'General case' 0 N--CA 1.535 3.783 0 C-N-CA 122.739 0.415 . . . . 0.0 110.577 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.46 -53.83 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.494 0.664 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.52 -37.96 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 124.208 1.003 . . . . 0.0 113.054 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.64 90.61 Favored 'General case' 1 N--CA 1.54 4.038 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.25 -34.34 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 C-N-CA 122.942 0.497 . . . . 0.0 109.883 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -43.25 79.87 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 122.657 0.383 . . . . 0.0 111.582 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.09 -31.65 51.03 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.47 0.577 . . . . 0.0 110.31 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.68 -45.03 93.31 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.152 0.581 . . . . 0.0 111.982 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -70.35 -24.87 63.05 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.169 0.587 . . . . 0.0 111.592 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.532 3.671 0 CA-C-N 118.413 0.552 . . . . 0.0 110.503 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.3 -14.33 31.03 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.645 1.178 . . . . 0.0 110.406 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.6 tp . . . . . 0 N--CA 1.536 3.857 0 CA-C-N 118.405 0.548 . . . . 0.0 111.425 -176.941 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 tm? . . . . . 0 N--CA 1.523 3.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -68.81 -34.14 75.03 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.931 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.53 -31.14 65.76 Favored Glycine 0 N--CA 1.514 3.897 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.406 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.86 -36.69 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 123.856 0.862 . . . . 0.0 110.46 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.06 -36.32 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 123.197 0.599 . . . . 0.0 109.649 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.51 -39.09 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -64.04 -41.75 97.3 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.45 -27.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-N 118.842 0.746 . . . . 0.0 111.486 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -68.54 -49.42 59.69 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.89 -38.44 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.75 68.29 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 123.038 0.535 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.41 91.67 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.155 0.582 . . . . 0.0 111.395 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.03 -43.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.723 0.809 . . . . 0.0 109.166 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -32.91 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 C-N-CA 123.953 0.901 . . . . 0.0 109.785 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -47.43 79.53 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.3 -55.86 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 19.9 m -68.35 -38.38 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.83 Favored 'General case' 0 N--CA 1.534 3.732 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.32 -34.73 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.884 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.87 -42.63 69.81 Favored 'General case' 1 N--CA 1.539 4.006 0 CA-C-N 119.559 1.072 . . . . 0.0 111.419 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 32.3 m -68.63 -31.24 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 122.066 -0.396 . . . . 0.0 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.21 -48.19 81.11 Favored 'General case' 0 N--CA 1.523 3.208 0 C-N-CA 123.203 0.601 . . . . 0.0 111.615 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.2 mttt . . . . . 0 N--CA 1.527 3.396 0 C-N-CA 123.159 0.583 . . . . 0.0 110.709 -179.11 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.525 3.294 0 CA-C-O 121.375 0.607 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.49 -29.53 74.97 Favored Glycine 1 N--CA 1.517 4.092 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.903 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.06 -36.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 123.62 0.768 . . . . 0.0 110.504 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.26 -36.64 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 C-N-CA 122.879 0.472 . . . . 0.0 110.383 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.18 -42.89 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 CA-C-O 121.802 0.811 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.99 -44.48 92.56 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.31 -33.27 53.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 CA-C-N 118.898 0.772 . . . . 0.0 112.117 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -66.82 -49.67 65.04 Favored 'General case' 0 N--CA 1.529 3.501 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.09 -37.24 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.82 -34.85 70.11 Favored 'General case' 0 N--CA 1.526 3.346 0 C-N-CA 122.664 0.386 . . . . 0.0 111.281 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.94 97.74 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 122.966 0.506 . . . . 0.0 111.727 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.05 -41.4 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.466 0 C-N-CA 123.538 0.735 . . . . 0.0 109.828 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.0 t -67.33 -32.82 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.791 0.836 . . . . 0.0 110.132 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.81 -48.05 73.02 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 18.6 tt -71.24 -44.46 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.8 m -66.86 -37.37 79.3 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.537 0 CA-C-N 120.447 1.476 . . . . 0.0 112.364 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.11 -31.84 69.29 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.62 -35.08 73.76 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.083 0.856 . . . . 0.0 111.011 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.89 -37.27 81.53 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-O 120.893 0.378 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.05 -40.66 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 C-N-CA 123.748 0.819 . . . . 0.0 109.792 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.79 -42.18 86.43 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.348 0.659 . . . . 0.0 110.472 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 65.8 tttm -56.06 -29.39 60.44 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 124.46 1.104 . . . . 0.0 111.901 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.4 t -63.86 -22.79 67.08 Favored 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 122.914 0.485 . . . . 0.0 111.558 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -90.63 -18.18 25.59 Favored 'General case' 0 N--CA 1.534 3.733 0 C-N-CA 123.78 0.832 . . . . 0.0 109.956 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 1 N--CA 1.54 4.063 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.526 3.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.03 60.45 Favored Glycine 1 N--CA 1.519 4.194 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.367 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.63 -45.97 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.245 0 C-N-CA 124.056 0.942 . . . . 0.0 111.255 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.24 -36.8 77.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.078 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.15 -39.52 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 123.335 0.654 . . . . 0.0 109.32 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -67.01 -44.31 80.63 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 23.5 m -57.71 -27.94 31.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 CA-C-N 118.984 0.811 . . . . 0.0 111.756 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 26.4 p -71.9 -48.58 44.56 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.329 0.651 . . . . 0.0 110.301 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 -31.81 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.306 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.56 81.56 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.409 0.683 . . . . 0.0 111.384 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.94 98.77 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 121.153 0.501 . . . . 0.0 111.499 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.08 -38.5 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 123.766 0.826 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -33.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.446 0.698 . . . . 0.0 111.394 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.58 -39.01 92.33 Favored 'General case' 0 N--CA 1.533 3.676 0 C-N-CA 122.454 0.302 . . . . 0.0 111.561 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.16 -55.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.77 -36.5 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.01 0.924 . . . . 0.0 113.237 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.39 67.72 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.35 -40.35 85.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 119.072 0.851 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -63.07 -38.97 93.3 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 122.641 0.376 . . . . 0.0 110.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.36 -39.8 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 C-N-CA 123.632 0.773 . . . . 0.0 109.703 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.81 -45.69 77.52 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.77 0.828 . . . . 0.0 110.995 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -70.49 -41.88 72.1 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.864 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 94.2 p -63.15 -27.05 69.11 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 122.834 0.454 . . . . 0.0 110.624 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -79.19 -31.16 43.74 Favored 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.7 tp . . . . . 0 N--CA 1.528 3.454 0 C-N-CA 123.07 0.548 . . . . 0.0 110.165 -178.571 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? . . . . . 0 N--CA 1.53 3.563 0 CA-C-O 121.559 0.695 . . . . 0.0 110.1 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -70.91 -20.87 62.44 Favored 'General case' 0 N--CA 1.523 3.211 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.773 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.59 -50.03 16.61 Favored Glycine 0 N--CA 1.512 3.749 0 C-N-CA 124.201 0.905 . . . . 0.0 113.711 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.39 -35.65 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 CA-C-N 117.924 0.862 . . . . 0.0 111.364 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.08 -34.81 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 122.626 0.37 . . . . 0.0 110.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.23 -42.25 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.11 -40.45 97.66 Favored 'General case' 0 N--CA 1.526 3.364 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.57 -27.81 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 119.131 0.878 . . . . 0.0 111.906 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 33.8 p -69.13 -49.61 55.45 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.98 -39.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.57 -34.73 69.51 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 122.906 0.482 . . . . 0.0 111.268 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.26 99.38 Favored 'General case' 0 N--CA 1.522 3.161 0 C-N-CA 123.127 0.571 . . . . 0.0 111.604 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.16 -43.21 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.261 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.94 -32.22 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 123.883 0.873 . . . . 0.0 109.367 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -47.18 74.67 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 122.969 0.508 . . . . 0.0 109.824 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.76 -51.41 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.44 0.696 . . . . 0.0 110.404 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.44 -37.9 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.803 0.841 . . . . 0.0 112.748 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.09 82.85 Favored 'General case' 0 N--CA 1.539 3.977 0 CA-C-N 118.542 0.61 . . . . 0.0 112.186 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.17 -33.68 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.349 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.21 -43.18 99.41 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 123.246 0.618 . . . . 0.0 110.517 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.69 -34.75 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 C-N-CA 123.103 0.561 . . . . 0.0 109.674 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.15 -27.68 69.25 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.259 0.624 . . . . 0.0 111.233 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm . . . . . 0 N--CA 1.531 3.605 0 C-N-CA 123.527 0.731 . . . . 0.0 110.922 -179.716 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t . . . . . 0 N--CA 1.531 3.577 0 CA-C-O 121.254 0.549 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.04 97.73 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.729 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.78 -36.03 63.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.127 0 CA-C-N 117.885 0.843 . . . . 0.0 111.679 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.58 -37.58 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.21 0.604 . . . . 0.0 109.708 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.05 -41.06 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -59.61 -48.47 81.52 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 124.5 1.12 . . . . 0.0 114.015 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.8 m -59.7 -32.36 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.914 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -72.15 -48.99 39.49 Favored 'General case' 0 N--CA 1.533 3.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.859 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.62 -32.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.696 0.398 . . . . 0.0 110.044 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.97 74.01 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.235 0.614 . . . . 0.0 111.332 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.44 77.49 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.396 0.278 . . . . 0.0 111.571 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.06 -43.62 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.512 0.725 . . . . 0.0 112.084 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.09 -32.86 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 CA-C-N 118.919 0.781 . . . . 0.0 111.931 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.1 mt -60.65 -36.92 79.87 Favored 'General case' 0 N--CA 1.537 3.898 0 CA-C-N 117.97 0.35 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.08 -47.72 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-O 121.489 0.662 . . . . 0.0 109.332 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.3 t -67.0 -37.73 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.263 0 C-N-CA 124.202 1.001 . . . . 0.0 111.606 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.11 90.25 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.94 -34.5 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 122.777 0.431 . . . . 0.0 109.943 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.81 -42.45 73.67 Favored 'General case' 1 N--CA 1.544 4.273 0 CA-C-N 118.875 0.762 . . . . 0.0 109.564 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.1 -31.66 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.13 -46.26 84.92 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.299 0.64 . . . . 0.0 111.472 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -69.0 -38.11 79.1 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.408 0.683 . . . . 0.0 110.772 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.6 p -63.77 -34.92 78.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 123.206 0.602 . . . . 0.0 110.668 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.78 -37.21 70.48 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 124.091 0.956 . . . . 0.0 109.731 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 59.1 tp . . . . . 0 N--CA 1.528 3.426 0 C-N-CA 123.925 0.89 . . . . 0.0 110.397 -179.308 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.7 p . . . . . 0 N--CA 1.525 3.321 0 CA-C-O 121.286 0.565 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.55 -30.27 62.42 Favored Glycine 0 N--CA 1.515 3.917 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.01 -36.83 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.662 0.785 . . . . 0.0 110.662 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.02 -37.82 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 C-N-CA 123.068 0.547 . . . . 0.0 109.605 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.9 -37.89 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -62.7 -46.41 88.26 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.95 -38.86 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 118.583 0.629 . . . . 0.0 112.074 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -64.46 -48.96 73.3 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.72 -37.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.32 80.54 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.57 0.348 . . . . 0.0 111.097 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.39 70.85 Favored 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.86 -38.61 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 O-C-N 122.121 -0.362 . . . . 0.0 110.416 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.2 t -64.83 -32.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 123.495 0.718 . . . . 0.0 110.016 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.44 -36.91 76.81 Favored 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 122.615 0.366 . . . . 0.0 110.28 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.4 -52.28 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 123.327 0.651 . . . . 0.0 109.435 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.28 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 C-N-CA 124.322 1.049 . . . . 0.0 112.85 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.77 83.42 Favored 'General case' 0 N--CA 1.537 3.916 0 CA-C-N 118.607 0.64 . . . . 0.0 112.338 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -69.33 -33.83 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 C-N-CA 123.497 0.719 . . . . 0.0 109.091 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.56 -42.67 99.18 Favored 'General case' 0 N--CA 1.537 3.892 0 C-N-CA 123.498 0.719 . . . . 0.0 111.33 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.09 -31.76 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.126 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.22 -46.51 80.37 Favored 'General case' 0 N--CA 1.529 3.503 0 CA-C-O 120.776 0.322 . . . . 0.0 111.005 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.66 -25.21 59.04 Favored 'General case' 0 N--CA 1.525 3.308 0 C-N-CA 123.547 0.739 . . . . 0.0 111.021 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 60.5 p -65.17 -33.57 76.33 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.654 0.382 . . . . 0.0 111.065 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 66.5 mt -90.78 -21.1 21.69 Favored 'General case' 0 N--CA 1.531 3.598 0 C-N-CA 124.122 0.969 . . . . 0.0 111.0 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 1 N--CA 1.543 4.213 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt . . . . . 0 N--CA 1.53 3.549 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 88.2 p -66.63 -39.55 88.33 Favored 'General case' 0 N--CA 1.528 3.438 0 C-N-CA 123.289 0.636 . . . . 0.0 109.931 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.44 -32.79 82.33 Favored Glycine 1 N--CA 1.519 4.201 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.366 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.57 -36.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.73 -34.24 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 C-N-CA 123.713 0.805 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.48 -43.68 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 CA-C-O 121.774 0.797 . . . . 0.0 109.337 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -67.18 -43.51 82.03 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.62 -36.65 55.05 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.288 0 CA-C-N 118.934 0.788 . . . . 0.0 111.47 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -65.95 -48.46 71.26 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.435 0.694 . . . . 0.0 111.149 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.97 -34.76 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.524 0.73 . . . . 0.0 109.826 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.85 75.62 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.04 74.49 Favored 'General case' 0 N--CA 1.519 3.007 0 C-N-CA 122.511 0.324 . . . . 0.0 111.555 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.87 -44.89 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.164 0.586 . . . . 0.0 111.939 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -65.98 -32.85 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 CA-C-N 118.648 0.658 . . . . 0.0 110.834 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.88 -43.19 98.79 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.125 0.57 . . . . 0.0 111.181 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.33 -52.94 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.252 0.621 . . . . 0.0 110.156 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.48 -37.16 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 124.759 1.224 . . . . 0.0 113.726 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.12 -35.86 72.09 Favored 'General case' 0 N--CA 1.537 3.88 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.88 -34.88 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.972 0.806 . . . . 0.0 110.526 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -69.38 -42.3 75.35 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.22 -42.44 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 73.0 m -67.18 -48.07 69.05 Favored 'General case' 0 N--CA 1.528 3.453 0 CA-C-O 121.448 0.642 . . . . 0.0 110.542 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.3 tttp . . . . . 0 N--CA 1.523 3.215 0 C-N-CA 124.256 1.022 . . . . 0.0 111.248 -178.884 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p . . . . . 0 N--CA 1.524 3.24 0 CA-C-O 120.451 0.167 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.99 -50.29 8.79 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.491 0.567 . . . . 0.0 113.893 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.74 -36.92 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -59.24 -33.22 50.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 118.57 0.623 . . . . 0.0 111.022 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.65 -43.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.32 -34.73 77.96 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.48 -36.95 55.33 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.511 0 CA-C-N 119.906 1.23 . . . . 0.0 111.562 -175.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.1 p -67.1 -48.58 67.74 Favored 'General case' 0 N--CA 1.525 3.312 0 C-N-CA 123.547 0.739 . . . . 0.0 110.358 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.42 -31.87 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.92 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.94 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.115 0.566 . . . . 0.0 111.378 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.35 72.97 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 122.879 0.472 . . . . 0.0 111.689 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.95 -46.2 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.42 0 C-N-CA 123.377 0.671 . . . . 0.0 111.892 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.47 -32.42 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 CA-C-N 118.057 0.39 . . . . 0.0 111.074 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.02 -47.68 61.13 Favored 'General case' 0 N--CA 1.525 3.289 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.65 -41.53 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.7 -47.91 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.6 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.42 89.26 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.13 -37.61 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.612 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -34.09 65.56 Favored 'General case' 1 N--CA 1.549 4.512 0 CA-C-N 120.371 1.441 . . . . 0.0 109.991 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.78 -33.51 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.18 -33.15 74.87 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.77 27.66 Favored 'General case' 1 N--CA 1.541 4.105 0 CA-C-N 118.968 0.804 . . . . 0.0 110.443 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 33.7 t -63.03 -43.36 98.91 Favored 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -86.88 -14.67 41.3 Favored 'General case' 1 N--CA 1.549 4.515 0 CA-C-N 118.229 0.468 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt . . . . . 0 N--CA 1.538 3.964 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.42 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.5 m . . . . . 0 N--CA 1.527 3.392 0 N-CA-C 111.241 0.089 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.57 -40.92 31.02 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.718 0.675 . . . . 0.0 111.432 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.51 -43.63 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 124.583 1.153 . . . . 0.0 112.311 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.25 -33.71 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 C-N-CA 122.753 0.421 . . . . 0.0 111.002 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.4 -41.01 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.93 -45.49 89.01 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.69 -30.88 38.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.943 0.792 . . . . 0.0 111.782 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 29.6 p -69.69 -48.64 58.97 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.377 0.671 . . . . 0.0 110.606 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.87 -32.26 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.595 0.758 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.52 78.83 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.323 0.649 . . . . 0.0 111.817 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.37 71.66 Favored 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 122.854 0.461 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.37 -44.0 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.377 0.671 . . . . 0.0 111.591 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.88 -32.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.529 -0.732 . . . . 0.0 110.427 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.23 -47.58 76.33 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.86 -43.18 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.93 -37.4 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.117 0.872 . . . . 0.0 112.738 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.66 68.38 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -66.38 -34.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.984 0.811 . . . . 0.0 110.864 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -66.6 -33.8 76.47 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 122.682 0.393 . . . . 0.0 110.513 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.37 -42.56 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 123.25 0.62 . . . . 0.0 109.717 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.8 t -65.46 -45.61 83.08 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.489 0.716 . . . . 0.0 111.085 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.05 -47.03 60.82 Favored 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.68 0.792 . . . . 0.0 110.896 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 97.9 p -63.67 -13.68 45.04 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.846 0.458 . . . . 0.0 111.879 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.34 -34.68 15.6 Favored 'General case' 0 N--CA 1.531 3.58 0 C-N-CA 123.928 0.891 . . . . 0.0 110.512 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 1 N--CA 1.539 4.019 0 C-N-CA 123.991 0.916 . . . . 0.0 112.296 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.7 tm? . . . . . 0 N--CA 1.53 3.539 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.7 p -61.5 -21.96 64.68 Favored 'General case' 0 N--CA 1.53 3.539 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.91 86.59 Favored Glycine 0 N--CA 1.509 3.528 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.782 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.58 71.46 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.082 0 CA-C-O 121.224 0.535 . . . . 0.0 109.651 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.55 -35.75 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 C-N-CA 123.07 0.548 . . . . 0.0 109.589 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 29.7 mm -69.99 -38.82 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -63.57 -45.55 89.94 Favored 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.94 -29.7 36.63 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.252 0 CA-C-N 118.929 0.786 . . . . 0.0 111.484 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 21.2 p -68.77 -48.71 63.01 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.2 0.6 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.41 -36.18 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.443 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.49 -37.56 74.22 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.762 0.425 . . . . 0.0 110.943 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.44 -45.52 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.366 0 C-N-CA 123.461 0.704 . . . . 0.0 111.5 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.29 -33.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 121.371 -0.831 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.83 -47.55 80.36 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 123.229 0.612 . . . . 0.0 112.402 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 7.9 tp -70.65 -38.86 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.78 -36.02 76.19 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 C-N-CA 124.022 0.929 . . . . 0.0 111.341 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.53 74.68 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 13.3 m -72.49 -35.8 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 CA-C-N 118.427 0.558 . . . . 0.0 111.761 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -70.98 -42.34 69.82 Favored 'General case' 0 N--CA 1.533 3.681 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.17 -35.93 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 CA-C-N 118.287 0.494 . . . . 0.0 110.985 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.6 m -66.6 -36.52 82.81 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-O 121.215 0.531 . . . . 0.0 109.929 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 N--CA 1.523 3.202 0 C-N-CA 123.939 0.896 . . . . 0.0 109.908 179.657 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 N--CA 1.524 3.258 0 CA-C-O 121.266 0.555 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.61 -36.49 48.55 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.24 -47.75 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.299 1.04 . . . . 0.0 110.997 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.47 -34.54 70.17 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.993 0.361 . . . . 0.0 110.792 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.5 -48.16 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.32 -38.57 85.12 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.79 -36.89 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.43 0 CA-C-N 119.645 1.111 . . . . 0.0 111.339 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.0 p -66.9 -48.41 68.81 Favored 'General case' 0 N--CA 1.524 3.235 0 C-N-CA 123.665 0.786 . . . . 0.0 110.714 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.68 -31.68 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 C-N-CA 123.918 0.887 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.42 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.034 0.533 . . . . 0.0 111.147 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.04 68.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 122.929 0.492 . . . . 0.0 111.947 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.84 -44.05 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.548 0.739 . . . . 0.0 111.981 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.57 -32.56 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 CA-C-N 118.323 0.511 . . . . 0.0 110.766 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.81 -34.93 76.8 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.22 0.608 . . . . 0.0 112.513 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -69.82 -54.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 118.075 0.398 . . . . 0.0 111.326 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.15 -36.59 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.84 66.91 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.1 -34.85 73.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.075 0 CA-C-N 119.306 0.957 . . . . 0.0 110.816 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.69 -36.64 76.14 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 122.958 0.503 . . . . 0.0 110.021 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 80.9 t -67.35 -44.54 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.516 0.727 . . . . 0.0 109.444 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 86.3 m -61.74 -41.95 98.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.327 0.651 . . . . 0.0 110.746 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -68.11 -39.93 82.68 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.933 0.893 . . . . 0.0 109.911 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -64.97 -40.11 94.5 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.444 0.697 . . . . 0.0 110.393 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -37.2 82.63 Favored 'General case' 0 N--CA 1.533 3.717 0 C-N-CA 124.309 1.044 . . . . 0.0 110.068 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.4 tp . . . . . 0 N--CA 1.53 3.56 0 C-N-CA 123.061 0.544 . . . . 0.0 110.248 -178.876 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 99.4 p . . . . . 0 N--CA 1.526 3.359 0 CA-C-O 121.326 0.584 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.97 -45.55 20.18 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.416 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -38.66 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.845 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -69.04 -34.78 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.709 -0.619 . . . . 0.0 110.975 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.25 -39.71 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -58.39 -49.08 78.52 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.8 -33.68 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -70.06 -49.17 53.78 Favored 'General case' 0 N--CA 1.529 3.502 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.18 -33.19 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 122.671 0.388 . . . . 0.0 110.372 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.32 78.08 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.09 0.556 . . . . 0.0 111.001 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.42 80.18 Favored 'General case' 0 N--CA 1.52 3.066 0 C-N-CA 122.777 0.431 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.22 -50.65 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 123.04 0.536 . . . . 0.0 111.09 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 m -62.88 -32.27 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 O-C-N 121.926 -0.484 . . . . 0.0 110.792 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.45 -43.02 88.67 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.334 0.654 . . . . 0.0 111.465 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -70.21 -48.01 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.24 -37.75 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 124.118 0.967 . . . . 0.0 112.584 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.539 3.994 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.86 -33.98 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.93 -43.34 93.07 Favored 'General case' 0 N--CA 1.535 3.789 0 C-N-CA 123.188 0.595 . . . . 0.0 112.532 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.9 -30.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 O-C-N 122.263 -0.273 . . . . 0.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 36.9 t -58.63 -46.0 88.04 Favored 'General case' 0 N--CA 1.526 3.337 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -74.09 -32.5 63.27 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 118.225 0.466 . . . . 0.0 111.187 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 83.4 p -63.22 -23.78 67.58 Favored 'General case' 0 N--CA 1.53 3.562 0 C-N-CA 122.717 0.407 . . . . 0.0 111.132 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.85 -23.13 22.87 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.886 0.874 . . . . 0.0 109.917 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.6 tp . . . . . 0 N--CA 1.534 3.766 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.524 3.248 0 CA-C-O 119.722 -0.18 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 89.3 p -70.66 -30.9 67.63 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.203 0.601 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.01 9.86 Favored Glycine 1 N--CA 1.516 4.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.167 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 214' ' ' ILE . 0.2 OUTLIER -63.38 -42.08 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 C-N-CA 123.345 0.658 . . . . 0.0 111.759 -176.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.96 -34.88 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.874 -0.516 . . . . 0.0 111.746 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.34 -43.95 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.74 -43.55 83.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.5 -38.48 63.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.132 0 CA-C-N 118.886 0.766 . . . . 0.0 111.987 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 31.3 p -66.08 -48.05 72.25 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.406 0.682 . . . . 0.0 111.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.1 -33.36 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 C-N-CA 123.638 0.775 . . . . 0.0 109.683 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.72 -34.61 76.09 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.73 73.99 Favored 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 122.603 0.361 . . . . 0.0 111.537 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.47 -44.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.332 0.653 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.13 -32.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 CA-C-N 118.61 0.641 . . . . 0.0 110.857 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.87 -42.12 93.04 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.216 0.606 . . . . 0.0 111.511 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 63.0 mt -70.14 -48.79 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.35 -36.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 124.972 1.309 . . . . 0.0 113.091 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.73 67.03 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.83 -36.79 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.918 0.781 . . . . 0.0 110.24 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -70.61 -42.25 71.21 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.977 0.511 . . . . 0.0 109.887 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.07 -35.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.24 -38.83 85.83 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 123.362 0.665 . . . . 0.0 110.323 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 81.8 tttt . . . . . 0 N--CA 1.531 3.577 0 C-N-CA 124.954 1.301 . . . . 0.0 111.902 -179.097 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 96.8 p . . . . . 0 N--CA 1.526 3.354 0 CA-C-O 121.183 0.516 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.94 -29.86 62.26 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.437 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.03 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.702 0.801 . . . . 0.0 110.499 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.19 -38.39 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.288 0.635 . . . . 0.0 109.93 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.16 -39.1 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -67.02 -46.71 73.65 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.06 -35.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.947 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.1 p -66.5 -49.49 66.39 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.84 -32.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.35 78.28 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 122.531 0.333 . . . . 0.0 111.665 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.49 73.98 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 122.628 0.371 . . . . 0.0 111.818 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.9 t -69.96 -43.46 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.324 0.649 . . . . 0.0 111.722 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.27 -32.6 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.581 0.628 . . . . 0.0 110.547 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.18 -34.63 72.35 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.19 -55.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 CA-C-N 117.868 0.304 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.87 -37.14 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.45 81.47 Favored 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.19 -34.78 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.453 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.397 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -69.56 -42.5 74.49 Favored 'General case' 1 N--CA 1.539 4.021 0 CA-C-N 119.407 1.003 . . . . 0.0 111.345 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.7 -31.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 O-C-N 121.981 -0.449 . . . . 0.0 110.303 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.96 -37.27 81.84 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.523 0.729 . . . . 0.0 111.696 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -82.84 -25.19 32.85 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.428 0.691 . . . . 0.0 110.449 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 m -68.02 -43.41 78.87 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.058 0.543 . . . . 0.0 111.828 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.1 -24.5 47.53 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.791 0.437 . . . . 0.0 111.143 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 57.9 tp . . . . . 0 N--CA 1.532 3.661 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.196 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.518 2.942 0 CA-C-O 120.727 0.299 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.84 -50.12 9.39 Favored Glycine 0 N--CA 1.516 3.971 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.271 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.87 -36.71 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 122.984 0.514 . . . . 0.0 112.112 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 36.6 pt -62.9 -33.75 62.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 CA-C-N 119.185 0.902 . . . . 0.0 110.852 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 84.3 mt -69.67 -39.25 77.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -66.14 -43.34 87.35 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.84 -28.18 32.4 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.37 0.986 . . . . 0.0 111.345 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 19.4 p -66.3 -48.52 70.1 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 123.509 0.723 . . . . 0.0 111.063 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -39.47 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 C-N-CA 123.694 0.797 . . . . 0.0 109.186 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.49 71.6 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.664 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.9 -33.21 75.31 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 122.712 0.405 . . . . 0.0 111.373 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.02 -48.54 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.334 0 C-N-CA 123.139 0.576 . . . . 0.0 111.102 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.55 -32.38 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 O-C-N 121.577 -0.702 . . . . 0.0 110.377 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.65 -47.78 83.28 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 123.424 0.689 . . . . 0.0 112.471 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -70.75 -37.48 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.879 0 CA-C-N 118.302 0.501 . . . . 0.0 110.085 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.92 -37.57 79.67 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 C-N-CA 123.155 0.582 . . . . 0.0 111.084 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.93 68.19 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.39 -37.08 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-N 118.893 0.769 . . . . 0.0 110.405 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -70.28 -42.08 72.56 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 122.739 0.416 . . . . 0.0 109.934 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.7 -42.63 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.26 -28.65 68.22 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 123.025 0.53 . . . . 0.0 111.062 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -68.18 -35.72 78.48 Favored 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 123.584 0.754 . . . . 0.0 110.617 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.7 m -63.59 -23.29 67.32 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.166 0.587 . . . . 0.0 109.828 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.6 -33.32 68.91 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.549 1.139 . . . . 0.0 108.299 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 44.4 mt . . . . . 0 N--CA 1.524 3.273 0 C-N-CA 123.613 0.765 . . . . 0.0 110.149 -179.291 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.518 2.973 0 CA-C-O 121.615 0.722 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 36.4 t -69.62 -24.93 63.72 Favored 'General case' 0 N--CA 1.524 3.251 0 O-C-N 121.532 -0.73 . . . . 0.0 110.007 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.32 -46.19 57.88 Favored Glycine 0 N--CA 1.511 3.669 0 C-N-CA 124.513 1.054 . . . . 0.0 114.242 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 13.6 tt -59.14 -36.36 62.37 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.303 0 CA-C-N 118.233 1.016 . . . . 0.0 111.03 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.83 -34.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.391 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 216' ' ' ILE . 1.6 mp -70.22 -41.8 78.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-N 119.175 0.898 . . . . 0.0 108.73 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.54 -45.27 94.49 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.6 -37.26 78.47 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.658 0.663 . . . . 0.0 112.025 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 73.0 p -65.41 -48.85 71.39 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 123.201 0.6 . . . . 0.0 112.512 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.45 -32.09 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.26 80.32 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 122.766 0.426 . . . . 0.0 111.792 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.43 55.17 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.66 -38.37 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.23 -32.29 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.994 -0.441 . . . . 0.0 110.536 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.1 -34.88 75.65 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 122.966 0.506 . . . . 0.0 111.557 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.49 -54.78 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 122.899 0.479 . . . . 0.0 111.475 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.04 -35.86 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.853 0 C-N-CA 124.236 1.015 . . . . 0.0 112.893 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.36 66.19 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.47 -34.51 66.0 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.502 1.047 . . . . 0.0 110.487 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.83 -26.22 66.81 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 122.836 0.454 . . . . 0.0 110.871 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -37.74 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.83 -40.44 88.0 Favored 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 123.487 0.715 . . . . 0.0 109.577 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.8 tttt . . . . . 0 N--CA 1.525 3.285 0 C-N-CA 124.219 1.008 . . . . 0.0 109.782 179.244 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.534 3.734 0 N-CA-C 112.241 0.459 . . . . 0.0 112.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -42.11 40.79 Favored Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.097 0.873 . . . . 0.0 111.26 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.6 mm -57.96 -38.88 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 124.223 1.009 . . . . 0.0 110.861 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.86 -34.52 31.03 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 CA-C-O 119.458 -0.306 . . . . 0.0 111.029 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.6 mp -70.57 -49.13 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 CA-C-N 119.279 0.945 . . . . 0.0 108.804 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -67.88 -27.55 66.76 Favored 'General case' 0 N--CA 1.53 3.564 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -56.46 -38.85 58.16 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.546 0 CA-C-N 120.109 1.322 . . . . 0.0 112.084 -174.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.3 p -64.05 -48.08 77.66 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 123.907 0.883 . . . . 0.0 110.769 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.87 -44.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.124 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.78 58.77 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.455 0.702 . . . . 0.0 111.812 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.64 95.89 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 122.998 0.519 . . . . 0.0 111.718 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -39.04 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.429 0.692 . . . . 0.0 109.719 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.82 -34.32 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.652 0.781 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -37.29 86.63 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.066 0.546 . . . . 0.0 111.881 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.13 -54.42 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 C-N-CA 122.911 0.484 . . . . 0.0 111.433 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.55 -36.3 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 C-N-CA 124.374 1.07 . . . . 0.0 113.747 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.68 -31.02 65.94 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.3 -38.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 119.036 0.834 . . . . 0.0 110.472 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.33 -32.76 73.11 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.899 0.48 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.61 -37.9 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.614 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.33 -46.67 72.78 Favored 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 123.397 0.679 . . . . 0.0 110.352 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.24 -26.64 65.8 Favored 'General case' 0 N--CA 1.524 3.265 0 C-N-CA 124.114 0.966 . . . . 0.0 110.915 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 68.9 m -63.33 -21.67 66.41 Favored 'General case' 0 N--CA 1.529 3.515 0 CA-C-N 118.133 0.424 . . . . 0.0 110.049 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 57.4 mt -91.44 -17.33 25.95 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 124.375 1.07 . . . . 0.0 110.592 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 53.1 tp . . . . . 0 N--CA 1.537 3.904 0 CA-C-O 119.029 -0.51 . . . . 0.0 112.179 -176.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.531 3.602 0 CA-C-O 121.106 0.479 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -24.79 75.56 Favored Glycine 0 N--CA 1.505 3.279 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.55 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -59.77 -48.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.982 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.14 -33.75 65.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 O-C-N 122.154 -0.341 . . . . 0.0 110.221 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.62 -38.93 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -67.12 -43.78 81.59 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.75 -32.72 43.48 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.367 0 CA-C-N 119.136 0.88 . . . . 0.0 111.645 -176.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -64.93 -48.22 74.88 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.51 0.724 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.03 -46.14 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.477 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -34.88 58.76 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 123.123 0.569 . . . . 0.0 111.903 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.13 91.93 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.825 0.45 . . . . 0.0 111.955 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.14 -40.12 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.273 0.629 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.36 -33.0 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 123.667 0.787 . . . . 0.0 110.151 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.31 -47.48 73.42 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.3 tt -70.69 -41.71 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.02 -37.29 79.07 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.079 0.854 . . . . 0.0 112.257 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.85 68.64 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 m -64.38 -34.87 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.027 0.831 . . . . 0.0 110.613 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -68.94 -40.35 79.02 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.828 0.451 . . . . 0.0 109.858 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.55 -38.4 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.95 -42.22 97.37 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.688 0.795 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.57 -44.21 91.43 Favored 'General case' 0 N--CA 1.527 3.381 0 C-N-CA 124.269 1.028 . . . . 0.0 109.784 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.2 t -64.55 -27.13 68.75 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.274 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 50.8 tp -91.56 -25.32 19.27 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.422 1.089 . . . . 0.0 111.315 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.5 tp . . . . . 0 N--CA 1.535 3.803 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 N--CA 1.53 3.526 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 61.0 m -57.93 -35.01 70.48 Favored 'General case' 0 N--CA 1.523 3.205 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.07 -38.21 40.94 Favored Glycine 0 N--CA 1.513 3.793 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.162 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.78 -44.34 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.874 0.87 . . . . 0.0 111.976 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.71 -33.82 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 C-N-CA 122.583 0.353 . . . . 0.0 110.919 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 89.3 mt -68.43 -38.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 O-C-N 121.79 -0.569 . . . . 0.0 109.54 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -67.04 -47.0 72.7 Favored 'General case' 0 N--CA 1.529 3.487 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.17 -34.8 58.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.145 0 CA-C-N 118.786 0.721 . . . . 0.0 111.926 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 82.7 p -66.62 -48.65 68.82 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.596 0.758 . . . . 0.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.11 -35.05 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.556 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.19 77.12 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.268 0.627 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.61 75.18 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 122.822 0.449 . . . . 0.0 111.632 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.93 -46.1 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.019 0.528 . . . . 0.0 111.64 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.83 -32.57 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 CA-C-N 118.697 0.68 . . . . 0.0 111.156 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.95 -41.5 99.52 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.21 0.604 . . . . 0.0 112.046 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 74.8 mt -70.56 -55.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 14.4 p -68.67 -41.73 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.36 82.14 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.15 -33.92 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 CA-C-N 118.101 0.41 . . . . 0.0 110.777 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -69.65 -27.11 64.77 Favored 'General case' 0 N--CA 1.536 3.864 0 CA-C-N 118.713 0.688 . . . . 0.0 110.539 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.26 -50.07 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 122.677 0.391 . . . . 0.0 110.508 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 31.3 p -63.81 -35.79 81.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 122.708 0.403 . . . . 0.0 111.2 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 tttm . . . . . 0 N--CA 1.525 3.307 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 179.431 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 42.8 t . . . . . 0 N--CA 1.518 2.941 0 CA-C-O 121.597 0.713 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.69 -49.63 68.89 Favored Glycine 0 N--CA 1.515 3.94 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.61 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.52 -35.97 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 CA-C-N 117.405 0.603 . . . . 0.0 110.753 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.4 mt -62.19 -36.66 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.975 0 C-N-CA 122.638 0.375 . . . . 0.0 110.44 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.91 -48.08 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 CA-C-O 121.584 0.707 . . . . 0.0 109.112 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -67.33 -41.2 85.63 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.42 -33.81 44.96 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.172 0.896 . . . . 0.0 112.082 -175.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 35.1 p -71.45 -48.56 48.64 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.338 0.655 . . . . 0.0 110.011 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.01 -31.71 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.288 0 C-N-CA 123.892 0.877 . . . . 0.0 109.621 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.66 Favored 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 123.455 0.702 . . . . 0.0 111.827 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.47 74.06 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 122.346 0.259 . . . . 0.0 111.174 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.97 -46.7 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 C-N-CA 123.411 0.684 . . . . 0.0 111.573 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.78 -32.11 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.411 0.55 . . . . 0.0 110.443 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -46.08 73.46 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.961 0.904 . . . . 0.0 111.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.13 -55.25 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.0 -36.41 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.19 66.4 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.65 -37.27 79.68 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.208 0.913 . . . . 0.0 110.59 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.79 -29.18 68.3 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 122.956 0.502 . . . . 0.0 110.732 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.52 -38.36 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.24 -47.23 71.39 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.349 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.44 -41.71 84.3 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.821 0.848 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -64.22 -31.45 72.66 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.022 0.529 . . . . 0.0 111.171 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.32 -37.65 74.78 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.461 0.704 . . . . 0.0 110.763 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.531 3.622 0 C-N-CA 123.316 0.647 . . . . 0.0 109.909 -179.638 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.521 3.1 0 CA-C-O 119.919 -0.086 . . . . 0.0 110.805 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.93 -50.88 7.39 Favored Glycine 1 N--CA 1.519 4.203 0 C-N-CA 123.439 0.543 . . . . 0.0 113.923 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.19 -39.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.66 -33.85 28.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.337 0.517 . . . . 0.0 111.007 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 23.5 mm -62.84 -42.99 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-O 121.278 0.561 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -64.38 -35.4 80.78 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.022 0.929 . . . . 0.0 112.717 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.47 -41.5 78.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-O 121.03 0.443 . . . . 0.0 110.476 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -65.03 -48.23 74.63 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.607 0.763 . . . . 0.0 111.271 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.72 -33.88 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.673 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.0 -35.19 80.41 Favored 'General case' 0 N--CA 1.523 3.217 0 C-N-CA 122.989 0.516 . . . . 0.0 111.56 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.33 63.3 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 122.832 0.453 . . . . 0.0 112.192 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.15 -43.63 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 123.107 0.563 . . . . 0.0 111.826 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.35 -32.82 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 CA-C-N 118.311 0.505 . . . . 0.0 110.713 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.64 -41.12 85.29 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.899 0.48 . . . . 0.0 111.339 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.09 -54.08 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 CA-C-O 121.686 0.755 . . . . 0.0 109.631 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.52 -35.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 125.788 1.635 . . . . 0.0 113.26 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.62 70.79 Favored 'General case' 0 N--CA 1.529 3.513 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.35 -41.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 CA-C-N 118.942 0.792 . . . . 0.0 111.454 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -65.15 -42.52 93.71 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.28 -36.97 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 CA-C-N 118.314 0.506 . . . . 0.0 110.822 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 97.0 m -67.75 -48.19 67.13 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 122.818 0.447 . . . . 0.0 111.346 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.2 -28.37 70.0 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.511 0.724 . . . . 0.0 111.411 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.65 -21.41 66.36 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 122.733 0.413 . . . . 0.0 110.88 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.1 mt -91.3 -30.4 16.61 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 124.197 0.999 . . . . 0.0 110.969 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 67.0 mt . . . . . 0 N--CA 1.534 3.75 0 C-N-CA 122.839 0.456 . . . . 0.0 112.13 -177.365 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 pt? . . . . . 0 N--CA 1.531 3.586 0 CA-C-O 120.8 0.333 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -67.08 -24.68 65.98 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.343 0.657 . . . . 0.0 111.174 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.41 -51.04 7.65 Favored Glycine 0 N--CA 1.516 3.997 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.58 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 tp -66.71 -37.02 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.082 0.553 . . . . 0.0 112.367 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . 0.452 HD13 ' O ' ' C' ' 215' ' ' ILE . 0.2 OUTLIER -62.77 -37.0 77.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.217 0 CA-C-N 118.256 0.48 . . . . 0.0 110.579 -177.64 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 87.4 mt -70.42 -48.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 CA-C-O 121.429 0.633 . . . . 0.0 109.595 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.36 -39.16 85.7 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.81 -39.04 68.98 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.251 0 CA-C-N 119.106 0.866 . . . . 0.0 111.914 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 20.1 p -63.75 -46.65 84.39 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.458 0.703 . . . . 0.0 110.756 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.65 -47.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.244 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.57 54.34 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.475 0.71 . . . . 0.0 111.902 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.61 95.9 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.95 0.5 . . . . 0.0 111.128 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.97 -40.43 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.5 -32.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 123.862 0.865 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -47.4 86.11 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-O 121.563 0.697 . . . . 0.0 110.797 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.11 -54.92 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.228 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.7 m -67.08 -37.03 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.73 68.04 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.1 m -65.06 -38.61 83.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 119.214 0.915 . . . . 0.0 110.558 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.53 -31.69 73.01 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 122.919 0.488 . . . . 0.0 110.878 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.89 -41.24 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 66.9 m -67.09 -39.91 86.87 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.627 0.771 . . . . 0.0 110.937 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp . . . . . 0 N--CA 1.523 3.2 0 C-N-CA 123.626 0.771 . . . . 0.0 110.248 -179.278 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.4 t . . . . . 0 N--CA 1.523 3.182 0 CA-C-O 121.109 0.48 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.16 -34.22 55.56 Favored Glycine 1 N--CA 1.518 4.134 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.79 -49.64 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.904 0.882 . . . . 0.0 111.103 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -63.44 -33.68 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 122.172 -0.33 . . . . 0.0 110.789 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.1 mt -69.57 -41.6 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -66.14 -44.34 84.46 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.72 -37.6 60.33 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.226 0 CA-C-N 119.101 0.864 . . . . 0.0 111.723 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 p -63.99 -48.24 77.17 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 123.553 0.741 . . . . 0.0 111.158 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.97 -45.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.261 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.89 67.66 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.142 0.577 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.93 96.77 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 122.976 0.51 . . . . 0.0 111.401 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.05 -41.89 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 123.189 0.595 . . . . 0.0 109.723 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.04 -32.83 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.857 0.863 . . . . 0.0 110.235 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.41 -40.96 89.89 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.095 0.558 . . . . 0.0 111.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -70.04 -52.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 122.936 0.495 . . . . 0.0 111.614 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.2 m -66.28 -37.42 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.26 92.39 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.74 -33.87 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -63.17 -43.44 98.26 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.522 0.729 . . . . 0.0 112.446 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.05 -31.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 122.393 0.277 . . . . 0.0 110.488 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 44.7 t -62.44 -32.39 73.24 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 123.044 0.538 . . . . 0.0 111.037 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.32 -44.84 78.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.653 0.781 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.0 p -64.66 -41.31 96.19 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-O 121.465 0.65 . . . . 0.0 109.616 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.8 -34.44 78.17 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 124.538 1.135 . . . . 0.0 109.694 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp . . . . . 0 N--CA 1.531 3.603 0 C-N-CA 123.586 0.754 . . . . 0.0 110.041 -179.097 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 93.0 p . . . . . 0 N--CA 1.53 3.537 0 CA-C-O 120.706 0.288 . . . . 0.0 111.438 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.99 -23.32 76.52 Favored Glycine 0 N--CA 1.511 3.683 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -51.27 74.0 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.72 -33.84 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 C-N-CA 122.778 0.431 . . . . 0.0 110.947 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.44 -38.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -66.78 -45.11 79.49 Favored 'General case' 0 N--CA 1.531 3.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.84 -34.06 47.27 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.992 0.815 . . . . 0.0 111.672 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.7 p -64.64 -48.43 74.86 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.233 0.613 . . . . 0.0 111.087 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.57 -41.01 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.33 -34.3 78.01 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.931 0.492 . . . . 0.0 111.576 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.03 67.55 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.26 -38.35 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.95 -32.64 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 CA-C-N 118.589 0.631 . . . . 0.0 110.55 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.7 tp -54.9 -34.7 63.34 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.145 0.578 . . . . 0.0 112.55 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.95 -55.74 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 CA-C-N 117.677 0.217 . . . . 0.0 111.382 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.5 -36.13 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 C-N-CA 124.33 1.052 . . . . 0.0 113.128 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.5 -31.02 65.61 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -58.32 -37.07 61.19 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.977 0.808 . . . . 0.0 110.641 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.21 -35.46 71.53 Favored 'General case' 0 N--CA 1.526 3.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.999 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.04 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.19 -41.87 85.12 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 123.481 0.712 . . . . 0.0 110.2 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -71.73 -37.01 70.66 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.851 0.86 . . . . 0.0 110.535 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 92.2 p -63.83 -17.68 63.36 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.027 0.531 . . . . 0.0 111.546 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.7 tp -83.57 -37.5 22.89 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.473 0.709 . . . . 0.0 110.338 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 10.3 mp . . . . . 1 N--CA 1.542 4.139 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 -178.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.53 3.532 0 CA-C-O 119.41 -0.329 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 91.9 p -68.19 -25.78 65.41 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 122.699 0.4 . . . . 0.0 110.758 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.02 -51.48 6.91 Favored Glycine 1 N--CA 1.518 4.16 0 O-C-N 123.117 0.261 . . . . 0.0 113.726 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 17.7 tt -67.18 -40.79 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 tp -54.45 -33.35 26.22 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.86 -42.05 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-O 121.458 0.647 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -64.87 -44.69 88.89 Favored 'General case' 0 N--CA 1.525 3.315 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 32.7 m -57.82 -35.15 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 CA-C-N 119.117 0.872 . . . . 0.0 111.95 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 36.7 p -62.83 -48.21 80.07 Favored 'General case' 0 N--CA 1.53 3.545 0 C-N-CA 123.527 0.731 . . . . 0.0 110.674 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.72 -48.76 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.346 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.97 -36.84 60.62 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 122.98 0.512 . . . . 0.0 111.882 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.81 94.61 Favored 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.077 0.551 . . . . 0.0 111.741 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.09 -41.36 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 C-N-CA 123.372 0.669 . . . . 0.0 109.571 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.15 -32.91 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.432 0.693 . . . . 0.0 109.495 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -47.3 79.19 Favored 'General case' 0 N--CA 1.539 3.985 0 CA-C-O 121.68 0.752 . . . . 0.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.34 -52.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.413 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.1 -36.05 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 124.875 1.27 . . . . 0.0 113.321 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.17 75.18 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.5 -37.98 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.639 0 CA-C-N 118.543 0.61 . . . . 0.0 111.732 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -69.31 -42.66 75.13 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 122.205 -0.31 . . . . 0.0 111.656 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.54 -32.11 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.41 0.55 . . . . 0.0 110.136 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.32 -39.25 85.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt . . . . . 0 N--CA 1.523 3.182 0 C-N-CA 124.346 1.058 . . . . 0.0 111.557 -178.701 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m . . . . . 0 N--CA 1.527 3.416 0 CA-C-O 120.796 0.332 . . . . 0.0 111.489 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.2 -26.89 67.27 Favored Glycine 0 N--CA 1.51 3.601 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -49.33 84.9 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 C-N-CA 123.219 0.608 . . . . 0.0 111.744 -177.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -67.15 -33.99 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.973 -0.455 . . . . 0.0 110.616 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.41 -38.84 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.8 -48.45 76.82 Favored 'General case' 0 N--CA 1.525 3.311 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.18 -36.12 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.933 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.8 p -66.85 -49.46 65.64 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.03 -33.09 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.33 77.6 Favored 'General case' 0 N--CA 1.523 3.189 0 C-N-CA 122.882 0.473 . . . . 0.0 111.211 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.5 83.35 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 122.759 0.424 . . . . 0.0 111.997 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.95 -45.23 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.406 0 C-N-CA 123.201 0.6 . . . . 0.0 111.263 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -67.66 -32.67 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 O-C-N 121.755 -0.591 . . . . 0.0 110.63 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -47.86 83.05 Favored 'General case' 0 N--CA 1.523 3.216 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.95 -44.62 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.82 -36.58 77.55 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 119.301 0.955 . . . . 0.0 112.448 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.11 67.19 Favored 'General case' 0 N--CA 1.526 3.338 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 4.3 m -70.24 -38.46 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 118.737 0.699 . . . . 0.0 111.543 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.23 -43.09 92.54 Favored 'General case' 0 N--CA 1.532 3.671 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.28 -31.9 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 CA-C-N 117.999 0.363 . . . . 0.0 110.03 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.9 t -66.5 -46.17 77.14 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.304 0.642 . . . . 0.0 110.712 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.09 -35.1 76.12 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.985 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 88.3 p -64.22 -34.93 79.23 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 122.791 0.436 . . . . 0.0 111.693 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.59 -20.07 25.47 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 124.035 0.934 . . . . 0.0 111.376 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp . . . . . 0 N--CA 1.535 3.801 0 C-N-CA 122.713 0.405 . . . . 0.0 110.284 -178.788 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.528 3.458 0 CA-C-O 120.262 0.077 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.54 -40.85 31.37 Favored Glycine 1 N--CA 1.52 4.24 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.18 -45.65 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.2 0 C-N-CA 124.443 1.097 . . . . 0.0 112.054 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 5.9 tp -55.58 -33.21 32.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 CA-C-N 118.529 0.604 . . . . 0.0 110.052 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.28 -46.5 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-O 121.822 0.82 . . . . 0.0 109.021 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.2 -41.9 85.04 Favored 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.74 -38.26 64.16 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 119.042 0.837 . . . . 0.0 111.776 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.9 p -64.04 -48.01 77.95 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.678 0.791 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.82 -45.74 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.07 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.44 54.07 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 123.372 0.669 . . . . 0.0 111.729 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -41.3 98.7 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-O 120.932 0.396 . . . . 0.0 111.384 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.11 -38.97 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.325 0 C-N-CA 123.558 0.743 . . . . 0.0 109.657 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.37 -33.1 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 123.617 0.767 . . . . 0.0 111.03 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.49 -43.47 93.29 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-N 118.594 0.634 . . . . 0.0 110.161 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.4 -54.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.36 0.664 . . . . 0.0 110.102 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.03 -37.82 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.301 1.04 . . . . 0.0 113.314 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.94 92.52 Favored 'General case' 1 N--CA 1.541 4.091 0 CA-C-N 118.575 0.625 . . . . 0.0 112.515 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.86 -34.1 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.21 -43.77 93.99 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.176 0.59 . . . . 0.0 112.051 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.29 -36.07 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 CA-C-O 120.818 0.342 . . . . 0.0 110.438 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.24 -39.44 86.18 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.297 0.639 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.44 -29.99 64.2 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 99.1 p -75.37 -43.15 51.92 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 122.748 0.419 . . . . 0.0 110.745 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.3 mt -77.27 -31.66 55.05 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.892 0.877 . . . . 0.0 111.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp . . . . . 0 N--CA 1.536 3.829 0 C-N-CA 123.069 0.547 . . . . 0.0 111.662 -176.977 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tp . . . . . 0 N--CA 1.532 3.642 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 24.4 t -62.27 -20.43 64.26 Favored 'General case' 0 N--CA 1.522 3.173 0 C-N-CA 123.829 0.851 . . . . 0.0 110.624 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.61 94.14 Favored Glycine 0 N--CA 1.508 3.488 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.184 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.3 pt -65.79 -35.39 75.05 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 CA-C-N 117.897 0.849 . . . . 0.0 111.265 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.14 -34.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 C-N-CA 123.203 0.601 . . . . 0.0 109.636 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.07 -44.31 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.421 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -67.02 -45.41 77.61 Favored 'General case' 0 N--CA 1.533 3.687 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.65 -35.85 52.15 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.3 p -66.06 -49.45 67.61 Favored 'General case' 0 N--CA 1.529 3.492 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.93 -37.82 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.14 72.76 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 122.64 0.376 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.23 94.87 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.938 0.495 . . . . 0.0 111.747 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.76 -42.12 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 123.322 0.649 . . . . 0.0 109.893 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.79 -32.97 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.547 0.739 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.87 -37.7 88.38 Favored 'General case' 0 N--CA 1.529 3.506 0 C-N-CA 122.89 0.476 . . . . 0.0 111.954 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.73 -54.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.707 0 C-N-CA 122.887 0.475 . . . . 0.0 111.624 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 22.7 m -66.86 -36.88 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.49 67.83 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.26 -36.55 77.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 119.393 0.997 . . . . 0.0 110.593 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.54 -30.27 71.0 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 122.784 0.434 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.16 -41.08 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.607 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.41 -48.31 67.7 Favored 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 123.465 0.706 . . . . 0.0 111.166 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 N--CA 1.53 3.531 0 C-N-CA 124.068 0.947 . . . . 0.0 111.708 -178.933 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.517 2.912 0 CA-C-O 120.684 0.278 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.36 -50.57 8.16 Favored Glycine 0 N--CA 1.512 3.734 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.805 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.35 -36.89 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 8.5 tp -60.12 -33.58 53.82 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.64 0.655 . . . . 0.0 110.42 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.13 -42.22 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -64.34 -29.23 70.31 Favored 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.22 -44.8 84.28 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.455 0 CA-C-N 119.673 1.124 . . . . 0.0 113.455 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.5 p -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.88 -36.76 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.142 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.6 70.41 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 122.616 0.366 . . . . 0.0 111.358 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.94 -43.68 98.13 Favored 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 122.651 0.38 . . . . 0.0 111.482 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.3 -42.77 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 C-N-CA 123.508 0.723 . . . . 0.0 110.003 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.42 -33.29 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.347 0 C-N-CA 123.407 0.683 . . . . 0.0 110.193 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.94 -38.57 91.55 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 122.813 0.445 . . . . 0.0 111.96 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.0 mt -70.34 -55.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 122.416 0.286 . . . . 0.0 111.546 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.7 -37.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.25 82.89 Favored 'General case' 0 N--CA 1.533 3.683 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.11 -34.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.622 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.0 -42.3 66.61 Favored 'General case' 1 N--CA 1.54 4.056 0 CA-C-N 119.504 1.047 . . . . 0.0 111.547 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.36 -32.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.4 p -67.27 -37.64 83.79 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-N 118.282 0.492 . . . . 0.0 111.103 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.61 -27.72 67.92 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.463 0.705 . . . . 0.0 111.452 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.6 p -72.21 -16.74 61.95 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 122.645 0.378 . . . . 0.0 111.32 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.4 -37.7 13.05 Favored 'General case' 0 N--CA 1.535 3.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.268 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 1 N--CA 1.545 4.298 0 C-N-CA 122.916 0.487 . . . . 0.0 111.152 -177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.5 p . . . . . 0 N--CA 1.526 3.351 0 CA-C-O 121.122 0.487 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.99 81.19 Favored Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.271 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.05 -36.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 C-N-CA 124.026 0.93 . . . . 0.0 110.533 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.42 -35.93 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 C-N-CA 122.966 0.506 . . . . 0.0 110.151 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.98 -38.13 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.54 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -65.21 -47.01 78.41 Favored 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.82 -29.92 41.44 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 118.699 0.682 . . . . 0.0 112.335 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.5 p -69.57 -49.9 49.75 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.55 -31.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.098 0.559 . . . . 0.0 111.238 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.04 79.39 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 122.855 0.462 . . . . 0.0 111.626 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.4 t -70.05 -48.26 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 123.268 0.627 . . . . 0.0 111.212 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.0 -32.02 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 CA-C-N 118.251 0.478 . . . . 0.0 110.106 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -46.98 62.93 Favored 'General case' 0 N--CA 1.535 3.776 0 C-N-CA 123.667 0.787 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.33 -54.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.81 -37.03 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 124.768 1.227 . . . . 0.0 113.818 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.43 -31.92 68.2 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.7 m -69.45 -36.09 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 119.332 0.969 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.92 -42.44 66.7 Favored 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.22 -38.36 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.24 -38.93 86.0 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 124.004 0.921 . . . . 0.0 111.039 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 22.1 t -70.08 -32.47 70.55 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 122.947 0.499 . . . . 0.0 110.108 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.31 -32.21 62.76 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.939 0.896 . . . . 0.0 109.904 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 79.8 mt . . . . . 0 N--CA 1.533 3.71 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.947 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? . . . . . 0 N--CA 1.528 3.439 0 CA-C-O 121.054 0.454 . . . . 0.0 111.366 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.0 m -70.65 -23.79 62.58 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.706 -0.621 . . . . 0.0 109.85 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.88 -50.09 55.04 Favored Glycine 0 N--CA 1.512 3.718 0 C-N-CA 124.264 0.935 . . . . 0.0 114.616 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.15 -36.03 60.69 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.094 0.947 . . . . 0.0 110.748 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.03 -34.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 122.871 0.468 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.4 -41.09 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.872 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -56.72 -41.8 78.09 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.512 0.725 . . . . 0.0 111.867 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 50.5 t -57.76 -45.88 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 19.3 p -62.87 -49.28 75.45 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.05 -38.45 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.133 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.8 78.79 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.46 64.39 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.99 -38.39 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.32 -32.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.551 0.614 . . . . 0.0 110.668 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.73 -36.02 71.48 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.149 0.58 . . . . 0.0 112.371 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -69.57 -54.85 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 122.763 0.425 . . . . 0.0 111.193 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.14 -35.99 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 C-N-CA 124.236 1.014 . . . . 0.0 113.227 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -31.11 65.9 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.27 -35.21 74.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.077 0 CA-C-N 119.401 1.001 . . . . 0.0 110.594 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.79 -33.79 75.51 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 122.887 0.475 . . . . 0.0 110.422 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.58 -43.0 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 C-N-CA 123.29 0.636 . . . . 0.0 109.8 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 61.7 m -65.47 -48.45 72.62 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.155 0.582 . . . . 0.0 110.891 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 mttp . . . . . 0 N--CA 1.522 3.152 0 C-N-CA 124.06 0.944 . . . . 0.0 111.487 -179.285 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 56.7 m . . . . . 0 N--CA 1.525 3.301 0 CA-C-O 121.237 0.541 . . . . 0.0 111.071 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.21 -41.38 31.59 Favored Glycine 1 N--CA 1.517 4.082 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.716 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 214' ' ' ILE . 1.4 mp -64.48 -47.62 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.974 0.91 . . . . 0.0 110.886 -176.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.2 -34.2 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 O-C-N 121.939 -0.475 . . . . 0.0 111.576 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.84 -43.13 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -67.05 -40.93 87.24 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.79 -33.28 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.151 0 CA-C-N 119.347 0.976 . . . . 0.0 112.791 -175.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -49.72 61.24 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.07 -31.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.435 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.24 -41.29 77.18 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.643 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.22 -43.66 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.505 0.722 . . . . 0.0 111.793 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.91 -32.26 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 CA-C-N 118.332 0.514 . . . . 0.0 110.791 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.11 -38.34 79.35 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.115 0.566 . . . . 0.0 112.317 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.23 -55.14 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.84 -37.41 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.09 89.19 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.8 -34.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.11 -43.82 97.99 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.413 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.59 -36.0 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 CA-C-O 120.987 0.422 . . . . 0.0 110.211 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.34 -48.33 67.83 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.375 0.67 . . . . 0.0 111.687 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -72.28 -45.16 61.26 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.871 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 94.8 p -65.04 -39.42 93.29 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 tp -72.89 -37.69 67.2 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 122.682 0.393 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.2 mp . . . . . 0 N--CA 1.539 3.987 0 C-N-CA 123.612 0.765 . . . . 0.0 111.247 -177.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p . . . . . 0 N--CA 1.526 3.363 0 CA-C-O 120.324 0.106 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.71 -44.74 19.44 Favored Glycine 0 N--CA 1.515 3.954 0 O-C-N 123.849 0.718 . . . . 0.0 111.48 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . 0.402 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -58.72 -46.24 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 C-N-CA 124.708 1.203 . . . . 0.0 111.585 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.9 -32.62 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 O-C-N 122.143 -0.348 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.72 -48.57 87.52 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.73 -0.606 . . . . 0.0 110.62 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -67.85 -40.04 83.74 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 20.1 m -57.52 -38.58 64.36 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 CA-C-N 119.929 1.24 . . . . 0.0 112.067 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -61.34 -48.1 82.85 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.694 0.798 . . . . 0.0 111.266 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.67 -44.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.479 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 -34.78 75.42 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 122.994 0.518 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.0 94.12 Favored 'General case' 0 N--CA 1.523 3.195 0 C-N-CA 123.017 0.527 . . . . 0.0 111.902 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.4 -44.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.49 -35.03 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.045 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.34 -38.06 79.39 Favored 'General case' 0 N--CA 1.532 3.629 0 C-N-CA 123.123 0.569 . . . . 0.0 111.327 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.98 -48.81 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.0 -35.53 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 C-N-CA 125.442 1.497 . . . . 0.0 112.158 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.85 68.57 Favored 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.01 -44.19 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.662 0.664 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -63.77 -42.11 97.84 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.93 -33.62 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.589 0.632 . . . . 0.0 110.798 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.9 m -67.22 -43.64 81.52 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.026 0.53 . . . . 0.0 110.611 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.49 -31.13 65.14 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.711 0.804 . . . . 0.0 110.249 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.92 -43.01 97.22 Favored 'General case' 0 N--CA 1.522 3.143 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.8 -14.76 41.28 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.683 0.793 . . . . 0.0 112.543 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.8 tp . . . . . 1 N--CA 1.542 4.133 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp . . . . . 0 N--CA 1.534 3.748 0 N-CA-C 110.708 -0.108 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -55.75 -20.88 16.28 Favored 'General case' 0 N--CA 1.528 3.461 0 O-C-N 121.781 -0.574 . . . . 0.0 111.493 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.95 -39.79 93.34 Favored Glycine 0 N--CA 1.51 3.594 0 O-C-N 124.112 0.883 . . . . 0.0 113.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -38.05 80.25 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 CA-C-N 117.524 0.662 . . . . 0.0 109.866 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 50.7 mt -56.74 -34.36 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.389 0.675 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 25.8 mm -69.6 -44.26 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.614 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.44 -36.81 75.5 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.276 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 40.5 p -63.77 -49.26 73.68 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.9 -38.88 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.78 73.71 Favored 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 122.718 0.407 . . . . 0.0 110.972 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.52 85.42 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.087 0.555 . . . . 0.0 112.04 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.291 0.636 . . . . 0.0 109.839 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.95 -32.48 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 123.592 0.757 . . . . 0.0 110.291 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.6 tp -64.23 -48.53 75.46 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 tt -71.95 -52.08 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.06 -37.01 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -31.78 68.9 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.18 -34.9 66.09 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.251 0.932 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -68.86 -38.62 79.86 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.046 0.451 . . . . 0.0 109.807 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.1 -41.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 C-N-CA 123.91 0.884 . . . . 0.0 109.599 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.21 -38.79 92.31 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.526 0.73 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.6 tttm . . . . . 0 N--CA 1.524 3.245 0 C-N-CA 123.47 0.708 . . . . 0.0 109.481 179.682 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.1 m . . . . . 0 N--CA 1.521 3.098 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.24 -50.28 8.58 Favored Glycine 0 N--CA 1.513 3.8 0 C-N-CA 123.984 0.802 . . . . 0.0 113.78 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.84 -36.91 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 42.5 pt -57.96 -33.81 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 118.951 0.796 . . . . 0.0 110.667 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.65 -41.19 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.66 -34.48 77.17 Favored 'General case' 0 N--CA 1.529 3.493 0 C-N-CA 123.471 0.708 . . . . 0.0 111.687 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.89 -38.03 63.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 CA-C-O 120.921 0.391 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.5 p -66.02 -49.15 68.74 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.302 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.02 -44.93 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.022 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.061 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.75 -34.57 67.68 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.351 0.66 . . . . 0.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.24 98.57 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 122.904 0.482 . . . . 0.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.1 t -69.94 -39.06 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.397 0.679 . . . . 0.0 109.627 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.7 -32.87 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 123.755 0.822 . . . . 0.0 109.869 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -47.21 84.89 Favored 'General case' 0 N--CA 1.535 3.794 0 CA-C-O 121.58 0.705 . . . . 0.0 110.748 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.06 -54.11 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.926 0.89 . . . . 0.0 112.702 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.63 -36.79 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.57 -31.73 68.27 Favored 'General case' 0 N--CA 1.528 3.455 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.09 -34.93 73.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.104 0 CA-C-N 119.348 0.976 . . . . 0.0 110.581 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -65.12 -36.08 83.15 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 122.561 0.344 . . . . 0.0 110.297 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.03 -37.43 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.633 0.773 . . . . 0.0 109.764 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 66.6 m -67.11 -48.33 68.45 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.236 0.614 . . . . 0.0 111.002 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -70.38 -27.72 64.53 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 123.784 0.834 . . . . 0.0 110.351 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.9 t -63.92 -37.9 89.09 Favored 'General case' 0 N--CA 1.528 3.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.546 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.79 -37.23 76.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 123.971 0.908 . . . . 0.0 110.505 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.531 3.625 0 C-N-CA 123.586 0.754 . . . . 0.0 110.384 -179.022 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.7 m . . . . . 0 N--CA 1.519 2.979 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.46 93.28 Favored Glycine 1 N--CA 1.518 4.158 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.272 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.9 tp -57.6 -36.38 53.92 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 118.116 0.958 . . . . 0.0 110.785 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.98 -40.17 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.781 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 216' ' ' ILE . . . . . 0.416 HD12 ' N ' ' B' ' 216' ' ' ILE . 1.5 mp -66.72 -41.3 87.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.144 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -59.25 -36.47 75.54 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.334 0.654 . . . . 0.0 112.042 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.21 -42.27 83.03 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.154 0 CA-C-O 121.023 0.439 . . . . 0.0 110.029 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 5.5 p -63.21 -48.39 78.5 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.602 0.761 . . . . 0.0 110.974 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.6 -42.94 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.441 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.87 75.86 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 122.885 0.474 . . . . 0.0 111.066 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.36 -48.99 68.42 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.05 0.54 . . . . 0.0 111.513 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -38.84 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 C-N-CA 123.248 0.619 . . . . 0.0 110.055 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.15 -32.91 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 C-N-CA 123.099 0.56 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.05 -34.89 79.51 Favored 'General case' 0 N--CA 1.534 3.76 0 C-N-CA 122.83 0.452 . . . . 0.0 111.83 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.66 -54.62 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 C-N-CA 122.804 0.442 . . . . 0.0 111.039 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -36.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.78 82.35 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.5 -34.78 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.215 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.86 -40.18 79.48 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 119.197 0.908 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.01 -31.62 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.808 0 CA-C-N 118.435 0.561 . . . . 0.0 110.964 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.25 -40.72 95.11 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 122.818 0.447 . . . . 0.0 111.345 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.27 -45.43 32.71 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.271 0.628 . . . . 0.0 109.973 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.8 t -63.16 -12.82 30.55 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 122.804 0.442 . . . . 0.0 111.68 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 64.3 tp -89.1 -35.92 16.02 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 124.308 1.043 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 1 N--CA 1.543 4.179 0 C-N-CA 123.979 0.912 . . . . 0.0 110.703 -177.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 6.7 tp . . . . . 0 N--CA 1.528 3.441 0 N-CA-C 111.503 0.186 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -70.5 -21.03 62.8 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 122.968 0.507 . . . . 0.0 110.857 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.43 -50.14 22.36 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 123.614 0.626 . . . . 0.0 113.814 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.24 -36.65 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 CA-C-N 117.432 0.616 . . . . 0.0 111.149 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.74 -35.1 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 117.942 0.337 . . . . 0.0 110.832 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.37 -42.56 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.737 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -66.58 -42.75 86.52 Favored 'General case' 0 N--CA 1.527 3.414 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.41 -33.47 47.95 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.847 0.749 . . . . 0.0 112.287 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 25.3 p -66.97 -50.27 62.82 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.98 -39.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.74 68.89 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.967 0.507 . . . . 0.0 111.306 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.21 94.06 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 122.841 0.457 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 51.3 t -70.05 -41.17 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 123.622 0.769 . . . . 0.0 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.81 -34.14 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.876 0.871 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.44 -36.76 83.61 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.125 0.57 . . . . 0.0 111.588 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.83 -54.24 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 C-N-CA 123.109 0.564 . . . . 0.0 111.085 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 m -67.76 -42.02 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.34 92.35 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.07 -37.02 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 CA-C-O 118.047 -0.977 . . . . 0.0 112.218 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -73.32 -36.57 66.25 Favored 'General case' 1 N--CA 1.548 4.443 0 CA-C-N 120.631 1.559 . . . . 0.0 109.801 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.86 -32.03 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 C-N-CA 123.188 0.595 . . . . 0.0 109.713 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.56 -38.12 83.51 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 123.304 0.642 . . . . 0.0 111.192 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 N--CA 1.531 3.586 0 C-N-CA 124.362 1.065 . . . . 0.0 111.633 179.613 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.574 1.867 0 N-CA-C 108.561 -0.903 . . . . 999.99000000000001 108.561 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -71.7 -34.77 8.6 Favored 'Trans proline' 1 N--CA 1.538 4.124 0 C-N-CA 122.153 1.902 . . . . 999.99000000000001 110.103 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 64.58 145.88 0.03 OUTLIER Glycine 1 N--CA 1.519 4.22 0 CA-C-N 115.449 -0.796 . . . . 891.5 111.367 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.8 p -166.46 35.63 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.576 0.75 . . . . 999.99000000000001 109.114 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 94.2 mt -72.9 -24.79 60.88 Favored 'General case' 0 N--CA 1.524 3.247 0 CA-C-N 115.099 -0.955 . . . . 872.25999999999999 110.203 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 71.2 m -70.24 -23.61 62.94 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.819 0.448 . . . . 422.23000000000002 109.979 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.41 -50.64 9.53 Favored Glycine 0 N--CA 1.511 3.681 0 CA-C-N 115.78 -0.645 . . . . 182.12 113.236 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -66.48 -37.48 79.7 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.797 0 CA-C-N 117.596 0.698 . . . . 429.51999999999998 111.002 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 16.9 mm -61.89 -41.86 92.45 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.058 0 C-N-CA 122.59 0.356 . . . . 386.43000000000001 110.488 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.8 mt -70.58 -45.02 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.701 0 O-C-N 121.665 -0.647 . . . . 161.88 109.36 179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -67.17 -40.56 86.61 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 114.482 1.29 . . . . 999.99000000000001 114.482 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.7 -31.57 40.2 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.227 0 CA-C-N 119.076 0.853 . . . . 168.06 111.209 -176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 33.6 p -69.52 -48.63 59.85 Favored 'General case' 0 N--CA 1.527 3.401 0 C-N-CA 123.419 0.688 . . . . 21.5 110.282 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 52.6 t -67.89 -34.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.192 0 CA-C-N 115.296 -0.865 . . . . 220.71000000000001 109.09 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.83 72.88 Favored 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 123.278 0.631 . . . . 59.039999999999999 111.039 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.59 -43.68 68.88 Favored 'General case' 0 N--CA 1.518 2.948 0 CA-C-N 115.801 -0.636 . . . . 25.920000000000002 111.121 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.62 -45.1 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.511 0 C-N-CA 123.422 0.689 . . . . 37.840000000000003 111.716 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.78 -32.83 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.602 0 CA-C-N 118.332 0.514 . . . . 282.56999999999999 110.432 -178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 49.6 tp -63.98 -36.16 83.06 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.482 0.713 . . . . 170.34999999999999 112.194 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 95.2 mt -69.8 -52.64 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.885 0 C-N-CA 122.838 0.455 . . . . 145.71000000000001 110.357 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.5 m -67.2 -37.5 79.28 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.611 0 O-C-N 121.807 -0.558 . . . . 205.37 112.162 -178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.23 85.35 Favored 'General case' 0 N--CA 1.536 3.836 0 N-CA-C 112.818 0.673 . . . . 54.0 112.818 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 p -63.18 -34.28 65.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.648 0 N-CA-C 109.838 -0.431 . . . . 167.28 109.838 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -69.76 -42.59 73.65 Favored 'General case' 1 N--CA 1.541 4.102 0 N-CA-C 109.647 -0.501 . . . . 382.56 109.647 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 77.2 t -68.46 -31.96 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.718 0 C-N-CA 123.3 0.64 . . . . 396.06 109.474 179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.7 t -65.07 -39.37 93.13 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.188 0.595 . . . . 241.93000000000001 110.467 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -77.67 -33.02 53.52 Favored 'General case' 0 N--CA 1.524 3.228 0 C-N-CA 123.645 0.778 . . . . 962.60000000000002 110.328 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 77.8 p -63.42 -24.1 67.69 Favored 'General case' 0 N--CA 1.533 3.698 0 CA-C-O 120.9 0.381 . . . . 329.86000000000001 110.409 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -81.93 -33.16 30.49 Favored 'General case' 0 N--CA 1.519 3.003 0 C-N-CA 124.094 0.958 . . . . 647.42999999999995 109.577 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 47.0 tp -93.71 -8.25 41.36 Favored 'General case' 1 N--CA 1.54 4.026 0 C-N-CA 124.619 1.167 . . . . 658.91999999999996 111.832 -177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -115.24 13.3 16.68 Favored 'General case' 0 N--CA 1.536 3.85 0 N-CA-C 105.935 -1.876 . . . . 999.99000000000001 105.935 176.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -64.06 169.85 4.06 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.832 1.253 . . . . 999.99000000000001 108.075 179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -53.17 -9.54 0.16 Allowed 'General case' 0 N--CA 1.537 3.889 0 CA-C-N 114.498 -1.228 . . . . 999.99000000000001 111.545 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 85.6 t -134.11 120.77 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 N-CA-C 104.399 -2.445 . . . . 999.99000000000001 104.399 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.05 142.21 44.27 Favored Pre-proline 0 N--CA 1.521 3.083 0 C-N-CA 125.731 1.612 . . . . 999.99000000000001 107.531 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 1 N--CA 1.54 4.239 0 CA-C-N 122.487 1.924 . . . . 999.99000000000001 110.588 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 4.5 mmt . . . . . 0 CA--C 1.58 2.124 0 N-CA-C 108.579 -0.897 . . . . 999.99000000000001 108.579 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -59.74 -76.95 0.02 OUTLIER 'Trans proline' 1 N--CA 1.544 4.487 0 C-N-CA 121.823 1.682 . . . . 999.99000000000001 111.233 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 58.78 73.3 0.48 Allowed Glycine 1 N--CA 1.518 4.15 0 C-N-CA 123.602 0.62 . . . . 999.99000000000001 112.223 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 67.9 m -158.9 21.03 0.2 Allowed 'General case' 0 N--CA 1.523 3.186 0 C-N-CA 123.611 0.764 . . . . 999.99000000000001 110.374 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.21 -38.87 50.52 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 124.827 1.251 . . . . 695.35000000000002 107.766 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 63.4 m -55.81 -29.29 59.52 Favored 'General case' 0 N--CA 1.524 3.234 0 CA-C-N 114.978 -1.01 . . . . 322.12 111.41 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.3 -35.82 56.22 Favored Glycine 1 N--CA 1.517 4.047 0 CA-C-N 115.444 -0.798 . . . . 118.7 111.417 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.6 mm -65.87 -36.92 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.45 0 C-N-CA 123.747 0.819 . . . . 351.56 110.187 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -65.72 -40.87 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.59 0 C-N-CA 123.151 0.58 . . . . 318.27999999999997 109.834 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 83.4 mt -70.08 -38.33 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.499 0 C-N-CA 123.421 0.688 . . . . 156.47999999999999 109.302 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -62.04 -47.44 84.72 Favored 'General case' 0 N--CA 1.527 3.413 0 N-CA-C 113.504 0.927 . . . . 999.99000000000001 113.504 -176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 15.2 m -59.24 -27.86 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.814 0 O-C-N 122.28 -0.262 . . . . 221.16999999999999 111.223 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 14.0 p -66.23 -48.22 71.26 Favored 'General case' 0 N--CA 1.535 3.816 0 CA-C-O 121.39 0.614 . . . . 21.870000000000001 110.368 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 53.8 t -68.13 -51.61 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.047 0 CA-C-N 115.281 -0.872 . . . . 176.34 109.076 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -54.23 -34.69 61.27 Favored 'General case' 0 N--CA 1.525 3.277 0 C-N-CA 122.889 0.476 . . . . 36.920000000000002 111.545 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.7 -44.86 92.38 Favored 'General case' 0 N--CA 1.523 3.21 0 C-N-CA 122.717 0.407 . . . . 26.879999999999999 111.166 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 80.5 t -69.75 -46.74 73.68 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 N-CA-C 109.471 -0.566 . . . . 93.609999999999999 109.471 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 74.1 t -59.5 -33.81 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.281 0.632 . . . . 229.62 110.192 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 48.6 tp -65.27 -39.46 92.64 Favored 'General case' 0 N--CA 1.531 3.599 0 C-N-CA 122.778 0.431 . . . . 164.03999999999999 110.632 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 87.3 mt -70.01 -46.91 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.674 0 N-CA-C 109.042 -0.725 . . . . 134.41999999999999 109.042 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 95.8 t -66.25 -36.73 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 C-N-CA 124.199 1.0 . . . . 189.86000000000001 111.344 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.0 -31.59 67.08 Favored 'General case' 0 N--CA 1.53 3.527 0 N-CA-C 112.72 0.637 . . . . 50.32 112.72 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 2.4 m -67.97 -44.33 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.959 0 CA-C-N 118.473 0.579 . . . . 179.11000000000001 109.661 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.9 m-85 -66.06 -42.62 89.21 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 122.842 0.457 . . . . 336.06999999999999 110.202 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 81.1 t -65.08 -38.73 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.625 0 N-CA-C 109.509 -0.552 . . . . 298.69999999999999 109.509 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.13 -48.48 67.97 Favored 'General case' 0 N--CA 1.529 3.476 0 C-N-CA 123.003 0.521 . . . . 272.98000000000002 111.418 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.73 -42.12 70.97 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 123.601 0.76 . . . . 892.98000000000002 111.112 -179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 98.4 p -63.8 -13.33 43.29 Favored 'General case' 0 N--CA 1.528 3.436 0 CA-C-O 119.228 -0.415 . . . . 295.12 111.308 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -91.24 -37.94 12.99 Favored 'General case' 0 N--CA 1.539 3.996 0 C-N-CA 123.704 0.801 . . . . 751.53999999999996 109.214 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.9 tp -80.88 -27.77 36.22 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.329 0.652 . . . . 539.80999999999995 110.728 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -90.27 -3.81 57.57 Favored 'General case' 0 N--CA 1.539 3.983 0 C-N-CA 123.738 0.815 . . . . 999.99000000000001 110.314 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 60.7 tttm -69.23 -6.42 28.96 Favored 'General case' 0 N--CA 1.535 3.795 0 C-N-CA 122.866 0.466 . . . . 999.99000000000001 109.82 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 71.0 6.1 5.74 Favored 'General case' 0 N--CA 1.517 2.898 0 C-N-CA 124.721 1.208 . . . . 999.99000000000001 111.236 177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.0 p -86.82 122.71 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.713 0 N-CA-C 107.47 -1.307 . . . . 999.99000000000001 107.47 178.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -97.33 114.16 64.37 Favored Pre-proline 0 N--CA 1.527 3.402 0 CA-C-O 116.822 -1.561 . . . . 999.99000000000001 107.083 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo . . . . . 1 N--CA 1.547 4.644 0 C-N-CA 122.465 2.11 . . . . 999.99000000000001 114.26 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 2.001 0 N-CA-C 109.366 -0.605 . . . . 999.99000000000001 109.366 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.31 42.03 0.96 Allowed 'Trans proline' 1 N--CA 1.541 4.309 0 C-N-CA 122.416 2.077 . . . . 999.99000000000001 110.271 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.12 -128.23 28.09 Favored Glycine 1 N--CA 1.519 4.208 0 N-CA-C 110.976 -0.849 . . . . 999.99000000000001 110.976 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 44.0 t -167.77 71.14 0.1 Allowed 'General case' 0 N--CA 1.517 2.924 0 C-N-CA 123.787 0.835 . . . . 997.00999999999999 108.999 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 89.4 mt -64.92 -18.2 65.02 Favored 'General case' 0 N--CA 1.525 3.306 0 C-N-CA 123.416 0.686 . . . . 581.98000000000002 110.887 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.2 m -70.2 -22.52 62.93 Favored 'General case' 0 N--CA 1.52 3.033 0 C-N-CA 122.889 0.476 . . . . 487.95999999999998 109.996 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.4 -50.73 9.39 Favored Glycine 0 N--CA 1.512 3.751 0 CA-C-N 115.926 -0.579 . . . . 126.84 113.157 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.0 tp -66.41 -37.0 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.83 0 CA-C-N 117.481 0.641 . . . . 390.08999999999997 110.918 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 96.6 mt -61.62 -41.08 88.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.062 0 C-N-CA 122.617 0.367 . . . . 395.69999999999999 110.189 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.42 -38.76 75.06 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.735 0 N-CA-C 109.37 -0.604 . . . . 188.96000000000001 109.37 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -64.49 -46.38 83.25 Favored 'General case' 0 N--CA 1.529 3.482 0 N-CA-C 113.995 1.109 . . . . 999.99000000000001 113.995 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.1 p -57.85 -27.89 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.966 0 CA-C-N 118.133 0.424 . . . . 199.56999999999999 111.424 -176.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 23.9 p -69.79 -48.22 59.99 Favored 'General case' 0 N--CA 1.532 3.632 0 CA-C-O 121.401 0.62 . . . . 22.73 110.227 179.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.96 -47.72 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.52 3.059 0 CA-C-N 115.321 -0.854 . . . . 203.96000000000001 108.967 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.92 -34.62 56.12 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.246 0.618 . . . . 49.700000000000003 111.504 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.21 -44.01 85.08 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 122.969 0.508 . . . . 25.300000000000001 110.963 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.11 -41.55 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.505 0 C-N-CA 123.323 0.649 . . . . 93.879999999999995 109.583 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 58.9 t -62.58 -35.28 69.49 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.397 0 C-N-CA 123.396 0.678 . . . . 243.0 109.935 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 52.8 tp -64.4 -42.41 96.12 Favored 'General case' 0 N--CA 1.529 3.497 0 C-N-CA 122.989 0.516 . . . . 85.120000000000005 111.953 -178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 77.3 mt -67.27 -51.3 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.748 0 C-N-CA 123.186 0.594 . . . . 125.45999999999999 111.196 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 25.7 m -67.31 -36.85 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.633 0 N-CA-C 112.751 0.648 . . . . 188.13999999999999 112.751 -178.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.11 -44.71 87.84 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.281 0.845 . . . . 48.460000000000001 113.281 -174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 30.0 m -59.45 -34.69 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.929 0 CA-C-N 118.69 0.677 . . . . 139.06999999999999 110.594 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -71.32 -42.26 68.82 Favored 'General case' 0 N--CA 1.536 3.842 0 N-CA-C 109.615 -0.513 . . . . 304.13999999999999 109.615 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.82 -40.03 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 N-CA-C 109.153 -0.684 . . . . 256.41000000000003 109.153 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.4 m -67.09 -40.25 86.92 Favored 'General case' 0 N--CA 1.526 3.351 0 N-CA-C 109.525 -0.546 . . . . 224.28 109.525 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -73.16 -28.89 62.48 Favored 'General case' 0 N--CA 1.528 3.448 0 C-N-CA 123.71 0.804 . . . . 901.13 110.139 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 37.6 t -69.16 -37.91 78.46 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 122.788 0.435 . . . . 340.58999999999997 110.233 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.6 tp -61.03 -37.56 83.02 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.103 0.961 . . . . 572.00999999999999 112.156 -178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -80.52 -27.5 37.62 Favored 'General case' 0 N--CA 1.538 3.954 0 N-CA-C 108.831 -0.803 . . . . 669.34000000000003 108.831 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 13.1 m95 -89.26 -4.2 58.25 Favored 'General case' 0 N--CA 1.537 3.92 0 C-N-CA 123.375 0.67 . . . . 999.99000000000001 110.002 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -86.09 -25.88 25.59 Favored 'General case' 0 N--CA 1.535 3.779 0 C-N-CA 123.582 0.753 . . . . 999.99000000000001 109.09 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -66.02 -33.23 75.34 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 124.217 1.007 . . . . 999.99000000000001 110.088 -179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 29.9 m -131.2 122.64 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.344 0 N-CA-C 107.418 -1.327 . . . . 999.99000000000001 107.418 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -95.04 141.92 23.91 Favored Pre-proline 0 N--CA 1.527 3.398 0 N-CA-C 107.408 -1.33 . . . . 999.99000000000001 107.408 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 1 N--CA 1.539 4.199 0 C-N-CA 122.006 1.804 . . . . 999.99000000000001 110.688 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.572 1.804 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -72.96 -167.55 0.36 Allowed 'Trans proline' 1 N--CA 1.54 4.222 0 C-N-CA 122.223 1.949 . . . . 0.0 110.257 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -165.08 33.91 0.25 Allowed Glycine 1 N--CA 1.517 4.079 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.9 p -167.47 179.69 4.82 Favored 'General case' 0 N--CA 1.52 3.058 0 C-N-CA 124.34 1.056 . . . . 0.0 108.735 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt -159.98 -37.71 0.05 Allowed 'General case' 0 N--CA 1.536 3.851 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.6 m -70.74 -30.43 66.94 Favored 'General case' 0 N--CA 1.524 3.272 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.54 -50.07 70.3 Favored Glycine 0 N--CA 1.514 3.899 0 CA-C-N 114.808 -1.087 . . . . 0.0 114.477 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 5.7 tp -58.72 -35.91 57.9 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.011 0 CA-C-N 117.863 0.831 . . . . 0.0 110.61 -178.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.4 mm -58.64 -34.48 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 C-N-CA 123.077 0.551 . . . . 0.0 110.981 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 32.6 mm -68.69 -45.11 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.671 0.748 . . . . 0.0 109.483 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -67.19 -46.36 74.15 Favored 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.71 -40.63 76.56 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.067 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -174.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 49.9 p -64.75 -49.22 71.64 Favored 'General case' 0 N--CA 1.528 3.43 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.24 -31.59 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.69 -34.71 71.59 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 122.825 0.45 . . . . 0.0 111.928 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.29 -32.88 70.87 Favored 'General case' 0 N--CA 1.525 3.313 0 C-N-CA 122.48 0.312 . . . . 0.0 111.418 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.3 t -68.68 -50.93 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 C-N-CA 123.514 0.726 . . . . 0.0 111.502 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.29 -31.89 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.89 0 O-C-N 122.064 -0.397 . . . . 0.0 109.992 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.39 -47.14 66.4 Favored 'General case' 0 N--CA 1.532 3.636 0 C-N-CA 123.561 0.744 . . . . 0.0 110.889 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.5 mm -67.77 -42.95 86.62 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.792 0 C-N-CA 122.794 0.438 . . . . 0.0 110.437 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 59.0 t -66.4 -39.69 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.576 0.75 . . . . 0.0 111.756 -178.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -47.27 85.86 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.71 0.404 . . . . 0.0 111.981 -176.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 p -68.63 -33.58 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.302 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.76 -42.82 99.48 Favored 'General case' 0 N--CA 1.538 3.966 0 C-N-CA 123.245 0.618 . . . . 0.0 110.903 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 71.9 t -66.96 -32.63 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 122.955 0.502 . . . . 0.0 110.168 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 60.9 m -64.23 -45.1 89.68 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 122.903 0.481 . . . . 0.0 111.401 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -70.67 -37.31 73.67 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.222 0.609 . . . . 0.0 110.593 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 34.2 t -63.87 -28.77 70.07 Favored 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 123.414 0.686 . . . . 0.0 111.82 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 59.9 tp -73.74 -37.54 65.03 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 123.688 0.795 . . . . 0.0 110.177 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 58.9 mt -88.28 -26.16 22.44 Favored 'General case' 0 N--CA 1.528 3.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.864 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.9 m0 -89.45 7.59 35.25 Favored 'General case' 0 N--CA 1.533 3.713 0 C-N-CA 123.372 0.669 . . . . 0.0 110.274 -178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -77.96 -12.76 60.01 Favored 'General case' 0 N--CA 1.521 3.112 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 56.5 mttp 74.19 -18.12 0.42 Allowed 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 125.598 1.559 . . . . 0.0 111.105 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.87 130.54 45.89 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 8.2 mp -93.74 141.89 24.39 Favored Pre-proline 0 N--CA 1.529 3.496 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 1 N--CA 1.54 4.211 0 CA-C-N 122.274 1.848 . . . . 0.0 110.591 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.586 2.356 0 CA-C-O 117.436 -1.268 . . . . 0.0 112.108 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -83.82 88.99 1.05 Allowed 'Trans proline' 0 N--CA 1.535 3.964 0 CA-C-N 122.694 1.998 . . . . 0.0 110.803 -178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 71.03 -172.53 43.79 Favored Glycine 1 N--CA 1.517 4.037 0 C-N-CA 123.685 0.659 . . . . 0.0 111.502 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 26.2 t 61.62 149.23 0.02 OUTLIER 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 124.687 1.195 . . . . 0.0 112.091 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.55 30.23 0.02 OUTLIER 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 124.341 1.057 . . . . 0.0 108.987 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 64.6 m -70.12 -22.16 63.04 Favored 'General case' 0 N--CA 1.518 2.934 0 C-N-CA 122.652 0.381 . . . . 0.0 111.067 -179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.44 -50.6 8.06 Favored Glycine 1 N--CA 1.518 4.116 0 C-N-CA 123.327 0.489 . . . . 0.0 113.912 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.3 tp -64.87 -41.03 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.2 pt -55.18 -34.04 31.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 CA-C-N 118.874 0.761 . . . . 0.0 111.745 -179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 31.5 mm -62.37 -44.83 99.63 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.085 0 CA-C-O 120.985 0.421 . . . . 0.0 110.174 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -61.22 -36.9 81.19 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.501 0.72 . . . . 0.0 111.983 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 -36.39 63.17 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.206 0 CA-C-N 118.343 0.52 . . . . 0.0 111.29 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 10.2 p -66.67 -49.8 64.99 Favored 'General case' 0 N--CA 1.532 3.663 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -175.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 8.3 p -71.34 -31.9 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.05 -35.79 79.68 Favored 'General case' 0 N--CA 1.522 3.162 0 C-N-CA 122.768 0.427 . . . . 0.0 111.217 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.36 69.31 Favored 'General case' 0 N--CA 1.519 3.016 0 C-N-CA 122.936 0.494 . . . . 0.0 112.106 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 66.1 t -68.59 -43.07 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.493 0 C-N-CA 123.453 0.701 . . . . 0.0 111.973 -177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.88 -32.59 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 CA-C-N 118.7 0.682 . . . . 0.0 110.36 -178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.3 tp -57.77 -38.7 75.91 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.172 0.589 . . . . 0.0 111.24 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.2 mm -66.11 -52.09 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 CA-C-O 122.04 0.924 . . . . 0.0 109.621 178.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 91.3 t -66.59 -36.4 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.015 0 C-N-CA 126.02 1.728 . . . . 0.0 113.135 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.67 -31.47 66.35 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.8 m -69.29 -38.1 76.98 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.003 0 CA-C-N 118.971 0.805 . . . . 0.0 110.218 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -69.48 -41.98 75.41 Favored 'General case' 0 N--CA 1.526 3.375 0 C-N-CA 123.112 0.565 . . . . 0.0 110.047 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 77.9 t -61.46 -33.57 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 C-N-CA 122.914 0.486 . . . . 0.0 110.128 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.6 m -67.52 -44.38 78.53 Favored 'General case' 0 N--CA 1.532 3.672 0 CA-C-O 121.576 0.703 . . . . 0.0 109.674 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 66.0 tttm -68.66 -27.07 65.66 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 124.59 1.156 . . . . 0.0 110.809 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.5 t -67.51 -15.85 63.89 Favored 'General case' 0 N--CA 1.52 3.047 0 C-N-CA 123.138 0.575 . . . . 0.0 111.972 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 62.3 mt -91.22 -37.31 13.4 Favored 'General case' 0 N--CA 1.536 3.874 0 C-N-CA 123.57 0.748 . . . . 0.0 111.468 -179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 9.4 mp -80.7 -27.73 36.88 Favored 'General case' 0 N--CA 1.537 3.923 0 C-N-CA 123.025 0.53 . . . . 0.0 110.34 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -89.87 -2.69 58.25 Favored 'General case' 0 N--CA 1.538 3.962 0 C-N-CA 123.591 0.757 . . . . 0.0 110.603 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -127.15 33.05 4.97 Favored 'General case' 0 N--CA 1.536 3.839 0 C-N-CA 124.488 1.115 . . . . 0.0 108.859 179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -146.02 -52.3 0.25 Allowed 'General case' 0 N--CA 1.527 3.395 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.5 t -83.82 122.62 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.154 0 N-CA-C 107.248 -1.389 . . . . 0.0 107.248 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 8.0 mp -93.77 141.72 24.15 Favored Pre-proline 0 N--CA 1.529 3.478 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo . . . . . 1 N--CA 1.539 4.167 0 CA-C-N 122.398 1.892 . . . . 0.0 110.684 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.7 mtt . . . . . 0 CA--C 1.574 1.868 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -72.9 164.63 35.03 Favored 'Trans proline' 1 N--CA 1.537 4.081 0 C-N-CA 122.286 1.991 . . . . 0.0 110.09 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.54 33.5 0.08 OUTLIER Glycine 1 N--CA 1.519 4.168 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 43.7 t -166.76 45.1 0.06 Allowed 'General case' 0 N--CA 1.519 3.01 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 4.4 tt -67.57 -8.77 36.85 Favored 'General case' 0 N--CA 1.528 3.43 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.908 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 69.5 m -70.52 -20.56 62.82 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 123.275 0.63 . . . . 0.0 109.91 177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.0 -50.29 58.6 Favored Glycine 1 N--CA 1.516 4.029 0 C-N-CA 124.053 0.835 . . . . 0.0 114.109 -177.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 18.5 tt -61.07 -35.57 66.38 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.158 0 CA-C-N 117.844 0.822 . . . . 0.0 110.513 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.4 mm -54.71 -33.96 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.638 0 C-N-CA 123.401 0.68 . . . . 0.0 110.551 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 34.8 mm -69.26 -41.9 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 CA-C-O 121.262 0.553 . . . . 0.0 109.573 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -66.03 -42.45 89.59 Favored 'General case' 0 N--CA 1.525 3.317 0 N-CA-C 114.55 1.315 . . . . 0.0 114.55 -176.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 35.9 m -57.94 -32.94 44.74 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.341 0 CA-C-N 119.354 0.979 . . . . 0.0 111.329 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 28.7 p -65.56 -48.45 72.36 Favored 'General case' 0 N--CA 1.531 3.608 0 C-N-CA 123.586 0.754 . . . . 0.0 110.979 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 60.1 t -67.18 -36.92 78.13 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.39 0 C-N-CA 123.781 0.832 . . . . 0.0 109.434 -179.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.53 -34.61 77.27 Favored 'General case' 0 N--CA 1.522 3.151 0 C-N-CA 123.442 0.697 . . . . 0.0 111.221 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -68.97 -38.27 79.27 Favored 'General case' 0 N--CA 1.519 3.001 0 C-N-CA 123.131 0.573 . . . . 0.0 112.099 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.19 -46.24 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.617 0 C-N-CA 122.729 0.411 . . . . 0.0 111.479 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 p -67.16 -32.51 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.643 0 CA-C-N 118.331 0.514 . . . . 0.0 110.305 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 55.0 tp -59.21 -43.59 92.26 Favored 'General case' 0 N--CA 1.529 3.525 0 C-N-CA 122.983 0.513 . . . . 0.0 110.78 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 86.2 mt -70.36 -54.13 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.394 0 C-N-CA 123.457 0.703 . . . . 0.0 110.071 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.12 -37.19 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.521 0 C-N-CA 124.621 1.168 . . . . 0.0 114.082 -176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.64 -35.0 71.82 Favored 'General case' 0 N--CA 1.534 3.729 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -174.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 10.8 m -70.34 -37.0 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.954 0 CA-C-N 119.223 0.92 . . . . 0.0 110.925 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -70.28 -41.93 72.76 Favored 'General case' 0 N--CA 1.53 3.568 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 95.1 t -68.01 -35.57 72.29 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.75 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.2 t -67.55 -48.09 67.97 Favored 'General case' 0 N--CA 1.526 3.36 0 C-N-CA 123.139 0.576 . . . . 0.0 111.748 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 28.7 pttt -62.08 -24.88 67.38 Favored 'General case' 0 N--CA 1.537 3.88 0 C-N-CA 123.485 0.714 . . . . 0.0 111.643 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 77.1 p -63.62 -19.52 64.93 Favored 'General case' 0 N--CA 1.53 3.529 0 C-N-CA 122.799 0.44 . . . . 0.0 111.515 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 9.2 mp -84.27 -37.27 21.93 Favored 'General case' 0 N--CA 1.533 3.685 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -84.46 -24.7 29.36 Favored 'General case' 0 N--CA 1.531 3.597 0 C-N-CA 123.875 0.87 . . . . 0.0 110.543 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -89.6 -0.24 57.39 Favored 'General case' 0 N--CA 1.538 3.948 0 C-N-CA 123.705 0.802 . . . . 0.0 109.866 -178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -124.5 33.77 5.17 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 124.809 1.244 . . . . 0.0 108.278 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -158.37 -67.99 0.09 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 58.9 t -94.55 133.12 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 50.6 mt -93.71 125.89 51.76 Favored Pre-proline 0 N--CA 1.524 3.247 0 CA-C-O 116.626 -1.654 . . . . 0.0 108.518 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 1 N--CA 1.538 4.102 0 CA-C-N 123.289 2.21 . . . . 0.0 110.149 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 79.3 mmm . . . . . 0 CA--C 1.573 1.829 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -72.59 -166.17 0.26 Allowed 'Trans proline' 1 N--CA 1.541 4.271 0 C-N-CA 122.17 1.913 . . . . 0.0 109.84 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -166.49 -160.1 13.23 Favored Glycine 1 N--CA 1.519 4.181 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 53.7 m -56.62 89.75 0.01 OUTLIER 'General case' 0 N--CA 1.521 3.099 0 C-N-CA 123.994 0.918 . . . . 0.0 111.616 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 87.5 mt -137.07 8.48 2.96 Favored 'General case' 0 N--CA 1.532 3.645 0 C-N-CA 124.732 1.213 . . . . 0.0 109.887 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 67.4 m -66.49 -40.04 89.06 Favored 'General case' 0 N--CA 1.522 3.141 0 C-N-CA 123.213 0.605 . . . . 0.0 110.527 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.62 -37.4 77.3 Favored Glycine 1 N--CA 1.517 4.088 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.685 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -60.24 -38.05 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.631 0 C-N-CA 124.45 1.1 . . . . 0.0 110.593 -178.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 84.3 mt -68.08 -38.31 79.59 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.0 mt -70.11 -37.43 71.95 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -59.08 -47.92 83.47 Favored 'General case' 0 N--CA 1.529 3.484 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 30.1 m -57.46 -30.93 37.39 Favored 'Isoleucine or valine' 1 N--CA 1.547 4.395 0 CA-C-N 118.41 0.55 . . . . 0.0 112.218 -175.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -72.2 -48.11 45.62 Favored 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 123.47 0.708 . . . . 0.0 110.011 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 93.1 t -69.45 -31.95 51.23 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.113 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.32 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -55.24 -34.96 64.45 Favored 'General case' 0 N--CA 1.525 3.286 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.96 -45.47 64.08 Favored 'General case' 0 N--CA 1.526 3.371 0 CA-C-O 121.162 0.506 . . . . 0.0 111.887 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.15 -38.43 81.12 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.237 0 C-N-CA 123.886 0.875 . . . . 0.0 112.693 -176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 36.0 m -65.44 -32.59 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.952 0 CA-C-N 119.334 0.97 . . . . 0.0 111.667 -178.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 67.2 mt -65.05 -47.83 75.97 Favored 'General case' 0 N--CA 1.532 3.642 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.9 tt -70.92 -44.96 75.37 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -177.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 14.5 m -67.52 -41.08 85.52 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.25 0 CA-C-N 119.53 1.059 . . . . 0.0 112.986 -178.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.34 -43.47 92.74 Favored 'General case' 0 N--CA 1.53 3.549 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 -174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.2 p -60.86 -34.54 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 122.693 0.397 . . . . 0.0 110.882 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -71.16 -42.36 69.19 Favored 'General case' 1 N--CA 1.539 4.005 0 CA-C-N 118.831 0.741 . . . . 0.0 109.819 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 99.2 t -68.25 -34.96 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.572 0 C-N-CA 123.572 0.749 . . . . 0.0 109.792 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.8 t -66.92 -43.13 84.07 Favored 'General case' 0 N--CA 1.525 3.296 0 C-N-CA 123.282 0.633 . . . . 0.0 111.012 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -62.58 -33.29 74.67 Favored 'General case' 0 N--CA 1.528 3.453 0 C-N-CA 123.9 0.88 . . . . 0.0 111.273 -178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.76 -16.23 60.65 Favored 'General case' 0 N--CA 1.523 3.205 0 C-N-CA 123.215 0.606 . . . . 0.0 111.814 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 52.8 mt -91.21 -37.59 13.23 Favored 'General case' 0 N--CA 1.529 3.516 0 C-N-CA 123.854 0.861 . . . . 0.0 111.308 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.47 -27.39 27.53 Favored 'General case' 1 N--CA 1.541 4.086 0 C-N-CA 123.489 0.716 . . . . 0.0 110.589 -178.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 38.8 m95 -100.09 13.17 35.02 Favored 'General case' 1 N--CA 1.54 4.027 0 C-N-CA 124.333 1.053 . . . . 0.0 109.223 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.01 -27.49 69.16 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.786 0.835 . . . . 0.0 110.372 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -167.12 -34.64 0.02 OUTLIER 'General case' 0 N--CA 1.531 3.619 0 C-N-CA 123.226 0.61 . . . . 0.0 109.825 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 59.0 t -83.37 127.85 39.33 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -178.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 49.3 mt -118.3 141.81 30.19 Favored Pre-proline 0 N--CA 1.53 3.548 0 CA-C-O 117.107 -1.425 . . . . 0.0 108.1 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 1 N--CA 1.541 4.281 0 CA-C-N 122.47 1.918 . . . . 0.0 110.837 -179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.581 2.152 0 CA-C-O 117.609 -1.186 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -88.63 -168.26 0.34 Allowed 'Trans proline' 0 N--CA 1.534 3.868 0 C-N-CA 122.593 2.195 . . . . 0.0 110.718 -178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.03 -141.24 3.4 Favored Glycine 1 N--CA 1.52 4.287 0 N-CA-C 110.363 -1.095 . . . . 0.0 110.363 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 23.0 t 61.4 47.68 6.59 Favored 'General case' 0 N--CA 1.519 2.982 0 C-N-CA 124.221 1.008 . . . . 0.0 111.535 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 30.7 mt -78.36 18.16 0.57 Allowed 'General case' 0 N--CA 1.528 3.456 0 CA-C-N 114.4 -1.273 . . . . 0.0 110.204 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.8 p -64.97 -20.7 66.62 Favored 'General case' 0 N--CA 1.528 3.437 0 O-C-N 121.887 -0.508 . . . . 0.0 110.508 178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -49.23 14.87 Favored Glycine 1 N--CA 1.516 4.012 0 C-N-CA 124.202 0.906 . . . . 0.0 113.17 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -57.81 -36.64 56.16 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.347 0 C-N-CA 123.262 0.625 . . . . 0.0 110.163 -177.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 61.5 mt -58.41 -34.09 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.722 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.585 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 21.1 mm -67.29 -40.62 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 CA-C-O 121.386 0.612 . . . . 0.0 109.958 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -64.63 -46.42 82.64 Favored 'General case' 0 N--CA 1.524 3.27 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 25.1 m -62.56 -34.13 63.33 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.096 0 CA-C-N 118.495 0.589 . . . . 0.0 112.334 -176.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 66.8 p -66.36 -49.22 67.65 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.119 0.568 . . . . 0.0 112.192 -178.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.5 p -71.76 -37.29 61.9 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -64.0 -37.62 88.09 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 122.582 0.353 . . . . 0.0 110.713 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.73 95.68 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 122.962 0.505 . . . . 0.0 111.817 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.3 -45.34 75.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.559 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 59.8 t -65.5 -32.93 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.293 0 C-N-CA 123.689 0.795 . . . . 0.0 109.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 43.8 tp -60.51 -40.82 92.83 Favored 'General case' 0 N--CA 1.535 3.783 0 C-N-CA 122.739 0.415 . . . . 0.0 110.577 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.46 -53.83 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 CA-C-O 121.494 0.664 . . . . 0.0 109.768 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 86.5 t -66.52 -37.96 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.3 0 C-N-CA 124.208 1.003 . . . . 0.0 113.054 -177.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.24 -45.64 90.61 Favored 'General case' 1 N--CA 1.54 4.038 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -176.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.25 -34.34 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.266 0 C-N-CA 122.942 0.497 . . . . 0.0 109.883 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.86 -43.25 79.87 Favored 'General case' 0 N--CA 1.534 3.772 0 C-N-CA 122.657 0.383 . . . . 0.0 111.582 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.0 m -69.09 -31.65 51.03 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 CA-C-N 118.47 0.577 . . . . 0.0 110.31 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 48.5 t -59.68 -45.03 93.31 Favored 'General case' 0 N--CA 1.527 3.387 0 C-N-CA 123.152 0.581 . . . . 0.0 111.982 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -70.35 -24.87 63.05 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.169 0.587 . . . . 0.0 111.592 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 49.5 m -63.74 -26.68 68.76 Favored 'General case' 0 N--CA 1.532 3.671 0 CA-C-N 118.413 0.552 . . . . 0.0 110.503 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 10.3 mp -91.3 -14.33 31.03 Favored 'General case' 0 N--CA 1.532 3.627 0 C-N-CA 124.645 1.178 . . . . 0.0 110.406 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.6 tp -80.16 -28.06 38.88 Favored 'General case' 0 N--CA 1.536 3.857 0 CA-C-N 118.405 0.548 . . . . 0.0 111.425 -176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -110.5 4.63 20.62 Favored 'General case' 1 N--CA 1.558 4.939 0 C-N-CA 122.993 0.517 . . . . 0.0 111.392 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -70.74 -19.85 62.69 Favored 'General case' 0 N--CA 1.535 3.815 0 C-N-CA 123.037 0.535 . . . . 0.0 109.884 177.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 61.9 mttm 70.71 8.99 6.76 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 124.621 1.168 . . . . 0.0 111.006 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 61.4 t -133.55 122.2 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.484 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.8 mp -94.05 141.74 24.06 Favored Pre-proline 0 N--CA 1.528 3.47 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 1 N--CA 1.539 4.187 0 CA-C-N 122.253 1.84 . . . . 0.0 110.603 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.575 1.918 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -72.93 -177.52 2.95 Favored 'Trans proline' 1 N--CA 1.538 4.119 0 C-N-CA 122.344 2.029 . . . . 0.0 110.337 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.55 170.59 27.11 Favored Glycine 1 N--CA 1.519 4.201 0 O-C-N 123.672 0.607 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.6 p -66.97 133.27 49.63 Favored 'General case' 0 N--CA 1.523 3.209 0 C-N-CA 123.714 0.806 . . . . 0.0 110.374 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -166.48 -45.58 0.02 OUTLIER 'General case' 0 N--CA 1.523 3.218 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.9 m -68.81 -34.14 75.03 Favored 'General case' 0 N--CA 1.524 3.237 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.931 179.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.53 -31.14 65.76 Favored Glycine 0 N--CA 1.514 3.897 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.406 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 39.8 mm -64.86 -36.69 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.283 0 C-N-CA 123.856 0.862 . . . . 0.0 110.46 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 67.4 mt -67.06 -36.32 76.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.742 0 C-N-CA 123.197 0.599 . . . . 0.0 109.649 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 64.7 mt -70.51 -39.09 75.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.448 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -64.04 -41.75 97.3 Favored 'General case' 0 N--CA 1.526 3.362 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.3 p -63.45 -27.69 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.979 0 CA-C-N 118.842 0.746 . . . . 0.0 111.486 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -68.54 -49.42 59.69 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.89 -38.44 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.473 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -34.75 68.29 Favored 'General case' 0 N--CA 1.526 3.345 0 C-N-CA 123.038 0.535 . . . . 0.0 111.237 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.81 -39.41 91.67 Favored 'General case' 0 N--CA 1.525 3.28 0 C-N-CA 123.155 0.582 . . . . 0.0 111.395 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -70.03 -43.4 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.723 0.809 . . . . 0.0 109.166 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.19 -32.91 56.21 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.301 0 C-N-CA 123.953 0.901 . . . . 0.0 109.785 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.57 -47.43 79.53 Favored 'General case' 0 N--CA 1.533 3.698 0 C-N-CA 123.512 0.725 . . . . 0.0 111.149 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.8 mt -70.3 -55.86 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -177.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 19.9 m -68.35 -38.38 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.068 0 N-CA-C 115.216 1.562 . . . . 0.0 115.216 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.49 -40.07 85.83 Favored 'General case' 0 N--CA 1.534 3.732 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -70.32 -34.73 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 CA-C-O 118.889 -0.576 . . . . 0.0 111.884 -177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.5 m-85 -70.87 -42.63 69.81 Favored 'General case' 1 N--CA 1.539 4.006 0 CA-C-N 119.559 1.072 . . . . 0.0 111.419 -178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 32.3 m -68.63 -31.24 50.17 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.812 0 O-C-N 122.066 -0.396 . . . . 0.0 110.333 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -62.21 -48.19 81.11 Favored 'General case' 0 N--CA 1.523 3.208 0 C-N-CA 123.203 0.601 . . . . 0.0 111.615 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -72.3 -29.06 63.5 Favored 'General case' 0 N--CA 1.527 3.396 0 C-N-CA 123.159 0.583 . . . . 0.0 110.709 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.68 -27.99 69.59 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.232 0.613 . . . . 0.0 111.556 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.2 tp -73.03 -37.54 66.87 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.65 0.78 . . . . 0.0 110.666 -178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.89 -27.13 22.37 Favored 'General case' 0 N--CA 1.539 3.994 0 C-N-CA 123.828 0.851 . . . . 0.0 109.861 -179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 28.2 m0 -88.9 13.64 12.25 Favored 'General case' 0 N--CA 1.536 3.867 0 C-N-CA 123.594 0.758 . . . . 0.0 109.92 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' C' ' 240' ' ' VAL . 63.4 tttp -132.36 -53.66 0.96 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 105.277 -2.119 . . . . 0.0 105.277 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 65.21 -19.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.165 0 C-N-CA 125.053 1.341 . . . . 0.0 112.429 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . 0.435 ' H ' ' C ' ' C' ' 238' ' ' LYS . 91.1 t -88.4 122.4 39.86 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.596 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -94.53 141.71 23.82 Favored Pre-proline 0 N--CA 1.525 3.296 0 CA-C-O 117.189 -1.386 . . . . 0.0 107.301 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo . . . . . 1 N--CA 1.54 4.222 0 CA-C-N 122.389 1.889 . . . . 0.0 110.697 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 CA--C 1.576 1.952 0 CA-C-O 117.602 -1.19 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -52.17 -39.28 71.65 Favored 'Trans proline' 1 N--CA 1.548 4.725 0 CA-C-N 122.46 1.914 . . . . 0.0 113.264 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 176.88 172.27 41.32 Favored Glycine 1 N--CA 1.518 4.162 0 N-CA-C 110.429 -1.069 . . . . 0.0 110.429 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 91.7 p -167.93 80.31 0.17 Allowed 'General case' 0 N--CA 1.522 3.128 0 C-N-CA 123.971 0.908 . . . . 0.0 108.79 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.63 -0.83 0.05 Allowed 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.432 0.693 . . . . 0.0 112.501 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 68.9 m -70.01 -40.23 75.38 Favored 'General case' 0 N--CA 1.525 3.294 0 C-N-CA 123.477 0.711 . . . . 0.0 110.522 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.49 -29.53 74.97 Favored Glycine 1 N--CA 1.517 4.092 0 CA-C-N 114.929 -1.032 . . . . 0.0 111.903 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 54.1 mt -66.06 -36.52 77.66 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.121 0 C-N-CA 123.62 0.768 . . . . 0.0 110.504 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.26 -36.64 77.7 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.883 0 C-N-CA 122.879 0.472 . . . . 0.0 110.383 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 61.6 mt -70.18 -42.89 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.492 0 CA-C-O 121.802 0.811 . . . . 0.0 109.154 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 23.4 t80 -63.99 -44.48 92.56 Favored 'General case' 0 N--CA 1.527 3.418 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 -176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.8 p -60.31 -33.27 53.23 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 CA-C-N 118.898 0.772 . . . . 0.0 112.117 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -66.82 -49.67 65.04 Favored 'General case' 0 N--CA 1.529 3.501 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 -178.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.09 -37.24 59.41 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.82 -34.85 70.11 Favored 'General case' 0 N--CA 1.526 3.346 0 C-N-CA 122.664 0.386 . . . . 0.0 111.281 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.08 -43.94 97.74 Favored 'General case' 0 N--CA 1.523 3.185 0 C-N-CA 122.966 0.506 . . . . 0.0 111.727 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.7 t -70.05 -41.4 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.466 0 C-N-CA 123.538 0.735 . . . . 0.0 109.828 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.0 t -67.33 -32.82 59.12 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.791 0.836 . . . . 0.0 110.132 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.81 -48.05 73.02 Favored 'General case' 0 N--CA 1.528 3.468 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 18.6 tt -71.24 -44.46 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.644 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 25.8 m -66.86 -37.37 79.3 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.537 0 CA-C-N 120.447 1.476 . . . . 0.0 112.364 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.11 -31.84 69.29 Favored 'General case' 0 N--CA 1.524 3.275 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.4 m -64.62 -35.08 73.76 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.083 0.856 . . . . 0.0 111.011 -178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.89 -37.27 81.53 Favored 'General case' 0 N--CA 1.529 3.491 0 CA-C-O 120.893 0.378 . . . . 0.0 110.199 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 60.9 t -68.05 -40.66 83.48 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.377 0 C-N-CA 123.748 0.819 . . . . 0.0 109.792 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 83.7 m -66.79 -42.18 86.43 Favored 'General case' 0 N--CA 1.525 3.278 0 C-N-CA 123.348 0.659 . . . . 0.0 110.472 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.63 ' HZ3' ' HE1' ' A' ' 237' ' ' TRP . 65.8 tttm -56.06 -29.39 60.44 Favored 'General case' 0 N--CA 1.529 3.495 0 C-N-CA 124.46 1.104 . . . . 0.0 111.901 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 32.4 t -63.86 -22.79 67.08 Favored 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 122.914 0.485 . . . . 0.0 111.558 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 7.5 mp -90.63 -18.18 25.59 Favored 'General case' 0 N--CA 1.534 3.733 0 C-N-CA 123.78 0.832 . . . . 0.0 109.956 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.9 mp -80.23 -27.79 38.66 Favored 'General case' 1 N--CA 1.54 4.063 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.63 ' HE1' ' HZ3' ' A' ' 233' ' ' LYS . 92.7 m95 -89.25 13.57 13.06 Favored 'General case' 1 N--CA 1.548 4.463 0 C-N-CA 123.028 0.531 . . . . 0.0 110.073 178.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -129.19 6.98 5.41 Favored 'General case' 0 N--CA 1.534 3.73 0 C-N-CA 125.007 1.323 . . . . 0.0 109.175 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -69.88 -31.99 70.11 Favored 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 124.098 0.959 . . . . 0.0 108.921 178.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.43 122.16 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.31 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.0 mp -100.63 141.8 23.38 Favored Pre-proline 0 N--CA 1.532 3.664 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo . . . . . 1 N--CA 1.541 4.287 0 CA-C-N 122.296 1.856 . . . . 0.0 110.508 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 24.7 ptt? . . . . . 0 CA--C 1.57 1.712 0 CA-C-O 117.658 -1.163 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.14 71.19 3.64 Favored 'Trans proline' 1 N--CA 1.54 4.207 0 C-N-CA 122.1 1.867 . . . . 0.0 110.12 179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.41 -150.51 51.76 Favored Glycine 1 N--CA 1.521 4.328 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.602 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.3 p -163.56 37.63 0.09 Allowed 'General case' 0 N--CA 1.521 3.112 0 CA-C-O 121.855 0.836 . . . . 0.0 109.372 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 68.1 mt 54.7 9.07 0.25 Allowed 'General case' 0 N--CA 1.521 3.115 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.207 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -60.88 -43.07 98.94 Favored 'General case' 0 N--CA 1.526 3.374 0 CA-C-O 121.062 0.458 . . . . 0.0 111.986 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.16 -36.03 60.45 Favored Glycine 1 N--CA 1.519 4.194 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.367 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 46.0 mm -62.63 -45.97 97.51 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.245 0 C-N-CA 124.056 0.942 . . . . 0.0 111.255 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 91.2 mt -63.24 -36.8 77.51 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.078 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 89.1 mt -70.15 -39.52 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 123.335 0.654 . . . . 0.0 109.32 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -67.01 -44.31 80.63 Favored 'General case' 0 N--CA 1.531 3.578 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 23.5 m -57.71 -27.94 31.22 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.265 0 CA-C-N 118.984 0.811 . . . . 0.0 111.756 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 26.4 p -71.9 -48.58 44.56 Favored 'General case' 0 N--CA 1.53 3.547 0 C-N-CA 123.329 0.651 . . . . 0.0 110.301 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.1 t -69.07 -31.81 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.306 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.59 -38.56 81.56 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 123.409 0.683 . . . . 0.0 111.384 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.29 -40.94 98.77 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-O 121.153 0.501 . . . . 0.0 111.499 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 51.8 t -70.08 -38.5 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.164 0 C-N-CA 123.766 0.826 . . . . 0.0 109.506 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.99 -33.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.819 0 C-N-CA 123.446 0.698 . . . . 0.0 111.394 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 82.1 mt -62.58 -39.01 92.33 Favored 'General case' 0 N--CA 1.533 3.676 0 C-N-CA 122.454 0.302 . . . . 0.0 111.561 -179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 16.2 mm -70.16 -55.06 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.606 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 22.3 m -66.77 -36.5 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 124.01 0.924 . . . . 0.0 113.237 -175.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.39 67.72 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.4 m -61.35 -40.35 85.87 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.111 0 CA-C-N 119.072 0.851 . . . . 0.0 110.729 -178.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -63.07 -38.97 93.3 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 122.641 0.376 . . . . 0.0 110.458 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 49.7 t -65.36 -39.8 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.434 0 C-N-CA 123.632 0.773 . . . . 0.0 109.703 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.8 t -66.81 -45.69 77.52 Favored 'General case' 0 N--CA 1.524 3.266 0 C-N-CA 123.77 0.828 . . . . 0.0 110.995 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.4 mtpt -70.49 -41.88 72.1 Favored 'General case' 0 N--CA 1.526 3.332 0 C-N-CA 123.642 0.777 . . . . 0.0 110.864 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 94.2 p -63.15 -27.05 69.11 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 122.834 0.454 . . . . 0.0 110.624 -179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.9 tp -79.19 -31.16 43.74 Favored 'General case' 0 N--CA 1.519 3.0 0 C-N-CA 123.691 0.797 . . . . 0.0 109.205 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 55.7 tp -80.7 -28.23 36.77 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 123.07 0.548 . . . . 0.0 110.165 -178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -95.38 -4.71 44.8 Favored 'General case' 1 N--CA 1.542 4.155 0 C-N-CA 123.525 0.73 . . . . 0.0 109.733 178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 65.7 mttm 63.95 26.75 14.25 Favored 'General case' 0 N--CA 1.519 3.018 0 C-N-CA 124.481 1.112 . . . . 0.0 112.418 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -73.3 -37.72 66.11 Favored 'General case' 0 N--CA 1.525 3.302 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 55.5 t -136.3 122.13 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.419 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.09 141.54 42.31 Favored Pre-proline 0 N--CA 1.527 3.387 0 CA-C-O 116.435 -1.745 . . . . 0.0 107.031 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo . . . . . 1 N--CA 1.55 4.82 0 CA-C-N 123.279 2.207 . . . . 0.0 114.542 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 57.8 mtt . . . . . 0 CA--C 1.581 2.16 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.34 -23.07 22.59 Favored 'Trans proline' 1 N--CA 1.548 4.733 0 CA-C-N 122.26 1.843 . . . . 0.0 113.155 179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 66.5 145.75 0.07 OUTLIER Glycine 1 N--CA 1.518 4.15 0 C-N-CA 123.871 0.748 . . . . 0.0 111.417 -179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 33.4 t -70.9 71.82 0.54 Allowed 'General case' 0 N--CA 1.519 3.02 0 C-N-CA 123.8 0.84 . . . . 0.0 110.448 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -66.19 -34.88 79.03 Favored 'General case' 0 N--CA 1.53 3.563 0 C-N-CA 124.154 0.982 . . . . 0.0 110.1 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -70.91 -20.87 62.44 Favored 'General case' 0 N--CA 1.523 3.211 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.773 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -72.59 -50.03 16.61 Favored Glycine 0 N--CA 1.512 3.749 0 C-N-CA 124.201 0.905 . . . . 0.0 113.711 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 19.5 tt -59.39 -35.65 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.993 0 CA-C-N 117.924 0.862 . . . . 0.0 111.364 -177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 63.6 mt -60.08 -34.81 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.756 0 C-N-CA 122.626 0.37 . . . . 0.0 110.313 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 77.2 mt -70.23 -42.25 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 178.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.1 t80 -63.11 -40.45 97.66 Favored 'General case' 0 N--CA 1.526 3.364 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -176.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 27.1 m -63.57 -27.81 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 119.131 0.878 . . . . 0.0 111.906 -177.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 33.8 p -69.13 -49.61 55.45 Favored 'General case' 0 N--CA 1.529 3.506 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -178.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 8.0 p -71.98 -39.28 66.39 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.452 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.57 -34.73 69.51 Favored 'General case' 0 N--CA 1.524 3.25 0 C-N-CA 122.906 0.482 . . . . 0.0 111.268 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.26 99.38 Favored 'General case' 0 N--CA 1.522 3.161 0 C-N-CA 123.127 0.571 . . . . 0.0 111.604 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.16 -43.21 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.261 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 78.8 t -62.94 -32.22 55.26 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 123.883 0.873 . . . . 0.0 109.367 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.9 -47.18 74.67 Favored 'General case' 0 N--CA 1.536 3.847 0 C-N-CA 122.969 0.508 . . . . 0.0 109.824 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 60.0 mt -68.76 -51.41 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.503 0 C-N-CA 123.44 0.696 . . . . 0.0 110.404 -179.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 58.1 t -66.44 -37.9 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.382 0 C-N-CA 123.803 0.841 . . . . 0.0 112.748 -177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.05 -48.09 82.85 Favored 'General case' 0 N--CA 1.539 3.977 0 CA-C-N 118.542 0.61 . . . . 0.0 112.186 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.17 -33.68 62.18 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.349 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.21 -43.18 99.41 Favored 'General case' 0 N--CA 1.536 3.855 0 C-N-CA 123.246 0.618 . . . . 0.0 110.517 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 72.4 t -68.69 -34.75 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 C-N-CA 123.103 0.561 . . . . 0.0 109.674 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.15 -27.68 69.25 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 123.259 0.624 . . . . 0.0 111.233 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -62.0 -30.72 71.13 Favored 'General case' 0 N--CA 1.531 3.605 0 C-N-CA 123.527 0.731 . . . . 0.0 110.922 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 48.7 m -63.35 -24.96 68.08 Favored 'General case' 0 N--CA 1.526 3.344 0 C-N-CA 123.09 0.556 . . . . 0.0 110.946 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 51.3 mt -91.32 -23.66 20.05 Favored 'General case' 0 N--CA 1.52 3.042 0 C-N-CA 124.218 1.007 . . . . 0.0 110.737 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.06 -28.68 27.43 Favored 'General case' 1 N--CA 1.544 4.27 0 C-N-CA 123.115 0.566 . . . . 0.0 112.258 -176.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.09 14.37 17.05 Favored 'General case' 1 N--CA 1.553 4.691 0 C-N-CA 124.074 0.949 . . . . 0.0 111.747 179.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -52.5 -23.14 5.69 Favored 'General case' 0 N--CA 1.531 3.617 0 C-N-CA 124.439 1.096 . . . . 0.0 111.107 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -71.29 -35.28 71.25 Favored 'General case' 0 N--CA 1.513 2.678 0 CA-C-N 114.611 -1.177 . . . . 0.0 108.9 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.8 t -96.5 122.07 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.512 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -108.56 114.32 59.1 Favored Pre-proline 0 N--CA 1.532 3.627 0 CA-C-O 116.599 -1.667 . . . . 0.0 107.104 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo . . . . . 1 N--CA 1.547 4.662 0 CA-C-N 123.028 2.117 . . . . 0.0 114.168 178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 75.4 mmm . . . . . 0 CA--C 1.573 1.854 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.05 -171.07 0.8 Allowed 'Trans proline' 1 N--CA 1.539 4.168 0 C-N-CA 122.146 1.897 . . . . 0.0 110.006 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.42 159.47 29.47 Favored Glycine 1 N--CA 1.518 4.101 0 N-CA-C 110.258 -1.137 . . . . 0.0 110.258 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 90.9 p -169.56 58.51 0.05 OUTLIER 'General case' 0 N--CA 1.519 3.014 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.9 tt -145.51 -9.91 0.55 Allowed 'General case' 0 N--CA 1.533 3.676 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.16 -178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.0 t -60.88 -20.35 61.74 Favored 'General case' 0 N--CA 1.531 3.577 0 CA-C-O 121.254 0.549 . . . . 0.0 110.758 177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.87 -40.04 97.73 Favored Glycine 0 N--CA 1.508 3.474 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.729 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.78 -36.03 63.64 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.127 0 CA-C-N 117.885 0.843 . . . . 0.0 111.679 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 61.0 mt -65.58 -37.58 80.34 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.576 0 C-N-CA 123.21 0.604 . . . . 0.0 109.708 -178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 63.9 mt -70.05 -41.06 79.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.495 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -59.61 -48.47 81.52 Favored 'General case' 0 N--CA 1.522 3.174 0 C-N-CA 124.5 1.12 . . . . 0.0 114.015 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 29.8 m -59.7 -32.36 49.23 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.914 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -176.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 24.5 p -72.15 -48.99 39.49 Favored 'General case' 0 N--CA 1.533 3.704 0 C-N-CA 122.605 0.362 . . . . 0.0 111.859 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 35.8 m -71.62 -32.42 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.501 0 C-N-CA 122.696 0.398 . . . . 0.0 110.044 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.95 -33.97 74.01 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.235 0.614 . . . . 0.0 111.332 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.54 -38.44 77.49 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.396 0.278 . . . . 0.0 111.571 -178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 47.5 t -70.06 -43.62 78.98 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.24 0 C-N-CA 123.512 0.725 . . . . 0.0 112.084 -177.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.09 -32.86 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.985 0 CA-C-N 118.919 0.781 . . . . 0.0 111.931 -177.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 63.1 mt -60.65 -36.92 79.87 Favored 'General case' 0 N--CA 1.537 3.898 0 CA-C-N 117.97 0.35 . . . . 0.0 110.794 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.8 mm -70.08 -47.72 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.709 0 CA-C-O 121.489 0.662 . . . . 0.0 109.332 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 62.3 t -67.0 -37.73 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.263 0 C-N-CA 124.202 1.001 . . . . 0.0 111.606 -179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.7 -45.11 90.25 Favored 'General case' 0 N--CA 1.533 3.68 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 p -65.94 -34.5 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 122.777 0.431 . . . . 0.0 109.943 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -69.81 -42.45 73.67 Favored 'General case' 1 N--CA 1.544 4.273 0 CA-C-N 118.875 0.762 . . . . 0.0 109.564 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 79.6 t -68.1 -31.66 52.72 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.925 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.13 -46.26 84.92 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.299 0.64 . . . . 0.0 111.472 -178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -69.0 -38.11 79.1 Favored 'General case' 0 N--CA 1.529 3.514 0 C-N-CA 123.408 0.683 . . . . 0.0 110.772 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.6 p -63.77 -34.92 78.97 Favored 'General case' 0 N--CA 1.528 3.437 0 C-N-CA 123.206 0.602 . . . . 0.0 110.668 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.78 -37.21 70.48 Favored 'General case' 0 N--CA 1.525 3.299 0 C-N-CA 124.091 0.956 . . . . 0.0 109.731 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 59.1 tp -80.26 -27.03 38.7 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 123.925 0.89 . . . . 0.0 110.397 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.5 m0 -89.27 -1.16 57.96 Favored 'General case' 0 N--CA 1.535 3.818 0 C-N-CA 123.422 0.689 . . . . 0.0 110.549 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -81.4 -29.57 33.91 Favored 'General case' 0 N--CA 1.527 3.392 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -68.15 -40.17 82.44 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 124.306 1.042 . . . . 0.0 109.967 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.5 122.48 53.14 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.563 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 7.7 mp -97.32 141.86 23.67 Favored Pre-proline 0 N--CA 1.53 3.54 0 C-N-CA 125.169 1.388 . . . . 0.0 107.284 -178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 1 N--CA 1.541 4.285 0 CA-C-N 122.235 1.834 . . . . 0.0 110.669 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 23.0 mmt . . . . . 0 CA--C 1.583 2.239 0 CA-C-O 117.756 -1.116 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -51.86 -29.12 33.53 Favored 'Trans proline' 1 N--CA 1.548 4.703 0 CA-C-N 122.337 1.87 . . . . 0.0 113.515 179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.68 53.82 29.2 Favored Glycine 1 N--CA 1.519 4.197 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.939 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 45.4 m 59.06 121.99 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.132 0 C-N-CA 124.658 1.183 . . . . 0.0 112.006 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -165.39 -49.13 0.03 OUTLIER 'General case' 0 N--CA 1.521 3.113 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.7 p -68.21 -34.76 76.85 Favored 'General case' 0 N--CA 1.525 3.321 0 CA-C-N 115.283 -0.872 . . . . 0.0 109.857 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.55 -30.27 62.42 Favored Glycine 0 N--CA 1.515 3.917 0 CA-C-N 114.967 -1.015 . . . . 0.0 111.237 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 38.2 mm -65.01 -36.83 78.73 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.662 0.785 . . . . 0.0 110.662 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 71.8 mt -70.02 -37.82 73.5 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.668 0 C-N-CA 123.068 0.547 . . . . 0.0 109.605 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 76.3 mt -69.9 -37.89 74.17 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -62.7 -46.41 88.26 Favored 'General case' 0 N--CA 1.523 3.191 0 N-CA-C 114.657 1.355 . . . . 0.0 114.657 -176.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.1 p -62.95 -38.86 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 118.583 0.629 . . . . 0.0 112.074 -176.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.4 p -64.46 -48.96 73.3 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 10.0 p -71.72 -37.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.48 -35.32 80.54 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.57 0.348 . . . . 0.0 111.097 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.81 -49.39 70.85 Favored 'General case' 0 N--CA 1.521 3.089 0 N-CA-C 112.411 0.522 . . . . 0.0 112.411 -178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.86 -38.61 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 O-C-N 122.121 -0.362 . . . . 0.0 110.416 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 27.2 t -64.83 -32.76 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 C-N-CA 123.495 0.718 . . . . 0.0 110.016 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.44 -36.91 76.81 Favored 'General case' 0 N--CA 1.534 3.752 0 C-N-CA 122.615 0.366 . . . . 0.0 110.28 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 57.5 mt -70.4 -52.28 30.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.416 0 C-N-CA 123.327 0.651 . . . . 0.0 109.435 179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 62.4 t -66.28 -37.74 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.18 0 C-N-CA 124.322 1.049 . . . . 0.0 112.85 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -47.77 83.42 Favored 'General case' 0 N--CA 1.537 3.916 0 CA-C-N 118.607 0.64 . . . . 0.0 112.338 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -69.33 -33.83 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 C-N-CA 123.497 0.719 . . . . 0.0 109.091 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -61.56 -42.67 99.18 Favored 'General case' 0 N--CA 1.537 3.892 0 C-N-CA 123.498 0.719 . . . . 0.0 111.33 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 68.9 t -66.09 -31.76 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.849 0 C-N-CA 122.998 0.519 . . . . 0.0 110.126 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.7 t -65.22 -46.51 80.37 Favored 'General case' 0 N--CA 1.529 3.503 0 CA-C-O 120.776 0.322 . . . . 0.0 111.005 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -74.66 -25.21 59.04 Favored 'General case' 0 N--CA 1.525 3.308 0 C-N-CA 123.547 0.739 . . . . 0.0 111.021 -179.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 60.5 p -65.17 -33.57 76.33 Favored 'General case' 0 N--CA 1.528 3.456 0 C-N-CA 122.654 0.382 . . . . 0.0 111.065 -179.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 66.5 mt -90.78 -21.1 21.69 Favored 'General case' 0 N--CA 1.531 3.598 0 C-N-CA 124.122 0.969 . . . . 0.0 111.0 -179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -22.75 40.51 Favored 'General case' 1 N--CA 1.543 4.213 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 9.4 m95 -88.91 -4.04 58.57 Favored 'General case' 1 N--CA 1.541 4.082 0 C-N-CA 123.79 0.836 . . . . 0.0 110.262 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -76.55 -11.85 59.93 Favored 'General case' 0 N--CA 1.534 3.755 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 72.33 -7.87 1.28 Allowed 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 124.676 1.19 . . . . 0.0 110.976 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 26.8 m -134.13 131.48 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -94.47 114.48 63.49 Favored Pre-proline 0 N--CA 1.525 3.294 0 CA-C-O 116.706 -1.616 . . . . 0.0 107.882 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo . . . . . 1 N--CA 1.548 4.715 0 C-N-CA 122.643 2.229 . . . . 0.0 114.556 178.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.7 ptt? . . . . . 0 CA--C 1.574 1.88 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -70.32 172.85 12.41 Favored 'Trans proline' 1 N--CA 1.54 4.256 0 C-N-CA 122.344 2.03 . . . . 0.0 110.518 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -179.9 163.87 31.33 Favored Glycine 1 N--CA 1.517 4.071 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.8 m 56.92 174.18 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.178 0 C-N-CA 124.256 1.023 . . . . 0.0 112.208 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 tt 76.23 -33.56 0.22 Allowed 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 124.415 1.086 . . . . 0.0 109.566 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 88.2 p -66.63 -39.55 88.33 Favored 'General case' 0 N--CA 1.528 3.438 0 C-N-CA 123.289 0.636 . . . . 0.0 109.931 179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.44 -32.79 82.33 Favored Glycine 1 N--CA 1.519 4.201 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.366 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 42.9 mm -65.57 -36.59 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.29 0 C-N-CA 123.963 0.905 . . . . 0.0 109.984 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 35.4 mm -63.73 -34.24 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.669 0 C-N-CA 123.713 0.805 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 21.7 mm -69.48 -43.68 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 CA-C-O 121.774 0.797 . . . . 0.0 109.337 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -67.18 -43.51 82.03 Favored 'General case' 0 N--CA 1.526 3.35 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 -176.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.4 p -57.62 -36.65 55.05 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.288 0 CA-C-N 118.934 0.788 . . . . 0.0 111.47 -176.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.7 p -65.95 -48.46 71.26 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.435 0.694 . . . . 0.0 111.149 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.5 t -69.97 -34.76 61.3 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.299 0 C-N-CA 123.524 0.73 . . . . 0.0 109.826 -179.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.12 -34.85 75.62 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.125 0.57 . . . . 0.0 111.819 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.3 -40.04 74.49 Favored 'General case' 0 N--CA 1.519 3.007 0 C-N-CA 122.511 0.324 . . . . 0.0 111.555 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.9 t -66.87 -44.89 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.164 0.586 . . . . 0.0 111.939 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.9 m -65.98 -32.85 59.97 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.73 0 CA-C-N 118.648 0.658 . . . . 0.0 110.834 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -60.88 -43.19 98.79 Favored 'General case' 0 N--CA 1.529 3.515 0 C-N-CA 123.125 0.57 . . . . 0.0 111.181 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 73.7 mt -70.33 -52.94 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.426 0 C-N-CA 123.252 0.621 . . . . 0.0 110.156 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 90.8 t -66.48 -37.16 79.02 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.241 0 C-N-CA 124.759 1.224 . . . . 0.0 113.726 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.12 -35.86 72.09 Favored 'General case' 0 N--CA 1.537 3.88 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -174.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 21.4 m -70.88 -34.88 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 CA-C-N 118.972 0.806 . . . . 0.0 110.526 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -69.38 -42.3 75.35 Favored 'General case' 0 N--CA 1.534 3.759 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 97.4 t -64.22 -42.44 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.911 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 73.0 m -67.18 -48.07 69.05 Favored 'General case' 0 N--CA 1.528 3.453 0 CA-C-O 121.448 0.642 . . . . 0.0 110.542 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -67.69 -43.08 80.99 Favored 'General case' 0 N--CA 1.523 3.215 0 C-N-CA 124.256 1.022 . . . . 0.0 111.248 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 42.6 t -63.89 -26.26 68.52 Favored 'General case' 0 N--CA 1.53 3.549 0 CA-C-O 121.267 0.556 . . . . 0.0 110.221 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 50.9 tp -91.2 -14.83 30.31 Favored 'General case' 0 N--CA 1.521 3.117 0 C-N-CA 125.016 1.326 . . . . 0.0 110.352 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 54.9 tp -80.0 -28.41 39.44 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.637 -177.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -89.45 -17.91 27.78 Favored 'General case' 1 N--CA 1.559 5.006 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 94.7 mttt 58.56 26.51 14.47 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.969 0.907 . . . . 0.0 111.473 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt 82.44 9.77 0.72 Allowed 'General case' 0 N--CA 1.532 3.63 0 C-N-CA 124.689 1.195 . . . . 0.0 111.213 179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 4.4 p -136.36 130.3 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.908 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 178.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 15.1 mt -93.65 134.59 26.24 Favored Pre-proline 0 N--CA 1.527 3.407 0 CA-C-O 116.779 -1.581 . . . . 0.0 108.482 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 1 N--CA 1.539 4.169 0 CA-C-N 122.999 2.107 . . . . 0.0 110.823 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 CA--C 1.572 1.806 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.85 163.66 37.77 Favored 'Trans proline' 1 N--CA 1.539 4.163 0 C-N-CA 122.176 1.918 . . . . 0.0 110.049 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.96 154.85 53.51 Favored Glycine 1 N--CA 1.518 4.15 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 48.3 t -73.97 127.5 33.06 Favored 'General case' 0 N--CA 1.516 2.833 0 C-N-CA 123.675 0.79 . . . . 0.0 110.21 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 7.0 tp 65.31 -0.37 1.15 Allowed 'General case' 0 N--CA 1.53 3.548 0 C-N-CA 123.952 0.901 . . . . 0.0 111.723 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 91.4 p -70.42 -23.1 62.68 Favored 'General case' 0 N--CA 1.524 3.24 0 C-N-CA 123.307 0.643 . . . . 0.0 111.137 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.99 -50.29 8.79 Favored Glycine 0 N--CA 1.515 3.917 0 C-N-CA 123.491 0.567 . . . . 0.0 113.893 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 19.4 tt -65.74 -36.92 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.531 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -176.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 39.0 pt -59.24 -33.22 50.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 118.57 0.623 . . . . 0.0 111.022 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.1 mt -69.65 -43.62 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.862 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -67.32 -34.73 77.96 Favored 'General case' 0 N--CA 1.53 3.543 0 N-CA-C 116.102 1.89 . . . . 0.0 116.102 -175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -57.48 -36.95 55.33 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.511 0 CA-C-N 119.906 1.23 . . . . 0.0 111.562 -175.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.1 p -67.1 -48.58 67.74 Favored 'General case' 0 N--CA 1.525 3.312 0 C-N-CA 123.547 0.739 . . . . 0.0 110.358 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 48.4 t -67.42 -31.87 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.279 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.92 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.23 -35.92 81.94 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 123.115 0.566 . . . . 0.0 111.378 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.44 -41.35 72.97 Favored 'General case' 0 N--CA 1.52 3.061 0 C-N-CA 122.879 0.472 . . . . 0.0 111.689 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 63.3 t -64.95 -46.2 92.39 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.42 0 C-N-CA 123.377 0.671 . . . . 0.0 111.892 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.8 p -67.47 -32.42 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.569 0 CA-C-N 118.057 0.39 . . . . 0.0 111.074 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 46.7 tp -70.02 -47.68 61.13 Favored 'General case' 0 N--CA 1.525 3.289 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 20.1 tt -70.65 -41.53 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.838 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -177.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.5 p -67.7 -47.91 78.09 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.6 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.42 89.26 Favored 'General case' 0 N--CA 1.522 3.17 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -176.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.13 -37.61 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.335 0 CA-C-O 118.086 -0.959 . . . . 0.0 112.612 -177.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -73.29 -34.09 65.56 Favored 'General case' 1 N--CA 1.549 4.512 0 CA-C-N 120.371 1.441 . . . . 0.0 109.991 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.78 -33.51 56.49 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.595 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 37.4 t -63.18 -33.15 74.87 Favored 'General case' 0 N--CA 1.531 3.611 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.47 -23.77 27.66 Favored 'General case' 1 N--CA 1.541 4.105 0 CA-C-N 118.968 0.804 . . . . 0.0 110.443 -179.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 33.7 t -63.03 -43.36 98.91 Favored 'General case' 0 N--CA 1.52 3.054 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -86.88 -14.67 41.3 Favored 'General case' 1 N--CA 1.549 4.515 0 CA-C-N 118.229 0.468 . . . . 0.0 111.084 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 1.3 tt -80.56 -28.63 37.19 Favored 'General case' 0 N--CA 1.538 3.964 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -114.34 -5.69 12.93 Favored 'General case' 1 N--CA 1.542 4.129 0 C-N-CA 124.515 1.126 . . . . 0.0 109.999 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 62.81 40.62 9.64 Favored 'General case' 0 N--CA 1.515 2.81 0 C-N-CA 125.044 1.338 . . . . 0.0 112.314 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 65.18 3.18 2.11 Favored 'General case' 0 N--CA 1.524 3.274 0 C-N-CA 124.144 0.978 . . . . 0.0 111.968 177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -124.92 122.75 64.14 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.013 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 21.6 mt -96.37 141.86 23.73 Favored Pre-proline 0 N--CA 1.525 3.279 0 CA-C-O 117.084 -1.436 . . . . 0.0 108.83 -178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 1 N--CA 1.54 4.261 0 CA-C-N 122.4 1.893 . . . . 0.0 110.716 -179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 59.7 mtt . . . . . 0 CA--C 1.585 2.315 0 CA-C-O 117.517 -1.23 . . . . 0.0 111.822 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -88.24 74.54 2.07 Favored 'Trans proline' 0 N--CA 1.534 3.889 0 C-N-CA 122.642 2.228 . . . . 0.0 110.777 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -176.15 -176.81 44.66 Favored Glycine 1 N--CA 1.519 4.175 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 95.4 p -166.73 76.75 0.19 Allowed 'General case' 0 N--CA 1.521 3.088 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -61.94 -39.75 93.18 Favored 'General case' 0 N--CA 1.529 3.484 0 C-N-CA 124.371 1.068 . . . . 0.0 110.222 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.5 m -58.91 -22.1 58.98 Favored 'General case' 0 N--CA 1.527 3.392 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.241 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.57 -40.92 31.02 Favored Glycine 1 N--CA 1.518 4.122 0 C-N-CA 123.718 0.675 . . . . 0.0 111.432 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 42.1 mm -60.51 -43.63 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.424 0 C-N-CA 124.583 1.153 . . . . 0.0 112.311 -176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 17.0 tt -63.25 -33.71 62.64 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.791 0 C-N-CA 122.753 0.421 . . . . 0.0 111.002 -179.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 24.2 mm -69.4 -41.01 80.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.86 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -63.93 -45.49 89.01 Favored 'General case' 0 N--CA 1.526 3.326 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -57.69 -30.88 38.36 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.943 0.792 . . . . 0.0 111.782 -176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 29.6 p -69.69 -48.64 58.97 Favored 'General case' 0 N--CA 1.529 3.522 0 C-N-CA 123.377 0.671 . . . . 0.0 110.606 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 58.1 t -68.87 -32.26 53.96 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.595 0.758 . . . . 0.0 109.422 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.62 -37.52 78.83 Favored 'General case' 0 N--CA 1.523 3.223 0 C-N-CA 123.323 0.649 . . . . 0.0 111.817 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.43 -42.37 71.66 Favored 'General case' 0 N--CA 1.521 3.125 0 C-N-CA 122.854 0.461 . . . . 0.0 111.834 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.8 t -67.37 -44.0 87.41 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.377 0.671 . . . . 0.0 111.591 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 13.2 p -67.88 -32.68 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.765 0 O-C-N 121.529 -0.732 . . . . 0.0 110.427 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 52.2 tp -65.23 -47.58 76.33 Favored 'General case' 0 N--CA 1.525 3.318 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 19.3 tt -70.86 -43.18 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 -176.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 25.1 m -66.93 -37.4 79.33 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.117 0.872 . . . . 0.0 112.738 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.66 -31.66 68.38 Favored 'General case' 0 N--CA 1.526 3.327 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -174.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -66.38 -34.92 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.98 0 CA-C-N 118.984 0.811 . . . . 0.0 110.864 -178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -66.6 -33.8 76.47 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 122.682 0.393 . . . . 0.0 110.513 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 50.4 t -64.37 -42.56 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.477 0 C-N-CA 123.25 0.62 . . . . 0.0 109.717 -179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 45.8 t -65.46 -45.61 83.08 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.489 0.716 . . . . 0.0 111.085 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -71.05 -47.03 60.82 Favored 'General case' 0 N--CA 1.522 3.166 0 C-N-CA 123.68 0.792 . . . . 0.0 110.896 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 97.9 p -63.67 -13.68 45.04 Favored 'General case' 0 N--CA 1.528 3.464 0 C-N-CA 122.846 0.458 . . . . 0.0 111.879 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 58.1 tp -90.34 -34.68 15.6 Favored 'General case' 0 N--CA 1.531 3.58 0 C-N-CA 123.928 0.891 . . . . 0.0 110.512 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 53.4 tp -92.81 -27.41 17.18 Favored 'General case' 1 N--CA 1.539 4.019 0 C-N-CA 123.991 0.916 . . . . 0.0 112.296 -177.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 96.9 m95 -99.45 13.22 34.07 Favored 'General case' 0 N--CA 1.537 3.882 0 C-N-CA 124.205 1.002 . . . . 0.0 111.043 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -70.42 -0.77 8.95 Favored 'General case' 0 N--CA 1.534 3.743 0 C-N-CA 122.604 0.361 . . . . 0.0 110.476 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 92.0 mttt 65.14 12.82 8.28 Favored 'General case' 0 N--CA 1.523 3.183 0 C-N-CA 124.674 1.19 . . . . 0.0 112.902 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 61.1 t -135.68 122.77 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 44.3 mt -118.36 141.69 30.06 Favored Pre-proline 0 N--CA 1.531 3.621 0 CA-C-O 117.075 -1.44 . . . . 0.0 108.14 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 1 N--CA 1.539 4.185 0 CA-C-N 122.522 1.936 . . . . 0.0 110.784 -179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 CA--C 1.574 1.874 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -79.71 -177.16 3.65 Favored 'Trans proline' 0 N--CA 1.533 3.845 0 C-N-CA 122.516 2.144 . . . . 0.0 110.474 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.25 173.82 6.53 Favored Glycine 1 N--CA 1.517 4.09 0 O-C-N 123.852 0.72 . . . . 0.0 111.924 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 95.2 p -169.12 179.69 3.92 Favored 'General case' 0 N--CA 1.521 3.107 0 C-N-CA 124.255 1.022 . . . . 0.0 108.829 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -63.24 -40.47 97.52 Favored 'General case' 0 N--CA 1.53 3.539 0 C-N-CA 123.709 0.804 . . . . 0.0 109.914 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 87.7 p -61.5 -21.96 64.68 Favored 'General case' 0 N--CA 1.53 3.539 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -61.58 -33.91 86.59 Favored Glycine 0 N--CA 1.509 3.528 0 CA-C-N 114.723 -1.126 . . . . 0.0 112.782 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -60.64 -36.58 71.46 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.082 0 CA-C-O 121.224 0.535 . . . . 0.0 109.651 -179.444 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 55.0 mt -66.55 -35.75 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.866 0 C-N-CA 123.07 0.548 . . . . 0.0 109.589 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 29.7 mm -69.99 -38.82 76.39 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.566 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -63.57 -45.55 89.94 Favored 'General case' 0 N--CA 1.525 3.291 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -176.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 34.7 m -57.94 -29.7 36.63 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.252 0 CA-C-N 118.929 0.786 . . . . 0.0 111.484 -177.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 21.2 p -68.77 -48.71 63.01 Favored 'General case' 0 N--CA 1.53 3.555 0 C-N-CA 123.2 0.6 . . . . 0.0 110.558 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 62.1 t -66.41 -36.18 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.771 0.829 . . . . 0.0 109.443 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.32 -35.84 74.55 Favored 'General case' 0 N--CA 1.522 3.164 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.691 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.49 -37.56 74.22 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.762 0.425 . . . . 0.0 110.943 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.44 -45.52 85.36 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.366 0 C-N-CA 123.461 0.704 . . . . 0.0 111.5 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 17.8 m -67.29 -33.57 63.58 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.7 0 O-C-N 121.371 -0.831 . . . . 0.0 110.872 -178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.0 tp -63.83 -47.55 80.36 Favored 'General case' 0 N--CA 1.528 3.474 0 C-N-CA 123.229 0.612 . . . . 0.0 112.402 -177.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 7.9 tp -70.65 -38.86 74.82 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 71.0 t -66.78 -36.02 76.19 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.213 0 C-N-CA 124.022 0.929 . . . . 0.0 111.341 177.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.48 -38.53 74.68 Favored 'General case' 0 N--CA 1.529 3.489 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -172.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 13.3 m -72.49 -35.8 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.675 0 CA-C-N 118.427 0.558 . . . . 0.0 111.761 -178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -70.98 -42.34 69.82 Favored 'General case' 0 N--CA 1.533 3.681 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.17 -35.93 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.887 0 CA-C-N 118.287 0.494 . . . . 0.0 110.985 -178.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 87.6 m -66.6 -36.52 82.81 Favored 'General case' 0 N--CA 1.53 3.529 0 CA-C-O 121.215 0.531 . . . . 0.0 109.929 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -69.26 -46.28 67.64 Favored 'General case' 0 N--CA 1.523 3.202 0 C-N-CA 123.939 0.896 . . . . 0.0 109.908 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 41.6 t -67.02 -42.51 84.78 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 123.703 0.801 . . . . 0.0 111.029 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -67.85 -36.96 81.24 Favored 'General case' 0 N--CA 1.528 3.426 0 C-N-CA 124.305 1.042 . . . . 0.0 110.784 -179.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp -79.83 -27.83 40.17 Favored 'General case' 0 N--CA 1.528 3.454 0 C-N-CA 122.832 0.453 . . . . 0.0 109.964 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -91.56 -17.66 25.28 Favored 'General case' 0 N--CA 1.536 3.843 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 65.6 pttt 33.7 36.58 0.02 OUTLIER 'General case' 0 N--CA 1.527 3.383 0 C-N-CA 126.843 2.057 . . . . 0.0 113.673 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 58.6 tttp 70.52 -7.37 1.04 Allowed 'General case' 0 N--CA 1.522 3.144 0 CA-C-N 114.248 -1.342 . . . . 0.0 111.172 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 91.8 t -92.07 123.32 44.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 47.5 mt -117.59 114.39 37.98 Favored Pre-proline 0 N--CA 1.526 3.33 0 CA-C-O 116.799 -1.572 . . . . 0.0 108.543 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo . . . . . 1 N--CA 1.548 4.713 0 CA-C-N 123.015 2.112 . . . . 0.0 114.161 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 CA--C 1.571 1.775 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.66 -176.37 2.76 Favored 'Trans proline' 1 N--CA 1.537 4.048 0 C-N-CA 122.188 1.925 . . . . 0.0 110.096 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.64 -23.0 72.07 Favored Glycine 1 N--CA 1.521 4.33 0 O-C-N 123.712 0.633 . . . . 0.0 111.983 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 60.6 p 58.19 167.12 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 124.693 1.197 . . . . 0.0 112.426 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 80.2 mt -81.43 19.9 0.94 Allowed 'General case' 0 N--CA 1.522 3.168 0 C-N-CA 124.162 0.985 . . . . 0.0 110.453 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 60.9 m -63.06 -38.93 93.16 Favored 'General case' 0 N--CA 1.524 3.258 0 C-N-CA 123.453 0.701 . . . . 0.0 111.276 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.61 -36.49 48.55 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.24 -47.75 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.527 0 C-N-CA 124.299 1.04 . . . . 0.0 110.997 -177.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -64.47 -34.54 70.17 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 117.993 0.361 . . . . 0.0 110.792 -178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 97.2 mt -70.5 -48.16 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -67.32 -38.57 85.12 Favored 'General case' 0 N--CA 1.528 3.441 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 12.0 p -57.79 -36.89 57.03 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.43 0 CA-C-N 119.645 1.111 . . . . 0.0 111.339 -176.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.0 p -66.9 -48.41 68.81 Favored 'General case' 0 N--CA 1.524 3.235 0 C-N-CA 123.665 0.786 . . . . 0.0 110.714 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 56.1 t -68.68 -31.68 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.33 0 C-N-CA 123.918 0.887 . . . . 0.0 109.774 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.03 -34.84 78.42 Favored 'General case' 0 N--CA 1.522 3.167 0 C-N-CA 123.034 0.533 . . . . 0.0 111.147 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.63 -44.04 68.02 Favored 'General case' 0 N--CA 1.518 2.965 0 C-N-CA 122.929 0.492 . . . . 0.0 111.947 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 61.7 t -65.84 -44.05 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.543 0 C-N-CA 123.548 0.739 . . . . 0.0 111.981 -177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 11.4 p -66.57 -32.56 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.589 0 CA-C-N 118.323 0.511 . . . . 0.0 110.766 -178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -61.81 -34.93 76.8 Favored 'General case' 0 N--CA 1.526 3.368 0 C-N-CA 123.22 0.608 . . . . 0.0 112.513 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -69.82 -54.51 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.973 0 CA-C-N 118.075 0.398 . . . . 0.0 111.326 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 26.5 m -67.15 -36.59 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -177.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.77 -31.84 66.91 Favored 'General case' 0 N--CA 1.529 3.495 0 N-CA-C 114.495 1.294 . . . . 0.0 114.495 -173.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 15.0 m -65.1 -34.85 73.4 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.075 0 CA-C-N 119.306 0.957 . . . . 0.0 110.816 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -69.69 -36.64 76.14 Favored 'General case' 0 N--CA 1.528 3.432 0 C-N-CA 122.958 0.503 . . . . 0.0 110.021 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 80.9 t -67.35 -44.54 87.12 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.516 0.727 . . . . 0.0 109.444 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 86.3 m -61.74 -41.95 98.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.327 0.651 . . . . 0.0 110.746 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -68.11 -39.93 82.68 Favored 'General case' 0 N--CA 1.526 3.343 0 C-N-CA 123.933 0.893 . . . . 0.0 109.911 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 69.1 m -64.97 -40.11 94.5 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.444 0.697 . . . . 0.0 110.393 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.44 -37.2 82.63 Favored 'General case' 0 N--CA 1.533 3.717 0 C-N-CA 124.309 1.044 . . . . 0.0 110.068 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 52.4 tp -80.09 -27.66 39.22 Favored 'General case' 0 N--CA 1.53 3.56 0 C-N-CA 123.061 0.544 . . . . 0.0 110.248 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 10.9 m95 -90.26 -1.73 57.95 Favored 'General case' 0 N--CA 1.538 3.975 0 C-N-CA 123.656 0.783 . . . . 0.0 109.712 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -70.33 -5.07 25.39 Favored 'General case' 0 N--CA 1.533 3.715 0 C-N-CA 123.388 0.675 . . . . 0.0 110.134 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp 71.72 -8.68 1.05 Allowed 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 125.027 1.331 . . . . 0.0 111.021 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 60.0 t -110.05 122.61 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.82 142.39 45.4 Favored Pre-proline 0 N--CA 1.526 3.343 0 C-N-CA 125.282 1.433 . . . . 0.0 108.115 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 1 N--CA 1.54 4.262 0 CA-C-N 122.175 1.813 . . . . 0.0 110.457 -178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 117.689 -1.148 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.84 146.6 48.31 Favored 'Trans proline' 1 N--CA 1.541 4.269 0 C-N-CA 122.035 1.823 . . . . 0.0 110.339 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 169.19 -41.63 0.21 Allowed Glycine 1 N--CA 1.516 4.004 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 99.4 p -70.43 -171.55 0.5 Allowed 'General case' 0 N--CA 1.52 3.069 0 C-N-CA 124.297 1.039 . . . . 0.0 110.429 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 82.7 -36.98 0.09 Allowed 'General case' 0 N--CA 1.528 3.445 0 C-N-CA 125.307 1.443 . . . . 0.0 109.089 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 99.4 p -70.23 -33.41 71.63 Favored 'General case' 0 N--CA 1.526 3.359 0 CA-C-O 121.326 0.584 . . . . 0.0 109.821 178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.97 -45.55 20.18 Favored Glycine 0 N--CA 1.511 3.635 0 CA-C-N 115.26 -0.882 . . . . 0.0 112.416 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -63.59 -38.66 82.83 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 C-N-CA 123.215 0.606 . . . . 0.0 111.845 -176.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -69.04 -34.78 65.61 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.829 0 O-C-N 121.709 -0.619 . . . . 0.0 110.975 -178.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.25 -39.71 77.13 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.91 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -58.39 -49.08 78.52 Favored 'General case' 0 N--CA 1.524 3.232 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.5 m -59.8 -33.68 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.93 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.7 p -70.06 -49.17 53.78 Favored 'General case' 0 N--CA 1.529 3.502 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 35.3 m -72.18 -33.19 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.509 0 C-N-CA 122.671 0.388 . . . . 0.0 110.372 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.24 -34.32 78.08 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 123.09 0.556 . . . . 0.0 111.001 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.55 -35.42 80.18 Favored 'General case' 0 N--CA 1.52 3.066 0 C-N-CA 122.777 0.431 . . . . 0.0 111.706 -178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.22 -50.65 45.34 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.379 0 C-N-CA 123.04 0.536 . . . . 0.0 111.09 -178.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 9.3 m -62.88 -32.27 55.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.78 0 O-C-N 121.926 -0.484 . . . . 0.0 110.792 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.1 tp -58.45 -43.02 88.67 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.334 0.654 . . . . 0.0 111.465 -178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 74.7 mt -70.21 -48.01 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.47 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 81.6 t -66.24 -37.75 80.38 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 124.118 0.967 . . . . 0.0 112.584 -177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.23 91.22 Favored 'General case' 0 N--CA 1.539 3.994 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -176.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.86 -33.98 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.125 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -64.93 -43.34 93.07 Favored 'General case' 0 N--CA 1.535 3.789 0 C-N-CA 123.188 0.595 . . . . 0.0 112.532 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 32.9 m -68.9 -30.96 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.743 0 O-C-N 122.263 -0.273 . . . . 0.0 110.288 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 36.9 t -58.63 -46.0 88.04 Favored 'General case' 0 N--CA 1.526 3.337 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -74.09 -32.5 63.27 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-N 118.225 0.466 . . . . 0.0 111.187 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 83.4 p -63.22 -23.78 67.58 Favored 'General case' 0 N--CA 1.53 3.562 0 C-N-CA 122.717 0.407 . . . . 0.0 111.132 -178.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 47.5 mt -88.85 -23.13 22.87 Favored 'General case' 0 N--CA 1.527 3.408 0 C-N-CA 123.886 0.874 . . . . 0.0 109.917 179.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.6 tp -80.61 -28.19 37.09 Favored 'General case' 0 N--CA 1.534 3.766 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -92.81 -3.02 55.42 Favored 'General case' 0 N--CA 1.539 3.976 0 C-N-CA 123.523 0.729 . . . . 0.0 110.176 178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 64.5 tttp -79.8 -20.26 46.58 Favored 'General case' 0 N--CA 1.528 3.471 0 C-N-CA 123.118 0.567 . . . . 0.0 109.7 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 48.9 tttp 68.06 34.1 4.23 Favored 'General case' 0 N--CA 1.515 2.811 0 C-N-CA 124.321 1.048 . . . . 0.0 110.617 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.401 ' C ' HD22 ' B' ' 241' ' ' LEU . 9.4 p -95.41 122.61 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.688 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.401 HD22 ' C ' ' B' ' 240' ' ' VAL . 2.5 mm? -119.9 141.53 31.52 Favored Pre-proline 0 N--CA 1.531 3.591 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 1 N--CA 1.539 4.192 0 CA-C-N 122.531 1.94 . . . . 0.0 110.697 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 59.4 mtm . . . . . 0 CA--C 1.586 2.33 0 CA-C-O 117.465 -1.255 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -85.78 177.02 5.05 Favored 'Trans proline' 0 N--CA 1.535 3.963 0 C-N-CA 122.447 2.098 . . . . 0.0 111.088 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.78 82.59 0.05 OUTLIER Glycine 1 N--CA 1.517 4.091 0 C-N-CA 123.813 0.721 . . . . 0.0 112.281 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 93.0 p -67.61 105.92 2.02 Favored 'General case' 0 N--CA 1.52 3.043 0 C-N-CA 123.843 0.857 . . . . 0.0 109.995 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 80.9 mt -77.12 1.58 17.74 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 123.587 0.755 . . . . 0.0 110.754 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 89.3 p -70.66 -30.9 67.63 Favored 'General case' 0 N--CA 1.522 3.129 0 C-N-CA 123.203 0.601 . . . . 0.0 110.647 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.72 -50.01 9.86 Favored Glycine 1 N--CA 1.516 4.025 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.167 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . 0.432 HD13 ' O ' ' C' ' 214' ' ' ILE . 0.2 OUTLIER -63.38 -42.08 95.02 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.807 0 C-N-CA 123.345 0.658 . . . . 0.0 111.759 -176.562 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -62.96 -34.88 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.918 0 O-C-N 121.874 -0.516 . . . . 0.0 111.746 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 92.8 mt -70.34 -43.95 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.955 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -66.74 -43.55 83.88 Favored 'General case' 0 N--CA 1.526 3.367 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -175.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 11.1 p -57.5 -38.48 63.75 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.132 0 CA-C-N 118.886 0.766 . . . . 0.0 111.987 -175.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 31.3 p -66.08 -48.05 72.25 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 123.406 0.682 . . . . 0.0 111.015 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 59.2 t -70.1 -33.36 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.235 0 C-N-CA 123.638 0.775 . . . . 0.0 109.683 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.72 -34.61 76.09 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.032 0.533 . . . . 0.0 111.531 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.32 -40.73 73.99 Favored 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 122.603 0.361 . . . . 0.0 111.537 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 60.0 t -67.47 -44.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.332 0.653 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 31.9 m -65.13 -32.88 60.2 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.712 0 CA-C-N 118.61 0.641 . . . . 0.0 110.857 -178.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.2 tp -59.87 -42.12 93.04 Favored 'General case' 0 N--CA 1.529 3.501 0 C-N-CA 123.216 0.606 . . . . 0.0 111.511 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 63.0 mt -70.14 -48.79 59.91 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.35 -36.93 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 124.972 1.309 . . . . 0.0 113.091 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.73 67.03 Favored 'General case' 0 N--CA 1.532 3.674 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -174.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.83 -36.79 65.9 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.994 0 CA-C-N 118.918 0.781 . . . . 0.0 110.24 -179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -70.61 -42.25 71.21 Favored 'General case' 0 N--CA 1.53 3.549 0 C-N-CA 122.977 0.511 . . . . 0.0 109.887 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.07 -35.08 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.5 t -67.24 -38.83 85.83 Favored 'General case' 0 N--CA 1.528 3.457 0 C-N-CA 123.362 0.665 . . . . 0.0 110.323 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.99 -24.05 67.57 Favored 'General case' 0 N--CA 1.531 3.577 0 C-N-CA 124.954 1.301 . . . . 0.0 111.902 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 66.1 p -63.83 -28.76 70.08 Favored 'General case' 0 N--CA 1.529 3.524 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 36.9 mt -71.78 -27.95 63.3 Favored 'General case' 0 N--CA 1.522 3.134 0 C-N-CA 124.118 0.967 . . . . 0.0 110.284 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -83.95 -18.76 36.2 Favored 'General case' 0 N--CA 1.533 3.717 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -89.02 -17.46 29.34 Favored 'General case' 1 N--CA 1.544 4.24 0 CA-C-O 118.095 -0.955 . . . . 0.0 112.726 -178.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -87.4 -22.92 24.73 Favored 'General case' 1 N--CA 1.547 4.384 0 CA-C-N 119.754 1.161 . . . . 0.0 109.808 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -69.41 -44.36 71.57 Favored 'General case' 0 N--CA 1.525 3.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 16.1 m -136.62 129.01 44.87 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.384 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -94.03 141.42 23.64 Favored Pre-proline 0 N--CA 1.527 3.393 0 CA-C-O 116.304 -1.808 . . . . 0.0 107.243 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo . . . . . 1 N--CA 1.549 4.735 0 C-N-CA 122.722 2.282 . . . . 0.0 114.74 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 26.1 mmt . . . . . 0 CA--C 1.577 2.014 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.48 -29.83 19.83 Favored 'Trans proline' 1 N--CA 1.541 4.299 0 C-N-CA 122.28 1.987 . . . . 0.0 110.475 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.19 -178.47 23.81 Favored Glycine 1 N--CA 1.518 4.157 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.463 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 92.0 p -67.21 175.64 2.56 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.835 0.854 . . . . 0.0 110.42 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -163.08 -48.31 0.04 OUTLIER 'General case' 0 N--CA 1.526 3.348 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 96.8 p -66.18 -34.16 77.4 Favored 'General case' 0 N--CA 1.526 3.354 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.335 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.94 -29.86 62.26 Favored Glycine 0 N--CA 1.516 3.992 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.437 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 38.4 mm -66.03 -36.92 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.702 0.801 . . . . 0.0 110.499 -179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 75.0 mt -67.19 -38.39 80.98 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 C-N-CA 123.288 0.635 . . . . 0.0 109.93 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.16 -39.1 76.62 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.422 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -67.02 -46.71 73.65 Favored 'General case' 0 N--CA 1.525 3.295 0 N-CA-C 114.349 1.241 . . . . 0.0 114.349 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.06 -35.62 53.29 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.947 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 39.1 p -66.5 -49.49 66.39 Favored 'General case' 0 N--CA 1.531 3.618 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.84 -32.55 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.533 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 -179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -62.01 -35.35 78.28 Favored 'General case' 0 N--CA 1.525 3.32 0 C-N-CA 122.531 0.333 . . . . 0.0 111.665 -179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -38.49 73.98 Favored 'General case' 0 N--CA 1.521 3.11 0 C-N-CA 122.628 0.371 . . . . 0.0 111.818 -179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 67.9 t -69.96 -43.46 79.38 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 123.324 0.649 . . . . 0.0 111.722 -177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.27 -32.6 58.81 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.762 0 CA-C-N 118.581 0.628 . . . . 0.0 110.547 -178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 42.1 tp -59.18 -34.63 72.35 Favored 'General case' 0 N--CA 1.525 3.295 0 C-N-CA 123.63 0.772 . . . . 0.0 112.359 -178.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.19 -55.21 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 CA-C-N 117.868 0.304 . . . . 0.0 110.811 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.87 -37.14 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.681 0 N-CA-C 113.272 0.842 . . . . 0.0 113.272 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -39.45 81.47 Favored 'General case' 0 N--CA 1.532 3.632 0 N-CA-C 114.064 1.135 . . . . 0.0 114.064 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.19 -34.78 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.453 0 CA-C-O 119.029 -0.51 . . . . 0.0 111.397 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -69.56 -42.5 74.49 Favored 'General case' 1 N--CA 1.539 4.021 0 CA-C-N 119.407 1.003 . . . . 0.0 111.345 -178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.7 -31.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.823 0 O-C-N 121.981 -0.449 . . . . 0.0 110.303 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 49.3 t -60.96 -37.27 81.84 Favored 'General case' 0 N--CA 1.525 3.303 0 C-N-CA 123.523 0.729 . . . . 0.0 111.696 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -82.84 -25.19 32.85 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 123.428 0.691 . . . . 0.0 110.449 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 39.9 m -68.02 -43.41 78.87 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 123.058 0.543 . . . . 0.0 111.828 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.1 -24.5 47.53 Favored 'General case' 0 N--CA 1.531 3.606 0 C-N-CA 122.791 0.437 . . . . 0.0 111.143 -178.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 57.9 tp -80.52 -27.83 37.54 Favored 'General case' 0 N--CA 1.532 3.661 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 40.6 m0 -89.91 -13.0 37.24 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 123.858 0.863 . . . . 0.0 110.404 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -73.03 -36.65 67.0 Favored 'General case' 0 N--CA 1.527 3.417 0 C-N-CA 124.01 0.924 . . . . 0.0 109.432 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -67.5 -47.55 69.68 Favored 'General case' 0 N--CA 1.521 3.091 0 C-N-CA 123.998 0.919 . . . . 0.0 109.312 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 26.9 m -136.54 122.78 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.544 0 C-N-CA 124.23 1.012 . . . . 0.0 108.655 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.26 141.59 42.4 Favored Pre-proline 0 N--CA 1.526 3.335 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo . . . . . 1 N--CA 1.539 4.193 0 CA-C-N 122.603 1.965 . . . . 0.0 110.676 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.585 2.319 0 CA-C-O 117.521 -1.228 . . . . 0.0 111.294 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_endo -88.93 4.5 5.35 Favored 'Trans proline' 1 N--CA 1.536 4.025 0 C-N-CA 122.644 2.229 . . . . 0.0 111.87 -178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 68.98 -102.9 0.97 Allowed Glycine 1 N--CA 1.518 4.157 0 C-N-CA 123.685 0.659 . . . . 0.0 111.676 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 38.7 t -167.21 -179.18 4.42 Favored 'General case' 0 N--CA 1.521 3.103 0 C-N-CA 123.776 0.831 . . . . 0.0 109.937 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -152.27 23.74 0.63 Allowed 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 123.993 0.917 . . . . 0.0 109.747 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 67.5 m -69.12 -26.36 64.87 Favored 'General case' 0 N--CA 1.518 2.942 0 C-N-CA 123.584 0.754 . . . . 0.0 110.895 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.84 -50.12 9.39 Favored Glycine 0 N--CA 1.516 3.971 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.271 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 7.1 tp -64.87 -36.71 78.37 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.603 0 C-N-CA 122.984 0.514 . . . . 0.0 112.112 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 36.6 pt -62.9 -33.75 62.23 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.135 0 CA-C-N 119.185 0.902 . . . . 0.0 110.852 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 84.3 mt -69.67 -39.25 77.93 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.04 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -66.14 -43.34 87.35 Favored 'General case' 0 N--CA 1.525 3.299 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 35.3 m -57.84 -28.18 32.4 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.37 0.986 . . . . 0.0 111.345 -177.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 19.4 p -66.3 -48.52 70.1 Favored 'General case' 0 N--CA 1.53 3.544 0 C-N-CA 123.509 0.723 . . . . 0.0 111.063 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 51.5 t -69.85 -39.47 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.256 0 C-N-CA 123.694 0.797 . . . . 0.0 109.186 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.83 -34.49 71.6 Favored 'General case' 0 N--CA 1.523 3.199 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.664 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -65.9 -33.21 75.31 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 122.712 0.405 . . . . 0.0 111.373 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 52.5 t -70.02 -48.54 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.334 0 C-N-CA 123.139 0.576 . . . . 0.0 111.102 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.6 m -67.55 -32.38 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.826 0 O-C-N 121.577 -0.702 . . . . 0.0 110.377 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 50.5 tp -58.65 -47.78 83.28 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 123.424 0.689 . . . . 0.0 112.471 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 17.9 tt -70.75 -37.48 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.879 0 CA-C-N 118.302 0.501 . . . . 0.0 110.085 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 99.5 t -66.92 -37.57 79.67 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.033 0 C-N-CA 123.155 0.582 . . . . 0.0 111.084 178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.93 68.19 Favored 'General case' 0 N--CA 1.525 3.32 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.6 m -70.39 -37.08 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-N 118.893 0.769 . . . . 0.0 110.405 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -70.28 -42.08 72.56 Favored 'General case' 0 N--CA 1.531 3.591 0 C-N-CA 122.739 0.416 . . . . 0.0 109.934 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.7 -42.63 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.831 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 84.2 m -67.26 -28.65 68.22 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 123.025 0.53 . . . . 0.0 111.062 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -68.18 -35.72 78.48 Favored 'General case' 0 N--CA 1.535 3.787 0 C-N-CA 123.584 0.754 . . . . 0.0 110.617 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 70.7 m -63.59 -23.29 67.32 Favored 'General case' 0 N--CA 1.526 3.367 0 C-N-CA 123.166 0.587 . . . . 0.0 109.828 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -71.6 -33.32 68.91 Favored 'General case' 0 N--CA 1.527 3.389 0 C-N-CA 124.549 1.139 . . . . 0.0 108.299 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 44.4 mt -80.25 -26.76 38.86 Favored 'General case' 0 N--CA 1.524 3.273 0 C-N-CA 123.613 0.765 . . . . 0.0 110.149 -179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -88.64 13.17 12.83 Favored 'General case' 1 N--CA 1.547 4.395 0 C-N-CA 122.778 0.431 . . . . 0.0 110.072 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -136.74 -56.9 0.73 Allowed 'General case' 0 N--CA 1.518 2.947 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt 71.25 -2.74 2.28 Favored 'General case' 0 N--CA 1.518 2.94 0 C-N-CA 124.649 1.179 . . . . 0.0 110.459 -178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 99.2 t -98.77 122.22 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.05 141.69 23.99 Favored Pre-proline 0 N--CA 1.525 3.295 0 N-CA-C 107.178 -1.416 . . . . 0.0 107.178 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo . . . . . 1 N--CA 1.54 4.264 0 CA-C-N 122.291 1.854 . . . . 0.0 110.699 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 CA--C 1.57 1.735 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -70.66 -19.51 31.77 Favored 'Trans proline' 1 N--CA 1.541 4.271 0 C-N-CA 122.109 1.873 . . . . 0.0 110.801 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 63.55 -178.28 7.01 Favored Glycine 1 N--CA 1.518 4.161 0 C-N-CA 123.737 0.684 . . . . 0.0 112.39 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 46.0 t -168.44 176.16 5.94 Favored 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 124.001 0.92 . . . . 0.0 109.585 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -170.37 46.48 0.03 OUTLIER 'General case' 0 N--CA 1.518 2.973 0 C-N-CA 123.741 0.816 . . . . 0.0 109.474 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 36.4 t -69.62 -24.93 63.72 Favored 'General case' 0 N--CA 1.524 3.251 0 O-C-N 121.532 -0.73 . . . . 0.0 110.007 178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -69.32 -46.19 57.88 Favored Glycine 0 N--CA 1.511 3.669 0 C-N-CA 124.513 1.054 . . . . 0.0 114.242 -178.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 13.6 tt -59.14 -36.36 62.37 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.303 0 CA-C-N 118.233 1.016 . . . . 0.0 111.03 -177.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 53.3 mt -54.83 -34.87 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.61 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.391 -178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.49 ' N ' HD12 ' C' ' 216' ' ' ILE . 1.6 mp -70.22 -41.8 78.86 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 CA-C-N 119.175 0.898 . . . . 0.0 108.73 178.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -60.54 -45.27 94.49 Favored 'General case' 0 N--CA 1.527 3.391 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 -175.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.8 p -62.6 -37.26 78.47 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.658 0.663 . . . . 0.0 112.025 -177.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 73.0 p -65.41 -48.85 71.39 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 123.201 0.6 . . . . 0.0 112.512 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.45 -32.09 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.417 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.54 -35.26 80.32 Favored 'General case' 0 N--CA 1.524 3.267 0 C-N-CA 122.766 0.426 . . . . 0.0 111.792 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.61 -48.43 55.17 Favored 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 9.9 p -69.66 -38.37 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -176.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 13.4 p -65.23 -32.29 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.774 0 O-C-N 121.994 -0.441 . . . . 0.0 110.536 -178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.4 tp -61.1 -34.88 75.65 Favored 'General case' 0 N--CA 1.526 3.355 0 C-N-CA 122.966 0.506 . . . . 0.0 111.557 -178.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 49.8 mt -66.49 -54.78 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.773 0 C-N-CA 122.899 0.479 . . . . 0.0 111.475 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 32.8 m -67.04 -35.86 75.62 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.853 0 C-N-CA 124.236 1.015 . . . . 0.0 112.893 -178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.36 66.19 Favored 'General case' 0 N--CA 1.529 3.518 0 N-CA-C 114.341 1.237 . . . . 0.0 114.341 -173.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 16.3 m -68.47 -34.51 66.0 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.502 1.047 . . . . 0.0 110.487 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -66.83 -26.22 66.81 Favored 'General case' 0 N--CA 1.529 3.521 0 C-N-CA 122.836 0.454 . . . . 0.0 110.871 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 57.3 t -66.97 -37.74 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 109.319 -0.622 . . . . 0.0 109.319 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -66.83 -40.44 88.0 Favored 'General case' 0 N--CA 1.526 3.362 0 C-N-CA 123.487 0.715 . . . . 0.0 109.577 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -67.38 -40.39 85.69 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 124.219 1.008 . . . . 0.0 109.782 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 35.0 t -64.59 -29.15 70.17 Favored 'General case' 0 N--CA 1.515 2.813 0 C-N-CA 123.553 0.741 . . . . 0.0 111.588 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 54.6 tp -91.41 -23.75 19.95 Favored 'General case' 0 N--CA 1.529 3.489 0 C-N-CA 124.502 1.121 . . . . 0.0 111.293 -178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 50.7 tp -80.31 -27.89 38.33 Favored 'General case' 0 N--CA 1.536 3.84 0 CA-C-O 118.446 -0.788 . . . . 0.0 112.981 -175.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -113.6 13.76 18.78 Favored 'General case' 1 N--CA 1.555 4.784 0 CA-C-N 118.755 0.707 . . . . 0.0 112.184 -179.171 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -77.46 -32.58 54.51 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -66.08 -41.7 90.33 Favored 'General case' 0 N--CA 1.525 3.305 0 C-N-CA 124.16 0.984 . . . . 0.0 110.037 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 55.4 t -132.16 122.02 47.65 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -95.01 141.74 23.66 Favored Pre-proline 0 N--CA 1.528 3.425 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo . . . . . 1 N--CA 1.539 4.192 0 CA-C-N 122.296 1.856 . . . . 0.0 110.707 -179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.585 2.32 0 CA-C-O 117.474 -1.251 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -85.59 72.68 4.18 Favored 'Trans proline' 0 N--CA 1.535 3.966 0 CA-C-N 122.775 2.027 . . . . 0.0 110.146 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 88.28 -122.96 6.51 Favored Glycine 1 N--CA 1.517 4.092 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 50.4 m 57.32 49.52 13.03 Favored 'General case' 0 N--CA 1.52 3.053 0 C-N-CA 124.052 0.941 . . . . 0.0 111.575 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 9.5 mp 56.94 9.14 0.58 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 124.616 1.166 . . . . 0.0 111.94 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 27.4 t -55.27 -34.4 64.04 Favored 'General case' 0 N--CA 1.534 3.734 0 CA-C-N 118.913 0.778 . . . . 0.0 112.241 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.66 -42.11 40.79 Favored Glycine 0 N--CA 1.516 3.997 0 O-C-N 124.097 0.873 . . . . 0.0 111.26 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 45.6 mm -57.96 -38.88 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.455 0 C-N-CA 124.223 1.009 . . . . 0.0 110.861 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.86 -34.52 31.03 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.109 0 CA-C-O 119.458 -0.306 . . . . 0.0 111.029 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . 0.493 HD12 ' N ' ' A' ' 216' ' ' ILE . 1.6 mp -70.57 -49.13 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.934 0 CA-C-N 119.279 0.945 . . . . 0.0 108.804 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -67.88 -27.55 66.76 Favored 'General case' 0 N--CA 1.53 3.564 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 8.3 p -56.46 -38.85 58.16 Favored 'Isoleucine or valine' 1 N--CA 1.55 4.546 0 CA-C-N 120.109 1.322 . . . . 0.0 112.084 -174.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 5.3 p -64.05 -48.08 77.66 Favored 'General case' 0 N--CA 1.53 3.526 0 C-N-CA 123.907 0.883 . . . . 0.0 110.769 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.87 -44.96 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.944 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.124 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.31 -34.78 58.77 Favored 'General case' 0 N--CA 1.524 3.234 0 C-N-CA 123.455 0.702 . . . . 0.0 111.812 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -44.64 95.89 Favored 'General case' 0 N--CA 1.523 3.198 0 C-N-CA 122.998 0.519 . . . . 0.0 111.718 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -39.04 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.398 0 C-N-CA 123.429 0.692 . . . . 0.0 109.719 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 77.1 t -65.82 -34.32 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.305 0 C-N-CA 123.652 0.781 . . . . 0.0 110.122 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 53.3 tp -63.2 -37.29 86.63 Favored 'General case' 0 N--CA 1.532 3.644 0 C-N-CA 123.066 0.546 . . . . 0.0 111.881 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.13 -54.42 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.667 0 C-N-CA 122.911 0.484 . . . . 0.0 111.433 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 33.0 m -66.55 -36.3 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.693 0 C-N-CA 124.374 1.07 . . . . 0.0 113.747 -177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.68 -31.02 65.94 Favored 'General case' 0 N--CA 1.53 3.556 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 5.2 m -61.3 -38.56 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-N 119.036 0.834 . . . . 0.0 110.472 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -68.33 -32.76 73.11 Favored 'General case' 0 N--CA 1.527 3.392 0 C-N-CA 122.899 0.48 . . . . 0.0 110.457 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 53.2 t -67.61 -37.9 79.53 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.614 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 68.0 m -67.33 -46.67 72.78 Favored 'General case' 0 N--CA 1.525 3.287 0 C-N-CA 123.397 0.679 . . . . 0.0 110.352 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -68.24 -26.64 65.8 Favored 'General case' 0 N--CA 1.524 3.265 0 C-N-CA 124.114 0.966 . . . . 0.0 110.915 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 68.9 m -63.33 -21.67 66.41 Favored 'General case' 0 N--CA 1.529 3.515 0 CA-C-N 118.133 0.424 . . . . 0.0 110.049 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 57.4 mt -91.44 -17.33 25.95 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 124.375 1.07 . . . . 0.0 110.592 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 53.1 tp -80.86 -28.41 36.07 Favored 'General case' 0 N--CA 1.537 3.904 0 CA-C-O 119.029 -0.51 . . . . 0.0 112.179 -176.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -114.28 12.61 17.69 Favored 'General case' 1 N--CA 1.559 4.979 0 C-N-CA 123.221 0.609 . . . . 0.0 111.322 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -65.75 -10.24 35.37 Favored 'General case' 0 N--CA 1.535 3.79 0 C-N-CA 123.226 0.61 . . . . 0.0 110.313 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 36.1 ttpt 92.07 -17.7 0.14 Allowed 'General case' 0 N--CA 1.536 3.863 0 C-N-CA 126.243 1.817 . . . . 0.0 110.286 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 135.76 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.456 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 42.2 mt -97.55 141.48 23.07 Favored Pre-proline 0 N--CA 1.527 3.397 0 CA-C-O 116.273 -1.822 . . . . 0.0 108.51 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo . . . . . 1 N--CA 1.55 4.806 0 C-N-CA 122.686 2.258 . . . . 0.0 114.723 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 CA--C 1.576 1.96 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -74.85 -175.24 2.23 Favored 'Trans proline' 1 N--CA 1.537 4.036 0 C-N-CA 122.326 2.017 . . . . 0.0 110.3 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -177.29 -13.59 0.02 OUTLIER Glycine 1 N--CA 1.524 4.505 0 N-CA-C 111.514 -0.634 . . . . 0.0 111.514 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 69.5 m -67.28 72.32 0.12 Allowed 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.844 0.858 . . . . 0.0 110.544 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 tt -162.6 -51.31 0.04 OUTLIER 'General case' 0 N--CA 1.53 3.529 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 29.6 t -55.49 -19.97 11.3 Favored 'General case' 0 N--CA 1.531 3.602 0 C-N-CA 123.642 0.777 . . . . 0.0 111.634 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -68.85 -24.79 75.56 Favored Glycine 0 N--CA 1.505 3.279 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.55 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 9.8 tp -59.77 -48.96 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.982 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 40.4 pt -65.14 -33.75 65.87 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.064 0 O-C-N 122.154 -0.341 . . . . 0.0 110.221 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 46.3 mt -69.62 -38.93 77.6 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.655 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -67.12 -43.78 81.59 Favored 'General case' 0 N--CA 1.529 3.477 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -175.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 27.4 m -57.75 -32.72 43.48 Favored 'Isoleucine or valine' 1 N--CA 1.546 4.367 0 CA-C-N 119.136 0.88 . . . . 0.0 111.645 -176.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 31.8 p -64.93 -48.22 74.88 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.51 0.724 . . . . 0.0 110.998 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 52.7 t -71.03 -46.14 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.131 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.477 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -53.15 -34.88 58.76 Favored 'General case' 0 N--CA 1.523 3.176 0 C-N-CA 123.123 0.569 . . . . 0.0 111.903 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.95 -46.13 91.93 Favored 'General case' 0 N--CA 1.523 3.197 0 C-N-CA 122.825 0.45 . . . . 0.0 111.955 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.1 t -70.14 -40.12 77.87 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.502 0 C-N-CA 123.273 0.629 . . . . 0.0 109.922 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -67.36 -33.0 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 123.667 0.787 . . . . 0.0 110.151 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 44.7 tp -66.31 -47.48 73.42 Favored 'General case' 0 N--CA 1.527 3.409 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 18.3 tt -70.69 -41.71 77.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -177.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 27.8 m -67.02 -37.29 79.07 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.234 0 CA-C-N 119.079 0.854 . . . . 0.0 112.257 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.71 -31.85 68.64 Favored 'General case' 0 N--CA 1.527 3.42 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -174.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 m -64.38 -34.87 72.13 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.094 0 CA-C-N 119.027 0.831 . . . . 0.0 110.613 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -68.94 -40.35 79.02 Favored 'General case' 0 N--CA 1.529 3.504 0 C-N-CA 122.828 0.451 . . . . 0.0 109.858 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 59.2 t -67.55 -38.4 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.487 0 C-N-CA 123.79 0.836 . . . . 0.0 109.177 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 43.9 t -63.95 -42.22 97.37 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.688 0.795 . . . . 0.0 110.315 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -64.57 -44.21 91.43 Favored 'General case' 0 N--CA 1.527 3.381 0 C-N-CA 124.269 1.028 . . . . 0.0 109.784 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 38.2 t -64.55 -27.13 68.75 Favored 'General case' 0 N--CA 1.515 2.801 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.274 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 50.8 tp -91.56 -25.32 19.27 Favored 'General case' 0 N--CA 1.529 3.518 0 C-N-CA 124.422 1.089 . . . . 0.0 111.315 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 52.5 tp -80.6 -27.98 37.21 Favored 'General case' 0 N--CA 1.535 3.803 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -113.99 13.17 18.18 Favored 'General case' 1 N--CA 1.558 4.972 0 CA-C-N 119.064 0.847 . . . . 0.0 113.252 -178.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -92.3 -30.82 15.65 Favored 'General case' 0 N--CA 1.537 3.912 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -65.52 -45.99 81.37 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 123.99 0.916 . . . . 0.0 110.032 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.36 122.81 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 C-N-CA 124.715 1.206 . . . . 0.0 107.87 179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 9.4 mp -97.61 141.78 23.53 Favored Pre-proline 0 N--CA 1.53 3.549 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 1 N--CA 1.54 4.227 0 CA-C-N 122.388 1.888 . . . . 0.0 110.734 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.818 -1.087 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -54.55 156.98 12.99 Favored 'Trans proline' 1 N--CA 1.549 4.775 0 CA-C-N 122.017 1.756 . . . . 0.0 112.882 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.58 -179.34 18.9 Favored Glycine 1 N--CA 1.517 4.093 0 C-N-CA 123.678 0.656 . . . . 0.0 111.791 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.2 t -169.2 166.07 10.81 Favored 'General case' 0 N--CA 1.52 3.03 0 C-N-CA 124.031 0.932 . . . . 0.0 109.2 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 tt -165.12 -51.27 0.03 OUTLIER 'General case' 0 N--CA 1.53 3.526 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 61.0 m -57.93 -35.01 70.48 Favored 'General case' 0 N--CA 1.523 3.205 0 CA-C-N 114.75 -1.114 . . . . 0.0 111.046 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.07 -38.21 40.94 Favored Glycine 0 N--CA 1.513 3.793 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.162 178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 33.5 mm -63.78 -44.34 98.22 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.874 0.87 . . . . 0.0 111.976 -177.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 17.8 tt -64.71 -33.82 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.691 0 C-N-CA 122.583 0.353 . . . . 0.0 110.919 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 89.3 mt -68.43 -38.17 78.91 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.876 0 O-C-N 121.79 -0.569 . . . . 0.0 109.54 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -67.04 -47.0 72.7 Favored 'General case' 0 N--CA 1.529 3.487 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.17 -34.8 58.3 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.145 0 CA-C-N 118.786 0.721 . . . . 0.0 111.926 -176.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 82.7 p -66.62 -48.65 68.82 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.596 0.758 . . . . 0.0 111.235 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 89.1 t -68.11 -35.05 70.06 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.556 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.19 77.12 Favored 'General case' 0 N--CA 1.523 3.216 0 C-N-CA 123.268 0.627 . . . . 0.0 111.248 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -38.61 75.18 Favored 'General case' 0 N--CA 1.52 3.057 0 C-N-CA 122.822 0.449 . . . . 0.0 111.632 -178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 77.9 t -67.93 -46.1 82.63 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.535 0 C-N-CA 123.019 0.528 . . . . 0.0 111.64 -178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 22.2 m -62.83 -32.57 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.747 0 CA-C-N 118.697 0.68 . . . . 0.0 111.156 -178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 43.9 tp -62.95 -41.5 99.52 Favored 'General case' 0 N--CA 1.525 3.322 0 C-N-CA 123.21 0.604 . . . . 0.0 112.046 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 74.8 mt -70.56 -55.56 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.653 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 14.4 p -68.67 -41.73 82.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.932 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -176.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.13 -39.36 82.14 Favored 'General case' 0 N--CA 1.536 3.872 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.15 -33.92 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.716 0 CA-C-N 118.101 0.41 . . . . 0.0 110.777 -179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -69.65 -27.11 64.77 Favored 'General case' 0 N--CA 1.536 3.864 0 CA-C-N 118.713 0.688 . . . . 0.0 110.539 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -68.26 -50.07 61.07 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.909 0 C-N-CA 122.677 0.391 . . . . 0.0 110.508 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 31.3 p -63.81 -35.79 81.76 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 122.708 0.403 . . . . 0.0 111.2 -178.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -65.96 -45.83 80.31 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 123.92 0.888 . . . . 0.0 109.946 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 68.8 m -63.3 -25.66 68.41 Favored 'General case' 0 N--CA 1.525 3.285 0 C-N-CA 123.348 0.659 . . . . 0.0 110.203 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.69 -25.12 33.28 Favored 'General case' 0 N--CA 1.529 3.492 0 C-N-CA 124.189 0.995 . . . . 0.0 108.344 178.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 1.2 tt -80.05 -27.35 39.43 Favored 'General case' 0 N--CA 1.539 3.98 0 C-N-CA 123.574 0.75 . . . . 0.0 109.132 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 81.7 m95 -88.8 13.42 12.57 Favored 'General case' 1 N--CA 1.545 4.284 0 C-N-CA 122.939 0.496 . . . . 0.0 110.361 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . 0.465 ' C ' ' H ' ' C' ' 240' ' ' VAL . 64.4 mttp -139.93 -62.77 0.51 Allowed 'General case' 0 N--CA 1.507 2.412 0 N-CA-C 105.998 -1.853 . . . . 0.0 105.998 178.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 84.0 tttt 70.77 -26.37 0.17 Allowed 'General case' 0 N--CA 1.528 3.436 0 C-N-CA 125.008 1.323 . . . . 0.0 110.719 -178.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . 0.465 ' H ' ' C ' ' C' ' 238' ' ' LYS . 19.1 m -136.86 136.67 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 C-N-CA 125.005 1.322 . . . . 0.0 107.592 178.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.85 141.65 24.02 Favored Pre-proline 0 N--CA 1.526 3.369 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 1 N--CA 1.538 4.114 0 CA-C-N 122.433 1.905 . . . . 0.0 110.659 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 11.6 ptp . . . . . 0 CA--C 1.577 2.016 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -51.2 128.28 24.73 Favored 'Trans proline' 1 N--CA 1.547 4.637 0 C-N-CA 122.328 2.019 . . . . 0.0 113.245 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.98 45.76 1.71 Allowed Glycine 1 N--CA 1.518 4.109 0 C-N-CA 123.819 0.723 . . . . 0.0 111.408 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 42.5 t -167.63 44.43 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.151 0 CA-C-O 121.922 0.868 . . . . 0.0 109.228 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.41 ' CD1' ' H ' ' A' ' 211' ' ' LEU . 0.0 OUTLIER -68.0 -9.44 45.68 Favored 'General case' 0 N--CA 1.529 3.506 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.746 179.467 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 42.8 t -71.14 -36.79 72.22 Favored 'General case' 0 N--CA 1.518 2.941 0 CA-C-O 121.597 0.713 . . . . 0.0 110.106 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -56.69 -49.63 68.89 Favored Glycine 0 N--CA 1.515 3.94 0 CA-C-N 114.326 -1.306 . . . . 0.0 114.61 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 6.5 tp -61.52 -35.97 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.79 0 CA-C-N 117.405 0.603 . . . . 0.0 110.753 -178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 57.4 mt -62.19 -36.66 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.975 0 C-N-CA 122.638 0.375 . . . . 0.0 110.44 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.91 -48.08 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.463 0 CA-C-O 121.584 0.707 . . . . 0.0 109.112 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -67.33 -41.2 85.63 Favored 'General case' 0 N--CA 1.524 3.271 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.42 -33.81 44.96 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.316 0 CA-C-N 119.172 0.896 . . . . 0.0 112.082 -175.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 35.1 p -71.45 -48.56 48.64 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.338 0.655 . . . . 0.0 110.011 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.3 t -67.01 -31.71 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.288 0 C-N-CA 123.892 0.877 . . . . 0.0 109.621 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -58.84 -34.52 71.66 Favored 'General case' 0 N--CA 1.526 3.352 0 C-N-CA 123.455 0.702 . . . . 0.0 111.827 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.15 -35.47 74.06 Favored 'General case' 0 N--CA 1.522 3.16 0 C-N-CA 122.346 0.259 . . . . 0.0 111.174 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 48.4 t -69.97 -46.7 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.364 0 C-N-CA 123.411 0.684 . . . . 0.0 111.573 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 13.5 m -61.78 -32.11 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.816 0 CA-C-N 118.411 0.55 . . . . 0.0 110.443 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.52 -46.08 73.46 Favored 'General case' 0 N--CA 1.528 3.466 0 C-N-CA 123.961 0.904 . . . . 0.0 111.524 -179.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 23.2 mm -63.13 -55.25 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.95 0 N-CA-C 112.762 0.652 . . . . 0.0 112.762 -176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.0 -36.41 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 N-CA-C 113.553 0.945 . . . . 0.0 113.553 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.83 -31.19 66.4 Favored 'General case' 0 N--CA 1.527 3.387 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -174.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -64.65 -37.27 79.68 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.124 0 CA-C-N 119.208 0.913 . . . . 0.0 110.59 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.79 -29.18 68.3 Favored 'General case' 0 N--CA 1.526 3.333 0 C-N-CA 122.956 0.502 . . . . 0.0 110.732 -179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.9 t -66.52 -38.36 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 42.6 t -67.24 -47.23 71.39 Favored 'General case' 0 N--CA 1.522 3.172 0 C-N-CA 123.472 0.709 . . . . 0.0 110.349 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -67.44 -41.71 84.3 Favored 'General case' 0 N--CA 1.523 3.221 0 C-N-CA 123.821 0.848 . . . . 0.0 111.184 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -64.22 -31.45 72.66 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 123.022 0.529 . . . . 0.0 111.171 -179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.32 -37.65 74.78 Favored 'General case' 0 N--CA 1.526 3.356 0 C-N-CA 123.461 0.704 . . . . 0.0 110.763 -178.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 76.2 mt -83.77 -27.68 28.71 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 123.316 0.647 . . . . 0.0 109.909 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 12.0 m95 -89.71 5.81 44.26 Favored 'General case' 1 N--CA 1.54 4.045 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -66.19 -16.85 64.33 Favored 'General case' 0 N--CA 1.526 3.34 0 C-N-CA 123.846 0.858 . . . . 0.0 109.968 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 54.6 tttm 73.09 -3.95 2.3 Favored 'General case' 0 N--CA 1.524 3.236 0 C-N-CA 124.489 1.116 . . . . 0.0 110.24 -179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 57.9 t -134.01 122.43 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.336 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -130.94 141.78 43.21 Favored Pre-proline 0 N--CA 1.526 3.365 0 CA-C-O 116.509 -1.71 . . . . 0.0 107.346 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo . . . . . 1 N--CA 1.55 4.847 0 C-N-CA 122.911 2.407 . . . . 0.0 115.019 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.578 2.026 0 CA-C-O 117.482 -1.247 . . . . 0.0 111.238 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -88.59 -16.37 2.5 Favored 'Trans proline' 0 N--CA 1.536 3.978 0 C-N-CA 122.503 2.136 . . . . 0.0 111.676 -178.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.11 136.1 30.38 Favored Glycine 1 N--CA 1.519 4.176 0 N-CA-C 111.416 -0.674 . . . . 0.0 111.416 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 43.6 t -169.1 56.41 0.05 OUTLIER 'General case' 0 N--CA 1.519 3.015 0 C-N-CA 124.152 0.981 . . . . 0.0 108.663 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 81.5 mt -71.8 10.88 0.6 Allowed 'General case' 0 N--CA 1.522 3.163 0 CA-C-N 114.904 -1.044 . . . . 0.0 111.537 -179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 65.1 m -70.32 -23.04 62.77 Favored 'General case' 0 N--CA 1.521 3.1 0 CA-C-N 118.052 0.387 . . . . 0.0 110.805 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.93 -50.88 7.39 Favored Glycine 1 N--CA 1.519 4.203 0 C-N-CA 123.439 0.543 . . . . 0.0 113.923 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 20.1 tt -66.19 -39.48 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.676 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 18.0 tt -54.66 -33.85 28.35 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.337 0.517 . . . . 0.0 111.007 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 23.5 mm -62.84 -42.99 98.5 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.989 0 CA-C-O 121.278 0.561 . . . . 0.0 109.909 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.6 m-30 -64.38 -35.4 80.78 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 124.022 0.929 . . . . 0.0 112.717 -177.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 50.7 t -57.47 -41.5 78.89 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.147 0 CA-C-O 121.03 0.443 . . . . 0.0 110.476 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 8.8 p -65.03 -48.23 74.63 Favored 'General case' 0 N--CA 1.528 3.427 0 C-N-CA 123.607 0.763 . . . . 0.0 111.271 -177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 48.3 t -70.72 -33.88 54.46 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.149 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.673 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.0 -35.19 80.41 Favored 'General case' 0 N--CA 1.523 3.217 0 C-N-CA 122.989 0.516 . . . . 0.0 111.56 -178.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.33 63.3 Favored 'General case' 0 N--CA 1.52 3.072 0 C-N-CA 122.832 0.453 . . . . 0.0 112.192 -178.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.8 t -68.15 -43.63 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.395 0 C-N-CA 123.107 0.563 . . . . 0.0 111.826 -177.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 11.6 p -67.35 -32.82 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.558 0 CA-C-N 118.311 0.505 . . . . 0.0 110.713 -178.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 41.2 tp -58.64 -41.12 85.29 Favored 'General case' 0 N--CA 1.53 3.568 0 C-N-CA 122.899 0.48 . . . . 0.0 111.339 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -67.09 -54.08 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 CA-C-O 121.686 0.755 . . . . 0.0 109.631 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -65.52 -35.56 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.213 0 C-N-CA 125.788 1.635 . . . . 0.0 113.26 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.66 -35.62 70.79 Favored 'General case' 0 N--CA 1.529 3.513 0 N-CA-C 113.585 0.958 . . . . 0.0 113.585 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.35 -41.97 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.754 0 CA-C-N 118.942 0.792 . . . . 0.0 111.454 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -65.15 -42.52 93.71 Favored 'General case' 0 N--CA 1.531 3.594 0 N-CA-C 112.089 0.403 . . . . 0.0 112.089 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.28 -36.97 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.795 0 CA-C-N 118.314 0.506 . . . . 0.0 110.822 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 97.0 m -67.75 -48.19 67.13 Favored 'General case' 0 N--CA 1.53 3.535 0 C-N-CA 122.818 0.447 . . . . 0.0 111.346 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -63.2 -28.37 70.0 Favored 'General case' 0 N--CA 1.534 3.728 0 C-N-CA 123.511 0.724 . . . . 0.0 111.411 -178.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 56.2 m -63.65 -21.41 66.36 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 122.733 0.413 . . . . 0.0 110.88 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 57.1 mt -91.3 -30.4 16.61 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 124.197 0.999 . . . . 0.0 110.969 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 67.0 mt -80.3 -27.4 38.47 Favored 'General case' 0 N--CA 1.534 3.75 0 C-N-CA 122.839 0.456 . . . . 0.0 112.13 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -99.15 6.81 46.3 Favored 'General case' 1 N--CA 1.543 4.181 0 C-N-CA 123.586 0.755 . . . . 0.0 110.936 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -143.07 31.51 1.39 Allowed 'General case' 0 N--CA 1.536 3.853 0 C-N-CA 123.532 0.733 . . . . 0.0 109.628 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.1 tmtm? -162.21 -60.94 0.05 OUTLIER 'General case' 0 N--CA 1.537 3.905 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 55.9 t -83.11 127.37 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.229 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 51.8 mt -93.68 141.97 24.51 Favored Pre-proline 0 N--CA 1.524 3.261 0 CA-C-O 117.237 -1.363 . . . . 0.0 108.314 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo . . . . . 1 N--CA 1.54 4.263 0 CA-C-N 122.295 1.855 . . . . 0.0 110.815 -178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 CA--C 1.586 2.347 0 CA-C-O 117.557 -1.211 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -89.07 47.38 1.08 Allowed 'Trans proline' 0 N--CA 1.535 3.915 0 C-N-CA 122.682 2.254 . . . . 0.0 110.917 -178.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 69.15 -70.67 0.45 Allowed Glycine 1 N--CA 1.518 4.126 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.512 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 98.0 p -166.21 167.31 16.26 Favored 'General case' 0 N--CA 1.524 3.226 0 C-N-CA 123.648 0.779 . . . . 0.0 109.263 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -80.73 20.24 0.76 Allowed 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 124.091 0.956 . . . . 0.0 110.978 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -67.08 -24.68 65.98 Favored 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.343 0.657 . . . . 0.0 111.174 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.41 -51.04 7.65 Favored Glycine 0 N--CA 1.516 3.997 0 CA-C-N 116.445 -0.343 . . . . 0.0 112.58 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 7.5 tp -66.71 -37.02 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.082 0.553 . . . . 0.0 112.367 -177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . 0.452 HD13 ' O ' ' C' ' 215' ' ' ILE . 0.2 OUTLIER -62.77 -37.0 77.97 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.217 0 CA-C-N 118.256 0.48 . . . . 0.0 110.579 -177.64 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 87.4 mt -70.42 -48.32 60.62 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.634 0 CA-C-O 121.429 0.633 . . . . 0.0 109.595 178.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -67.36 -39.16 85.7 Favored 'General case' 0 N--CA 1.53 3.561 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 9.7 p -57.81 -39.04 68.98 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.251 0 CA-C-N 119.106 0.866 . . . . 0.0 111.914 -176.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 20.1 p -63.75 -46.65 84.39 Favored 'General case' 0 N--CA 1.53 3.567 0 C-N-CA 123.458 0.703 . . . . 0.0 110.756 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.65 -47.99 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.008 0 CA-C-N 115.152 -0.931 . . . . 0.0 109.244 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.81 -34.57 54.34 Favored 'General case' 0 N--CA 1.523 3.204 0 C-N-CA 123.475 0.71 . . . . 0.0 111.902 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.61 95.9 Favored 'General case' 0 N--CA 1.523 3.184 0 C-N-CA 122.95 0.5 . . . . 0.0 111.128 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.3 t -69.97 -40.43 78.64 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.513 0 C-N-CA 123.362 0.665 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 76.4 t -61.5 -32.95 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.374 0 C-N-CA 123.862 0.865 . . . . 0.0 110.192 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.33 -47.4 86.11 Favored 'General case' 0 N--CA 1.534 3.739 0 CA-C-O 121.563 0.697 . . . . 0.0 110.797 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 53.5 mt -67.11 -54.92 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.37 0 CA-C-N 115.339 -0.846 . . . . 0.0 113.228 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 20.7 m -67.08 -37.03 78.49 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.794 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.44 -31.73 68.04 Favored 'General case' 0 N--CA 1.527 3.41 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.1 m -65.06 -38.61 83.21 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.03 0 CA-C-N 119.214 0.915 . . . . 0.0 110.558 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -64.53 -31.69 73.01 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 122.919 0.488 . . . . 0.0 110.878 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 50.5 t -64.89 -41.24 91.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.646 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 66.9 m -67.09 -39.91 86.87 Favored 'General case' 0 N--CA 1.524 3.242 0 C-N-CA 123.627 0.771 . . . . 0.0 110.937 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -74.98 -42.68 57.1 Favored 'General case' 0 N--CA 1.523 3.2 0 C-N-CA 123.626 0.771 . . . . 0.0 110.248 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 94.1 p -63.69 -12.75 37.02 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.024 0.53 . . . . 0.0 111.686 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -76.02 -37.75 58.05 Favored 'General case' 0 N--CA 1.522 3.145 0 C-N-CA 122.609 0.364 . . . . 0.0 110.435 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 52.3 mt -107.78 -27.98 9.94 Favored 'General case' 1 N--CA 1.543 4.183 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -177.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -89.73 -9.64 48.63 Favored 'General case' 1 N--CA 1.547 4.397 0 CA-C-N 118.568 0.622 . . . . 0.0 112.404 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -81.62 -8.23 59.68 Favored 'General case' 0 N--CA 1.539 3.991 0 CA-C-N 118.62 0.646 . . . . 0.0 110.176 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm 64.77 2.69 1.77 Allowed 'General case' 0 N--CA 1.522 3.156 0 C-N-CA 124.481 1.112 . . . . 0.0 112.49 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 60.6 t -131.69 122.65 50.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.647 0 N-CA-C 106.357 -1.72 . . . . 0.0 106.357 178.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 25.2 mt -99.47 141.42 22.79 Favored Pre-proline 0 N--CA 1.526 3.367 0 CA-C-O 116.125 -1.893 . . . . 0.0 108.539 -179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo . . . . . 1 N--CA 1.549 4.779 0 C-N-CA 122.58 2.186 . . . . 0.0 114.843 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 CA--C 1.586 2.351 0 CA-C-O 117.597 -1.192 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -89.22 -169.8 0.41 Allowed 'Trans proline' 0 N--CA 1.535 3.928 0 C-N-CA 122.611 2.207 . . . . 0.0 110.855 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -173.88 -2.68 0.03 OUTLIER Glycine 1 N--CA 1.521 4.362 0 O-C-N 123.695 0.622 . . . . 0.0 111.619 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 98.9 p -66.92 110.0 3.16 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.731 0.812 . . . . 0.0 110.102 179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 75.6 mt -65.84 -3.26 4.74 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.884 0.874 . . . . 0.0 111.502 -179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 35.4 t -63.28 -41.62 99.01 Favored 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 123.377 0.671 . . . . 0.0 111.751 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.16 -34.22 55.56 Favored Glycine 1 N--CA 1.518 4.134 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 42.5 mm -64.79 -49.64 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.904 0.882 . . . . 0.0 111.103 -178.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 38.6 pt -63.44 -33.68 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.981 0 O-C-N 122.172 -0.33 . . . . 0.0 110.789 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 96.1 mt -69.57 -41.6 80.42 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.776 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -66.14 -44.34 84.46 Favored 'General case' 0 N--CA 1.529 3.509 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -175.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 10.5 p -57.72 -37.6 60.33 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.226 0 CA-C-N 119.101 0.864 . . . . 0.0 111.723 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 36.3 p -63.99 -48.24 77.17 Favored 'General case' 0 N--CA 1.527 3.38 0 C-N-CA 123.553 0.741 . . . . 0.0 111.158 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 57.4 t -68.97 -45.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.261 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.61 -34.89 67.66 Favored 'General case' 0 N--CA 1.525 3.317 0 C-N-CA 123.142 0.577 . . . . 0.0 111.32 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -64.08 -42.93 96.77 Favored 'General case' 0 N--CA 1.521 3.096 0 C-N-CA 122.976 0.51 . . . . 0.0 111.401 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 64.4 t -70.05 -41.89 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.604 0 C-N-CA 123.189 0.595 . . . . 0.0 109.723 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 72.1 t -65.04 -32.83 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.385 0 C-N-CA 123.857 0.863 . . . . 0.0 110.235 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.41 -40.96 89.89 Favored 'General case' 0 N--CA 1.527 3.403 0 C-N-CA 123.095 0.558 . . . . 0.0 111.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -70.04 -52.53 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.779 0 C-N-CA 122.936 0.495 . . . . 0.0 111.614 -177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 24.2 m -66.28 -37.42 79.66 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.728 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.58 -45.26 92.39 Favored 'General case' 0 N--CA 1.535 3.806 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -176.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 7.5 p -72.74 -33.87 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.403 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -63.17 -43.44 98.26 Favored 'General case' 0 N--CA 1.531 3.623 0 C-N-CA 123.522 0.729 . . . . 0.0 112.446 -177.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 30.5 m -69.05 -31.7 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.769 0 C-N-CA 122.393 0.277 . . . . 0.0 110.488 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 44.7 t -62.44 -32.39 73.24 Favored 'General case' 0 N--CA 1.528 3.452 0 C-N-CA 123.044 0.538 . . . . 0.0 111.037 -179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -67.32 -44.84 78.17 Favored 'General case' 0 N--CA 1.527 3.424 0 C-N-CA 123.653 0.781 . . . . 0.0 110.55 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 97.0 p -64.66 -41.31 96.19 Favored 'General case' 0 N--CA 1.524 3.229 0 CA-C-O 121.465 0.65 . . . . 0.0 109.616 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 1.2 tt -65.8 -34.44 78.17 Favored 'General case' 0 N--CA 1.532 3.67 0 C-N-CA 124.538 1.135 . . . . 0.0 109.694 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.6 tp -80.03 -21.85 43.05 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.586 0.754 . . . . 0.0 110.041 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 35.8 m0 -89.03 13.07 13.8 Favored 'General case' 0 N--CA 1.535 3.796 0 C-N-CA 123.599 0.759 . . . . 0.0 110.478 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -122.04 10.42 10.1 Favored 'General case' 1 N--CA 1.542 4.16 0 C-N-CA 124.556 1.142 . . . . 0.0 109.077 176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 91.7 mttt 64.97 -24.1 0.08 Allowed 'General case' 0 N--CA 1.517 2.922 0 C-N-CA 124.862 1.265 . . . . 0.0 113.637 178.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.9 m -83.64 122.5 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 10.9 mp -105.09 142.11 23.98 Favored Pre-proline 0 N--CA 1.537 3.894 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 -179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo . . . . . 1 N--CA 1.54 4.245 0 CA-C-N 122.415 1.898 . . . . 0.0 110.769 -179.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.576 1.973 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.28 120.01 6.69 Favored 'Trans proline' 1 N--CA 1.545 4.507 0 C-N-CA 122.278 1.986 . . . . 0.0 113.007 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 65.26 -172.41 22.07 Favored Glycine 1 N--CA 1.519 4.205 0 N-CA-C 111.573 -0.611 . . . . 0.0 111.573 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 97.7 p -167.69 171.19 10.34 Favored 'General case' 0 N--CA 1.521 3.121 0 C-N-CA 123.784 0.834 . . . . 0.0 109.44 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -66.51 -39.04 88.45 Favored 'General case' 0 N--CA 1.528 3.434 0 C-N-CA 124.206 1.003 . . . . 0.0 109.667 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 93.0 p -55.58 -19.97 11.91 Favored 'General case' 0 N--CA 1.53 3.537 0 C-N-CA 124.048 0.939 . . . . 0.0 111.438 178.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.99 -23.32 76.52 Favored Glycine 0 N--CA 1.511 3.683 0 N-CA-C 111.294 -0.723 . . . . 0.0 111.294 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -51.27 74.0 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.057 0 C-N-CA 123.068 0.547 . . . . 0.0 111.662 -177.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 19.1 tt -64.72 -33.84 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.724 0 C-N-CA 122.778 0.431 . . . . 0.0 110.947 -178.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 69.8 mt -69.44 -38.3 76.8 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -66.78 -45.11 79.49 Favored 'General case' 0 N--CA 1.531 3.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 32.4 m -57.84 -34.06 47.27 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.231 0 CA-C-N 118.992 0.815 . . . . 0.0 111.672 -176.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.7 p -64.64 -48.43 74.86 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.233 0.613 . . . . 0.0 111.087 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 59.5 t -67.57 -41.01 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.132 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -65.33 -34.3 78.01 Favored 'General case' 0 N--CA 1.521 3.122 0 C-N-CA 122.931 0.492 . . . . 0.0 111.576 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.5 -46.03 67.55 Favored 'General case' 0 N--CA 1.519 2.983 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 11.4 p -70.26 -38.35 74.19 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.699 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -176.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 33.9 m -66.95 -32.64 58.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.788 0 CA-C-N 118.589 0.631 . . . . 0.0 110.55 -179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 47.7 tp -54.9 -34.7 63.34 Favored 'General case' 0 N--CA 1.525 3.31 0 C-N-CA 123.145 0.578 . . . . 0.0 112.55 -177.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 38.3 mm -68.95 -55.74 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.772 0 CA-C-N 117.677 0.217 . . . . 0.0 111.382 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 29.9 m -67.5 -36.13 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.796 0 C-N-CA 124.33 1.052 . . . . 0.0 113.128 -178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.5 -31.02 65.61 Favored 'General case' 0 N--CA 1.528 3.448 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -58.32 -37.07 61.19 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.977 0.808 . . . . 0.0 110.641 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -71.21 -35.46 71.53 Favored 'General case' 0 N--CA 1.526 3.348 0 CA-C-N 115.967 -0.561 . . . . 0.0 109.999 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 47.6 t -68.04 -36.95 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 78.3 m -67.19 -41.87 85.12 Favored 'General case' 0 N--CA 1.521 3.109 0 C-N-CA 123.481 0.712 . . . . 0.0 110.2 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -71.73 -37.01 70.66 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.851 0.86 . . . . 0.0 110.535 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 92.2 p -63.83 -17.68 63.36 Favored 'General case' 0 N--CA 1.526 3.372 0 C-N-CA 123.027 0.531 . . . . 0.0 111.546 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 55.7 tp -83.57 -37.5 22.89 Favored 'General case' 0 N--CA 1.529 3.488 0 C-N-CA 123.473 0.709 . . . . 0.0 110.338 -179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 10.3 mp -86.83 -21.47 26.41 Favored 'General case' 1 N--CA 1.542 4.139 0 C-N-CA 123.857 0.863 . . . . 0.0 110.12 -178.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 58.9 m95 -114.06 13.97 18.25 Favored 'General case' 0 N--CA 1.537 3.9 0 C-N-CA 124.967 1.307 . . . . 0.0 109.193 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -56.91 -43.62 81.57 Favored 'General case' 0 N--CA 1.534 3.759 0 CA-C-O 121.941 0.877 . . . . 0.0 108.672 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? 178.01 -34.44 0.01 OUTLIER 'General case' 0 N--CA 1.522 3.134 0 CA-C-N 113.649 -1.614 . . . . 0.0 108.469 178.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.2 p -84.53 128.25 39.09 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.284 0 C-N-CA 123.87 0.868 . . . . 0.0 108.972 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -94.0 141.5 23.77 Favored Pre-proline 0 N--CA 1.529 3.501 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo . . . . . 1 N--CA 1.539 4.156 0 CA-C-N 122.427 1.902 . . . . 0.0 110.705 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.584 2.279 0 CA-C-O 117.553 -1.213 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -89.47 68.17 2.24 Favored 'Trans proline' 0 N--CA 1.534 3.9 0 C-N-CA 122.714 2.276 . . . . 0.0 110.835 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 67.0 -148.94 50.91 Favored Glycine 1 N--CA 1.521 4.306 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.416 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 47.8 t -164.45 144.49 7.71 Favored 'General case' 0 N--CA 1.518 2.932 0 C-N-CA 123.667 0.787 . . . . 0.0 109.178 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -73.05 -1.87 19.0 Favored 'General case' 0 N--CA 1.53 3.532 0 C-N-CA 123.9 0.88 . . . . 0.0 110.46 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 91.9 p -68.19 -25.78 65.41 Favored 'General case' 0 N--CA 1.518 2.947 0 C-N-CA 122.699 0.4 . . . . 0.0 110.758 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.02 -51.48 6.91 Favored Glycine 1 N--CA 1.518 4.16 0 O-C-N 123.117 0.261 . . . . 0.0 113.726 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 17.7 tt -67.18 -40.79 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 8.9 tp -54.45 -33.35 26.22 Favored 'Isoleucine or valine' 1 N--CA 1.545 4.28 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 28.2 mm -68.86 -42.05 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.995 0 CA-C-O 121.458 0.647 . . . . 0.0 109.359 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -64.87 -44.69 88.89 Favored 'General case' 0 N--CA 1.525 3.315 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 32.7 m -57.82 -35.15 50.23 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.254 0 CA-C-N 119.117 0.872 . . . . 0.0 111.95 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 36.7 p -62.83 -48.21 80.07 Favored 'General case' 0 N--CA 1.53 3.545 0 C-N-CA 123.527 0.731 . . . . 0.0 110.674 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.72 -48.76 74.83 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.992 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.346 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.97 -36.84 60.62 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 122.98 0.512 . . . . 0.0 111.882 -179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -63.11 -44.81 94.61 Favored 'General case' 0 N--CA 1.523 3.206 0 C-N-CA 123.077 0.551 . . . . 0.0 111.741 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 59.0 t -70.09 -41.36 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.442 0 C-N-CA 123.372 0.669 . . . . 0.0 109.571 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 56.8 t -63.15 -32.91 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.474 0 C-N-CA 123.432 0.693 . . . . 0.0 109.495 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.38 -47.3 79.19 Favored 'General case' 0 N--CA 1.539 3.985 0 CA-C-O 121.68 0.752 . . . . 0.0 110.102 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 69.8 mt -68.34 -52.31 38.6 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.308 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.413 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 75.2 t -66.1 -36.05 76.51 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.574 0 C-N-CA 124.875 1.27 . . . . 0.0 113.321 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.85 -38.17 75.18 Favored 'General case' 0 N--CA 1.534 3.727 0 N-CA-C 113.753 1.02 . . . . 0.0 113.753 -173.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 14.7 m -72.5 -37.98 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.639 0 CA-C-N 118.543 0.61 . . . . 0.0 111.732 -179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -69.31 -42.66 75.13 Favored 'General case' 0 N--CA 1.534 3.73 0 O-C-N 122.205 -0.31 . . . . 0.0 111.656 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.54 -32.11 53.92 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.957 0 CA-C-N 118.41 0.55 . . . . 0.0 110.136 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 43.7 t -67.32 -39.25 85.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -67.7 -26.56 66.24 Favored 'General case' 0 N--CA 1.523 3.182 0 C-N-CA 124.346 1.058 . . . . 0.0 111.557 -178.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 49.2 m -63.54 -27.95 69.61 Favored 'General case' 0 N--CA 1.528 3.468 0 C-N-CA 122.575 0.35 . . . . 0.0 110.785 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.3 -14.39 30.92 Favored 'General case' 0 N--CA 1.53 3.527 0 C-N-CA 124.491 1.117 . . . . 0.0 110.345 179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 50.8 tp -80.06 -28.39 39.22 Favored 'General case' 0 N--CA 1.538 3.939 0 CA-C-O 118.911 -0.566 . . . . 0.0 111.654 -176.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -108.87 1.36 20.79 Favored 'General case' 1 N--CA 1.559 5.003 0 C-N-CA 122.916 0.486 . . . . 0.0 111.447 179.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -75.76 -42.55 50.04 Favored 'General case' 0 N--CA 1.531 3.597 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -71.45 -57.6 4.28 Favored 'General case' 0 N--CA 1.519 2.976 0 CA-C-N 114.602 -1.181 . . . . 0.0 109.279 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.8 t -94.64 121.87 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.387 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.8 mp -99.81 141.55 22.98 Favored Pre-proline 0 N--CA 1.531 3.607 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 1 N--CA 1.538 4.113 0 CA-C-N 122.426 1.902 . . . . 0.0 110.668 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 CA--C 1.574 1.89 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -78.81 -20.89 10.13 Favored 'Trans proline' 1 N--CA 1.536 4.025 0 C-N-CA 122.415 2.077 . . . . 0.0 110.749 -179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 177.83 111.07 0.29 Allowed Glycine 1 N--CA 1.516 4.014 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 59.1 p 60.21 156.87 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 C-N-CA 124.629 1.172 . . . . 0.0 111.8 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.9 tt -165.47 -53.57 0.03 OUTLIER 'General case' 0 N--CA 1.532 3.627 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 66.5 m -55.65 -20.43 13.95 Favored 'General case' 0 N--CA 1.527 3.416 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.489 179.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -74.2 -26.89 67.27 Favored Glycine 0 N--CA 1.51 3.601 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 179.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.43 -49.33 84.9 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.088 0 C-N-CA 123.219 0.608 . . . . 0.0 111.744 -177.666 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 7.8 tp -67.15 -33.99 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.714 0 O-C-N 121.973 -0.455 . . . . 0.0 110.616 -178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.41 -38.84 77.93 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.892 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -63.8 -48.45 76.82 Favored 'General case' 0 N--CA 1.525 3.311 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 -176.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 35.5 m -58.18 -36.12 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.933 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -176.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 34.8 p -66.85 -49.46 65.64 Favored 'General case' 0 N--CA 1.529 3.5 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.03 -33.09 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.528 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -63.65 -34.33 77.6 Favored 'General case' 0 N--CA 1.523 3.189 0 C-N-CA 122.882 0.473 . . . . 0.0 111.211 -179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -67.34 -37.5 83.35 Favored 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 122.759 0.424 . . . . 0.0 111.997 -178.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 52.4 t -69.95 -45.23 77.37 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.406 0 C-N-CA 123.201 0.6 . . . . 0.0 111.263 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 10.7 m -67.66 -32.67 57.83 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.654 0 O-C-N 121.755 -0.591 . . . . 0.0 110.63 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 55.6 tp -61.92 -47.86 83.05 Favored 'General case' 0 N--CA 1.523 3.216 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 19.7 tt -70.95 -44.62 75.61 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.67 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 34.3 m -66.82 -36.58 77.55 Favored 'Isoleucine or valine' 1 N--CA 1.549 4.495 0 CA-C-N 119.301 0.955 . . . . 0.0 112.448 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.3 -31.11 67.19 Favored 'General case' 0 N--CA 1.526 3.338 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -173.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 4.3 m -70.24 -38.46 74.59 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.801 0 CA-C-N 118.737 0.699 . . . . 0.0 111.543 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -65.23 -43.09 92.54 Favored 'General case' 0 N--CA 1.532 3.671 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -177.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.28 -31.9 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.802 0 CA-C-N 117.999 0.363 . . . . 0.0 110.03 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 47.9 t -66.5 -46.17 77.14 Favored 'General case' 0 N--CA 1.527 3.384 0 C-N-CA 123.304 0.642 . . . . 0.0 110.712 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.09 -35.1 76.12 Favored 'General case' 0 N--CA 1.524 3.253 0 C-N-CA 123.777 0.831 . . . . 0.0 110.985 -179.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 88.3 p -64.22 -34.93 79.23 Favored 'General case' 0 N--CA 1.528 3.433 0 C-N-CA 122.791 0.436 . . . . 0.0 111.693 -179.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 73.5 mt -88.59 -20.07 25.47 Favored 'General case' 0 N--CA 1.53 3.533 0 C-N-CA 124.035 0.934 . . . . 0.0 111.376 -178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 56.0 tp -80.82 -27.84 36.42 Favored 'General case' 0 N--CA 1.535 3.801 0 C-N-CA 122.713 0.405 . . . . 0.0 110.284 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -100.83 10.02 41.64 Favored 'General case' 1 N--CA 1.543 4.203 0 C-N-CA 124.116 0.966 . . . . 0.0 109.998 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -86.9 -21.91 26.02 Favored 'General case' 0 N--CA 1.531 3.588 0 C-N-CA 123.903 0.881 . . . . 0.0 108.73 177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -65.83 -43.67 87.87 Favored 'General case' 0 N--CA 1.52 3.064 0 C-N-CA 124.232 1.013 . . . . 0.0 108.766 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.0 m -136.33 125.12 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.269 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -94.93 141.4 23.23 Favored Pre-proline 0 N--CA 1.527 3.42 0 CA-C-O 116.272 -1.823 . . . . 0.0 107.153 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo . . . . . 1 N--CA 1.549 4.745 0 C-N-CA 122.948 2.432 . . . . 0.0 115.049 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 CA--C 1.575 1.927 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -51.06 -51.53 11.01 Favored 'Trans proline' 1 N--CA 1.544 4.468 0 C-N-CA 122.404 2.069 . . . . 0.0 113.424 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 174.4 107.93 0.21 Allowed Glycine 1 N--CA 1.518 4.128 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 67.8 m -76.28 114.88 15.46 Favored 'General case' 0 N--CA 1.518 2.949 0 C-N-CA 123.774 0.83 . . . . 0.0 109.398 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -167.37 21.6 0.03 OUTLIER 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.48 0.712 . . . . 0.0 110.296 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m -63.56 -34.76 78.52 Favored 'General case' 0 N--CA 1.528 3.458 0 C-N-CA 122.798 0.439 . . . . 0.0 111.027 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.54 -40.85 31.37 Favored Glycine 1 N--CA 1.52 4.24 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 59.6 mt -63.18 -45.65 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.2 0 C-N-CA 124.443 1.097 . . . . 0.0 112.054 -176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 5.9 tp -55.58 -33.21 32.37 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.192 0 CA-C-N 118.529 0.604 . . . . 0.0 110.052 179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 16.1 mm -69.28 -46.5 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.81 0 CA-C-O 121.822 0.82 . . . . 0.0 109.021 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -67.2 -41.9 85.04 Favored 'General case' 0 N--CA 1.527 3.4 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 -175.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.74 -38.26 64.16 Favored 'Isoleucine or valine' 1 N--CA 1.543 4.202 0 CA-C-N 119.042 0.837 . . . . 0.0 111.776 -175.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 42.9 p -64.04 -48.01 77.95 Favored 'General case' 0 N--CA 1.526 3.357 0 C-N-CA 123.678 0.791 . . . . 0.0 110.943 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.5 t -68.82 -45.74 80.4 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.922 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.07 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -52.83 -34.44 54.07 Favored 'General case' 0 N--CA 1.523 3.214 0 C-N-CA 123.372 0.669 . . . . 0.0 111.729 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.49 -41.3 98.7 Favored 'General case' 0 N--CA 1.525 3.277 0 CA-C-O 120.932 0.396 . . . . 0.0 111.384 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 60.6 t -70.11 -38.97 76.5 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.325 0 C-N-CA 123.558 0.743 . . . . 0.0 109.657 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 72.0 t -58.37 -33.1 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.562 0 C-N-CA 123.617 0.767 . . . . 0.0 111.03 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 88.5 mt -59.49 -43.47 93.29 Favored 'General case' 0 N--CA 1.539 3.987 0 CA-C-N 118.594 0.634 . . . . 0.0 110.161 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.4 -54.15 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 C-N-CA 123.36 0.664 . . . . 0.0 110.102 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 64.0 t -66.03 -37.82 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.482 0 C-N-CA 124.301 1.04 . . . . 0.0 113.314 -176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.32 -44.94 92.52 Favored 'General case' 1 N--CA 1.541 4.091 0 CA-C-N 118.575 0.625 . . . . 0.0 112.515 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 29.8 m -72.86 -34.1 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.223 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -64.21 -43.77 93.99 Favored 'General case' 0 N--CA 1.533 3.705 0 C-N-CA 123.176 0.59 . . . . 0.0 112.051 -177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.29 -36.07 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.878 0 CA-C-O 120.818 0.342 . . . . 0.0 110.438 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 72.0 m -67.24 -39.44 86.18 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.297 0.639 . . . . 0.0 110.616 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -72.44 -29.99 64.2 Favored 'General case' 0 N--CA 1.524 3.261 0 C-N-CA 123.853 0.861 . . . . 0.0 111.031 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 99.1 p -75.37 -43.15 51.92 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 122.748 0.419 . . . . 0.0 110.745 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 52.3 mt -77.27 -31.66 55.05 Favored 'General case' 0 N--CA 1.527 3.422 0 C-N-CA 123.892 0.877 . . . . 0.0 111.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 56.7 tp -80.67 -27.63 37.04 Favored 'General case' 0 N--CA 1.536 3.829 0 C-N-CA 123.069 0.547 . . . . 0.0 111.662 -176.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -92.01 0.65 57.47 Favored 'General case' 1 N--CA 1.545 4.283 0 C-N-CA 123.411 0.684 . . . . 0.0 110.509 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 58.1 tttm -104.84 -14.38 15.52 Favored 'General case' 1 N--CA 1.543 4.217 0 C-N-CA 124.117 0.967 . . . . 0.0 109.64 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? 62.85 52.24 2.75 Favored 'General case' 0 N--CA 1.515 2.817 0 C-N-CA 124.679 1.191 . . . . 0.0 111.548 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . 0.534 ' C ' HD23 ' B' ' 241' ' ' LEU . 94.6 t -131.7 122.3 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . 0.534 HD23 ' C ' ' B' ' 240' ' ' VAL . 0.0 OUTLIER -128.6 141.87 42.98 Favored Pre-proline 0 N--CA 1.533 3.715 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 -179.274 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 1 N--CA 1.54 4.212 0 CA-C-N 122.322 1.865 . . . . 0.0 111.029 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -52.48 150.47 20.87 Favored 'Trans proline' 1 N--CA 1.547 4.661 0 CA-C-N 121.969 1.739 . . . . 0.0 113.258 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . 172.3 -48.96 0.17 Allowed Glycine 1 N--CA 1.519 4.187 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 59.8 p 58.38 159.54 0.02 OUTLIER 'General case' 0 N--CA 1.524 3.243 0 C-N-CA 124.783 1.233 . . . . 0.0 112.443 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tp -81.23 12.44 3.51 Favored 'General case' 0 N--CA 1.532 3.642 0 C-N-CA 124.124 0.97 . . . . 0.0 109.943 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 24.4 t -62.27 -20.43 64.26 Favored 'General case' 0 N--CA 1.522 3.173 0 C-N-CA 123.829 0.851 . . . . 0.0 110.624 178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -60.74 -46.61 94.14 Favored Glycine 0 N--CA 1.508 3.488 0 CA-C-N 114.964 -1.016 . . . . 0.0 113.184 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.3 pt -65.79 -35.39 75.05 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.024 0 CA-C-N 117.897 0.849 . . . . 0.0 111.265 -178.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 38.0 mm -54.14 -34.39 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 C-N-CA 123.203 0.601 . . . . 0.0 109.636 -178.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 67.8 mt -70.07 -44.31 78.36 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.421 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -67.02 -45.41 77.61 Favored 'General case' 0 N--CA 1.533 3.687 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 15.0 p -57.65 -35.85 52.15 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.142 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -175.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 44.3 p -66.06 -49.45 67.61 Favored 'General case' 0 N--CA 1.529 3.492 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.93 -37.82 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.44 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.01 -35.14 72.76 Favored 'General case' 0 N--CA 1.525 3.288 0 C-N-CA 122.64 0.376 . . . . 0.0 111.273 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.23 94.87 Favored 'General case' 0 N--CA 1.521 3.085 0 C-N-CA 122.938 0.495 . . . . 0.0 111.747 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.76 -42.12 80.08 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 123.322 0.649 . . . . 0.0 109.893 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.3 t -65.79 -32.97 60.51 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.331 0 C-N-CA 123.547 0.739 . . . . 0.0 110.161 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 48.4 tp -63.87 -37.7 88.38 Favored 'General case' 0 N--CA 1.529 3.506 0 C-N-CA 122.89 0.476 . . . . 0.0 111.954 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.73 -54.62 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.707 0 C-N-CA 122.887 0.475 . . . . 0.0 111.624 -177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 22.7 m -66.86 -36.88 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.72 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.49 67.83 Favored 'General case' 0 N--CA 1.53 3.544 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.7 m -66.26 -36.55 77.67 Favored 'Isoleucine or valine' 1 N--CA 1.539 4.017 0 CA-C-N 119.393 0.997 . . . . 0.0 110.593 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -65.54 -30.27 71.0 Favored 'General case' 0 N--CA 1.531 3.579 0 C-N-CA 122.784 0.434 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 52.5 t -68.16 -41.08 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.607 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 72.8 m -67.41 -48.31 67.7 Favored 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 123.465 0.706 . . . . 0.0 111.166 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.95 -25.07 67.97 Favored 'General case' 0 N--CA 1.53 3.531 0 C-N-CA 124.068 0.947 . . . . 0.0 111.708 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 36.6 t -63.9 -40.96 97.72 Favored 'General case' 0 N--CA 1.524 3.267 0 CA-C-O 121.323 0.582 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 48.8 tp -72.8 -35.18 67.3 Favored 'General case' 0 N--CA 1.522 3.162 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.606 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.29 -20.85 43.44 Favored 'General case' 0 N--CA 1.531 3.582 0 C-N-CA 123.18 0.592 . . . . 0.0 110.498 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 30.9 m0 -89.05 -18.08 28.04 Favored 'General case' 0 N--CA 1.538 3.932 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 56.4 mttp 60.13 6.17 0.93 Allowed 'General case' 0 N--CA 1.518 2.971 0 C-N-CA 124.414 1.086 . . . . 0.0 113.129 177.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -72.81 -38.42 67.19 Favored 'General case' 0 N--CA 1.529 3.491 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 61.5 t -135.99 123.61 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.659 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 30.3 mt -103.04 141.5 22.61 Favored Pre-proline 0 N--CA 1.527 3.404 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.286 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 1 N--CA 1.539 4.166 0 CA-C-N 122.62 1.972 . . . . 0.0 110.803 -179.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 CA--C 1.576 1.964 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.18 159.26 47.69 Favored 'Trans proline' 1 N--CA 1.54 4.256 0 C-N-CA 122.304 2.002 . . . . 0.0 109.861 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.59 -43.1 69.85 Favored Glycine 1 N--CA 1.519 4.22 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 38.6 m 56.45 77.67 0.24 Allowed 'General case' 0 N--CA 1.521 3.084 0 C-N-CA 124.256 1.022 . . . . 0.0 112.031 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -161.3 21.32 0.12 Allowed 'General case' 0 N--CA 1.53 3.559 0 C-N-CA 123.73 0.812 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 62.9 m -69.89 -27.73 65.04 Favored 'General case' 0 N--CA 1.517 2.912 0 C-N-CA 123.531 0.732 . . . . 0.0 110.989 -179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.36 -50.57 8.16 Favored Glycine 0 N--CA 1.512 3.734 0 CA-C-N 116.058 -0.519 . . . . 0.0 112.805 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 21.0 tt -66.35 -36.89 78.46 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.516 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 8.5 tp -60.12 -33.58 53.82 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.046 0 CA-C-N 118.64 0.655 . . . . 0.0 110.42 -179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 73.4 mt -70.13 -42.22 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.813 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.8 m-30 -64.34 -29.23 70.31 Favored 'General case' 0 N--CA 1.527 3.385 0 N-CA-C 115.73 1.752 . . . . 0.0 115.73 -174.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.22 -44.8 84.28 Favored 'Isoleucine or valine' 1 N--CA 1.548 4.455 0 CA-C-N 119.673 1.124 . . . . 0.0 113.455 -174.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 31.5 p -62.16 -49.19 76.82 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -177.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.3 p -71.88 -36.76 59.22 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.248 0 C-N-CA 122.783 0.433 . . . . 0.0 110.142 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.93 -36.6 70.41 Favored 'General case' 0 N--CA 1.531 3.622 0 C-N-CA 122.616 0.366 . . . . 0.0 111.358 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.94 -43.68 98.13 Favored 'General case' 0 N--CA 1.522 3.133 0 C-N-CA 122.651 0.38 . . . . 0.0 111.482 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 59.3 t -70.3 -42.77 78.82 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.549 0 C-N-CA 123.508 0.723 . . . . 0.0 110.003 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 56.0 t -64.42 -33.29 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.347 0 C-N-CA 123.407 0.683 . . . . 0.0 110.193 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.9 tp -63.94 -38.57 91.55 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 122.813 0.445 . . . . 0.0 111.96 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 76.0 mt -70.34 -55.16 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.578 0 C-N-CA 122.416 0.286 . . . . 0.0 111.546 -177.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 23.8 m -67.7 -37.58 78.87 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.805 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -177.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.42 -39.25 82.89 Favored 'General case' 0 N--CA 1.533 3.683 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -175.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.6 p -72.11 -34.2 49.39 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.372 0 CA-C-O 119.054 -0.498 . . . . 0.0 111.622 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -72.0 -42.3 66.61 Favored 'General case' 1 N--CA 1.54 4.056 0 CA-C-N 119.504 1.047 . . . . 0.0 111.547 -179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 34.8 m -68.36 -32.01 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.729 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 19.4 p -67.27 -37.64 83.79 Favored 'General case' 0 N--CA 1.532 3.662 0 CA-C-N 118.282 0.492 . . . . 0.0 111.103 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -66.61 -27.72 67.92 Favored 'General case' 0 N--CA 1.528 3.446 0 C-N-CA 123.463 0.705 . . . . 0.0 111.452 -178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 83.6 p -72.21 -16.74 61.95 Favored 'General case' 0 N--CA 1.525 3.307 0 C-N-CA 122.645 0.378 . . . . 0.0 111.32 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -91.4 -37.7 13.05 Favored 'General case' 0 N--CA 1.535 3.791 0 C-N-CA 123.725 0.81 . . . . 0.0 112.268 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.67 -27.88 26.78 Favored 'General case' 1 N--CA 1.545 4.298 0 C-N-CA 122.916 0.487 . . . . 0.0 111.152 -177.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.94 -16.89 18.6 Favored 'General case' 1 N--CA 1.544 4.264 0 C-N-CA 123.587 0.755 . . . . 0.0 109.631 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 59.93 39.53 20.12 Favored 'General case' 0 N--CA 1.516 2.834 0 C-N-CA 125.195 1.398 . . . . 0.0 112.212 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 93.9 mttt 60.53 8.73 1.79 Allowed 'General case' 0 N--CA 1.516 2.872 0 C-N-CA 124.433 1.093 . . . . 0.0 112.652 178.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 31.1 m -123.39 123.0 66.55 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.11 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -96.78 113.98 63.75 Favored Pre-proline 0 N--CA 1.517 2.914 0 CA-C-O 116.659 -1.638 . . . . 0.0 107.096 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo . . . . . 1 N--CA 1.547 4.646 0 C-N-CA 122.511 2.141 . . . . 0.0 114.396 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.572 1.797 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.98 68.38 3.94 Favored 'Trans proline' 1 N--CA 1.539 4.167 0 C-N-CA 122.171 1.914 . . . . 0.0 110.168 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.47 84.13 0.26 Allowed Glycine 1 N--CA 1.518 4.164 0 CA-C-N 115.384 -0.826 . . . . 0.0 111.039 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 32.7 t 58.96 30.78 20.66 Favored 'General case' 0 N--CA 1.523 3.18 0 C-N-CA 124.179 0.992 . . . . 0.0 111.829 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.99 -17.79 61.42 Favored 'General case' 0 N--CA 1.524 3.226 0 CA-C-N 114.285 -1.325 . . . . 0.0 110.524 179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 97.5 p -65.18 -39.52 93.01 Favored 'General case' 0 N--CA 1.526 3.351 0 C-N-CA 123.712 0.805 . . . . 0.0 111.131 -179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.98 -31.99 81.19 Favored Glycine 1 N--CA 1.519 4.205 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.271 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 41.3 mm -66.05 -36.84 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.262 0 C-N-CA 124.026 0.93 . . . . 0.0 110.533 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 41.1 mm -68.42 -35.93 72.75 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.706 0 C-N-CA 122.966 0.506 . . . . 0.0 110.151 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 66.6 mt -69.98 -38.13 74.52 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.54 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -65.21 -47.01 78.41 Favored 'General case' 0 N--CA 1.524 3.244 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 10.0 p -58.82 -29.92 41.44 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.043 0 CA-C-N 118.699 0.682 . . . . 0.0 112.335 -176.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 32.5 p -69.57 -49.9 49.75 Favored 'General case' 0 N--CA 1.529 3.48 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 7.4 p -71.55 -31.77 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.775 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 179.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.84 -33.98 73.87 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 123.098 0.559 . . . . 0.0 111.238 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.22 -35.04 79.39 Favored 'General case' 0 N--CA 1.523 3.222 0 C-N-CA 122.855 0.462 . . . . 0.0 111.626 -178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 49.4 t -70.05 -48.26 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.357 0 C-N-CA 123.268 0.627 . . . . 0.0 111.212 -178.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 10.5 m -64.0 -32.02 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.828 0 CA-C-N 118.251 0.478 . . . . 0.0 110.106 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.36 -46.98 62.93 Favored 'General case' 0 N--CA 1.535 3.776 0 C-N-CA 123.667 0.787 . . . . 0.0 110.094 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.33 -54.15 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.294 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.634 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 57.6 t -66.81 -37.03 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.628 0 C-N-CA 124.768 1.227 . . . . 0.0 113.818 -177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.43 -31.92 68.2 Favored 'General case' 0 N--CA 1.532 3.638 0 N-CA-C 114.139 1.162 . . . . 0.0 114.139 -173.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 11.7 m -69.45 -36.09 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.937 0 CA-C-N 119.332 0.969 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -71.92 -42.44 66.7 Favored 'General case' 0 N--CA 1.528 3.469 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 90.4 t -68.22 -38.36 79.48 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.741 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 41.9 t -67.24 -38.93 86.0 Favored 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.113 0.565 . . . . 0.0 110.862 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -69.47 -24.76 63.83 Favored 'General case' 0 N--CA 1.531 3.585 0 C-N-CA 124.004 0.921 . . . . 0.0 111.039 -178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 22.1 t -70.08 -32.47 70.55 Favored 'General case' 0 N--CA 1.52 3.052 0 C-N-CA 122.947 0.499 . . . . 0.0 110.108 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 54.7 tp -74.31 -32.21 62.76 Favored 'General case' 0 N--CA 1.525 3.315 0 C-N-CA 123.939 0.896 . . . . 0.0 109.904 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 79.8 mt -80.22 -16.06 55.62 Favored 'General case' 0 N--CA 1.533 3.71 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -88.85 -17.44 29.67 Favored 'General case' 0 N--CA 1.535 3.8 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt 55.09 13.22 0.75 Allowed 'General case' 0 N--CA 1.523 3.208 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 176.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -74.63 -11.68 60.25 Favored 'General case' 0 N--CA 1.536 3.843 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 28.6 m -134.43 125.19 46.75 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.411 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 47.0 mt -118.36 141.93 30.46 Favored Pre-proline 0 N--CA 1.529 3.497 0 C-N-CA 125.125 1.37 . . . . 0.0 108.729 -177.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo . . . . . 1 N--CA 1.541 4.276 0 CA-C-N 122.374 1.883 . . . . 0.0 110.801 -178.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 17.5 ptm . . . . . 0 CA--C 1.576 1.963 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -69.91 159.77 52.07 Favored 'Trans proline' 1 N--CA 1.542 4.325 0 C-N-CA 122.298 1.998 . . . . 0.0 110.371 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.62 -10.69 58.54 Favored Glycine 1 N--CA 1.518 4.165 0 C-N-CA 123.643 0.64 . . . . 0.0 112.167 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 46.6 m 57.28 176.89 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.097 0 C-N-CA 124.277 1.031 . . . . 0.0 112.209 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 3.1 tm? 69.92 -32.3 0.23 Allowed 'General case' 0 N--CA 1.528 3.439 0 C-N-CA 125.513 1.525 . . . . 0.0 111.366 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.0 m -70.65 -23.79 62.58 Favored 'General case' 0 N--CA 1.524 3.237 0 O-C-N 121.706 -0.621 . . . . 0.0 109.85 176.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -65.88 -50.09 55.04 Favored Glycine 0 N--CA 1.512 3.718 0 C-N-CA 124.264 0.935 . . . . 0.0 114.616 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 9.9 tp -59.15 -36.03 60.69 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 118.094 0.947 . . . . 0.0 110.748 -178.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 57.7 mt -59.03 -34.69 53.82 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 C-N-CA 122.871 0.468 . . . . 0.0 110.772 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 30.0 mm -67.4 -41.09 85.86 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.872 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -56.72 -41.8 78.09 Favored 'General case' 0 N--CA 1.524 3.237 0 C-N-CA 123.512 0.725 . . . . 0.0 111.867 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 50.5 t -57.76 -45.88 86.97 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 19.3 p -62.87 -49.28 75.45 Favored 'General case' 0 N--CA 1.529 3.496 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -175.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.05 -38.45 63.64 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.796 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.133 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -66.34 -34.8 78.79 Favored 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -70.25 -46.46 64.39 Favored 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -177.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.99 -38.39 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.58 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.32 -32.72 59.36 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.8 0 CA-C-N 118.551 0.614 . . . . 0.0 110.668 -179.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.9 tp -57.73 -36.02 71.48 Favored 'General case' 0 N--CA 1.527 3.416 0 C-N-CA 123.149 0.58 . . . . 0.0 112.371 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 65.1 mt -69.57 -54.85 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.581 0 C-N-CA 122.763 0.425 . . . . 0.0 111.193 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 33.3 m -67.14 -35.99 75.74 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.757 0 C-N-CA 124.236 1.014 . . . . 0.0 113.227 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.61 -31.11 65.9 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -173.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 8.3 m -66.27 -35.21 74.41 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.077 0 CA-C-N 119.401 1.001 . . . . 0.0 110.594 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -67.79 -33.79 75.51 Favored 'General case' 0 N--CA 1.528 3.469 0 C-N-CA 122.887 0.475 . . . . 0.0 110.422 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 62.6 t -61.58 -43.0 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.55 0 C-N-CA 123.29 0.636 . . . . 0.0 109.8 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 61.7 m -65.47 -48.45 72.62 Favored 'General case' 0 N--CA 1.526 3.336 0 C-N-CA 123.155 0.582 . . . . 0.0 110.891 -179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -68.42 -41.04 80.97 Favored 'General case' 0 N--CA 1.522 3.152 0 C-N-CA 124.06 0.944 . . . . 0.0 111.487 -179.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 91.1 p -70.1 -29.19 66.1 Favored 'General case' 0 N--CA 1.528 3.463 0 C-N-CA 122.881 0.472 . . . . 0.0 110.654 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 57.5 tp -84.07 -34.87 24.1 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.687 0.795 . . . . 0.0 111.124 -178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 53.5 tp -81.05 -27.74 35.63 Favored 'General case' 0 N--CA 1.538 3.955 0 C-N-CA 123.804 0.841 . . . . 0.0 113.052 -176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -103.21 13.99 32.69 Favored 'General case' 1 N--CA 1.548 4.447 0 C-N-CA 124.424 1.09 . . . . 0.0 111.321 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -119.16 -7.84 10.25 Favored 'General case' 1 N--CA 1.541 4.121 0 C-N-CA 124.198 0.999 . . . . 0.0 110.983 -179.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -68.37 -43.95 76.23 Favored 'General case' 0 N--CA 1.534 3.735 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 7.9 p -92.79 122.52 44.34 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.439 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 8.7 mp -109.41 141.6 23.9 Favored Pre-proline 0 N--CA 1.534 3.757 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo . . . . . 1 N--CA 1.541 4.275 0 CA-C-N 122.474 1.919 . . . . 0.0 110.446 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 66.3 mtt . . . . . 0 CA--C 1.571 1.767 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -72.6 81.09 1.61 Allowed 'Trans proline' 1 N--CA 1.538 4.125 0 C-N-CA 122.184 1.923 . . . . 0.0 110.253 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.17 173.2 19.93 Favored Glycine 1 N--CA 1.519 4.201 0 C-N-CA 123.664 0.65 . . . . 0.0 111.605 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 97.1 p -167.64 179.75 4.71 Favored 'General case' 0 N--CA 1.523 3.22 0 C-N-CA 123.714 0.806 . . . . 0.0 109.777 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 41.6 mt 66.6 -9.81 0.31 Allowed 'General case' 0 N--CA 1.518 2.953 0 C-N-CA 124.849 1.26 . . . . 0.0 112.912 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 56.7 m -70.4 -38.11 74.59 Favored 'General case' 0 N--CA 1.525 3.301 0 C-N-CA 123.309 0.644 . . . . 0.0 111.071 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.21 -41.38 31.59 Favored Glycine 1 N--CA 1.517 4.082 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.716 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 214' ' ' ILE . 1.4 mp -64.48 -47.62 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.218 0 C-N-CA 123.974 0.91 . . . . 0.0 110.886 -176.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 19.5 tt -57.2 -34.2 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.053 0 O-C-N 121.939 -0.475 . . . . 0.0 111.576 -177.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.84 -43.13 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.745 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -67.05 -40.93 87.24 Favored 'General case' 0 N--CA 1.526 3.335 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 28.7 m -57.79 -33.28 45.05 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.151 0 CA-C-N 119.347 0.976 . . . . 0.0 112.791 -175.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 44.1 p -67.7 -49.72 61.24 Favored 'General case' 0 N--CA 1.529 3.493 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -178.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 7.1 p -72.07 -31.98 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -60.62 -34.18 73.87 Favored 'General case' 0 N--CA 1.524 3.263 0 C-N-CA 123.158 0.583 . . . . 0.0 111.435 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -69.24 -41.29 77.18 Favored 'General case' 0 N--CA 1.521 3.099 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.643 -178.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 49.5 t -68.22 -43.66 84.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.352 0 C-N-CA 123.505 0.722 . . . . 0.0 111.793 -177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 23.1 m -66.91 -32.26 57.19 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.64 0 CA-C-N 118.332 0.514 . . . . 0.0 110.791 -178.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 50.2 tp -59.11 -38.34 79.35 Favored 'General case' 0 N--CA 1.525 3.29 0 C-N-CA 123.115 0.566 . . . . 0.0 112.317 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 30.3 mm -70.23 -55.14 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.846 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.1 m -66.84 -37.41 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.532 3.662 0 N-CA-C 114.158 1.17 . . . . 0.0 114.158 -176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.09 -46.09 89.19 Favored 'General case' 0 N--CA 1.532 3.673 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 34.2 m -72.8 -34.44 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.35 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.11 -43.82 97.99 Favored 'General case' 0 N--CA 1.527 3.405 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.413 -176.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.59 -36.0 68.81 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.619 0 CA-C-O 120.987 0.422 . . . . 0.0 110.211 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 48.8 t -67.34 -48.33 67.83 Favored 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.375 0.67 . . . . 0.0 111.687 -178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 62.8 mtpt -72.28 -45.16 61.26 Favored 'General case' 0 N--CA 1.525 3.279 0 C-N-CA 123.063 0.545 . . . . 0.0 110.871 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 94.8 p -65.04 -39.42 93.29 Favored 'General case' 0 N--CA 1.525 3.314 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 53.5 tp -72.89 -37.69 67.2 Favored 'General case' 0 N--CA 1.533 3.681 0 C-N-CA 122.682 0.393 . . . . 0.0 111.909 -177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.76 -24.29 31.19 Favored 'General case' 0 N--CA 1.539 3.987 0 C-N-CA 123.612 0.765 . . . . 0.0 111.247 -177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.4 m0 -89.05 -7.13 56.48 Favored 'General case' 1 N--CA 1.541 4.112 0 CA-C-N 118.259 0.481 . . . . 0.0 110.357 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -81.47 -38.39 26.46 Favored 'General case' 0 N--CA 1.528 3.45 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.75 -57.31 4.46 Favored 'General case' 0 N--CA 1.518 2.926 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.791 179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 61.2 t -94.08 122.16 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.179 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -96.43 141.79 23.61 Favored Pre-proline 0 N--CA 1.527 3.424 0 N-CA-C 107.154 -1.425 . . . . 0.0 107.154 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo . . . . . 1 N--CA 1.54 4.226 0 CA-C-N 122.32 1.864 . . . . 0.0 110.682 -179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 17.9 ptt? . . . . . 0 CA--C 1.576 1.971 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -51.39 175.12 0.06 OUTLIER 'Trans proline' 1 N--CA 1.545 4.552 0 C-N-CA 122.454 2.102 . . . . 0.0 113.621 179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . -178.11 172.5 45.03 Favored Glycine 1 N--CA 1.519 4.169 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 47.4 m 56.25 53.02 9.36 Favored 'General case' 0 N--CA 1.52 3.05 0 C-N-CA 124.007 0.923 . . . . 0.0 111.614 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -165.63 -48.2 0.03 OUTLIER 'General case' 0 N--CA 1.525 3.28 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 98.1 p -61.07 -26.27 67.52 Favored 'General case' 0 N--CA 1.526 3.363 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.918 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.71 -44.74 19.44 Favored Glycine 0 N--CA 1.515 3.954 0 O-C-N 123.849 0.718 . . . . 0.0 111.48 178.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . 0.402 ' N ' HD12 ' B' ' 214' ' ' ILE . 1.5 mp -58.72 -46.24 90.69 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.609 0 C-N-CA 124.708 1.203 . . . . 0.0 111.585 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 16.4 tt -56.9 -32.62 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.751 0 O-C-N 122.143 -0.348 . . . . 0.0 110.852 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . . . . . . . . . 19.4 mm -62.72 -48.57 87.52 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.042 0 O-C-N 121.73 -0.606 . . . . 0.0 110.62 -179.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -67.85 -40.04 83.74 Favored 'General case' 0 N--CA 1.531 3.601 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 -176.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 20.1 m -57.52 -38.58 64.36 Favored 'Isoleucine or valine' 1 N--CA 1.551 4.578 0 CA-C-N 119.929 1.24 . . . . 0.0 112.067 -175.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 43.0 p -61.34 -48.1 82.85 Favored 'General case' 0 N--CA 1.53 3.556 0 C-N-CA 123.694 0.798 . . . . 0.0 111.266 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 60.4 t -69.67 -44.55 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.521 3.107 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.479 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.06 -34.78 75.42 Favored 'General case' 0 N--CA 1.525 3.292 0 C-N-CA 122.994 0.518 . . . . 0.0 111.084 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -60.19 -42.0 94.12 Favored 'General case' 0 N--CA 1.523 3.195 0 C-N-CA 123.017 0.527 . . . . 0.0 111.902 -179.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.6 t -70.4 -44.52 77.26 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.548 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 68.9 t -64.49 -35.03 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.522 3.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.045 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.34 -38.06 79.39 Favored 'General case' 0 N--CA 1.532 3.629 0 C-N-CA 123.123 0.569 . . . . 0.0 111.327 -179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 77.4 mt -68.98 -48.81 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.598 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.0 -35.53 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.388 0 C-N-CA 125.442 1.497 . . . . 0.0 112.158 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -57.56 -33.85 68.57 Favored 'General case' 0 N--CA 1.526 3.36 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 -173.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.01 -44.19 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.536 3.856 0 CA-C-N 118.662 0.664 . . . . 0.0 111.02 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -63.77 -42.11 97.84 Favored 'General case' 0 N--CA 1.529 3.507 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -177.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 34.3 m -65.93 -33.62 64.82 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.958 0 CA-C-N 118.589 0.632 . . . . 0.0 110.798 -179.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 75.9 m -67.22 -43.64 81.52 Favored 'General case' 0 N--CA 1.529 3.524 0 C-N-CA 123.026 0.53 . . . . 0.0 110.611 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -72.49 -31.13 65.14 Favored 'General case' 0 N--CA 1.524 3.268 0 C-N-CA 123.711 0.804 . . . . 0.0 110.249 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 33.2 t -63.92 -43.01 97.22 Favored 'General case' 0 N--CA 1.522 3.143 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 4.5 pp -86.8 -14.76 41.28 Favored 'General case' 0 N--CA 1.531 3.603 0 C-N-CA 123.683 0.793 . . . . 0.0 112.543 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 51.8 tp -90.07 -27.71 19.5 Favored 'General case' 1 N--CA 1.542 4.133 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.79 14.15 25.75 Favored 'General case' 1 N--CA 1.556 4.835 0 CA-C-N 119.665 1.121 . . . . 0.0 113.917 -177.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 47.8 mtmt -63.73 -3.55 2.42 Favored 'General case' 1 N--CA 1.54 4.031 0 CA-C-N 118.557 0.617 . . . . 0.0 110.842 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 21.4 ttpp 82.87 48.65 0.02 OUTLIER 'General case' 0 N--CA 1.516 2.854 0 C-N-CA 125.2 1.4 . . . . 0.0 109.372 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 9.2 p -136.35 122.4 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.524 3.232 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.55 141.64 23.46 Favored Pre-proline 0 N--CA 1.528 3.445 0 N-CA-C 107.024 -1.472 . . . . 0.0 107.024 -178.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 1 N--CA 1.539 4.203 0 CA-C-N 122.524 1.937 . . . . 0.0 110.725 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 23.9 ptt? . . . . . 0 CA--C 1.576 1.965 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.27 145.51 54.4 Favored 'Trans proline' 1 N--CA 1.541 4.307 0 C-N-CA 122.2 1.933 . . . . 0.0 110.334 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -69.52 -29.23 71.63 Favored Glycine 1 N--CA 1.517 4.058 0 C-N-CA 123.777 0.704 . . . . 0.0 111.716 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 49.4 m 56.57 100.47 0.02 OUTLIER 'General case' 0 N--CA 1.522 3.155 0 C-N-CA 124.167 0.987 . . . . 0.0 111.31 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 7.7 tp -148.62 -5.43 0.42 Allowed 'General case' 0 N--CA 1.534 3.748 0 C-N-CA 123.783 0.833 . . . . 0.0 110.708 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -55.75 -20.88 16.28 Favored 'General case' 0 N--CA 1.528 3.461 0 O-C-N 121.781 -0.574 . . . . 0.0 111.493 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.95 -39.79 93.34 Favored Glycine 0 N--CA 1.51 3.594 0 O-C-N 124.112 0.883 . . . . 0.0 113.045 -179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -62.37 -38.05 80.25 Favored 'Isoleucine or valine' 1 N--CA 1.544 4.275 0 CA-C-N 117.524 0.662 . . . . 0.0 109.866 -178.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 50.7 mt -56.74 -34.36 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.727 0 C-N-CA 123.389 0.675 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 25.8 mm -69.6 -44.26 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.454 0 CA-C-O 121.708 0.766 . . . . 0.0 109.614 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -67.25 -40.69 86.31 Favored 'General case' 0 N--CA 1.525 3.303 0 N-CA-C 115.229 1.566 . . . . 0.0 115.229 -176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 12.4 p -61.44 -36.81 75.5 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.09 0 CA-C-N 118.934 0.788 . . . . 0.0 112.276 -175.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 40.5 p -63.77 -49.26 73.68 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.9 -38.88 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.491 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -59.94 -34.78 73.71 Favored 'General case' 0 N--CA 1.524 3.241 0 C-N-CA 122.718 0.407 . . . . 0.0 110.972 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.52 85.42 Favored 'General case' 0 N--CA 1.523 3.196 0 C-N-CA 123.087 0.555 . . . . 0.0 112.04 -179.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 58.9 t -69.63 -41.33 80.19 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.408 0 C-N-CA 123.291 0.636 . . . . 0.0 109.839 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.95 -32.48 58.17 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.212 0 C-N-CA 123.592 0.757 . . . . 0.0 110.291 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 53.6 tp -64.23 -48.53 75.46 Favored 'General case' 0 N--CA 1.529 3.519 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 20.5 tt -71.95 -52.08 27.19 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.74 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 9.7 p -67.06 -37.01 78.49 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.133 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.89 -31.78 68.9 Favored 'General case' 0 N--CA 1.525 3.296 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -174.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.18 -34.9 66.09 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.131 0 CA-C-N 119.251 0.932 . . . . 0.0 110.734 -178.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -68.86 -38.62 79.86 Favored 'General case' 0 N--CA 1.529 3.497 0 CA-C-O 121.046 0.451 . . . . 0.0 109.807 179.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.1 -41.27 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 C-N-CA 123.91 0.884 . . . . 0.0 109.599 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 71.1 m -64.21 -38.79 92.31 Favored 'General case' 0 N--CA 1.526 3.353 0 C-N-CA 123.526 0.73 . . . . 0.0 110.45 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -72.0 -47.02 54.97 Favored 'General case' 0 N--CA 1.524 3.245 0 C-N-CA 123.47 0.708 . . . . 0.0 109.481 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 38.7 t -63.66 -12.81 37.09 Favored 'General case' 0 N--CA 1.519 2.975 0 C-N-CA 123.702 0.801 . . . . 0.0 112.391 -179.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 59.1 tp -91.0 -37.52 13.41 Favored 'General case' 0 N--CA 1.533 3.695 0 C-N-CA 123.925 0.89 . . . . 0.0 111.801 -178.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 52.1 mt -91.79 -27.57 17.92 Favored 'General case' 1 N--CA 1.54 4.051 0 C-N-CA 123.555 0.742 . . . . 0.0 111.474 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -98.15 13.47 31.05 Favored 'General case' 0 N--CA 1.535 3.786 0 C-N-CA 124.284 1.034 . . . . 0.0 109.232 179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.74 -21.25 66.31 Favored 'General case' 0 N--CA 1.527 3.393 0 C-N-CA 124.447 1.099 . . . . 0.0 109.685 178.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.33 -21.08 66.49 Favored 'General case' 0 N--CA 1.522 3.146 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.307 179.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . . . . . . . . . 22.3 m -135.98 123.01 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.683 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . . . . . . . . . 38.7 mt -116.71 141.73 28.61 Favored Pre-proline 0 N--CA 1.532 3.636 0 CA-C-O 117.049 -1.453 . . . . 0.0 108.329 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo . . . . . 1 N--CA 1.54 4.213 0 CA-C-N 122.533 1.94 . . . . 0.0 110.772 -179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 CA--C 1.585 2.316 0 CA-C-O 117.468 -1.254 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -88.92 22.53 0.83 Allowed 'Trans proline' 0 N--CA 1.535 3.952 0 C-N-CA 122.608 2.205 . . . . 0.0 111.397 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -65.69 159.19 46.03 Favored Glycine 1 N--CA 1.519 4.201 0 C-N-CA 123.608 0.623 . . . . 0.0 111.561 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 93.4 p -72.29 64.87 0.59 Allowed 'General case' 0 N--CA 1.521 3.106 0 C-N-CA 123.84 0.856 . . . . 0.0 109.881 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.92 -36.42 83.33 Favored 'General case' 0 N--CA 1.53 3.574 0 C-N-CA 123.989 0.915 . . . . 0.0 109.889 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 70.1 m -70.55 -20.88 62.77 Favored 'General case' 0 N--CA 1.521 3.098 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.983 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -75.24 -50.28 8.58 Favored Glycine 0 N--CA 1.513 3.8 0 C-N-CA 123.984 0.802 . . . . 0.0 113.78 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 20.0 tt -65.84 -36.91 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.678 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ILE . . . . . . . . . . . . . 42.5 pt -57.96 -33.81 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.986 0 CA-C-N 118.951 0.796 . . . . 0.0 110.667 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.65 -41.19 91.53 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.815 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -62.66 -34.48 77.17 Favored 'General case' 0 N--CA 1.529 3.493 0 C-N-CA 123.471 0.708 . . . . 0.0 111.687 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' VAL . . . . . . . . . . . . . 63.5 t -57.89 -38.03 63.89 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.102 0 CA-C-O 120.921 0.391 . . . . 0.0 110.292 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' THR . . . . . . . . . . . . . 7.5 p -66.02 -49.15 68.74 Favored 'General case' 0 N--CA 1.526 3.327 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.302 -177.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.02 -44.93 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.022 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.061 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . . . . . . . . . . . -56.75 -34.57 67.68 Favored 'General case' 0 N--CA 1.524 3.251 0 C-N-CA 123.351 0.66 . . . . 0.0 111.607 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.24 98.57 Favored 'General case' 0 N--CA 1.523 3.213 0 C-N-CA 122.904 0.482 . . . . 0.0 111.401 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' VAL . . . . . . . . . . . . . 57.1 t -69.94 -39.06 77.07 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.522 0 C-N-CA 123.397 0.679 . . . . 0.0 109.627 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.7 -32.87 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.423 0 C-N-CA 123.755 0.822 . . . . 0.0 109.869 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -47.21 84.89 Favored 'General case' 0 N--CA 1.535 3.794 0 CA-C-O 121.58 0.705 . . . . 0.0 110.748 -179.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 75.5 mt -63.06 -54.11 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.527 3.418 0 C-N-CA 123.926 0.89 . . . . 0.0 112.702 -177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.63 -36.79 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.921 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.57 -31.73 68.27 Favored 'General case' 0 N--CA 1.528 3.455 0 N-CA-C 114.371 1.248 . . . . 0.0 114.371 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' VAL . . . . . . . . . . . . . 6.8 m -66.09 -34.93 73.54 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.104 0 CA-C-N 119.348 0.976 . . . . 0.0 110.581 -179.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -65.12 -36.08 83.15 Favored 'General case' 0 N--CA 1.53 3.53 0 C-N-CA 122.561 0.344 . . . . 0.0 110.297 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' VAL . . . . . . . . . . . . . 52.2 t -67.03 -37.43 79.33 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.449 0 C-N-CA 123.633 0.773 . . . . 0.0 109.764 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' CYS . . . . . . . . . . . . . 66.6 m -67.11 -48.33 68.45 Favored 'General case' 0 N--CA 1.526 3.33 0 C-N-CA 123.236 0.614 . . . . 0.0 111.002 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -70.38 -27.72 64.53 Favored 'General case' 0 N--CA 1.533 3.7 0 C-N-CA 123.784 0.834 . . . . 0.0 110.351 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' SER . . . . . . . . . . . . . 43.9 t -63.92 -37.9 89.09 Favored 'General case' 0 N--CA 1.528 3.45 0 CA-C-O 121.151 0.501 . . . . 0.0 110.546 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LEU . . . . . . . . . . . . . 56.4 tp -69.79 -37.23 76.24 Favored 'General case' 0 N--CA 1.525 3.293 0 C-N-CA 123.971 0.908 . . . . 0.0 110.505 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LEU . . . . . . . . . . . . . 69.0 mt -80.65 -23.44 39.69 Favored 'General case' 0 N--CA 1.531 3.625 0 C-N-CA 123.586 0.754 . . . . 0.0 110.384 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 41.6 m0 -89.68 -8.75 51.7 Favored 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 123.864 0.866 . . . . 0.0 109.921 -179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 61.0 mtpt -126.62 44.3 2.91 Favored 'General case' 0 N--CA 1.529 3.475 0 C-N-CA 124.842 1.257 . . . . 0.0 108.168 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -160.28 -22.75 0.06 Allowed 'General case' 0 N--CA 1.526 3.373 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.582 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 9.3 p -83.5 124.78 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.523 3.188 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.47 114.45 18.21 Favored Pre-proline 0 N--CA 1.526 3.367 0 CA-C-O 116.818 -1.563 . . . . 0.0 108.455 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo . . . . . 1 N--CA 1.548 4.712 0 CA-C-N 122.941 2.086 . . . . 0.0 114.416 178.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 207' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 CA--C 1.576 1.949 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 208' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -50.53 142.49 30.62 Favored 'Trans proline' 1 N--CA 1.549 4.761 0 CA-C-N 122.02 1.757 . . . . 0.0 113.491 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 209' ' ' GLY . . . . . . . . . . . . . . . 173.96 -161.79 32.22 Favored Glycine 1 N--CA 1.517 4.058 0 N-CA-C 110.151 -1.18 . . . . 0.0 110.151 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 210' ' ' SER . . . . . . . . . . . . . 48.3 m 58.19 58.84 3.31 Favored 'General case' 0 N--CA 1.52 3.035 0 C-N-CA 124.207 1.003 . . . . 0.0 111.753 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 211' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.44 13.04 0.82 Allowed 'General case' 0 N--CA 1.527 3.397 0 C-N-CA 123.755 0.822 . . . . 0.0 110.66 179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 212' ' ' SER . . . . . . . . . . . . . 68.7 m -71.46 -43.15 67.17 Favored 'General case' 0 N--CA 1.519 2.979 0 CA-C-O 121.112 0.482 . . . . 0.0 110.34 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 213' ' ' GLY . . . . . . . . . . . . . . . -64.38 -45.46 93.28 Favored Glycine 1 N--CA 1.518 4.158 0 CA-C-N 114.744 -1.116 . . . . 0.0 115.272 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 214' ' ' ILE . . . . . . . . . . . . . 8.9 tp -57.6 -36.38 53.92 Favored 'Isoleucine or valine' 1 N--CA 1.54 4.061 0 CA-C-N 118.116 0.958 . . . . 0.0 110.785 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 215' ' ' ILE . . . . . . . . . . . . . 79.9 mt -54.98 -40.17 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.538 3.948 0 CA-C-O 119.452 -0.309 . . . . 0.0 111.781 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 216' ' ' ILE . . . . . 0.416 HD12 ' N ' ' B' ' 216' ' ' ILE . 1.5 mp -66.72 -41.3 87.83 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.144 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 217' ' ' TYR . . . . . . . . . . . . . 74.3 t80 -59.25 -36.47 75.54 Favored 'General case' 0 N--CA 1.529 3.512 0 C-N-CA 123.334 0.654 . . . . 0.0 112.042 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 218' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.21 -42.27 83.03 Favored 'Isoleucine or valine' 1 N--CA 1.542 4.154 0 CA-C-O 121.023 0.439 . . . . 0.0 110.029 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 219' ' ' THR . . . . . . . . . . . . . 5.5 p -63.21 -48.39 78.5 Favored 'General case' 0 N--CA 1.532 3.64 0 C-N-CA 123.602 0.761 . . . . 0.0 110.974 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 220' ' ' VAL . . . . . . . . . . . . . 57.8 t -68.6 -42.94 83.69 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.954 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.441 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 221' ' ' ALA . . . . . . . . . . . . . . . -61.25 -34.87 75.86 Favored 'General case' 0 N--CA 1.524 3.255 0 C-N-CA 122.885 0.474 . . . . 0.0 111.066 -179.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 222' ' ' ALA . . . . . . . . . . . . . . . -66.36 -48.99 68.42 Favored 'General case' 0 N--CA 1.519 2.981 0 C-N-CA 123.05 0.54 . . . . 0.0 111.513 -179.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 223' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.98 -38.84 76.47 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.451 0 C-N-CA 123.248 0.619 . . . . 0.0 110.055 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 224' ' ' VAL . . . . . . . . . . . . . 25.1 t -66.15 -32.91 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.526 0 C-N-CA 123.099 0.56 . . . . 0.0 110.148 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 225' ' ' LEU . . . . . . . . . . . . . 46.3 tp -65.05 -34.89 79.51 Favored 'General case' 0 N--CA 1.534 3.76 0 C-N-CA 122.83 0.452 . . . . 0.0 111.83 -178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 82.0 mt -69.66 -54.62 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.555 0 C-N-CA 122.804 0.442 . . . . 0.0 111.039 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 227' ' ' VAL . . . . . . . . . . . . . 28.2 m -67.04 -36.95 78.35 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.811 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 228' ' ' ALA . . . . . . . . . . . . . . . -58.86 -39.78 82.35 Favored 'General case' 0 N--CA 1.531 3.617 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -174.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 229' ' ' VAL . . . . . . . . . . . . . 3.8 p -72.5 -34.78 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.531 3.624 0 CA-C-O 119.115 -0.469 . . . . 0.0 111.215 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 230' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -68.86 -40.18 79.48 Favored 'General case' 1 N--CA 1.539 4.002 0 CA-C-N 119.197 0.908 . . . . 0.0 111.715 -178.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 231' ' ' VAL . . . . . . . . . . . . . 30.9 m -68.01 -31.62 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.808 0 CA-C-N 118.435 0.561 . . . . 0.0 110.964 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 232' ' ' CYS . . . . . . . . . . . . . 83.2 m -61.25 -40.72 95.11 Favored 'General case' 0 N--CA 1.532 3.628 0 C-N-CA 122.818 0.447 . . . . 0.0 111.345 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 233' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -76.27 -45.43 32.71 Favored 'General case' 0 N--CA 1.524 3.232 0 C-N-CA 123.271 0.628 . . . . 0.0 109.973 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 234' ' ' SER . . . . . . . . . . . . . 32.8 t -63.16 -12.82 30.55 Favored 'General case' 0 N--CA 1.526 3.37 0 C-N-CA 122.804 0.442 . . . . 0.0 111.68 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 235' ' ' LEU . . . . . . . . . . . . . 64.3 tp -89.1 -35.92 16.02 Favored 'General case' 0 N--CA 1.527 3.418 0 C-N-CA 124.308 1.043 . . . . 0.0 109.61 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 236' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.72 -27.59 26.87 Favored 'General case' 1 N--CA 1.543 4.179 0 C-N-CA 123.979 0.912 . . . . 0.0 110.703 -177.59 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 237' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -108.63 13.69 25.02 Favored 'General case' 0 N--CA 1.536 3.826 0 C-N-CA 125.063 1.345 . . . . 0.0 109.718 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 238' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -50.86 -29.23 11.33 Favored 'General case' 0 N--CA 1.524 3.233 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 239' ' ' LYS . . . . . . . . . . . . . 63.9 tttp -165.79 -11.58 0.02 OUTLIER 'General case' 0 N--CA 1.533 3.719 0 C-N-CA 122.886 0.474 . . . . 0.0 110.638 -176.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 240' ' ' VAL . . . . . . . . . . . . . 60.9 t -83.01 122.15 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.525 3.309 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 241' ' ' LEU . . . . . . . . . . . . . 9.5 mp -99.38 142.16 24.12 Favored Pre-proline 0 N--CA 1.534 3.736 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 242' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 1 N--CA 1.541 4.296 0 CA-C-N 122.218 1.828 . . . . 0.0 110.83 -178.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 207' ' ' MET . . . . . . . . . . . . . 16.7 tpt . . . . . 0 CA--C 1.579 2.088 0 CA-C-O 117.629 -1.177 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 208' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -51.06 104.08 0.08 OUTLIER 'Trans proline' 1 N--CA 1.548 4.729 0 CA-C-N 122.442 1.908 . . . . 0.0 113.579 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 209' ' ' GLY . . . . . . . . . . . . . . . -71.01 152.72 50.51 Favored Glycine 1 N--CA 1.518 4.131 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 210' ' ' SER . . . . . . . . . . . . . 51.1 m 55.56 -177.62 0.04 OUTLIER 'General case' 0 N--CA 1.523 3.203 0 C-N-CA 123.954 0.902 . . . . 0.0 112.006 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 211' ' ' LEU . . . . . . . . . . . . . 6.7 tp 66.85 -1.22 1.42 Allowed 'General case' 0 N--CA 1.528 3.441 0 C-N-CA 124.161 0.985 . . . . 0.0 111.503 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 212' ' ' SER . . . . . . . . . . . . . 70.5 m -70.5 -21.03 62.8 Favored 'General case' 0 N--CA 1.524 3.248 0 C-N-CA 122.968 0.507 . . . . 0.0 110.857 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 213' ' ' GLY . . . . . . . . . . . . . . . -71.43 -50.14 22.36 Favored Glycine 1 N--CA 1.516 4.01 0 C-N-CA 123.614 0.626 . . . . 0.0 113.814 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 214' ' ' ILE . . . . . . . . . . . . . 6.3 tp -62.24 -36.65 75.58 Favored 'Isoleucine or valine' 0 N--CA 1.537 3.896 0 CA-C-N 117.432 0.616 . . . . 0.0 111.149 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 215' ' ' ILE . . . . . . . . . . . . . 43.4 mm -59.74 -35.1 58.0 Favored 'Isoleucine or valine' 0 N--CA 1.539 3.992 0 CA-C-N 117.942 0.337 . . . . 0.0 110.832 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 86.5 mt -70.37 -42.56 78.59 Favored 'Isoleucine or valine' 0 N--CA 1.534 3.737 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 217' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -66.58 -42.75 86.52 Favored 'General case' 0 N--CA 1.527 3.414 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -175.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 218' ' ' VAL . . . . . . . . . . . . . 7.5 p -58.41 -33.47 47.95 Favored 'Isoleucine or valine' 1 N--CA 1.541 4.117 0 CA-C-N 118.847 0.749 . . . . 0.0 112.287 -176.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 219' ' ' THR . . . . . . . . . . . . . 25.3 p -66.97 -50.27 62.82 Favored 'General case' 0 N--CA 1.528 3.474 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -177.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 220' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.98 -39.62 66.81 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.327 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 221' ' ' ALA . . . . . . . . . . . . . . . -57.23 -34.74 68.89 Favored 'General case' 0 N--CA 1.528 3.435 0 C-N-CA 122.967 0.507 . . . . 0.0 111.306 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 222' ' ' ALA . . . . . . . . . . . . . . . -62.99 -39.21 94.06 Favored 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 122.841 0.457 . . . . 0.0 111.168 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 223' ' ' VAL . . . . . . . . . . . . . 51.3 t -70.05 -41.17 79.15 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.446 0 C-N-CA 123.622 0.769 . . . . 0.0 109.697 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.4 t -61.81 -34.14 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.373 0 C-N-CA 123.876 0.871 . . . . 0.0 110.531 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 51.6 tp -66.44 -36.76 83.61 Favored 'General case' 0 N--CA 1.528 3.461 0 C-N-CA 123.125 0.57 . . . . 0.0 111.588 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 81.3 mt -69.83 -54.24 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.517 0 C-N-CA 123.109 0.564 . . . . 0.0 111.085 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 227' ' ' VAL . . . . . . . . . . . . . 21.3 m -67.76 -42.02 85.77 Favored 'Isoleucine or valine' 0 N--CA 1.528 3.43 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -176.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 228' ' ' ALA . . . . . . . . . . . . . . . -59.59 -42.34 92.35 Favored 'General case' 0 N--CA 1.527 3.412 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -175.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 229' ' ' VAL . . . . . . . . . . . . . 6.9 p -62.07 -37.02 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.529 3.489 0 CA-C-O 118.047 -0.977 . . . . 0.0 112.218 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 230' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -73.32 -36.57 66.25 Favored 'General case' 1 N--CA 1.548 4.443 0 CA-C-N 120.631 1.559 . . . . 0.0 109.801 179.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 231' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.86 -32.03 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.533 3.715 0 C-N-CA 123.188 0.595 . . . . 0.0 109.713 178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 232' ' ' CYS . . . . . . . . . . . . . 49.8 t -60.56 -38.12 83.51 Favored 'General case' 0 N--CA 1.53 3.536 0 C-N-CA 123.304 0.642 . . . . 0.0 111.192 -178.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 233' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -51.16 -24.39 4.13 Favored 'General case' 0 N--CA 1.531 3.586 0 C-N-CA 124.362 1.065 . . . . 0.0 111.633 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 234' ' ' SER . . . . . . . . . . . . . 35.4 t -63.72 -39.81 95.22 Favored 'General case' 0 N--CA 1.52 3.065 0 C-N-CA 122.814 0.446 . . . . 0.0 110.89 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 235' ' ' LEU . . . . . . . . . . . . . 53.0 tp -69.88 -31.49 69.33 Favored 'General case' 0 N--CA 1.527 3.402 0 C-N-CA 123.935 0.894 . . . . 0.0 111.476 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 236' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.21 -27.75 38.76 Favored 'General case' 0 N--CA 1.537 3.89 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 -178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 237' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -89.66 -14.6 34.47 Favored 'General case' 1 N--CA 1.542 4.152 0 C-N-CA 123.342 0.657 . . . . 0.0 109.968 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 238' ' ' LYS . . . . . . . . . . . . . 50.8 tttm 95.19 59.55 0.0 OUTLIER 'General case' 0 N--CA 1.538 3.928 0 C-N-CA 126.09 1.756 . . . . 0.0 113.073 176.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 239' ' ' LYS . . . . . . . . . . . . . 80.4 tttt 52.57 54.4 10.67 Favored 'General case' 0 N--CA 1.511 2.62 0 C-N-CA 124.329 1.052 . . . . 0.0 112.812 176.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 240' ' ' VAL . . . . . 0.465 ' C ' HD22 ' C' ' 241' ' ' LEU . 21.7 m -92.17 122.38 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.535 3.778 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 177.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 241' ' ' LEU . . . . . 0.465 HD22 ' C ' ' C' ' 240' ' ' VAL . 3.6 mm? -129.61 134.33 26.09 Favored Pre-proline 0 N--CA 1.536 3.84 0 N-CA-C 106.079 -1.822 . . . . 0.0 106.079 -179.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 242' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 1 N--CA 1.539 4.171 0 CA-C-N 122.924 2.08 . . . . 0.0 110.652 179.766 . . . . . . . . 1 1 . 1 stop_ save_